Women's experiences of breast cancer::a longitudinal perspective by Swainston, Katherine
WOMEN'S EXPERIENCES OF BREAST CANCER: 
A LONGITUDINAL PERSPECTIVE 
KATHERINE ALICE SWAINSTON 
A thesis submitted in partial fulfilment of the 
requirements of Teesside University for 
the degree of Doctor of Philosophy 
August 2012 
ACKNOWLEDGMENTS 
I would like to thank my supervisory team, Professor Anna van Wersch and 
Associate Professor Carol Campbell, for their support, guidance, and 
encouragement during this project. 
I must also acknowledge the team at the Symptomatic Breast Unit including the 
Consultant Surgeons and the Breast Care Nurses. They not only assisted in the 
recruitment process but conveyed a wealth of knowledge into the healthcare 
trajectory and disease management for breast cancer. 
Above all, I am thankful to the women who gave their time and energy to 
participate in this research during some of the most difficult moments of their 
lives. Their openness and honesty has enabled me to gain an insight into 




Utilising a hermeneutic phenomenological approach twenty women's 
experiences of breast cancer were explored through semi-structured interviews 
at three time points during their healthcare trajectory from recent diagnosis to 
early follow-up. Phenomenological analysis guided by van Manen's (1990) 
principles revealed numerous multifaceted themes some of which were time 
limited while others spanned the data collection period. Use was made of an 
adapted life grid approach in order to enhance the implicit meanings to be 
elicited through interpretation of text. Central themes depicting the 
medicalisation of breast cancer, perceptions and management of the body and 
participants' emotional journey were uncovered. 
Breast cancer was found to represent a biographical disruption that had a long-
term impact on a woman's body, self, identity and sense of embodiment. 
Changes to the body, due to breast cancer treatment, and an altered way of 
being in the world, elicited disruption to the body-self relationship, a separation 
that was reinforced by the healthcare system. Participants were found to adopt 
a variety of coping strategies to manage ongoing change and the stress elicited 
by experiencing breast cancer as a chronic illness. Avoidance, information 
management, conscious passivity in treatment decision-making and positive 
cognitive restructuring are examples of such mechanisms. However, women's 
experiences of each theme identified and the emergence and maintenance of 
these themes varied according to women's biography, diagnosis and prescribed 
treatment regime, cancer schema, and social support. Accordingly, models of 
care must address women's individual experiences and recognise their 
changing needs throughout the year post diagnosis. 
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OVERVIEW OF THE THESIS 
This thesis reports an exploration of women's experiences of breast cancer 
throughout the healthcare trajectory from shortly after diagnosis to early follow-
up, one year later. 
Chapter 1, 'Biomedical Perspectives on Breast Cancer', provides the reader 
with contextual and background information regarding breast cancer, describing 
the existing medical knowledge on the disease including incidence and risk 
factors. Current debates regarding screening for breast cancer are illustrated 
with consideration of the effectiveness of breast self-examination and 
mammography. The healthcare trajectory from identification to diagnosis, 
treatment and follow-up is reviewed as is the contradictory research base 
pertaining to breast cancer treatment decision-making. The chapter concludes 
by documenting the view of breast cancer as a chronic rather than acute illness 
and the associated issues of survivorship. 
Chapter 2 entitled 'The Illness Experience of Breast Cancer: Self, Identity, Body 
and Embodiment' provides an overview of self and identity theory from both 
psychological and sociological standpoints. The notion of embodiment is 
described and the relationship between the mind and body in times of illness is 
discussed. The ways in which the medical profession can reinforce a mind-body 
separation, with specific reference to breast cancer and Frank's (1995) 
conceptualisation of problems of embodiment and typologies of body-self are 
reviewed. Drawing on a variety of perspectives the meaning of women's breasts 
and the associated impact on women's sense of self and identity following 
breast surgery are explored. The controversy surrounding women's use of 
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reconstruction and prostheses to maintain a 'normal' bodily appearance is also 
highlighted. Finally, existing empirical research is evaluated with a focus on 
qualitative and longitudinal studies of cancer patients' experiences in relation to 
self, identity and embodiment. 
Physiological and psychological theories of stress and coping form the first part 
of Chapter 3 'Stress and Coping with the Breast Cancer Experience'. This 
chapter provides an overview of the most commonly reported coping strategies 
in the breast cancer literature and documents the most influential theories of 
social support and its impact on coping with cancer. Given the vast quantity of 
research concerning women's psychological well-being following a breast 
cancer diagnosis, the most prominent works in the field are appraised with 
particular attention to the impact on quality of life and the development of 
psychological morbidities. The notion of control and its relationship with breast 
cancer and psychological well-being is investigated. 
Chapter 4 describes the study methodology incorporating a history of the 
emergence of hermeneutic phenomenology and its suitability for exploring 
women's longitudinal experiences of breast cancer. The development and use 
of illness/treatment grids to aid the data collection process as based on a life 
grid approach is discussed and an overview of participant characteristics is 
provided. 
Chapters 5, 6, and 7 constitute the 'data' chapters and represent the so-called 
'parts' of women's experiences as outlined in Heidegger's hermeneutic 
phenomenological approach (e.g. Heidegger, 1927/1996). Given the multitude 
and diversity of themes identified the extant literature is applied to the study 
findings throughout the data chapters. 
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Chapter 5 'The Medicalisation of Breast Cancer' reports women's interactions 
with the healthcare system and the issue of waiting from symptom identification 
to early follow-up. The themes presented demonstrate how women's lives 
became medicalised through diagnostic and treatment regimes resulting in a 
wait for normality and desire to return to their former self. Women's roles with 
regards to treatment decision-making and the influence of historical context, 
acceptance of medical opinions, and women's pursuit of survival, in this process 
are revealed. Women's cancer schemas are described including perceptions of 
aetiology and the implications of these beliefs on psychological adjustment and 
help-seeking behaviour. Coping strategies pertaining to the management of 
information throughout the year post diagnosis are uncovered as is women's 
struggle to regain responsibility for their breast health. Finally, this chapter 
reports findings indicative of an ongoing reliance on the medical profession and 
the consequence for breast self-examination throughout the healthcare 
trajectory. 
Chapter 6, 'The Body', is divided into three parts, the first of which presents 
themes pertaining to women's perceptions of the body. This section 
demonstrates how through rationalising breast surgery the meanings women 
ascribed to their breasts were revealed. It additionally outlines women's 
perceptions of breast loss from immediately post-surgery and highlights the 
impact on women's identity and notions of self. The bodily limitations that 
women experienced as a result of breast cancer treatment are discussed in 
relation to a loss of healthy identity and lack of embodiment. The second part of 
this chapter focuses on women's body management and the strategies adopted 
to cope with the changed body including women's use and non-use of external 
breast prostheses and reconstructive surgery. It is argued that women's 
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attempts to re-image the body through clothing and disguising chemotherapy-
induced alopecia are related to stigma, body regulation and societal control. 
Women's experiences of complementary therapies are considered as a means 
of managing treatment side-effects. The final section and theme contends that 
women's perceptions of their body and ongoing management of appearances 
act as permanent reminders of bodily change. 
The themes that represent women's emotional journey are presented in 
Chapter 7 'The Mind'. Drawing on models of grief this chapter charts women's 
psychological responses and adjustment to breast cancer throughout the year 
post diagnosis commencing with acute stress reactions. Women's attempts to 
protect others and their self-concept are discussed and their search for meaning 
and reflection on existential concerns regarding mortality are demonstrated with 
reference to associated coping strategies. The psychosocial distress that 
frequently emerged following a period of reflection is reviewed and qualitative 
accounts of depression and loss of personality are presented. Literature from 
positive psychology is applied to women's use of positivity and the notion of 
biographical disruption is used to conceptualise women's altered frame of 
reference. The changes women made to their lives as a direct result of 
experiencing breast cancer are reported ranging from health-related behaviour 
change to re-defining life priorities and reforming relationships. The final theme 
presented portrays the untidy ends that remain a core component of women's 
experiences of breast cancer over time revealing the impact of uncertainty and 
the challenge of moving beyond breast cancer. 
Chapter 8, 'Discussion', considers women's experiences as a 'whole' and 
contextualises the study results in light of self, embodiment and coping theory 
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as well as reviewing implications for current healthcare policy. Reflection on the 
research methodology, study limitations and directions for future research are 
discussed. 
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CHAPTER 1: BIOMEDICAL PERSPECTIVES ON BREAST 
CANCER 
1.1 Introduction 
This chapter reviews biomedical perspectives on breast cancer beginning with 
prevalence and the biology of the disease with the aim of providing contextual 
information regarding the dominant objectivist model of breast cancer care in 
the UK. It charts the healthcare trajectory from identification to treatment 
pathways and follow-up and provides an overview of the contested area of 
decision-making in this context. Risk and the increasing acknowledgment of 
breast cancer as a chronic illness are additionally considered. The chapter 
draws on UK Government reports that are currently influencing practice and 
documents produced by cancer charities alongside empirical research to 
highlight the continuing magnitude of the disease as well as current debates in 
the field. In turn, the need for further research into breast cancer and specifically 
that exploring the illness experience from a longitudinal perspective and 
constructivist philosophy is outlined. 
1.2 Prevalence 
The past three decades has seen the incidence of breast cancer increase in 
many parts of the world and the disease remains the most common female 
cancer in developed countries (Jemal, Siegel, Xu & Ward, 2010). In 2009 
40,260 new cases of breast cancer were diagnosed in England, with more than 
99% of cases being diagnosed in women (Office for National Statistics, 2011). 
Accounting for 32% of cancers in women in the UK (Clinical Knowledge 
Summaries, 2009) with a lifetime prevalence rate of one in eight for women, 
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breast cancer has become the most common cancer in women in the UK. On a 
global scale it is estimated that 1.38 million women were diagnosed worldwide 
in 2008 accounting for nearly a quarter of all female cancer cases (Ferlay, 
Parkin & Steliarova-Foucher, 2010). Incidence rates vary across the globe with 
the highest rates being found in Europe while the lowest rates have been 
observed in Africa and Asia (Ferlay et al., 2010). Variation in the incidence of 
breast cancer is also observed across the UK. The North East of England is 
reported to have the third highest proportion (11%) of breast cancer cases in 
England with only the Thames and South West regions reporting a greater 
incidence of the disease (West Midlands Cancer Intelligence Unit, 2011). Higher 
rates of diagnosis have consistently been reported in the least deprived 
populations of the UK such as those in the South West however, the North East 
reports one of the greatest percentages of breast cancer cases in the most 
deprived quintile (West Midlands Cancer Intelligence Unit, 2011). 
In line with having one of the highest incidences of breast cancer in the world 
12,047 women and 69 men died from breast cancer in the UK in 2008 (Cancer 
Research UK, 2011a). Data suggests that 5% of women diagnosed with breast 
cancer at the time of diagnosis had metastases (NICE, 2009). That said, 
survival rates are over 80% and the latest available statistics suggests that on 
31st December 2006 approximately 298,000 individuals were alive ten years 
after receiving a breast cancer diagnosis, 99% of whom were women (National 
Cancer Intelligence Network, 2010). However, 35% of patients develop 
metastases in the ten years following diagnosis (NICE, 2009) and at least one 
third of patients develop recurrent disease (NICE, 2002). 
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Deaths from breast cancer have been reported to be decreasing in North 
America, Australia and the majority of Nordic and Western European countries 
(Autier et al., 2010) yet breast cancer survival rates in England continue to 
remain lower than those in the best performing countries (Coleman et al., 2011). 
Variation in the stage of breast cancer at diagnosis and differences in breast 
cancer treatment are believed to be influential in explaining European variation 
in breast cancer mortality rates (e.g. Allemani et al., 2010; Sant et al., 2003). A 
large scale investigation of hospital reports found that women in the UK were 
diagnosed at a later stage, were operated on less often, had fewer nodes 
sampled, and had a lower rate of axillary dissection compared to women in 
other European countries (Sant et al., 2003). 
Delayed presentation to a GP has been suggested as one explanation for the 
diagnosis of UK women at a more advanced stage of breast cancer (Coleman 
et al., 2011) and a link between such delay and survival is apparent (Richards, 
Westcombe, Love, Littlejohns & Ramirez, 1999). Delay in help-seeking for a 
breast symptom has been found to be associated with older age, non-
recognition of symptom seriousness, and lower education level (Macleod, 
Mitchell, Burgess, Macdonald & Ramirez, 2009). Moreover, a recent study has 
found that 37% of women surveyed in the UK stated that they might not seek 
advice from their GP due to worry that they would be wasting the doctors' time 
(Forbes, Atkins, Thurnham, Layburn, Haste & Ramirez, 2011). Fear of what the 
doctor might find, embarrassment and a lack of confidence in talking about their 
symptoms were also among the most prevalent barriers to help-seeking 
identified by Forbes et al. (2011). Socio-cultural factors may also play a role in 
such delays particularly regarding the meanings ascribed to breasts. Symbolic 
associations with maternity and the relationship between beauty and health 
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have been reported to constitute explanations for delay in a sample of women in 
the USA (Potrata, 2011). This issue aside, mortality rates should be interpreted 
with caution as they provide a delayed picture of survival trends given that a 
substantial proportion of women will have been diagnosed several years prior to 
death (Coleman et al., 2011). 
Reported projections regarding the future incidence of breast cancer in England 
are mixed as while some studies predict an increase amounting to 
approximately 1% annually to 2020 (M0ller et al., 2007) others argue that age-
standardised incidence of breast cancer in the UK will decline by 8% between 
2007 and 2030 (Mistry, Parkin, Ahmad & Sasieni, 2011). Such differences may 
be accounted for by recent changes to breast cancer screening and a 
substantial decrease in the use of Hormone Replacement Therapy (Parkin, 
2009). Nonetheless, predictions to 2022 indicate a rise in the number of cases 
of breast cancer in the North East of England due to increases in both risk and 
population (Northern & Yorkshire Cancer Registry and Information Service, 
2008). 
The high prevalence of breast cancer in women and in the North East of 
England provides the foundation for the sample recruited for the present study. 
Accordingly, unless otherwise stated, the discussions within this thesis are 
restricted to female breast cancer. The following section describes the biology 
of the disease including the staging systems currently in use to aid treatment 
planning in the symptomatic breast unit from which the study sample was 
drawn. 
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1.3 What is breast cancer? 
Cell growth and division is a necessary function of the body in order that growth 
and repair of body tissues can take place. However, when the cells that make 
up the breast tissue fail to die and instead endlessly divide breast cancer is the 
result. This uncontrolled growth produces tumours known as neoplasms. These 
primary tumours may or may not be felt or seen in the form of a breast lump or 
other deformations of the breast (e.g. leaking nipple, skin dimpling, change in 
skin colour or texture) (Breast Cancer Care, 2010). While breast cancer begins 
in breast tissue it can spread to nearby tissues or organs as well as to other 
parts of the body. If breast cancer is isolated within the breast or is located in 
the breast tissue and the nearby lymph nodes and has not spread to other parts 
of the body it is termed 'early' (NICE, 2009). 'Locally advanced' is the term used 
to describe breast cancer that may be identified within a large part of the breast, 
may be growing into the skin or muscle of the chest and may be present in the 
lymph nodes though has not spread to other body parts. 'Advanced' breast 
cancer is diagnosed when cancer has spread to other parts of the body or when 
its growth into nearby tissues cannot be fully removed via surgical intervention 
(NICE, 2009). 
Breast cancer is further defined in terms of type, being described as either non-
invasive or invasive (NICE, 2009). Non-invasive breast cancer, also known as 
carcinoma in situ, is found in the milk ducts with no evidence of spread to the 
surrounding breast tissue (NICE, 2009). The most common form, known as 
ductal carcinoma in situ (DCIS) (Department of Health, 2010), is a lesion that 
during the early 1980s was reported as being relatively uncommon and was 
associated with patients presenting with palpable tumours and severe nipple 
discharges (Skinner & Silverstein, 2001). However, advances in mammography 
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technology and greater use of mammography screening has resulted in a rapid 
increase in the incidence of DCIS and accordingly women typically present as 
asymptomatic with nonpalpable tumours (Skinner & Silverstein, 2001). While if 
left untreated DCIS can develop into invasive breast cancer, it has been 
estimated that two thirds of such cases will not progress into invasive tumours 
(Page, Dupont, Rogers, Jensen & Schuyler, 1995). Consequently, issues 
regarding the overdiagnosis of DCIS due to publicly organised mammography 
screening (J0rgensen & G0tzsche, 2009) and debate as to whether DCIS 
should be treated like early stage invasive breast cancer has arisen (Allegra et 
al., 2010). Furthermore, many believe that the anxiety-inducing term 'carcinoma' 
should be removed from diagnosis (Allegra et al., 2010). Nevertheless, there is 
no definitive way of determining whether a DCIS of the breast will remain 
encapsulated or become invasive (Zahl, Maehlen & Welch, 2008). As 
evidenced via several women in the sample recruited for the present study, 
DCIS of the breast was diagnosed via a symptomatic breast unit and treated as 
breast cancer by both women and healthcare professionals. 
In contrast, invasive breast cancer is characterised by spread or 'invasion' into 
the surrounding breast tissue. This type of breast cancer has the ability to 
spread into tissue outside of the breast. Invasive ductal breast cancer is the 
most common form of breast cancer, developing in the cells that line the breast 
ducts, accounting for approximately 80% of all breast cancers (Department of 
Health, 2010). When breast cancer spreads to other parts of the body, usually 
via the lymph nodes or the bloodstream, it is known as secondary or metastatic 
breast cancer (National Cancer Institute, 2011). 
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When breast cancer is diagnosed it is given a stage describing the size of the 
cancer and how far it has spread (Breakthrough Breast Cancer, 2009). One 
staging system often utilised in breast cancer diagnosis is the TNM system 
(Macmillan Cancer Support, 2011). This can provide detailed information about 
the extent of the cancer by describing the size of the tumour (T), whether 
cancer has spread to the lymph nodes (N) and whether cancer has spread to 
another part of the body - metastases (M) (Benson, 2003). While this staging 
system has been applied in oncology for over fifty years its usefulness is now in 
question (Mason, 2006). Burke (2004) argues that in order to provide 
individualised care that can guide treatment decisions a new system 
incorporating newly discovered biomarkers is needed. He further purports that 
routine screening that can detect cancer at earlier stages and the influence of 
treatments other than surgery are not accounted for in the TNM staging system 
leading to inaccurate predictions of prognosis (Burke, 2004). Accordingly, this 
may be pertinent to breast cancer care particularly given developments in 
knowledge of biomarkers including the role of oestrogen and progesterone 
positive and negative markers. Nevertheless, others oppose abandoning this 
framework and are working to improve the existing system believing that 
prognostic markers could be used in addition to the TNM system 
(Gospodarowicz, Miller, Groome, Greene, Logan & Sobin, 2004). 
The number system of staging may also be used which categorises breast 
cancer from stage 0 to stage 4 (Cancer Research UK, 2011b) with non-invasive 
cancer such as DCIS being classified as stage 0 (Department of Health, 2010). 
Subsequent stages are defined by the location of breast cancer cells (e.g. in the 
breast, lymph nodes, elsewhere in the body) and/or the size of the tumour (in 
centimetres). More advanced stages such as stage 3 indicate that cancer cells 
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are stuck together or to other structures such as the skin or chest wall. A 
diagnosis of stage 4 breast cancer describes a tumour of any size and that the 
cancer has spread elsewhere in the body (metastasis). 
Cancer cells are also graded in terms of low, medium and high to indicate the 
speed of growth and likelihood of spread. As such low grade (G1) tumours 
although abnormal are slow growing and less likely to spread while high grade 
(G3) tumours can grow quickly and are more likely to spread (Department of 
Health, 2010). The exact causes of female breast cancer are currently 
unknown, though several risk factors have been identified and are reviewed in 
the following discussion. 
1.4 Risk 
Age is one such non-modifiable risk factor with increasing age being linked to a 
greater likelihood of developing breast cancer (e.g. Cancer Research UK, 
2009a; McPherson, Steel & Dixon, 2000). Eighty one percent of cases occur in 
women aged 50 years and over with nearly half of cases being diagnosed in 
women aged 50-69 years (Office for National Statistics, 2010). That said, breast 
cancer is the most commonly diagnosed cancer in women under 35 years 
(Cancer Research UK, 2009a). 
As some breast cancer cells can be stimulated to grow with greater exposure to 
oestrogen, starting periods at a younger age, entering into menopause at a later 
age, not having children or doing so later in life may increase the risk of breast 
cancer by prolonging women's oestrogen exposure (Travis & Key, 2003). Being 
overweight or obese after the menopause causes greater production of 
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oestrogen and accordingly the risk of developing breast cancer is greater in this 
group of women (Travis & Key, 2003). 
Socio-economic variations are evident with higher incidence rates of breast 
cancer being recorded in more affluent women. A recent comparison of two 
time periods, 1995-1999 and 2000-2004, reported that incidence in the most 
deprived groups in 2000-2004 were approximately 20% lower than in the most 
affluent (National Cancer Intelligence Network, 2008). Having a first pregnancy 
later in life and lower parity are more prevalent in women of higher socio-
economic status. Similarly, an increase in the use of Hormone Replacement 
Therapy (HRT) has been documented as contributing to the increase in breast 
cancer cases seen during the 1990s (Beral, Banks, Reeves & Wallace, 1997), 
its use also being noted to be higher in more affluent women (Quinn, Cooper, 
Rachet, Mitry & Coleman, 2008). Berry and Ravdin (2007) estimate that due to 
the fall in the use of HRT (seen from 2001 onwards) there were 1,400 fewer 
cases of breast cancer in 2005 in women aged 50-59 in the UK than would 
have occurred without this decreased use. 
While most breast cancers are not hereditary approximately 5-10% of breast 
cancers can be attributed to one of two predisposing genes, known as BRCA1 
and BRCA2 (McPherson et al., 2000; Rahman & Stratton, 1998). Mutations in 
these genes relate to a lifetime risk of developing breast cancer of 50-85% and 
a 20-40% risk of developing ovarian cancer (Levy-Lahad & Friedman, 2007). 
The TP53 gene, the first tumour suppressor gene to be identified and the most 
common genetic change identified in human cancers, has also been associated 
with an increased risk of developing breast cancer (Gasco, Shami & Crook, 
2002). The overall frequency of TP53 mutation in breast cancer is believed to 
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be approximately 20% (Pharoah, Day & Caldas, 1999). Women who have a 
significant family history of breast cancer i.e. the development of breast cancer 
in two close relatives such as a mother, sister, or daughter before the age of 50 
years, may be eligible for genetic screening though a living relative with breast 
cancer is required for this procedure. Surveillance for breast cancer via annual 
MRI scans if less than 49 years of age and annual mammograms if over 50 
years old should be offered if any of the relevant genes are identified (NICE, 
2006). 
Large scale studies have demonstrated that benign (non-cancerous) breast 
disease can additionally increase women's risk of developing breast cancer, in 
either the same or previously unaffected breast (Hartmann et al., 2005). 
Similarly, a previous diagnosis of breast cancer increases women's risk of 
developing the disease for a second time (Department of Health, 2010). 
Lifestyle factors including alcohol consumption, obesity, smoking and a lack of 
physical activity are not only risk factors for developing breast cancer but 
increase the risk of cancer recurrence (Kwan et al., 2010; McTiernan, Irwin & 
Vongruenigen, 2010) and the development of contralateral breast cancer (Li, 
Daling, Porter, Tang & Malone, 2009). Breastfeeding is known to have some 
preventative effects, a factor which relates to the production of oestrogen, 
though an exact link remains elusive (Collaborative Group on Hormonal Factors 
in Breast Cancer, 2002). 
How women interpret their risk and how their perceptions affect screening 
behaviours and decision-making for preventive surgeries such as mastectomy 
is not completely understood (Pilarski, 2009). The complexity associated with 
this body of literature is represented by studies showing that objective breast 
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cancer risk factors are poor predictors of perceived breast cancer risk and 
screening behaviour (Katapodi, Dodd, Lee & Facione, 2009). Quantitative 
research studies tend to focus on women's assessment of their breast cancer 
risk. A cross-sectional community based survey undertaken in the USA with a 
multicultural sample of 184 women found that 50% of women perceived their 
breast cancer risk to be the same as the risk of their friends/peers (Katapodi, 
Dodd, Facione, Humphreys & Lee, 2010). Forty percent of women responders 
perceived their risk to be less than their friends/peers with only 10% of women 
perceiving that their risk was higher than their friends/peers. Family history and 
breast cancer worry were identified as significant predictors of risk judgments 
for the individual. Knowledge and salience of risk factors were found to inform 
comparative judgements. However, women's perceptions of their risk factors 
may not be accurate. Furthermore, the relatively small number of women with a 
family history of breast cancer and other risk factors limits the conclusions that 
can be drawn from the statistical analyses. Nonetheless, the study findings 
suggest that women may under-estimate or over-estimate their risk of breast 
cancer which may have implications for screening behaviours, use of health 
services and women's psychological well-being. 
By contrast, a focus group study exploring psychosocial components influencing 
older women's breast cancer risk appraisal (Wood & Della-Monica, 2011) 
uncovered that worry, fear and anxiety were commonly expressed as women 
associated screening with a breast cancer diagnosis. 'Self-regulating 
empowerment' was the second theme discussed incorporating women's 
discourse on being proactive with their health, their engagement in health-
promoting protective behaviours and information-seeking behaviours. The final 
theme, optimism, referred to how women perceived their life experiences as 
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enabling them to cope with the stress of receiving a breast cancer diagnosis 
should it occur. The use of a small, homogenous sample from a specific area of 
the USA provides a problem generalising the study findings to the UK. 
Furthermore, an issue relating to the misinterpretation of some of the focus 
group questions was acknowledged by the study authors. While older age is a 
non-modifiable risk factor and consequently this study explores an at risk 
population, risk perceptions may be different for women at different stages of 
their life. 
The literature further suggests that the media representation of breast cancer 
and related risk factors in popular magazine articles portrays women not only as 
victims of an insidious disease but as victims of their behaviours (Lupton, 2004). 
The suggestion is that by, for example, delaying childbirth and using the 
contraceptive pill, women are making unhealthy or unnatural choices. 
Accordingly, women are seen to be increasing their risk of developing breast 
cancer, a disease that strikes a part of the body that is equated with being a 
woman. In taking more control over their lives by changing the prescribed roles 
and behaviours women are viewed as causing an epidemic and threatening the 
social order. The extent of this blaming has not been found to be the case in 
other press articles (e.g. Wilkes et al., 2001). While many women do recognise 
that there are risks over which they have no control there is evidence that 
women believe that the biggest cause of their breast cancer is childbearing and 
menopause (Wilkinson, 2000). 
Inaccurate perceptions of breast cancer risk and risk factors may influence 
women's responses to the disease including health protective behaviours. 
However, given the strong association between endogenous risk factors and 
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the development of breast cancer, secondary prevention strategies are currently 
emphasised and promoted, by not only the UK Government and National Health 
Service but by the media. The following section considers screening with 
regards to both mammography and breast self-examination and highlights 
current debates in the effectiveness of these strategies. 
1.5 Screening 
1.5.1 Mammography 
Under national guidelines all women between the ages of 50 and 70 who are 
registered with a GP are currently offered regular routine breast screening via 
mammography (breast X-ray) with the aim of detecting breast cancer at an early 
stage (NHS, 2011). However, given the rolling nature of the programme inviting 
women from GP practices (or geographical areas) in three yearly cycles, some 
women will not attend screening until they are nearly 53 years of age. A 
randomised trial to extend this screening programme began in 2009 to include 
women from 47 years up to 73 years. The trial is due to be completed in 2016 
though all women within this age range are anticipated to become eligible for 
mammography screening by the end of 2012 (NHS, 2011). Difficulties 
interpreting mammograms due to greater density breast tissue in younger 
women as well as the lower incidence of breast cancer in women less than 50 
years of age constitute the reasons for the minimum age requirement. Despite 
women aged over 70 years having the highest rates of breast cancer in the UK 
(Office for National Statistics, 2010), after 73 years women cease to receive a 
routine appointment for mammography screening, though they can continue to 
request this via their GP. However, a recent study exploring the views of older 
women (over 70 years) towards mammographic screening reported that over 
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half (53%) of questionnaire respondents were unaware that they could request 
breast screening (Collins et al., 2010). Furthermore, most women (81.5%) had 
not attended breast screening since turning 70 years (Collins et al., 2010). 
Approximately 1.88 million women were screened in the UK in 2010-11 via the 
National Breast Screening Programme representing growth of 45.1% from 
2000-2001 (The Health and Social Care Information Centre, 2012). Expansion 
of the breast screening programme as detailed previously and population 
growth among women in the targeted age group are likely explanations for this 
increase (The Health and Social Care Information Centre, 2012). A participation 
rate of 70% is the national minimum standard (NHSBSP, 2005) in the UK and is 
an established goal within population health screening to ensure cost-
effectiveness (Cosp, Castillejo, Vila, Marti & Emparanza, 2009). In 2010-11 
uptake of mammography screening for routine invitations (women aged 50-70 
years) was reported to be 73.4% (The Health and Social Care Information 
Centre, 2012). A variety of factors influencing participation have been reported 
in the literature including socioeconomic group, awareness of prevention 
programmes and the method of invitation (Cosp et al., 2009). While in the UK 
an effective active method of recruitment, as identified in a systematic review by 
Cosp and colleagues, by way of personalised letters of invitation is adopted, the 
percentage of eligible women attending screening varies across Strategic 
Health Authorities (STAs) in England. In the year 2010-2011 this ranged from 
63.6% to 78.6% (The Health and Social Care Information Centre, 2012). 
Women who are not registered with a GP and who are not aware that they can 
request screening after 73 years are inevitably not considered in the reporting of 
such figures. 
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In women aged 50 to 70 years the detection rate in 2010-11 was 7.6 per 1000 
women screened, a figure which has risen from those seen ten years ago given 
the introduction of two-view mammography in 2002 (The Health and Social 
Care Information Centre, 2012). The NHS breast screening programme 
conveys that an estimated 1400 lives are saved as a direct result of 
mammography each year in England (Department of Health, 2009) however 
recent systematic reviews have cast doubt on their effectiveness. G0tzsche and 
Neilson (2006) reported that for every 2000 women invited for screening 
throughout a ten year period one will have her life prolonged while a further ten 
healthy women will be diagnosed with breast cancer and treated unnecessarily. 
This suggestion that some degree of overdiagnosis and overtreatment is an 
inevitable outcome of breast screening (Welch, 2004 as cited in Kosters & 
G0tzsche, 2008) stems from the finding that several screen-detected cancers 
are slow growing and may not develop into invasive cancer if left untreated 
(Zahl, Maehlen & Welch, 2008). False-positive mammograms may, however, 
elicit an emotional impact and influence women's future screening behaviour. 
The results of a meta-analysis suggested that women who received false-
positive results conducted more frequent breast self-examination, demonstrated 
variation in rates of subsequent mammography uptake and had higher levels of 
distress and anxiety and more thoughts of breast cancer than women who had 
received normal results (Brewer, Salz & Lillie, 2007). 
Recently, a retrospective trend analysis of three country pairs comprising the 
Netherlands versus Belgium, Sweden versus Norway and Northern Ireland (the 
UK) versus the Republic of Ireland compared breast cancer mortality in relation 
to implementation of breast screening (Autier, Boniol, Gavin & Vatten, 2011). 
The countries in each pairing were similar with regards to healthcare services 
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and prevalence of risk factors for breast cancer death however mammography 
screening was implemented ten to fifteen years later in the second country in 
each pair. The study findings suggest that screening did not play a direct role in 
the decreasing mortality trends observed. Further to such findings an 
independent review of breast screening efficacy was announced in October 
2011 to be conducted by The Department of Health in partnership with Cancer 
Research UK, with the results anticipated in 2012 (NHS Breast Screening 
Programme News, 2011). 
1.5.2 Breast self-examination 
Breast self-examination (BSE) refers to a woman being aware of the normal 
look and feel of her breasts and looking for changes including the size or shape 
of the breasts, skin texture, the presence of lumps, discharge from one or both 
nipples, swelling, redness and pain in the breasts or armpits (Breast Cancer 
Care, 2010). Women have long been taught that being breast aware can lead to 
an earlier diagnosis of breast cancer and in turn improve chances of survival 
(Kearney, 2006) and it has been documented that the majority of breast 
tumours are detected by women themselves (Arndt et al., 2002). However, this 
method of screening is also not without controversy. 
A systematic review (Kosters & G0tzsche, 2008) identified two large population-
based randomised trials assessing breast self-examination versus no breast 
self-examination. The first study, a collaboration between the Russian 
Federation and the World Health Organisation (Semiglazov et al, 1999), 
randomised women aged 40-64 years (excluding women with previous breast 
cancer or other malignancies) from St Petersburg and Moscow into a control or 
intervention group. Women in the intervention group who attended a routine 
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health check received a clinical breast examination, instruction in breast self-
examination, and a follow-up calendar. However, discrepancies in published 
sample sizes, a lack of follow-up and non-reporting of study statistics from the 
Moscow site were noted limitations of this trial leading Kosters and G0tzsche to 
include only data from the St Petersburg site that was published in English. In 
the second study conducted in Shanghai (Thomas et al., 2002) 289,392 women 
aged 30-66 years were randomised into either an intervention group receiving 
education and reinforcement or to a control group. Kosters & G0tzsche 
assessed the Shanghai study as having a thorough training program including 
extensive instructions for breast self-examination, thorough follow-up 
procedures and higher compliance rates than the Russian study. No statistically 
significant differences in breast cancer mortality were identified between the 
intervention and control groups by either of these studies leading Kosters & 
G0tzsche (2008) to conclude that there was not a beneficial effect of breast 
self-examination. While in the Russian trial more cancers were found in the 
intervention group than the control group this was not the case in Shanghai 
which Kosters & G0tzsche suggest may be attributable to the lack of 
mammography available in Shanghai. Furthermore, as the trials showed that 
women who were randomised to the breast self-examination intervention were 
almost twice as likely to undergo a biopsy of the breast with benign results the 
authors suggest that BSE may lead to increased harm. 
Meta-analyses of breast self-examination from the Canadian Task Force on 
Preventive Health Care (Baxter, 2001) and Hackshaw and Paul (2003) support 
the aforementioned findings and provide further evidence of harm as a result of 
increased medical visits, unnecessary biopsies and emotional distress (Baxter, 
2001). The Shanghai trial in particular has been cited as responsible for 
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changing practice in a number of organisations (Kearney, 2006) and the 
Canadian Task Force on Preventive Health Care have gone so far as to 
recommend that doctors no longer teach BSE to women between 40 and 69 
years of age during annual reviews. 
However, a cohort study of nearly 30,000 women in Finland (Gastrin et al., 
1994) and a Canadian case-control study (Harvey, Miller, Baines & Corey, 
1997) reported findings suggesting that higher rates of breast self-examination 
were associated with decreased risk of mortality from breast cancer (relative to 
the general population). Gastrin and colleagues concluded that well performed 
breast self-examination in conjunction with a medical professional who was able 
to interpret women's findings was crucial in eliciting benefit from BSE. These 
studies do nevertheless lack the methodological rigour of randomised trials. 
In summary, the effectiveness of breast screening whether via mammography 
or breast self-examination is a contested area. However, these methods do 
elicit diagnoses of breast cancer each year in the UK and represent a proportion 
of cases reviewed by the Symptomatic Breast Unit from which the current study 
sample is drawn. The following section outlines the healthcare trajectory from 
referral to possible treatment options. 
1.6 The healthcare trajectory 
1.6.1 Identification & diagnosis 
In line with the 2007 Cancer Reform Strategy all patients referred to a specialist 
breast clinic by their GP who are suspected of having breast cancer should be 
seen within two weeks. Symptoms may include a lump in a woman over 30 
years of age that is not related to menstrual changes. Nipple changes such as 
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discharge, new nipple distortion and/or nipple eczema that is not present 
elsewhere and is not responsive to steroid treatment also warrant referral. 
Furthermore, symptoms including skin tethering, an area of the skin that has 
become fixed or eczema that as above is not relieved by steroid treatment 
constitute referral under the two week rule (NICE, 2005). Other symptoms that 
may result in referral include skin ulceration, a persistently recurring cyst, an 
abscess, pain which does not respond to initial treatment and one-sided 
lumpiness not associated with the woman's menstrual cycle (Breakthrough 
Breast Cancer, 2009). Women for whom abnormalities have been detected 
during routine mammography will automatically be sent for further assessment. 
Upon referral to a specialist breast unit for investigation and potentially 
treatment women are reviewed by a multi-disciplinary team, a process which is 
now regarded as best practice (Association of Breast Surgery - BASO, 2009). 
The standard procedure upon attendance at a specialist clinic begins with a 
discussion regarding the breast symptoms being experienced and completion of 
a questionnaire including questions pertaining to family history of breast 
disease. This is followed by a breast examination by a nurse or doctor including 
the lymph glands in the armpits. A mammogram or ultrasound scan of the 
breast (for women under 35 years) may be subsequently undertaken, the 
results of which will determine whether a fine needle aspiration (FNA), whereby 
a sample of breast cells are removed using a fine needle and syringe, or core 
biopsy, using a larger needle to obtain a sample of breast tissue, is required 
(Breakthrough Breast Cancer 2009). Undergoing a clinical examination, 
radiological assessment and either a FNA or core biopsy is known as a triple 
assessment. At a one-stop clinic all testing is undertaken during their first visit to 
clinic and women receive the results of these investigations later that day. 
24 
Depending upon the hospital this may not be possible particularly if a core 
biopsy has been required and women may wait up to one week for their results 
(Macmillan Cancer Support, 2011). 
The main treatments for breast cancer are surgery, chemotherapy, 
radiotherapy, hormone therapy and biological (targeted) therapy which may be 
used in isolation or combination. In the UK if locally or early advanced breast 
cancer is diagnosed surgery is the first method of treatment (NICE, 2009) and is 
the focus of the following sub-section. 
1.6.2 Primary surgical treatment 
The type of surgery undertaken is largely dependent upon the type of breast 
cancer identified (NICE, 2009). Breast conserving surgery, otherwise known as 
a lumpectomy or wide local excision, involves removal of the tumour and a 
small amount of surrounding breast tissue. A mastectomy is the term applied to 
the removal of the whole breast. 
Noting that favourable outcomes were associated with less invasive surgery the 
concerns of a few influential surgeons that the standard use of radical 
mastectomy may constitute overtreatment led to a series of randomised 
controlled trials in the 1970s assessing the effectiveness of less invasive 
surgery (Lerner, 2001). A growing recognition that breast cancer warranted 
multimodal treatment added impetus to the decreasing popularity of aggressive 
surgery (Katz & Hawley, 2007). Several studies (e.g. Fisher et al., 2002) have 
since reported results of women followed-up for twenty years showing that for 
early stage breast cancer lumpectomy/breast conserving surgery yields 
comparable outcomes, in terms of local recurrence and survival, to modified 
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radical mastectomy. Moreover, better quality of life outcomes have been 
documented by several studies particularly regarding body image following 
breast conserving surgery as opposed to mastectomy (e.g. Janni et al., 2001). 
However, continuing high rates of mastectomy (e.g. Nattinger, Gottleib, 
Hoffman, Walker & Goodwin, 1996) throughout the 1980s and 1990s have 
resulted in persistent concerns about the overtreatment of women by surgeons. 
The psychological impact of breast surgery is discussed further in Chapter 2 
however the following sub-section reviews breast reconstruction and current 
guidance as to its use in the UK. 
1.6.3 Breast reconstruction 
While breast conservation has become the standard of care where possible 
(Fitzgal & Gnant, 2006) it is estimated that up to one third of breast cancer 
patients still require mastectomy (Cordeiro, 2008). NICE treatment guidelines 
(2009) state that where a mastectomy is necessary the healthcare team should 
discuss the possibility of reconstructing the breast during the mastectomy 
surgery, a procedure termed immediate reconstruction. This is not suitable for 
all women given the presence of other conditions or a need to wait until other 
treatments have been completed. Rates of mastectomy with immediate 
reconstruction vary across the UK with the North East of England having the 
lowest rate of this combined surgery (National Collaborating Centre for Cancer, 
2009). Furthermore, when compared to other UK regions, the North East has 
the smallest rate of other excision (primarily lumpectomy) and the highest rate 
of mastectomy without reconstruction, and uniquely similar figures are reported 
for these two surgical interventions (National Collaborating Centre for Cancer, 
2009). 
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If reconstruction is undertaken at a later date it is known as delayed. Delaying 
reconstruction until after the completion of adjuvant therapies was thought to be 
beneficial to prevent delays in the administration of chemotherapy (Heneghan et 
al., 2011). Moreover, radiotherapy has been found to compromise the viability of 
a reconstruction, impairing wound healing and leading to fat necrosis, capsular 
contracture and reduced cosmetic outcome (Chevray, 2008). Comparable 
quality of life scores have nevertheless been found in women who underwent 
immediate breast reconstruction and women who underwent breast conserving 
surgery (Heneghan et al., 2011). This Irish study utilised validated quality of life 
scales sensitive to breast cancer and a large cohort with 179 women completing 
assessment though a mean follow-up time of 36 months is relatively short. 
Reconstruction can involve the insertion of a breast implant or by using tissue 
from another part of the body (autologous tissue) to create a breast (e.g. deep 
inferior epigastric perforator (DIEP flap); Allen & Treece, 1994) or a combination 
of both procedures (e.g. latissimus dorsi flap and implant). 
While a number of reviews have found overall good levels of satisfaction with 
breast reconstructive surgery (e.g. Guyomard, Leinster & Wilkinson, 2007) other 
studies not included in such reviews provide evidence that reconstructive 
surgery does not always meet women's expectations (e.g. Crompvoets, 2006). 
Pain, hardness in the breast and a lack of breast symmetry are commonly 
reported (Contant, van Wersch, Menke-Pluymers, Wai, Eggermont & van Geel 
(2004). The systematic review by Guyomard and colleagues (2007) highlights 
the limitations of studies assessing patient satisfaction with reconstruction. They 
observed numerous methodological issues including small sample sizes, the 
predominant use of convenience samples, limited use of validated 
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questionnaires and exploration of the meaning of satisfaction as well as lack of 
methodological homogeneity. 
A retrospective case note study (Venus & Prinsloo, 2010) from one UK hospital 
of immediate breast reconstruction using the pedicled latissimusdorsi flap with a 
silicone implant reported that the majority of patients were satisfied with their 
reconstruction. High scores were reported in relation to women's perceptions of 
their appearance when wearing a bra. Progressively lower satisfaction scores 
were reported for perceptions of appearance when not wearing a bra and for 
symmetry though these scores remained above the mid-point of the satisfaction 
scale. The study notes few complications though acknowledged that capsular 
contracture rates may be higher in a longer-term follow-up as this is often a 
delayed effect that can occur several years post-surgery. 
Interestingly, satisfaction with breast reconstruction has been found to vary 
between countries. In a comparison of 182 pairs of British and French patients 
and their partners (split equally between the two countries), British patients 
reported significantly higher satisfaction due to a closer match between their 
expectation and the outcome (Guyomard, Leinster, Wilkinson, Servant & 
Pereira, 2009). No differences were identified between patients and their 
partners' satisfaction. In terms of factors affecting satisfaction, statistically 
significant differences were found in the decision-making process with 
Consultants and partners being viewed as more influential in France, which the 
authors attribute in part to a greater emphasis on body image in French culture 
particularly given French women's greater desire to 'preserve their femininity' 
(p. 786). Higher satisfaction with pain management was reported in France 
though British women were more confident following reconstruction. The 
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authors note that breast reconstruction is twice as common in France and 
highlight differences in the two healthcare systems with a French medical team 
performing both mastectomy and reconstruction while in the UK two separate 
teams perform the surgeries. Furthermore, implants are the primary method of 
reconstruction in France whereas in the UK a mixture of implants, latissimus 
dorsi (LD) and deep inferior epigastric perforator (DIEP) flap procedures are 
undertaken. The study is however limited by the use of retrospective self-report 
measures. 
Most recently pioneering skin-sparing and nipple-sparing procedures (the latter 
in select cases) have been undertaken in one stage as opposed to two thereby 
reducing the number of required surgeries. The study reported excellent 
aesthetic results for immediate reconstruction with silicone implants with low 
rates of complications in 220 women undergoing treatment in Italy (Salgarello, 
Barone-Adesi, Terribile & Masetti, 2011). In one of the few qualitative studies 
exploring motives for women's decisions regarding type of reconstructive 
surgery thirty one women from the Netherlands were interviewed in accordance 
with a phenomenological approach (Gopie et al., 2011). Women opting for 
implant breast reconstruction were found to describe surgery-related issues 
such as a shorter recovery time, less impact of surgery, being able to regain 
their daily lives and less scarring as key factors influencing their decision. 
Women opting for DIEP flap were predominantly concerned with regaining a 
natural breast that would be more symmetrical and believed that this offered a 
safer long-term solution as implants would require revision at a later date. The 
opportunity to have an abdominoplasty as part of the operation and the hope 
that this procedure would improve the sexual relationship with their partner were 
also motives discussed by women opting for a DIEP flap. This study additionally 
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revealed that women undergoing delayed breast reconstruction perceived a 
need to recover from their breast cancer treatment whereas women having 
immediate breast reconstruction were not concerned with its timing. For the 
women undergoing mastectomy, reconstructive surgery was viewed as an 
integral part of the procedure to regain a complete body image. However, the 
study is limited in that not all women included in this study had received a 
diagnosis of breast cancer and interviews were undertaken prior to surgery. The 
influence of healthcare professionals in the decision-making process pertaining 
to immediate or delayed reconstruction was also not discussed and long-term 
review of women's motivations and greater in-depth study of the role of breast 
cancer in this context may elicit different findings. 
1.6.4 Lymph node assessment 
The disease status of the axillary lymph nodes (lymph nodes under the arm) is 
the most significant prognostic indicator for women with early breast cancer 
(Veronesi, Galimberti, Zurrida, Merson, Greco & Luini, 1993). Assessment of 
the lymph nodes is essential for determining staging and prognosis, as well as 
to guide treatment decision-making (Lyman et al., 2005). Furthermore, in 
women with spread to these lymph nodes, axillary clearance aims to treat 
metastases through surgical removal (Veronesi et al., 1993). While technology 
such as ultrasonography can often identify potentially diseased nodes, failure to 
detect small metastases and false negative results are common (Lyman et al., 
2005). Consequently, histological examination of removed tissue is believed to 
be the most accurate method of lymph node assessment (Lyman et al., 2005). 
However, surgery to the axilla, particularly axillary clearance, is associated with 
morbidity including lymphedema (excessive fluid build-up in the arm as a result 
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of a blockage of the lymph nodes), shoulder dysfunction and nerve injury 
(Chetty, Jack, Prescott, Tyler & Rodger, 2000). 
Attempts to minimise such morbidity especially in women undergoing staging 
who are found to be node negative has led to the development of dual 
localisation sentinel lymph node biopsy (SLNB). Unlike standard axillary node 
sampling in which a minimum of four individual lymph nodes are chosen from 
the axillary fat, the SLNB procedure (which can be undertaken via standard or 
endoscopic methods) involves the selective removal of the first draining nodes 
(SIGN, 2005). Systematic studies have shown that breast cancer spreads to the 
sentinel lymph nodes (SLN) prior to other axillary nodes and that SLNB, if 
performed in selected patients with early stage breast cancer, can reduce the 
need for axillary dissection and avoid the associated morbidity (Veronesi et al., 
2003). In the UK the National Institute for Health and Clinical Excellence (2009) 
has stated a preference for the use of SLNB for staging the axilla in 
radiologically or cytologically (where tested) node-negative patients. Women 
with ductal carcinoma in situ who are having a mastectomy or who may be at 
risk of invasive disease should also be offered this procedure (NICE, 2009). If 
cancer is found in the sentinel lymph nodes women should be offered removal 
of some of the remaining lymph nodes, axillary lymph node dissection (NICE, 
2009). 
Analysis techniques have been developed such that intraoperative analysis of 
sentinel lymph nodes can be undertaken enabling node positive patients to 
undergo immediate axillary clearance (Byrne, Cutress, Gill, Wise, Yiangou & 
Agrawal, 2012). However, as this facility is not available in all relevant settings 
in the UK, many patients are required to wait for histology results (Byrne et al., 
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2012) and those who are found to have metastases in the sentinel lymph nodes 
(approximately 30%) undergo a delayed completion axillary dissection (Mansel 
et al., 2006). Following surgery women may be offered further treatment in an 
attempt to eradicate any remaining cancer cells and this is considered in the 
subsequent sub-section. 
1.6.5 Adjuvant therapy 
In the UK, in addition to information regarding tumour grade, size and nodal 
status, post-surgical histological examination also evaluates hormone receptor 
and human epidermal growth factor receptor 2 (HER2) status (NICE, 2009). It 
has been estimated that approximately 75% of breast cancers are oestrogen 
receptor (ER) positive (i.e. oestrogen stimulates the growth of breast cancer) 
(Anderson, Chatterjee, Ershler & Brawley, 2002). Consequently, stopping or 
lowering the level of this hormone via targeted endocrine therapy, such as 
Tamoxifen, can help to treat ER positive cancers. The daily self-administration 
of Tamoxifen for up to five years post-surgery is the standard treatment for 
women with these tumours who are pre-menopausal at diagnosis (NICE, 2009). 
Trials have shown that Tamoxifen, which works as an aromatase inhibitor 
reducing the level of oestrogen, reduces the risk of local recurrence and breast 
cancer mortality irrespective of age and menopausal status (Early Breast 
Cancer Trialists' Collaborative Group, 2005). 
Approximately 15-25% of breast cancers are HER2 positive indicating that this 
protein is encouraging the growth of breast cancer (Smith et al., 2007). HER2 
positive breast cancers are associated with aggressive disease, higher 
likelihood of recurrence and poor prognosis (Baselga, Perez, Pienkowski & Bell, 
2006). Treatment with targeted therapies (e.g. Trastuzumab, otherwise known 
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by the brand name Herceptin) may be used to block the effects of HER2. This 
drug, administered intravenously over the course of an hour, is typically 
undertaken once a week every three weeks for early breast cancer and weekly 
for more advanced breast cancers (Department of Health, 2009a). However, 
this treatment is not suitable for women with heart problems or uncontrolled 
high blood pressure. 
NICE (2009) recommends that given the prognostic value of ER and HER2 
status, such histological results should be made available to the 
multidisciplinary team to guide decisions regarding adjuvant treatment. 
Computer programmes such as Adjuvant! Online (Ravdin et al., 2001) which 
are designed to help inform discussions between patients and healthcare 
professionals as to the benefits of adjuvant therapy may support the decision-
making process. This tool takes into account patient age, tumour size, 
histological grade, hormonal receptor status and comorbidities to predict 
disease course and potentially effective treatment(s). However, the current 
version does not include HER2 status and variation in the use and interpretation 
of such web-based tools may lead to some women with early stage breast 
cancer being under- or over-treated with chemotherapy (NICE, 2012). 
Chemotherapy, the use of anti-cancer (cytotoxic) drugs to kill cancer cells, or 
shrink larger tumours, is usually given after surgery if the tumour is large, of a 
high grade, HER2 positive or if a triple negative result is obtained (negative for 
oestrogen, progesterone and HER2) and if cancer cells are detected in the 
lymph nodes (Macmillan Cancer Support, 2011). If breast cancer is in an 
advanced form and has spread to other organs in the body chemotherapy may 
be utilised to shrink the tumour, relieve symptoms and help to lengthen life 
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(Department of Health, 2010). Several different drugs are commonly used often 
in combination though the exact prescription depends upon the type of breast 
cancer and the extent of spread (NICE, 2009). Chemotherapy is usually given 
as an outpatient treatment either intravenously or in tablet form and treatments 
are typically scheduled once every two to three weeks over a period of four to 
eight months (Department of Health, 2010). 
Chemotherapy has the ability to stop the production of oestrogen and as a 
consequence some women may enter an early menopause as a result of this 
treatment. Additional side-effects include nausea/vomiting, decreased appetite, 
fatigue, hair loss, a sore mouth and infections caused by the influence of 
chemotherapy on healthy cells such as immune cells (Department of Health, 
2010). In response to the notion of the over-use of chemotherapy particularly 
given the toxic side-effects associated with this treatment, a new test called 
IHC4 has been developed in the UK. This molecular test aims to identify women 
with oestrogen receptor positive breast cancer who would benefit from 
chemotherapy as well as those who are at a low-risk of recurrence (Barton et 
al., 2012). In a recent appraisal by the National Institute for Health and Clinical 
Excellence (2012) the IHC4 test was thought to have promise given the 
relatively low financial cost of approximately £100-200 per test (a fraction of the 
cost of alternative tests). 
Chemotherapy is commonly used in combination with other treatments such as 
Tamoxifen or Herceptin and/or radiotherapy. Irrespective of whether 
chemotherapy or radiotherapy is undertaken first, guidance states that 
treatment should commence 31 days from agreement of the treatment plan 
(NICE, 2009). Radiotherapy uses controlled doses of radiation to kill or damage 
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cancer cells (Cancer Research UK, 2009). While it was widely believed that 
radiotherapy would not have a key role in the treatment of cancer (National 
Radiotherapy Advisory Group, 2007), radiotherapy has continued to play an 
important part in cancer care and demand for this treatment has increased 
rapidly (Williams, Summers, Drinkwater & Barrett, 2007). Insufficient 
radiotherapy capacity has resulted with regards to both workforce and 
equipment which has, in turn, had a negative effect on waiting times (Cancer 
Research UK, 2009). This issue may have particular pertinence to breast 
cancer given increasing incidence rates. With regards to breast cancer 
treatment considerable variation in access to radiotherapy between cancer 
networks across the UK and increasing waiting times have been reported (Jack, 
Davies, Robinson, Sainsbury & M0ller, 2007). The recent extension to 
radiotherapy of the national target of 31 days from agreement of treatment plan 
to commencing treatment (National Cancer Reform Strategy, 2007) has been 
deemed unachievable for many parts of the UK (Cancer Partners UK, 2010). 
Furthermore, in the USA and many European countries a waiting time for 
radiotherapy of more than seven days would be considered unacceptable 
(Cancer Partners UK, 2010). It is believed that some variation in access to 
radiotherapy across the UK may be linked to socioeconomic status with fewer 
patients receiving radiotherapy in regions with higher deprivation such as the 
North East of England (Williams, 2009). 
In line with international standards on the treatment of breast cancer, external 
radiotherapy is typically administered daily (Monday to Friday) for five weeks 
though shorter fractionation schedules are common practice in the UK (NICE, 
2009). NICE guidance (2009) states that radiation may be applied to the 
remaining breast tissue following breast conserving surgery (including for 
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women diagnosed with DCIS) and to the chest wall following mastectomy to 
complete local treatment. A boost of high dose radiation (breast boost) may also 
be offered to women undergoing breast conserving surgery in the area where 
the cancer was removed however this may affect the appearance of the breast 
particularly for women with larger breasts. Women considered to be at a high 
risk of regional relapse may also be offered radiotherapy to the lymph nodes 
(NICE, 2009). However, despite such guidance variation in the use of post-
mastectomy radiotherapy persists in the UK for women at an intermediate risk 
of local recurrence and patients diagnosed with ductal carcinoma in situ (Mallon 
& McIntosh, 2012). The advancement of radiotherapy technologies which are 
more effective at targeting the tumour and sparing surrounding 'normal' tissue 
may further increase the demand for radiotherapy (Cancer Research UK, 
2009b). However, side-effects can occur including irritation and darkening of the 
skin, fatigue and lymphedema (Breast Cancer Care, 2012). 
Pre-menopausal women with early invasive oestrogen receptor positive breast 
cancer who have chosen not to have chemotherapy in addition to taking 
Tamoxifen may be offered ovary ablation. This may be via low dose 
radiotherapy or surgery to remove the ovaries, though these methods are 
permanent and do bring about the menopause (Breakthrough Breast Cancer, 
2009). Alternatively, ovary suppression using a drug called Goserelin, a 
luteinising hormone-releasing hormone agonist, can temporarily stop women's 
periods though in those closer to menopausal age this may not occur following 
treatment completion (NICE, 2009). As has been demonstrated throughout this 
sub-section treatment options vary given a range of factors including prognostic 
indicators. Furthermore, the use of technology by the multidisciplinary team to 
aid treatment decision-making is increasingly prevalent yet would seem to 
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contradict the notion of encouraging women's participation in making treatment 
decisions, a topic that is discussed further in the following sub-section. 
1.6.6 Treatment decision-making 
Concerns about overtreatment in conjunction with the emergence of the feminist 
and consumerist movements during the 1980s sparked an interest in treatment 
decision-making (Lerner, 2001). The majority of treatment decisions are made 
within the first weeks following diagnosis and surgical decisions are typically 
made during the first consultation with the assigned surgeon (Katz & Hawley, 
2007). The level of patient involvement in treatment decision-making has 
received particular attention though is marked by contradictory findings and 
potentially influential differences in the study samples used. Rates of passivity 
in treatment decision-making by women with newly diagnosed breast cancer 
have, for example, been reported to be as high as 40% (Vogel, Helmes & 
Hasenburg, 2008) and as low as 8% (Lam, Fielding, Chan, Chow and Ho, 
2003). The findings of research, such as that of Vogel, Helmes and Hasenburg 
(2008), assessing patient involvement in treatment decision-making ought to be 
considered in light of numerous limitations. Differences between study 
participants and non-responders are commonly reported thereby restricting 
generalisability. The use of self-report measures and inherent difficulties 
measuring multifactorial constructs like decision-making via forced choice 
questionnaires are further issues. What is more, given the nature of the disease 
equal treatment options are not always available for all women though this is 
often not taken into account. 
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In the aforementioned study by Vogel and colleagues a further 31% of patients 
wanted to select their own treatment while 29% wanted collaboration. It is this 
notion of shared decision-making that is at the core of the latest Government 
White Paper for Health (2010) promoting "involving patients fully in their own 
care, with decisions made in partnership with clinicians, rather than by clinicians 
alone" (p. 13). Conceptually, consensus on the meaning of shared treatment 
decision-making has yet to be reached and the steps clinicians can use to 
implement this approach lacks definition (Moumjid, Gafni, Bremond & Carrere, 
2007). Attempts to measure shared decision-making, particularly in the context 
of breast cancer where women are encouraged to bring a significant other to 
medical encounters resulting in a triad as opposed to a dyad interaction, are 
problematic and lack empirical study as the notion of shared decision-making is 
open to interpretation (Charles, Gafni & Freeman, 2010). 
Women who do actively engage in treatment decision-making have been found 
to report a significantly higher quality of life than those opting for a passive role 
(Hack, Degner, Watson & Sinha, 2006) and may lead to better long-term health 
outcomes (e.g. Anderson, Bowen, Morea, Stein & Baker, 2009). Such studies 
typically use relatively large samples, 205 women in the research of Hack and 
colleagues with this study additionally reporting a statistically significant number 
of women reporting decisional role regret with many preferring more active 
involvement than had been enabled. A lack of assessment of quality of life at 
baseline and a retrospective measure of preferred involvement somewhat limit 
the reliability of the findings. By contrast, qualitative content analysis of 
women's accounts pertaining to treatment decision-making on a popular UK 
breast cancer website revealed that women often willingly handed over control 
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to healthcare professionals due to the difficulties and stress experienced 
following diagnosis and in making decisions of such importance (Seale, 2005). 
The quality of decision-making has been assessed via satisfaction surveys with 
research frequently using measures of women's desired versus actual levels of 
decisional involvement. However, incongruous findings are commonplace and 
the majority of such studies focus on surgical decisions and are conducted in 
the USA and Canada impacting upon UK applicability. While some research 
indicates that over half of women with breast cancer do not attain their desired 
level of involvement (Degner et al., 1997), Temple and colleagues (2006) 
reported that 60% of their sample of 157 women believed that they had 
participated in treatment decision-making to their desired level. Nevertheless, 
achieving the desired level of involvement has been linked to greater 
satisfaction with breast cancer treatment decisions suggesting that the process 
may be as crucial as the decision made (Sabo, St-Jaques & Rayson, 2007). 
Contrary to the underlying premise of involving patients to reduce unnecessary 
surgery greater patient involvement in decision-making has been found to be 
associated with more invasive treatment i.e. mastectomy (Katz et al., 2005). A 
variety of factors have been attributed to women's decisions to undergo 
mastectomy including for "peace of mind", to lower the risk of local recurrence 
and to avoid radiotherapy (Collins et al., 2009). In a prospective cohort study of 
157 women's surgical treatment decisions (Temple et al., 2006) women cited 
doctors' advice and potential for a complete cure as key deciders. 
To explore women's perspectives of breast cancer treatment decision-making 
O'Brien and colleagues (2008) used qualitative interviewing with video-
stimulated recall with twenty one women considering surgery and adjuvant 
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therapy. Treatment decision-making was found to commence soon after 
diagnosis involving several processes including information gathering and 
identifying preferred treatment options prior to the surgical/oncology 
consultation though women continued to rely heavily on information provided by 
healthcare professionals. Measures to enhance the study's rigour were 
undertaken however, it is possible that participants perceptions of treatment 
decision-making and behaviour during consultations were influenced by the 
videotaping and interview process. Indeed, rather than aid recall the authors 
acknowledge that the video often served to provide women with another 
opportunity to reflect on the consultation as they had forgotten or misinterpreted 
details since the consultation occurred. 
Presenting conceptual models of decision-making women's reaction to their 
diagnosis, information provision, perceived sense of urgency, prior knowledge 
of cancer, women's body image and supportive relationships in women's lives 
were considered influential in early breast cancer treatment decision-making 
(Halkett, Arbon, Scutter & Borg, 2005). In a qualitative hermeneutic 
phenomenological interview study with 18 women the authors (Halkett, Arbon, 
Scutter & Borg, 2007) later documented that the multitude of decisions women 
are required to make following diagnosis result in emotional challenges and that 
women perceived a need to prepare for such decision-making. Having support 
from family and friends in making decisions was viewed as of importance and 
the decisions made were deemed to affect women's lives in the long-term. 
Women did not participate in this study until after surgery and all adjuvant 
therapies had been completed though details of the timing of interviews and 
which treatments were undertaken by the women participating were not stated. 
Thomas-MacLean (2004a) also reported the difficulties women face when 
40 
making treatment decisions and noted that these decisions are often questioned 
even after treatment completion. 
Research considering non-surgical treatment decisions is particularly limited. 
One qualitative focus group study exploring chemotherapy decisions in 34 older 
women with breast cancer found that the majority of women did not believe that 
they had a choice though they preferred this non-involvement (Kreling, 
Figueiredo, Sheppard & Mandelblatt, 2006). Conducted in the USA the sample 
of ethnically diverse women including a high proportion of African-American and 
Latina women over 65 years of age limits the transferability of the findings to the 
UK. The time elapsed between diagnosis and focus group participation also 
varied widely from one to ten years bringing the possibility of recall bias. 
Designed to be understood by lay individuals and therefore help patients with 
cancer who desire involvement in treatment decision-making, decision-aids 
were introduced to provide disease-specific knowledge and information on 
treatment regimes (Vodermaier, Caspari, Wang, Koehm, Ditsch & Untch, 2011). 
Systematic reviews and meta-analyses have shown that decision-aids increase 
the likelihood of patient participation as well as disease and treatment 
knowledge and decrease decisional conflict (e.g. O'Brien et al., 2009; 
Vodermaier et al., 2011; Waljee, Rogers & Alderman, 2007). Research 
conducted to determine whether decision aids can influence outcomes such as 
anxiety and depressive symptoms, quality of life or body image have however 
been inconclusive. Issues relating to the methodologies of primary empirical 
studies including modest sample sizes, post-randomisation exclusions, multiple 
treatment interference and limited reliability of the measures used may help to 
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explain contradictory findings. Involving women in aspects of breast cancer care 
extends to follow-up practices and is discussed in the next segment. 
1.6.7 Follow-up 
Following treatment completion women are entitled to undergo a mammogram 
every year either up until the age at which they are entered into the NHS Breast 
Screening Programme or if already over 47 years every year until five years 
post diagnosis. Routine follow-up appointments are also provided by either the 
GP practice, the breast clinic or a combination of these services in line with 
women's preferences. Randomised trials conducted in the UK provide evidence 
that follow-up care by a woman's general practitioner is equivalent to hospital-
based outpatient care in detecting cancer recurrence (Grunfeld et al., 1996). 
Furthermore, this level of care elicits a high level of patient satisfaction and 
greater cost-effectiveness than specialist hospital care (Grunfeld et al., 1999a; 
Grunfeld et al., 1999b). This may become of increasing importance given the 
growing demand for follow-up services by breast cancer survivors. 
1.7 Survivorship 
Increases in breast cancer survival due to improvements in early detection and 
treatment have resulted in women diagnosed with early node-negative breast 
cancer having a 95-98% survival in many countries (Cancer Research UK, 
2011). Consequently, in conjunction with general gains in life expectancy, there 
are a large number of women living with the long-term effects of breast cancer 
and its treatment (Brennan & Houssami, 2011). In acknowledgment of such 
factors cancer has been re-categorised from an acute illness to a chronic illness 
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(Tritter and Calnan, 2002). The issue of survivorship was raised in the Cancer 
Reform Strategy (Department of Health, 2007) which announced the National 
Survivorship Initiative recognising the long-term impact of a cancer diagnosis 
and treatment. A review of the long-term care needs of breast cancer survivors 
(Brennan & Houssami, 2011) illustrated that the management of treatment side-
effects such as premature menopause and lymphoedema in addition to care 
relating to bone health, psycho-social and sexual health as well as evaluation of 
risk factors require attention if women's long-term needs are to be met. The 
psychological aspects of women's experiences are discussed further in the 
following literature review chapters and the need for longitudinal research in 
particular is highlighted. 
1.8 Chapter summary 
While providing contextual information, the content of this chapter also reflects 
the domination of the breast cancer literature by medical aspects of the disease 
from prevalence and risk to the efficacy of screening and treatment modalities. 
Indeed, women's experiences can incorporate a multitude of diagnostic tests 
and treatments and women are increasingly encouraged to actively participate 
in making treatment decisions that may influence their physical and 
psychological well-being as well as their future. However, treatment decision-
making is a complex process and our understanding of women's perceptions 
and experiences in relation to the wide range of available treatments is limited 
particularly given the shortcomings of existing studies and specifically the lack 
of applicability to the UK. Furthermore, the focus of the medical model on 
cure/treatment leads to a neglect of the chronic nature of breast cancer and the 
long-term physical and psychological effects that are emerging as being 
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associated with survivorship. The following chapter begins to review the 
psychological impact of breast cancer through exploration of the illness 
experience framed by theories of self, identity, and embodiment. The influence 
of the biomedical model is additionally considered in relation to women's 
relationships with their bodies and experiences. 
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CHAPTER 2: THE ILLNESS EXPERIENCE OF BREAST 
CANCER: SELF, IDENTITY, BODY AND EMBODIMENT 
2.1 Introduction 
Research on the illness experience is wide-ranging encompassing a number of 
areas from the meanings ascribed to illness, to the impact of illness on 
individuals' lives, sense of self and the coping strategies (discussed in chapter 
3) they employ throughout their experience. As described in Chapter 1 (p. 42), 
breast cancer constitutes a chronic illness and for many women can involve 
lengthy treatment regimes which have the potential to change women's bodies 
(via both surgical and non-surgical interventions) and sense of self. 
Furthermore, long-term immersion in the medical model has further potential to 
have an enduring impact on the relationship between women's body and self. 
Accordingly, this chapter reviews the prevailing theories of self, identity and 
embodiment. The specific gender connotations a breast cancer diagnosis can 
elicit are highlighted and the existing application of the aforementioned theories 
to the illness experience and breast cancer are discussed. 
2.2 Self and identity theory 
The study of self and identity is marked by confusion in the multitude of 
language used to analyse selfhood. Terms such as 'the subject', 'identity', 'the 
self', 'self-identity' and 'self-concept' are often used interchangeably. 
Differences in terminology reflect historical and political transitions and the use 
of these terms by a large number of disciplines, each with its own theoretical 
and methodological standpoints (Stevens, 1996) adds ambiguity and complexity 
to the literature base. Furthermore, colloquial understandings of self and identity 
permeate everyday life and as noted by Baumeister (1986) both terms are 
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social constructions and that defining something that does not exist is fraught 
with difficulty. While many writers choose not to differentiate between 'self' and 
'identity' (e.g. Piot-Ziegler, Sassi, Rafoul, & Delaloye, 2010) others argue 
against this stating that there are forms of identity that are not based on the self 
(e.g. collective identities). Despite debate regarding definitions, the study of self 
and identity remains central to the exploration of human behaviour and 
experience and the relationship between social life and subjectivity (Wetherell, 
2009). 
Philosophical and theological traditions discussed self and identity as early as 
the 1690s and established psychological and sociological literature on this topic 
dates back to the late nineteenth century with James' classic text in 1890 
(James, 1950). The 1950s saw an increased interest in the topic as it moved 
into mainstream psychology though was heavily influenced by sociological 
conceptions of self and identity (e.g. Goffman, 1959). Developments were made 
in the realms of personality (Snyder, 1974) and cognitive psychology (Markus, 
1977), all of which set the scene for exploration of a multifaceted self featuring 
enduring and changing components (Swann, 1983). 
2.2.1 Defining the self 
Numerous writers have attempted to capture the meaning of 'self' such as 
Charmaz (1987) who refers to the concept of self as "an emergent structure or 
organisation as it may shift or change as the person reflexively interprets the 
identification it imagines that self or others confer upon him or her" (p. 284). In 
other words, self is how one views oneself, otherwise termed self-concept, and 
is the product of relationships and interactions with others (Charmaz, 1983). 
Alternate definitions view self as "the autobiographical narrative used to account 
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for and explain the life world of the narrating "I" (Kelly & Dickinson, 1997; p. 
254). Self can also be defined in terms of one's personality, the combination of 
an individual's temperament, abilities, goals and values, and is what makes 
them unique, differentiating them from others (Tesser, 2002). It is additionally 
viewed by some as an executive agent regulating one's behaviour (Epstein, 
1975 as cited in Bertero & Wilmoth, 2007) and as a psychological entity that is 
the subject of a person's experiences, an inner being, it is "me". 
A distinction between an inner and outer self has been proposed on the basis of 
the philosophy of Levinas (1991) whereby the inner self may be described as 
the soul and is the private element of the self. Conversely, the outer self acts 
within the social world in terms of our habits and discourse as well as framing 
thought processes resultant to socialisation (van Wersch, 2001). As such, 
perceptions of self can be said to be context-dependent as how the self is 
experienced in a specific instance depends on time and place and specific 
historical, social and material circumstances (Goffman, 1959). It seems that 
most commonly, the term self refers to a representation or set of 
representations about oneself. It is the beliefs, perceptions, values and thoughts 
that people have about themselves. 
Harre (1998) expanded discussion of the components of self to describe three 
senses of self. The first, termed self-1, relates to the notion that each person 
has a unique viewpoint of the world from which to perceive and act upon the 
environment. In other words, self-1 has a sense of self as perceiver and actor, 
having a place in the world of things and events. Self-2 describes the concept 
that each person exercises their powers to display a unique set of attributes and 
with this goes the sense of totality of those attributes, at least what the person 
47 
believes them to be. Our culture and social positions are manifested in our 
bodily dispositions and tastes. Self-3 refers to the sort of person that we are 
taken by others to be. This stems from how our attributes are expressed 
publicly and in turn give rise to the beliefs and opinions of others. Self-3 is 
however complicated by the self that individuals want to project. 
2.2.2 Concepts of identity 
Harre's (1998) three aspects of personhood or self reflect the idea of personal 
(or individual) identity but he emphasises that in contemporary writing an 
individual's identity is not his or her singularity as a unique person but rather the 
group, class or type to which they belong. This description of social identity 
dates back to Gergen's work during the early 1970s and broadly refers to 
membership in social categories (Gergen, 1991). It requires distinguishing those 
who share an identity from those who do not, the marking out of "us" and "them" 
(Woodward, 2002). In laying claim to such an identity we assign a label to 
ourselves and to others. 
The concepts of individual and social identity are, however, not mutually 
exclusive. Who we are perceived to be by others (and the groups with which 
we are perceived to belong) may in turn influence how we see ourselves (e.g. 
Brewer, 2001) and result in a reaction to who the social world is defining us as 
being. Empirically speaking, identity comprises both personal and social 
components in varying combinations depending on social context (Oakes, 
Haslam & Turner, 1994). In addition, increasing globalisation and a continually 
changing human experience has led postmodern authors to acknowledge that 
individuals manage multiple and often conflicting identities (Frie, 2011). In the 
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case of women this may include identities such as that of wife, mother, and 
worker. However, a diagnosis of breast cancer may also elicit a renegotiation of 
a healthy identity to that of a 'patient' (Mathieson & Stam, 1995) as individuals 
attempt to become familiar with relevant medical discourse in order to express 
concerns and help them to navigate the healthcare system. Longitudinal 
exploration of the illness experience, as in the present study, may be 
particularly valuable in identifying multiple identities, including that of 'cancer 
patient' as well as revealing any changes to these identities throughout the 
healthcare trajectory. 
A further notion of identity that many researchers (e.g. Harre) do not explicitly 
discuss is that our identities are, in a sense, also those of our bodies. It can be 
argued that the body is a resource for interaction in the world as through the 
body an individual communicates and performs actions and tasks and 
consequently has meaning in the social world for its inhabitor and others 
(Corbin and Strauss, 1988). The body has become central to determining who 
we are and is the medium via which our identities can be conveyed and 
therefore can be observed as a representation of the self (Shilling, 1993). The 
body can provide a sense of certainty about who we are, about our identity, 
however the bodies we inhabit offer limitations to the identities to which we 
might like to lay claim (Woodward, 2002). 
2.2.3 Self and identity in illness 
As noted by Mercer (1990) "identity only becomes an issue when it is in crisis" 
(p.43) such as at times of illness and disability. Writers including Bury (1982, 
2001) and Frank (1997) have conceptualised the impact of illness on the self as 
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a biographical disruption whereby the story constructed by an individual about 
their past, present and future, their life, is interpreted and changed as a result of 
illness. Frank (1997) speaks of this in terms of a loss of destination or map of 
the future as plans are postponed or cancelled due to the physical limitations 
acquired through illness. Contemporary theories of self attempt to estimate the 
degree to which self may be fragmenting or breaking down (Elliott, 2008). 
Disruption to everyday tasks and daily habits elicited by illness and treatment 
regimes alter an individual's way of being in the world and challenges their 
ideas about their notion of self leading to new levels of insight (Goud, 1995). 
Clarke and James (2003) argue that in acquiring and accepting a medical 
diagnosis, an individual adopts a "transitional identity" as a person whose body 
is temporarily in poor functioning order, a person in a "special medically 
legitimated place in the social order" (p. 1993). This label enables the individual 
to accept a medicalised yet normal self (Tishelman and Sachs, 1998). 
The self can nevertheless detract and individuals may avoid viewing the self as 
ill and attempt to maintain an unchanged self, not reconstructing the self until 
acting in their changed daily lives means they have no choice but to accept an 
altered self (Charmaz, 2002). Alternatively, they may seek to return to normal, 
in other words, their life and self as it was prior to illness (restored self) or 
attempt to develop a self that they perceive to be better than before 
(supranormal self) (Charmaz, 1987). These theories assume a relatively fixed 
self to which the actor is trying to adjust and it is the loss of self that Charmaz 
(1983) argues constitutes a fundamental form of suffering. 
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2.2.4 Development of a new self-concept 
The postmodern view of the self, however, is one that is flexible, open to 
change and is continually being re-written (Bunton, 1997). Authors such as 
Corbin and Strauss (1988) argue that bodily limitations must now be 
incorporated into a new self-concept which arises from the development of new 
habits and ways of acting in the world. Similarly, Frank (1991) states that illness 
provides an opportunity to develop new behaviours, reassess priorities and 
reform relationships. In 1993 he described illness as a vehicle for self-
transformation suggesting three self-change narratives, the rediscovery of self 
who has always been; a radical new self that is still evolving; and finally, that 
there is no "new" self. 
Morse (1997) proposes a model of how when experiencing illness an individual 
might move towards the development of a new self-concept. Stages one and 
two, 'vigilance and disruption: enduring to survive', occurs during the acute 
phase of physical illness and relates to how this overshadows an individual's 
sense of identity, disruption or change. Stage three, 'enduring to live: striving to 
regain self', refers to how individuals are forced to recognise physical changes 
and the loss of function that they have experienced. At this stage the individual 
will start to seek to restore as much physical functioning as possible. The fourth 
stage, 'suffering: striving to restore self', is concerned with the effects of what 
has happened now being recognised and how the person begins to struggle 
with grief and mourning for what has been lost. They begin to hope and set 
realistic goals for the self while learning to live with difficulties and setbacks but 
they may also refuse to accept the limitations imposed on them by their illness 
and still strive for complete physical recovery. Stage five, 'learning to live with 
the altered self', is about accepting the (potentially changed) body and the 
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limitations it brings. This latter stage is akin to that of Norris and colleagues 
(Norris, Kunes-Connell & Stockard-Spelic, 1998) who describe 'reimaging the 
self' (p. 1). Essentially, learning to live with illness, particularly chronic illness 
involves changes in identity as the individual grapples with changes in their 
sense of self that existed prior to the illness (Karnilowicz, 2011). Accordingly, 
illness can dominate identity and permeate all aspects of life or effect only part 
of the self (Kralik, Koch, Price & Howard, 2004) and as such these theories may 
be highly pertinent to the chronic nature of experiencing breast cancer. The 
following section extends the discussion of the self by considering the 
relationship between the self and the body. 
2.3 Embodiment 
Embodiment is viewed as a way of thinking about human beings, one that is in 
contrast to Western thinking of mind and body as separate (Wilde, 1999). It is 
often described as being situated in the world, and being affected by social, 
cultural, political, and historic forces (Benner, 1994) though the term is often 
used loosely to refer to holistic understandings about life (Wilde, 1999). In 
replacing Cartesian dualistic notions which objectify the body, having a sense of 
embodiment is to see the person as a whole, an embodied being. This move 
enables new ways of thinking about human beings and facilitates the study of 
taken-for-granted processes in everyday life. The focus on how individuals live 
and experience the world through their bodies reflects the phenomenological 
philosophy of Merleau-Ponty (1962) and provides a perspective through which 
meanings of health and illness can be explored as well as how individuals 
manage issues in illness. 
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2.3.1 The impact of illness on embodiment 
In the normal course of events our relationship to our bodies remains largely 
unproblematic and only during illness does it become the object of attention 
(Leder, 1990). When the body becomes ill it becomes the central aspect of 
experience with illness taking over consciousness and dominating the 
individuals life (Kelly & Field, 1996). Chronic illness focuses an individual's 
attention on physical activities and bodily functions that were previously taken-
for-granted (Leventhal, Idler, & Leventhal, 1999). Illness disrupts the 
relationship between the self and the body as when the body changes the self 
becomes uncertain (Conrad, 1987). The body becomes detached from the self 
reflecting the traditionalist view of the body characterising it almost as a physical 
machine, animated by a controlling mind, which directs its activities and 
responses (Radley, 1994). This notion was reinforced by van den Berg (1966) 
who described how a healthy individual is allowed to be their body yet in illness 
this assimilation is disturbed and the body becomes foreign and an adversary 
which the person has to revolt against. 
Women frequently talk about their bodies in ways that suggest such 
fragmentation with the self located 'outside' the body (Williams & Bendelow, 
1998). Women in labour talk about 'the contractions' and during menopause 
discuss 'the hot flushes', not their own, not mine. Accordingly, the body is 
viewed as separate from the self and is seen as alien and dysfunctional 
(Williams, 1996). The medical model presupposes a 'self' or 'person' which is 
embodied in the sense of having a body not in the sense of being a body. As we 
think of our bodies as something we have, that belongs to us and which we 
maintain or allow to deteriorate, the medical world becomes primarily concerned 
with the body and in improving or restoring the place in which we inhabit. In this 
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context of medicine and illness the body is seen as a physiological system 
which is understood in terms of concepts that analyse its constituent parts and 
their relations (Radley, 1996). 
2.3.2 Medical objectification of the body 
Once an individual becomes ill their body becomes the object of the doctor's 
attention and is typically spoken about in terms of the 'diseased body parts'. In 
relation to cancer people often speak of an invasion inside the body even if the 
causative agent is external. The disease, for example a tumour, is seen as 
separate from the self and it is 'the tumour' that requires treatment, as opposed 
to the person. Cassell (1976) reported how a woman with a mass in her breast 
spoke of "my breast" and "my nipple" but of the tumour as "it", asking the doctor 
to "make it go away". Cassell argued that it is the disease itself that is objectified 
though conceded that this can be dependent upon the disease in question as 
such objectification has not been found, for example, in relation to diabetes and 
hypertension. This finding may be linked to the lack of a single body part as a 
focal point for lay discussions of diabetes and hypertension and perceptions of 
lower severity of these illnesses as compared with breast cancer. 
The medical world can reinforce the separation of body and self objectifying the 
body by making it a 'physical thing' which is subjected to medical procedures, 
treatment and prescribed regimens. The body becomes subject to radiation, 
drugs and/or surgery to make it function properly once more (Radley, 1996). 
Objectifying a disease such as cancer may however serve the needs of both 
patients and healthcare professionals helping to "distance that disease and the 
distress it causes from the person experiencing it" (Maclachlan, 2004, p.27). 
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This is perhaps self-protective and supportive for the patient and for the doctor 
who will feel as if they are "fighting an it and not you" (Maclachlan, 2004, p.27). 
This can be likened to Goffman's (1968) dramaturgical model which refers to 
how institutionalisation entails a 'stripping of identity' or 'loss of self' to aid 
patient management. Maclachan extends this discussion by referring to the 
objectification of the body resultant to patients trust in doctors and handing over 
control of the body stating that it is "probably a desire not to be responsible for 
dismembering oneself" (p.29). This could have particular connotations in 
relation to breast cancer treatment decision-making. 
Furthermore, as people come to regard their body in such a manner they too 
begin to describe their bodies through highly technical medical language. This 
communication with health professionals can leave the patient feeling that the 
medical details of their disease is the only valid focus of their experience but 
that it is necessary to learn this in order to articulate their concerns (Mathieson 
& Stam, 1995). They note that this cannot help but present an identity threat to 
individuals who are already asking themselves 'What does it mean to be a 
cancer patient?' As this sense of embodiment is renegotiated an individual will 
in conjunction be bringing together their past and present selves to form a 
coherent self-identity. 
2.3.3 Liminality 
The transition from health to illness and the ensuing disruption to life may be 
considered through the concept of liminality which is argued to link illness and 
embodiment (Little, Jordens, Paul, Montgomery & Philipson, 1998). When 
applied to the narratives of individuals experiencing colon cancer Little et al. 
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(1998) propose liminality to be a process consisting of two stages. Firstly, upon 
diagnosis, an individual is theorised to enter into a state of acute liminality, 
experiencing cancer as an existential threat. The length of time an individual is 
within this phase is believed to be dependent upon their biography, the nature 
of the diagnosis, treatment required and prognosis, as well as social support 
and individual differences. Sustained liminality is purported to follow and is 
entered as an individual reaches a convalescent phase and begins to reassert 
control of their lives while managing the uncertainty of cancer which they 
propose renders liminality an enduring state. The notion of sustained liminality 
can be likened to Frank's (1995) concept of 'cancer patientness' (p.136), an 
identity which remains given changes to the self and reinforcement (via the 
body, self and healthcare system) of being a person who has had cancer. Little 
et al. (1998) argue that sustained liminality is observed via narratives of 
experiencing illness through the body and that perceiving bodily limitations is to 
experience separation of body and self. Accordingly, the concept of liminality 
may have application to the present study given the potential long-term 
disruption to women's lives resultant to experiencing a chronic illness and, as 
discussed further in the remainder of this chapter, the potential impact of breast 
cancer on the relationship between the body and self. 
2.3.4 Frank's problems of embodiment 
Frank (1995), a key writer on the illness experience and self change, proposes 
four general problems of embodiment (control, body-relatedness, other-
relatedness, and desire) that everyone attempts to resolve throughout their lives 
yet which require more "self-conscious solutions" (1995, p. 29) during illness. 
The actions of the self to these four problems are theorised to give way to four 
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continua of responses. He further describes four ideal typical bodies which are 
said to characterise a tendency that the self can choose to enact given the 
problems of embodiment. 
The first of these problems refers to the body's capacity to control its 
functioning. While predictable, control requires no attention however Frank 
argues that disease is a loss of predictability which can result in losses in bodily 
functions and that "illness is about learning to live with lost control" (1995, p.30). 
Where being in control is at one end of the continuum, contingency, a belief that 
body control is not possible, is at the other. Seeking ultimate predictability or 
accepting a degree of contingency is the individual's choice when faced with 
this problem. Body-relatedness is Frank's terminology pertaining to the question 
'Do I have a body or am I a body?' Those individuals who are not in contact with 
their body, or not attending to it, are said to be dissociated from their body. In 
contrast, others may be living in a body with which they are associated which 
Frank argues is easy when an individual is healthy and not facing mortality. 
However during times of illness modern medicine encourages dissociation by 
focusing on, for example, statistics and diagnostic images rather than patient's 
bodily awareness. Once again, Frank argues that bodies are neither associated 
nor dissociated but individuals fall on a continuum between these extremes and 
that the quality of association changes. In discussing other-relatedness the 
extremes of dyadic and monadic are utilised when considering the body's 
relations to others. The dyadic body recognises that while the body is "mine" it 
is shared and influenced by others while the monadic body is separate and 
alone. While during illness some individuals choose this latter stance and 
medicine encourages monadic bodies by limiting patients contact with one 
another, Frank proposes that illness provides an opportunity for the sharing of 
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experiences. The final embodiment problem, desire (or wanting more), relates 
to individuals desires (e.g. for a normal, healthy appearance) and how these are 
expressed for, with and through the body (e.g. by disguising the impact of 
treatment). 
Frank further presents four theoretical ideal typical bodies that relate to each of 
the four continua of embodiment problems. These aim to provide a "heuristic 
guide" (Frank, 1991, p.53) that can be utilised to order and understand 
behaviour. He describes the body as a moral problem and that "selves act in 
ways that choose their bodies, but bodies also create selves who act" (Frank, 
1995, p. 40). Individuals, particularly during illness, may not choose their bodies 
yet they remain responsible for their bodies and decide how to exercise this 
responsibility. The first of Frank's ideal body types is known as the disciplined 
body and is one characterised by actions of self-regimentation. Given the loss 
of control experienced during illness this body-self attempts to reassert 
predictability and in doing so the self becomes dissociated from a body 
subjected to therapeutic regimes, one that has become "it" to be treated. This 
body is monadic rarely seeking association with others and lacks desire though 
make "good patients" in their medical compliance. The narrative of this body-
self is not told about itself, but about the pursuit of the regime. For the mirroring 
body the body is an instrument with the object of consumption, the aim being to 
recreate the body in the images of other 'ideal' e.g. healthier, bodies - those 
often depicted in popular culture. The mirroring body again seeks predictability 
though via appearance and accordingly fears disfigurement. This body-self is 
associated with its body on a surface level with the visual image being of 
paramount importance. Acting alone the body is monadic and while producing 
desires, these too represent its monadic nature as it wants for itself. 
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The dominating body is one defined in terms of force. It represents ill persons 
dissociating from their bodies but is dyadic in being linked to others by 
attempting to control them, displacing their rage against contingency at others. 
This domination of others Frank argues may reflect the bitterness experienced 
as a result of the loss of desire of the body-self. The communicative body-self is 
an idealised type accepting contingency as part of life as well as the fragility of 
the body. It is associated with itself acknowledging that the body-self is a unity, 
it is dyadic seeing its own suffering in the others bodies and produces desire, 
wanting and needing to relieve the suffering of others. This body is a 
communicating tool in both a verbal and non-verbal sense. Frank related this 
body to female reproduction and sees communicative potential in the caring 
practices of medicine. 
The naturalistic assumptions in Frank's typology have, however, been 
highlighted by Halford, Savage and Witz (1997) who note that his notion that the 
communicative body is uncontrollable is based on visualising menstruation, 
pregnancy and childbirth in passive terms. Shilling (1993) further states that 
Frank does not explore whether and how different types of body usage are 
chosen, changed or socially influenced. Yet, given the potential impact on 
women's bodies and self, Frank's problems of embodiment and body types may 
have application to women's experiences of breast cancer by providing a 
theoretical base to aid understanding of women's responses to the disease. 
The previous discussions have shown that questions or concerns about identity 
and self are closely related to embodiment. "If one accepts that the human body 
mediates experiences of the self, and that impaired bodies therefore mediate 
different experiences of the self and the world, then there is value in recognising 
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someone's physical status, although not defining them by it alone" (Maclachlan 
2004; p.72). This quotation illustrates the importance of considering the self and 
the body during illness and the potential of narratives in exploring meaning and 
links between individuals, culture and the illness experience. Furthermore, with 
regards to breast cancer the meanings ascribed to women's breasts and the 
psychological consequences associated with breast cancer surgery may have 
an additional impact on women's perceptions of embodiment and sense of self 
and are discussed in the following section. 
2.4 Breast cancer and the female body 
2.4.1 The meaning of breasts 
"Women do experience gender in an embodied way: they live in and through 
their bodies that are marked and framed through discourses and practices of 
society" (Lee, 1997; p. 455.). Women's perceptions of their bodies and the way 
with which they speak about their bodies cannot be separated from their 
experience of them, the way they use their bodies to engage with the world or 
from the opposing discourses through which we assign meaning to the body 
(Ciclitira & Weaver, 2002). Women's breasts are imbued with social, cultural 
and political meanings which shape the way women view and experience their 
embodied self. Breasts are coded as a marker of womanhood and femininity yet 
ambiguously both a visual sign of female sexualisation while a symbol of 
motherhood, being essential for nurturing infants (Wilmoth, Coleman, Smith & 
Davis, 2004). Women's breasts have become objectified and fetishised with 
such construction depicting breasts as decorative rather than functional 
(Millsted & Frith, 2003). Breasts are argued to have become over-sexualised as 
evidenced by images of topless women in daily national UK newspapers 
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through which some bodies are judged to be more valuable than others (Brook, 
1999). The presentation of these photos of 'perfect' breasts is claimed to make 
an average woman feel imperfect and can result in the need for psychosexual 
counselling following breast surgery (Ussher, 1993) given resultant changes to 
women's body image and sense of self. 
Langellier and Sullivan (1998) explored women's discourse and identified four 
types of talk regarding breasts, the first of which they termed 'medicalised 
breast' alluding to the construction of breasts as a physical body part with 
disease. The 'functional breast' was seen as a symbol of women's abilities to 
emotionally nurture others and the 'gendered breast' viewed breasts as a sign 
of femininity, beauty and sexual desirability. Finally, the 'sexualised breast' 
referred to the look and feel of the breast. Langellier and Sullivan proposed that 
women talk about these types of breasts as belonging to them and their 
children, husbands and lovers. Meyerowitz and Hart (1996) remark that women 
with breast cancer are targeted for research due to an underlying assumption 
that breasts are so central to the sense of womanhood that the illness will 
destroy women's psychological integrity. Conversely, other researchers argue 
that it is no more devastating to women than other cancers (Mendelsohn, 1990). 
2.4.2 The impact of breast surgery 
Women's fear of breast loss was illustrated in a Turkish phenomenological 
study exploring twenty women's experiences of undergoing an excisional breast 
biopsy (Demir, Donmez, Ozsaker & Diramali, 2008). Although the findings are 
limited by few available details regarding the study sample and sociocultural 
specificity it was identified that as well as an intense fear that the lump was 
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cancerous, women feared that their breast would be removed and several 
women experienced dreams of this nature. The study additionally reported that 
women discussed fear of cancer more frequently than fear of breast loss which 
supports previous findings of Fallowfield and Hall (1991) which indicated that 
women's primary fear is the fear of cancer. 
Furthermore, a qualitative study exploring Taiwanese women's experience 
about facing mastectomy (Fang, Shu & Fetzer, 2011) revealed that while 
survival was the priority, as this was necessary to fulfil women's responsibilities 
(e.g. childrearing), the meaning of the breast was integral to women's 
deliberations over mastectomy. The authors state that women persuaded 
themselves to accept mastectomy and an awareness of post-mastectomy 
alternatives such as reconstructive surgery and external breast prostheses 
alleviated some of the negative impact associated with breast loss. Moreover, 
some women in the study discussed how having smaller breasts reduced the 
effect of mastectomy. This research study employed three individual interviews 
followed by one focus group of seven women and employed content analysis. 
The small sample size and specific geographical area as well as recruitment via 
a support group constitute limitations. In relation to the latter point women who 
choose not to participate in support groups may have different experiences from 
women who do so. Finally, the length of time between mastectomy decision-
making and data collection was an average of four years which may have 
influenced recall. 
It is widely acknowledged that the loss of one or both breasts may evoke 
feelings of mutilation and altered body image (e.g. Kunkel, Chen, & Okunlola, 
2002) and experiences of emotional pain may continue long after treatment 
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completion as women grieve for the loss of a breast or feel as if part of them 
has 'died' (Langellier & Sullivan, 1998). Reporting data resultant from twenty 
interviews and a further eighteen questionnaires with women from a diverse 
range of backgrounds Manderson and Stirling (2007) report that women can 
feel embarrassed, ugly or self-conscious following mastectomy and that breasts 
are so aligned with the self that having one breast is associated with being 'half 
a woman' (p.82). This Australian anthropological study focused on women's 
lexical choices and found that after breast loss women continue to speak of 
'the/my breasts' and struggle to find words for the post-mastectomy body. In 
doing so women frequently refer to the absence of the breast or alternatively 
speak of the whole self to refer to the absent body part. Importantly, however, 
only some of the women questioned had undergone mastectomy following a 
breast cancer diagnosis with others having opted for prophylactic mastectomy. 
Women's experiences of altered body image following breast cancer surgery 
were at the heart of a qualitative phenomenological study of ten Swedish 
women aged 43-62 years (Lindwall & Bergbom, 2009). Analysis revealed that 
upon diagnosis women began to perceive their bodies as 'a stranger' (p. 282) 
and as housing something threatening to their existence and viewed their body 
as having failed them. Women eluded to the lack of symptoms experienced 
which they noted made acceptance of losing a breast more difficult. The body 
became a prison as women became dependent on others given the new 
limitations imposed by the body. Surgery was identified to be a frightening 
experience with women reporting being fearful of what the surgeon may find 
particularly in relation to spread to the lymphatic system yet it was deemed as 
necessary for survival. After surgery women saw their bodies as forever altered 
with the scars as reminders of breast cancer and had to learn to live with 
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different bodily discomforts due to treatment side-effects. The study authors 
acknowledge several limitations including the small sample size, that all women 
were married and living with their partners and that participants were 
interviewed only once between one and five months post-surgery. Furthermore, 
the majority of the sample underwent mastectomy with three women 
undergoing bilateral mastectomies and only two women having a lumpectomy. 
It is possible that women experience post-surgery bodies differently depending 
upon the type of breast surgery conducted. 
Mastectomy patients, for example, have been found to be more likely to dislike 
their appearance without clothes (e.g. Alicikus et al., 2009) and avoid looking at 
themselves in the mirror (Langellier & Sullivan, 1998). Van Wersch (2001) 
additionally comments on the importance of dressing behaviour as identified in 
several prior studies whereby women undergoing lumpectomy cite relief at not 
needing to alter their wardrobe and being able to wear their existing clothes. 
When given the choice of mastectomy or lumpectomy the meaning of a 
woman's breasts may influence the surgical treatment decision-making process. 
In a passage from Moch (1995), a book discussing twenty women's breast 
cancer stories, one woman comments that 'I didn't want to lose my breast...I 
knew that for sure' (p.14) with Moch adding that for this woman her breasts 
were too important to her sexually to be completely removed and consequently 
a lumpectomy was chosen. 
In a review of sexuality after breast cancer focusing on published papers 
(quantitative and qualitative) from 1998 to 2010 Emilee, Ussher and Perz (2010) 
found that while some women experience positive changes to their sexuality 
following a diagnosis the vast majority of evidence suggests a range of negative 
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physical and emotional changes to women's sexuality. Disturbances in sexual 
functioning, chemically induced menopause, loss of femininity, feelings of 
sexual unattractiveness, and negative body image were among the factors 
identified with psychological changes being influenced by social constructions of 
'normal' sexuality and femininity. Overall, issues with sexuality and body image 
in particular were found to be most common during the first year. 
Moreover, body image has been reported to be more likely to be affected if a 
mastectomy had been undertaken rather than breast conserving or 
reconstructive surgery (e.g. Fobair, Stewart, Chang, D'Onofrio, Banks, & Bloom, 
2006). In a sample of 56 women with breast cancer aged 37 to 68 years 
Moreira and Canavarro (2010) also found less disturbance to quality of life if 
breast conserving surgery rather than total mastectomy was undertaken. This 
study sought to overcome some of the issues prevalent in body image research 
by adopting a longitudinal approach and use of a multidimensional perspective 
on body image. In doing so the study examined dimensions of body image 
(appearance investment, self-consciousness, shame and appearance 
satisfaction) and psychosocial adjustment (QoL and emotional distress) from 
the time of surgery (time one) to six months post treatment (time two). The 
authors reported a significant decrease in anxiety levels over time showing that 
levels of psychological distress are higher during the initial phase of the illness. 
Moreover, measures taken at time one demonstrated that women's perceived 
importance of their body and having a mastectomy compared with breast 
conserving surgery were predictors of subsequent appearance satisfaction, self-
consciousness of appearance and body shame. In relation to body image only 
body shame increased over time and initial body image was not found to predict 
later adjustment. This Portuguese study, however, lacked baseline assessment 
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of all study variables, including body image, prior to surgery. Furthermore, the 
timing of the first assessment point two to four days post-surgery may have 
influenced the findings as many women were yet to observe the bodily changes 
resulting from surgery. An issue pertaining to the internal consistency of one of 
the quality of life measures was additionally acknowledged by the researchers 
who also note that a behavioural dimension of body image was not considered 
in the study. 
Similarly, a cross-sectional survey of one hundred women in Brazil concluded 
that measures related to sexuality were on the whole unfavourable following 
mastectomy (Manganiello, Hoga, Reberte, Miranda & Rocha, 2011). Sexuality 
was most affected in women with low educational level, those with older 
partners, and women who did not have a breast reconstruction. The study 
limitations do, nevertheless, include the use of a cross-sectional design, 
relatively low number of participants, and sample characteristics commensurate 
with a Latina population, which limit applicability to other populations. This 
section has reviewed the psychological impact of breast surgery including the 
effects on women's body image and sexuality. In the discussion that follows, the 
emphasis on disguising breast surgery via reconstruction and the wearing of 
external breast prostheses is highlighted and the implications of doing so in 
relation to the self is considered. The content of these two sections may be 
particularly pertinent to the present study given the high rate of mastectomies 
conducted in the North East of England (see Chapter 1, p.26). 
2.4.3 Reconstruction and prostheses as the norm 
Young (1992) argues that Western medicine's objectification of the body has led 
to women's breasts being viewed as detachable and replaceable. Indeed, it is 
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very uncommon for a woman who has undergone mastectomy to forego 
reconstructive surgery or the use of a prosthesis (Crouch & McKenzie, 2000). 
However, Matuschka who bared her mastectomy scar on the cover of New York 
Times magazine in 1993 writes "If we keep quiet about what mastectomy does 
to women's bodies, if we refuse to accept women's bodies in whatever condition 
they are in, we are doing a disservice to womankind" (1993, p.162). Women 
have reported wearing a prosthesis to appear 'normal' to those in public and to 
avoid being viewed as asymmetrical or less than whole by male partners, 
husbands and children (Manderson & Stirling, 2007). This is exemplified by 
Thomas-MacLean's (2005) study through which interviews revealed women's 
descriptions of feeling a loss of symmetry and that surgery had led them to 
'manage appearances' or 'hide their deformity' from others. 
Similar findings were reported following a series of focus groups exploring 
women's experiences of external breast prostheses (Roberts, Livingston, White 
& Gibbs, 2003). Twelve women recently fitted with a prosthesis, fourteen breast 
care nurses and thirteen prosthesis fitters participated in this Australian study. 
Prostheses were described as restoring women's impaired body image, sense 
of normality and feminine identity. Nevertheless, women's initial reactions to 
their use was generally found to be negative given practical problems such as 
dislodgement, restricted choice of clothing, sweating in warm weather and 
discomfort due to the weight of the prosthesis. Many women chose not to wear 
their prosthesis when at home alone and viewed the prosthesis as a foreign 
object which served as a constant reminder of their breast loss. Adjustment to 
the use of a breast prosthesis was found to improve over time though provision 
of sufficient information and support, characteristics of the fitter and the fitting 
experience aided women's acceptance and satisfaction with their prosthesis. A 
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lack of information regarding the focus group participants, however, somewhat 
limits the interpretation of the study findings. The homogenous nature of the 
small sample particularly with regards to the women who had experienced 
breast cancer and mastectomy is an additional limitation. All such women were 
considered to have adequate spoken and written English and were identified as 
being better informed about prostheses than women for whom English was not 
their first language. Furthermore, these study participants were treated in a 
public hospital which had a high presence of breast care nurses. 
Through three case studies Bredin (1999) illustrated that mastectomy changes 
the female body, self and social identity, the latter via concealment, withdrawal, 
self-consciousness and changed behaviour with others. Bredin argues that 
conventional medicine reinforces the concealment of problems experienced by 
some women in living with an altered body image despite the use of prostheses 
to enable them to conform to "normality". The women depicted in Bredin's study 
participated as they were experiencing difficulties adjusting to their changed 
body image and in conjunction with the small sample size these cases may not 
be typical of women's responses to mastectomy. 
Support for Bredin's conclusions comes from Spence (2001), who after 
personally experiencing breast cancer notes that mastectomy can result in not 
only the loss of a breast but in the loss of social identity. Spence comments that 
breast cancer professionals assume that female identity is totally invested in 
'femininity' and they too focus on their ability to reconstruct women. However, if 
a woman does not choose reconstruction or the use of prosthesis she, by 
default, chooses a desexualised image and loses her feminine social identity. 
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What is more, this has led to the argument that a prosthesis not only hides the 
lack of symmetry but is a disguise for those who do not wish to be regarded by 
others as potentially doomed. In an exploratory study of data collected over two 
interviews undertaken six to eight weeks apart with seven women who had 
undergone mastectomy Crouch and McKenzie (2000) concluded that from the 
moment a woman is diagnosed as having breast cancer she will begin to think 
about life with one or no breasts and will wonder how to go on so diminished. 
The maimed and asymmetrical body among bodies not so affected will forever 
be a reminder of the unpredictability of the body, uncertainty about the future 
and fear of recurrence and death. Prostheses served to hide the perceived lack 
of symmetry and flawed beauty in social circumstances but the endangered 
body in conjunction with women's fears were experienced as a secret, private 
pre-occupation. Women were interviewed two to twenty years following 
mastectomy and such retrospective data collection may have influenced 
women's recall and in turn their illness narratives. 
Similarly, Goffman (1997) argues that this cultural necessity to disguise and 
keep secret single-breasted status not only prevents a woman from being 
'discredited' but serves as a reminder of living with a stigmatised disease. 
Normalising appearance in an attempt to regain womanhood and keep illness a 
secret to avoid stigmatisation has more recently been noted by Vargens and 
Bertero (2007). This notion is of particular importance when considering the 
links between the internalisation of stigma, self-blame (Crocker & Quinn, 2000) 
and low-self-esteem (Else-Quest, LoConte, Schiller, & Shibley Hyde, 2009). 
Ethnographic research involving interviews with twenty three cancer survivors 
demonstrates the implications of presenting the changed body in social 
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encounters including avoidance by others, perceiving being stared at and being 
met with specific statements that prevent further dialogue about experiencing 
cancer (Rasmussen, Hansen & Elverdam, 2010). Only four of the participants in 
this Danish study had breast cancer, all of whom had undergone surgery 
though the amalgamation of their data with other cancers and lack of gender 
specific consideration limits the conclusions that can be drawn. 
Nevertheless, in a similar vein Lorde (1985) criticises 'other one-breasted 
women' for 'hiding behind the mask of prosthesis or the dangerous fantasy of 
reconstruction' and argues that 'the socially sanctioned prosthesis is merely 
another way of keeping women with breast cancer silent and separate from 
others' (p. 16) - for the sake of society, so as not to spoil public optimism. 
Likewise, Broom (2001) views reconstruction as a way of concealing the 
material traces of cancer treatment. Breast reconstruction is deemed as a 
means by which women can be aided to rebuild their body image, confidence 
and self-esteem that has been diminished following breast surgery (e.g. Farrell 
Yelland, 2000). An investigation of immediate breast reconstruction with silicone 
prosthesis one year post-surgery in a group of 61 women who had undergone 
prophylactic mastectomy and 63 women who underwent mastectomy for breast 
cancer reported that the most important perceived advantage of such 
reconstructive surgery was not requiring the use of an external breast 
prosthesis (Contant et al., 2004). Approximately one third of participants were 
found to have specific complaints regarding the implant including pain and skin 
tension though 80% of women were satisfied with the surgery. Lower 
satisfaction was found to be predominantly associated with poor perceived 
cosmetic outcome, a greater need for information and higher number of specific 
prosthesis-related complaints. The Dutch study is limited by the use of self-
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report measures and the fact that in the UK immediate breast reconstruction is 
not available to all women with breast cancer. It does, nonetheless, highlight the 
importance women ascribe to having breasts. Clothing is also a commonly 
reported reason provided by women for choosing breast reconstruction as 
opposed to breast prosthesis as women perceive the latter option to limit 
clothing choices and reduce enjoyment in activities such as swimming and sun-
bathing (van Wersch, 2001). 
The emphasis on breast prostheses and reconstruction would suggest that 
breasts are a necessity, however, prostheses cannot perform the material 
functions of a real breast. As such Broom (2001) argues that reconstructed 
breasts are for the sexual incitement of others and that public advice describing 
reconstruction as a means by which a man's anxieties and distress can be 
reduced implies that the woman should work in accordance with her partners 
preferences and that pleasing her partner should be a high priority regardless of 
her own emotions. 
The quantity of literature depicting breast cancer and breast reconstruction in a 
positive light is overwhelming. Farrell Yelland's (2000) book, for example, 
depicts women's stories of breast cancer with celebrities discussing their 
reconstruction, always in a positive light, and often describing the new breasts 
as being better than before. For writers like Broom (2001) the concern is that in 
masking injuries and always portraying breast cancer in a positive way progress 
towards less savage treatments and more effective primary prevention may be 
impeded. Lorde (1985) too contributes to this debate by stating that the 
emphasis on reconstruction and prosthesis undermines the individual struggles 
of women to cope with the consequence of the disease and to take control over 
71 
their lives after breast surgery. Furthermore, despite a change to women's inner 
self as a consequence of experiencing breast cancer, reconstruction may 
provide an opportunity to keep the outer self unchanged thereby requiring less 
reconstruction of a woman's sense of self (van Wersch, 2001). 
The nature of breast cancer can therefore complicate the connection between 
identity and the body via breasts being seen as a symbol of femininity and 
sexuality and by influencing a woman's sense of embodiment. 'The body is and 
is not the self: if they were entirely separate, the mastectomy would not be 
traumatic; if they were entirely coextensive, it would not be speakable' 
(Hartman, 2004, p.156). Crouch and McKenzie (2000) argue that treatment 
decisions are most likely to be influenced by women's feelings and attitudes 
towards their bodies and the preservation of the integrity of their bodies. What is 
more, if breast conservation is as important as it seems to most women by 
implication the loss of a breast can be assumed to be a considerable threat to a 
woman's embodied identity and self (Crouch and McKenzie, 2000). The 
following section brings together the notions of self, body, and embodiment in 
relation to women's experiences of breast cancer. 
2.5 Self, embodiment and women's experiences of breast cancer 
Qualitative research investigating women's experiences of breast cancer and its 
meaning has increased in the last decade however it is predominantly focused 
on pre-determined aspects of women's experiences and applying theoretical 
models. Analysis of individual's illness stories can provide an insight into 
experiences of suffering and coping in the context of chronic illness. Frank 
(1995) developed the concept of illness narratives and proposed three narrative 
types through which illness experiences are revealed. Frank's (1995) first 
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category of illness narratives is argued to be the most common form of 
narrative, restitution. The structure of such a narrative focuses on the move 
from health to sickness and a return to a previous state of health. It is about 
moving back and forth from health and illness and focuses on experiences of 
diagnostic tests and medical regimes. Frank argues that while it can be 
advantageous to hear stories of a return to good health it can equally be 
considered to be medicalised and consequently a form of social control, 
reinforcing the importance of the medical model. The chaos narrative "imagines 
life never getting better" (1995; p. 97) and tends to lack specific sequencing of 
timing. These narratives may therefore be difficult to hear though Frank argues 
it is vital to hear these stories of "wreckage" as they enhance our understanding 
of the illness experience. The quest narrative depicts illness as being useful and 
is commonly seen in terms of illness as a "challenge" which gave impetus for 
change. Frank suggests three sub-types to the quest narrative: memoir 
whereby events are related simply; manifesto in which illness is reported to be a 
motivator for social change or action; and automythology where illness reveals 
fate or destiny (Frank, 1995). The quest narrative may be considered 
therapeutic or conversely limited depicting movement through illness "as too 
clean and the transformation too complete, and they implicitly deprecate those 
who fail to rise out of their own ashes" (Frank, 1995, p.135). 
Through interviews with twelve women Thomas-MacLean (2004b) explored 
experiences of breast cancer in relation to Frank's three narrative types. She 
found that restitution was most desired by participants and reflected their desire 
to return to a time of normality. Thomas-MacLean eluded to the prospect that 
for women with breast cancer full restitution may not be possible particularly 
given fears of recurrence and that conscious action through the use of 
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prostheses is needed daily to maintain "normality". Accordingly, the term 
"reconstruction" was proposed to replace restitution especially given the 
possibility that some women may not want to return to their prior status. She 
noted contradictions in women's restitution narratives as they expressed issues 
pertaining to a changed body yet stated that they had not changed as a person. 
Chaos narratives occurred most frequently when participants talked about body 
difficulties and the involvement of other people in their lives and manifested at 
different times in participants' narratives. The study reported identifying few 
quest narratives and noted that some women who recalled stories from media 
quest narratives felt that these missed elements of chaos that represent the true 
nature of the breast cancer experience. 
The application of Frank's narrative types to the narratives of women with 
breast cancer in the Thomas-MacLean (2004) study revealed limitations in that 
some women found it difficult to articulate their experience and for one woman 
Thomas-MacLean reported no emerging narrative type as breast cancer was 
perceived to be insignificant. The study itself was limited by the sample used 
including only women who had undergone mastectomy, as opposed to 
lumpectomy, and included no women who had elected to undergo 
reconstructive surgery. Moreover, the time since diagnosis ranged from one to 
twenty four years which may have influenced women's recollections of 
experience and narrative types. 
A meta-synthesis (Bertero & Wilmoth, 2007) of 30 qualitative research reports 
conducted between 1990 and 2003 with 795 women from the USA, Canada, 
Australia, the UK, Sweden, Norway and South Korea and Hong Kong, 
investigated the impact of breast cancer on the self. Methods used by the 
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included studies were described as qualitative, grounded theory, 
phenomenology, narrative, content analysis, focus groups and combinations of 
these methods. Four aspects of the self were found to be affected by a breast 
cancer diagnosis and its treatment. Firstly, awareness of their own mortality was 
illustrated through women's descriptions of an overwhelming fear of death 
which for many women led to a review of their life, seeking meaning in their 
illness and reordering life's priorities. Living with an uncertain certainty 
constituted the second finding with women perceiving the only certainty as 
knowing they would be a "breast cancer patient". Being uncertain about their 
future quantity and quality of life affected women's sense of self as they tried to 
regain control of their lives and resume their normal activities. 
The third aspect, attachment validation was found to comprise of four elements, 
the validation of women's own self via emphasising the importance of their 
existence, which often involved spiritual reflection. Validation from women's 
significant other that they are loved despite a changed body was considered 
vital to women's well-being. Validation from family was more complex as 
women tried to protect loved ones yet wanting to tell the truth though typically 
felt that their families did not understand their experience. The healthcare team 
also provided validation by recognising women as individuals and facilitating a 
role in treatment decision-making. Finally, redefinition of the self in both a 
physical and mental sense emerged from the review. Women were described 
as experiencing an altered body image, feeling imperfect due to breast surgery 
and the other treatments undertaken. Women's sense of self was affected with 
many studies reporting that women no longer felt complete questioning their 
womanhood and femininity. Limits to physical functioning additionally led to 
decreased value of the self. 
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Bertero and Wilmoth (2007) summarised by concluding that following a breast 
cancer diagnosis women work to rebuild their lives, incorporating a new outlook 
and a new sense of self. This review employed measures to maximise the 
credibility of the data interpretations though some issues are apparent. When 
describing the process of meta-method via assessment of the primary research 
papers the authors report finding that five articles were literature reviews and 
eight were predominantly quantitative in nature but with some qualitative 
element, one article was a single case and six did not meet the review inclusion 
criteria. Furthermore, the vast majority of studies were from the USA with only 
three studies from the UK and content analysis was the most common 
approach of the included studies potentially limiting the depth of data collected. 
A number of factors influential in women's experiences were also not reported 
in the review such as the types of treatment women underwent from the studies 
and the length of time from diagnosis to data collection. 
Helping to address the paucity of UK based research and a lack of longitudinal 
data collected from the point of diagnosis McCann, Illingworth, Wengestrom and 
colleagues (2010) conducted an exploration of the experiences of twelve 
women with breast cancer within the first year following diagnosis using 
biographical disruption and embodiment to guide analysis. They described the 
emergence of two key concepts 'Identity transition: moving between health and 
illness' and 'Making the transition to the future? Living with breast cancer and 
moving on'. The authors illustrated that women's narratives move towards 
illness with references to bodily changes such as breast and hair loss and that 
this altered appearance often led to a disrupted identity and sense of self. As 
time progressed many of the study participants discussed both difficulties 
coping with multiple side-effects and with envisaging an end to their experience. 
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Physical scars and ongoing side-effects from hormonal therapies were believed 
to contribute to this resulting in breast cancer having a prevailing effect in 
women's lives. The paper, however, reports few methodological details lacking 
information pertaining to the timing of the interviews during the first year and the 
type of surgery experienced by the twelve women. A highly structured and 
framed approach to data collection and analysis may have further served to limit 
the exploration of the meanings of breast cancer to the individual women 
interviewed. This is particularly so given that this was part of a larger study into 
a number of cancer experiences and accordingly a generalised interview 
schedule was used. 
A second UK based longitudinal study (Tighe, Molassiotis, Morris & Richardson, 
2011) did focus on women's experiences of breast cancer and aimed to explore 
issues relating to symptoms, treatments and its effects. Interviews were 
conducted with ten women, the majority with early stage breast cancer, over the 
course of a year (39 interviews in total). The study adopted a thematic narrative 
approach using the 'cancer journey' as a device to aid 'storytelling', essentially 
data collection from the earliest possible point from diagnosis through to living 
with and beyond cancer treatment. All women were undergoing active treatment 
involving combinations of chemotherapy, radiotherapy, endocrine therapy, with 
eight participants having undergone surgery. The core themes said to have 
been identified across all cases were symptom experience, coping and 
meaning, and relationships, however the authors note that these were personal 
to each sufferer. Rather than providing an overview of these themes the paper 
presents findings from only four women's experiences representing the 
overwhelming aspects of personal suffering for these individuals. The findings 
focus on the symptom experience though the paper concluded that women feel 
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unprepared for the impact on their abilities to cope. Furthermore, unmet needs 
for fatigue management, adaptation to hair loss and disfigurement, and for 
sexual health and relationship counselling were identified. Finally, the study 
concluded that women's narratives show a cancer journey that was not static 
but an unstable process of despair and renewal in the context of their inter-
personal relationships and inter-personal existential crises. 
While the two aforementioned studies (McCann et al., 2010; Tighe et al., 2011) 
adopt a longitudinal perspective, in contrast to the present research, a focus on 
specific aspects of the illness experience (transitions and the symptom 
experience) limits the insight gained into women's experiences of breast cancer 
and the meaning of issues relevant to women over time. Nonetheless, in 
summary, it can be surmised that breast cancer may impact upon women's 
identities, sense of self, and embodiment to varying degrees given changes to, 
and perceptions of, the body and ways of being in the world. 
2.6 Chapter summary 
Despite the complexities of defining the multifaceted concepts of self and 
identity, being diagnosed with a life-threatening illness and specifically one 
underpinned with feminine connotations undeniably challenges a woman's 
sense of who they are and how they view their body. It alters how they view 
themselves in relation to others and in turn influences their interactions. With 
regards to embodiment, in accordance with the aforementioned model of Morse 
(1997), women revalue their lives and their focus may shift from the outer body 
to the inner person. In doing so they become more embodied in 'what they are' 
and less embodied in what they physically can do and they incorporate any 
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physical changes into a new identity and learn to 'live with the altered self'. 
However, adaptation to bodily changes and a new self-concept depends on the 
physical response of a woman's body as well as her emotional well-being. 
Psychological adjustment to breast cancer is discussed in the forthcoming 
chapter wherein theories of stress and coping are reviewed and the impacts of 
coping styles on women's well-being are considered. 
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CHAPTER 3: STRESS AND COPING WITH THE BREAST 
CANCER EXPERIENCE 
3.1 Introduction 
The psychological impact of receiving a diagnosis of breast cancer and an 
exploration of how women cope with the illness are the focus of review 
throughout this chapter. Models of stress and coping are firstly described in 
order to provide a theoretical underpinning to which women's experiences of 
breast cancer may be applied. Research investigating women's adoption of a 
range of coping strategies and the psychological issues previously identified as 
being faced by women during their experience of breast cancer are evaluated. 
3.2 Theories of stress and coping 
A number of theories of stress and coping have been applied to illness and 
specifically to breast cancer and consequently may be of relevance to the 
present study. Stressors can be defined as "threats, demands, or structural 
constraints that, by the very fact of their occurrence or existence, call into 
question the operating integrity of the organism" (Wheaton, 1997; p.46). This 
description would seem to acknowledge that stressors may have biological, 
personal and social components. 
3.2.1 Physiological models of stress 
One of the earliest models of stress developed by Canon (1932 as cited in 
Ogden, 2007) proposed that external threats elicit a 'fight or flight' response 
denoted by physiological changes of increased activity rate and arousal. In 
times of emergency the instinctive response to the external stressor results in 
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an individual seeking to escape from or defend themselves from the threatening 
situation. However, the re-classification of breast cancer to a chronic illness 
(Tritter & Calnan, 2002) may limit the applicability of the fight or flight model to 
breast cancer. While Selye's (1950) general adaptation syndrome is also based 
on physiological reactions to stress it does consider stress in the longer-term. 
The model consists of three main stages, 'alarm' which occurs as soon as the 
individual is faced with the stressful situation and refers to an increase in activity 
of bodily processes. If the stressor is not removed the individual enters the 
second stage, 'resistance', during which the individual attempts to cope and 
reverse the effects of the first 'alarm' stage. The final stage 'exhaustion' is 
reached following repeated exposure to the stressful situation leading to bodily 
resources e.g. sugars, running out. Selye purports that such deficiencies cause 
physiological disorders and potentially death. These models, however, view 
stress as an automatic response to an external stressor neglecting 
psychological factors and the potential for an active interaction between the 
individual and the stressor rather than simply a passive response. Furthermore, 
the literature exploring the parameters of these models is predominantly 
conducted on animals and women are underrepresented in human stress 
studies. 
Proposed as an alternative to Canon's (1932) theory of fight or flight, the "tend-
and-befriend" biobehavioural model (Taylor, Klein, Lewis, Gruenewald, Gurung 
& Updegraff, 2000) describes women's responses to stress as having evolved 
as a result of differential parental investment. Specifically, it is theorised that 
females respond to stress through a tending pattern which involves nurturing 
activities designed to protect the self and offspring, and by creating and 
maintaining social networks (befriending) that reduce risk. Taylor et al. (2000) 
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contend that the model is based on the attachment-caregiving system, and that 
neuroendocrine responses in conjunction with female reproductive hormones 
underpin women's pattern of stress reactions. While this theory is limited due to 
the combined observations from human and animal literature used by the 
authors as well as a lack of consideration of the nature of the stressor, the focus 
on female stress responses may have applicability to the present study. 
3.2.2 Psychological models of stress 
The role for a psychological dimension in stress responses was introduced by 
Lazarus in the late 1970s in his transactional model of stress and theory of 
appraisal (e.g. Lazarus & Folkman, 1987). The model states that if an individual 
perceives an event as stressful a stress response is elicited. Individual 
differences are therefore paramount in this theory with primary appraisals, those 
made initially by the individual, being viewed as either irrelevant, benign and 
positive, or harmful and negative. During secondary appraisal the pros and cons 
of the individuals coping strategies are evaluated. 
In relation to cancer there is a growing body of literature on the effects of stress 
on cancer relevant biological processes (e.g. Antoni et al., 2006) and recent 
reviews present data to suggest that psychological intervention can influence 
stress-tumour pathways (McGregor & Antoni, 2009). This highlights the 
importance of adaptation to the stressful aspects of cancer which can vary 
along the disease trajectory from diagnosis to awaiting and undergoing 
treatment and on to treatment completion, medical follow-up and survivorship 
(Knobf, 2011). Research with 232 women with newly diagnosed breast cancer 
indicates that such adaptation is twofold (Compas, Beckjord, Agocha et al., 
2006). This begins with involuntary automatic responses to the stress of the 
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diagnosis and treatment illustrated by uncontrollable, intrusive thoughts or 
heightened psychological reactivity. Secondly, there are controlled voluntary 
responses represented by goal directed efforts to cope with the experience. 
Accordingly, in exploring women's longitudinal experiences of breast cancer, 
the present study may provide greater insight into women's perceptions of, and 
responses to, stress as well as coping mechanisms utilised throughout the first 
year following diagnosis. 
3.2.3 Theories of coping 
Cognitive theories of coping posit that major life stressors challenge an 
individual's view of the world and sense of self due to the discrepancy elicited 
between the information inherent in the stressor and people's positively skewed 
expectations about the world (Lepore, 2001 as cited in Kernan & Lepore, 2009). 
The belief that 'bad things do not happen to good people' (Kernan & Lepore, 
2009; p. 1177) is challenged when a 'good' person gets cancer and it is this 
psychological discord that leads to distress and an individual utilising coping 
efforts to resolve the discrepancy (Kernan & Lepore, 2009). On the basis of 
Lazarus' theory, the stress and coping paradigm of Lazarus and Folkman 
(1984) denotes that the greater the perceived threat and less able an individual 
feels in relation to coping, the greater the stress response. The model proposes 
that coping strategies can be classified as 'problem-focused coping' referring to 
behaviour directed at solving the problem and 'emotion-focused coping' which is 
behaviour directed at changing emotional reactions to the problem. This latter 
element covers defensive and avoidance strategies. A further classification can 
be made here between active and passive strategies (Carrico et al., 2006). 
Avoidance is otherwise termed a passive strategy and relates to an individual's 
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attempts to avoid rather than confront the source of distress, whereas active 
coping efforts are aimed at facing a problem directly and determining viable 
solutions to reduce the effect of the stressor (Folkman, Lazarus, Dunkel-
Schetter, DeLongis & Gruen, 1986). Coping is viewed as being independent of 
outcome. In line with the "goodness of fit" principle emphasising the importance 
of fit between coping and context, problem-focused coping is said to fit 
controllable situations compared to emotion-focused coping which fits 
uncontrollable ones (Folkman, Schaefer & Lazarus, 1979). It is nevertheless 
argued that this general principle does not cover the entire range of strategies 
that could be effective for coping with uncontrollable stressors (Benyamini, 
2009) such as a breast cancer diagnosis. 
Alternatively, self-regulation models attempt to explain how individuals cope 
with stressors and deem people to be problem-solvers motivated by goals, 
gathering information which is integrated with prior knowledge in order to form a 
subjective assessment of their status, which in turn guides their coping efforts 
(Benyamini, 2009). The most prominent theory of self-regulation in the health 
and illness literature is Leventhal's Common-Sense Model (CSM; Leventhal, 
Meyer & Nerenz, 1980). This proposes that when an individual encounters a 
health problem a process is initiated at both cognitive and emotional levels 
which work in parallel to firstly form illness representations by drawing upon 
current somatic symptoms and comparing these to previous illness experiences 
and external information. Subsequently, coping procedures are executed aimed 
at managing the stressor and strategies are implemented to address its 
emotional representation. Finally, an individual is said to appraise their status 
based on their coping efforts and this steers future actions. 
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If an individual perceives the outcome to be unsatisfactory this can either lead 
to changing their initial representations and coping strategies or to retain their 
initial representations but change their methods of coping. Furthermore, the 
model purports that there are higher level abstract representations and lower 
level concrete representations, each level with specific coping strategies. As an 
example, at an abstract level cancer worries may lead to greater attention to 
bodily changes while at a concrete level identification of a specific symptom 
may lead the individual to seek care (Benyamini, 2009). While the process 
should be the same for all individuals the content will differ at the level of the 
stressor and of the self, given that the self-regulation process is said to be 
embedded within the self, as well as the social and cultural context ascribed to 
the illness. The longitudinal nature of the present study may be particularly 
beneficial in facilitating exploration of variation in coping strategies over time 
and the implications for women's breast health. 
The relationship between stress and illness is complex and can be mediated by 
a number of factors including coping styles, social support, notions of control, 
personality and lifestyle. Moreover, stress can affect an individual in both 
psychological and physiological terms and coping responses can be 
multifaceted. An Australian study aiming to identify psychosocial concerns and 
needs explored coping via seven focus groups involving thirty four individuals 
including women diagnosed with breast cancer within the last year, oncology 
nurses, and volunteers working with cancer patients, the majority of whom had 
experienced breast cancer (Beatty, Oxlad, Koczwara & Wade, 2008). Thematic 
analysis revealed consistency across the three participant groups in relation to 
five themes the first of which was coping with side-effects including fatigue, 
insomnia, lymphoedema, and malnutrition. The second theme related to coping 
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with self-concept change incorporating coming to terms with an altered body 
image and changed roles within the home. Stress and adjustment reactions 
were commonly reported in relation to diagnosis, treatment and treatment 
completion with women citing distress, depression and isolation. Managing the 
impact on others, relationship and intimacy issues, and managing the emotional 
reactions of others in their social networks constituted the fourth theme. Finally, 
theme five, termed survival and growth, encompassed issues of coping with 
uncertainty and mortality. It should be noted that the three specific concerns of 
uncertainty of treatment success, coping with fatigue and maintaining a 'game 
face' were not cited by the nurse participant group. The five themes elicited a 
number of needs women perceived would aid their ability to cope with breast 
cancer including wanting to increase bodily self-esteem, develop a non-breast 
cancer identity and explore the positives of diagnosis. Focusing on gaining 
control through exercising personal choice, finding opportunities for emotional 
expression, filtering information to minimise feeling overwhelmed and a need to 
maintain normality and gain positivity were also highlighted. The study was 
limited by the small self-selecting sample which impacts upon the 
representativeness of the views recorded. Moreover, the issue of recall bias 
was acknowledged with participants in the volunteer group responding with self-
referential observations, commenting on longer-term experiences rather than 
the period of diagnosis and treatment. The present research overcomes the 
limitation of retrospective data and lack of focus on the healthcare trajectory by 
exploring women's experiences at time-points from post-surgery to early follow-
up. 
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3.3 Coping and breast cancer 
There is a vast body of literature pertaining to breast cancer and coping styles 
and their impact on various outcomes. This section draws on the most 
influential and recent empirical research to review the most prevalent coping 
strategies and their associated impact on psychological outcomes. 
3.3.1 Coping strategies 
The coping strategies utilised by women impact on their adaptation and 
response to breast cancer (Doumit, Huijer, Kelley et al., 2010). Specifically, the 
strategies used during the diagnostic phase have been found to be indicators of 
psychological adjustment after surgery (e.g. Jadoulle, Rokbani, Ogez et al., 
2006). 
Through a six-month prospective correlation study Jadoulle and colleagues 
(2006) demonstrated that anxiety and depression scores six months after 
surgery were associated with scores obtained at diagnosis observing a 
decrease in anxiety levels and stability in mood at the six month time point. 
Similarly, coping scores recorded during the chronic phase (six months post-
surgery) were related to those obtained at the acute illness phase (in hospital, 
the day before surgery). A decrease in the use of instrumental strategies (i.e. 
active problem-focused strategies such as information-seeking) over time was 
noted while distraction and palliative strategies (i.e. self-help responses to 
alleviate the unpleasantness of the situation such as getting rest) remained 
stable over time. Moreover, analysis of the relationships between mood and 
coping suggests that these palliative coping strategies were often detrimental at 
six months post diagnosis while distraction had a protective effect on mood at 
both time points. This study conducted in Belgium utilised translated self-report 
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measures that were not validated in French and while 151 women completed 
time one assessment only 107 of these women did so at time two. Selection 
bias and lack of control for cancer grade and treatment type were further 
methodological issues limiting the inferences that can be drawn from the study 
results. 
However, the coping literature predominantly suggests that active coping 
strategies produce more favourable outcomes compared to passive coping 
strategies such as avoidance (Kim, Han, Shaw, McTavish & Gustafson, 2010). 
The strategy of avoidance can extend to communication which can have 
negative consequences for cancer patients (Donovan-Kicken & Caughlin, 
2011). Avoiding talking about breast cancer can impede communication with 
others thereby limiting social support which in turn can heighten psychological 
distress (Harrison, MaGuire & Pitceathly, 1995; Northouse, Laten & Reddy, 
1995). This strategy may also influence women's cognitions who without 
communication may be more likely to engage in denial or self-blame (Carver, 
1997) and limit gaining perspective and moving towards acceptance of their 
illness (Pennebaker, 1997). 
In a quantitative study by Donovan-Kicken and Caughlin (2011) with 140 
American women who were undergoing treatment or had recently completed 
treatment for breast cancer, an online self-guided questionnaire was used to 
examine coping behaviours and topic avoidance. Not only was topic avoidance 
associated with higher levels of anxiety and depression but emotional support 
and self-blame were found to be strong mediators of topic avoidance and 
psychological distress. Furthermore, acceptance mediated the relationship 
between topic avoidance and depression with lower levels of acceptance 
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conferring greater avoidance and depression. The authors suggest that topic 
avoidance may influence coping options that people recognise and pursue. The 
statistical models used, however, only imply causality and it is plausible that the 
relationship between these factors works the other way with depression leading 
to poor coping and avoidance. 
Spending time with others can nevertheless be helpful not only as emotional 
support but as a means of distraction. In a qualitative study investigating coping 
with cancer in a sample of seven Chinese cancer patients (Chen & Chang, 
2012) interviews were analysed in accordance with grounded theory. A core 
concept termed "balance process of life fluctuation" was identified 
encompassing three themes: negative feelings, self-adjustment and self 
reinterpretation. Negative feelings and emotions were commonly reported from 
diagnosis to treatment completion and were related to mental distress and loss 
of physical control. Participants were reported to have found ways to adjust 
personal beliefs (e.g. self-encouragement, acceptance) and lifestyles including 
work schedules, workload and diet with effective coping strategies leading to a 
greater sense of meaning in life and a positive future perspective. Positive self-
reinterpretation was found to be an effective strategy for cancer patients in 
coping with their illness. However, only five of the seven participants had breast 
cancer and disease specific differences were not established. The lack of long-
term follow-up further limits the study findings. 
A previous Chinese study by Li and Lambert (2007) found that in one hundred 
women with newly diagnosed breast cancer, planning and self-distraction were 
prominent coping strategies in addition to positive reframing. Positive cognitive 
restructuring or reframing is an active strategy whereby individuals attempt to 
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view things in a more positive light. Women have described this as the 'best' 
strategy for coping with fear and uncertainty about the future (Manuel et al., 
2007). Factors contributing to positive thinking include being physically fit, 
having good humour and positive self-talk (Drageset et al., 2009). Making 
changes, social support, physical activity, medication and rest are also well 
documented active strategies (Manuel et al., 2007). However, Manuel and 
colleagues (2007) noted that different strategies are best suited to different 
aspects of women's breast cancer experience reporting, for example, that social 
support was most helpful for dealing with anger or depression while positive 
cognitive restructuring was more beneficial for managing future concerns. 
Religious approaches to coping were among the most frequently reported 
strategies by cancer patients in several studies (e.g. Taleghani et al., 2006; 
Zwingmann, Muller, Korber & Murken, 2008). Having trust that 'God' was in 
control of their illness women became stronger believers in an after-life concept, 
less afraid of death (Shaw et al., 2007) and their faith led to hope and a need to 
cope with whatever 'God' had planned for them (Doumit et al., 2010). Moreover, 
in their qualitative study exploring ten Lebanese women's experiences of coping 
with breast cancer Doumit and colleagues (2010) stated that another prominent 
method of coping was to make comparisons to acceptable chronic illnesses, 
predominantly diabetes which does not hold the same stigmatising connotations 
as breast cancer in Lebanese culture. However, the study was constrained by 
its small sample, the wide range of breast cancer experience held by 
participants (up to nine years post diagnosis), specific sample characteristics 
and limited applicability to other cultures. 
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A Norwegian descriptive qualitative study of twenty one women with newly 
diagnosed breast cancer explored coping strategies between the time of 
diagnosis and surgery (Drageset, Lindstrom & Underlid, 2009). A series of 
opposing means of coping were uncovered including information seeking 
versus a step-by-step approach to knowledge acquisition. Information seeking 
has been documented as a positive coping strategy among women with breast 
cancer (e.g. Rees & Bath, 2000) but the preference of some women for the use 
of a step-by-step approach enabled them to face the realities of their diagnosis 
gradually. This was concluded as facilitating the process of acceptance, a 
means of preparing for what was to come and ensured a focus on facts rather 
than potential occurrences. The authors noted that this coping strategy gave 
women a sense of control over a situation that they deemed as being out of 
their control and kept anxiety at a manageable level. The second coping 
strategy reported was classified as business as usual versus enjoying life. 
Maintaining a normal life was viewed as important while awaiting surgery as it 
led to some control over life, strengthened self-confidence and reduced anxiety. 
Living as usual has previously been found to be a meaningful way of coping by 
Landmark and Wahl (2002). 
Women in the Drageset et al. (2009) research study tried not to be 
overwhelmed by their emotional reactions and dealt with their emotions by 
either displaying expressive emotions such as crying which helped to stop 
feelings of depersonalisation or by holding back with the aim of avoiding 
feelings of weakness and self-pity which were seen as reducing their ability to 
cope. This is an important finding as the expression of emotional feelings after 
diagnosis has been linked to better survival rates (Reynolds, Hurley, Torres, 
Jackson, Boyd & Chen, 2000). Indeed, emotional suppression, particularly 
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anger suppression, characterised by a conscious effort to inhibit the expressive 
elements of emotional experiences, predicted higher reports of symptoms 
relating to immune function and cardiovascular arousal and with appraisals of 
poorer coping during chemotherapy for breast cancer (Schlatter & Cameron, 
2010). Another key finding was that irrespective of how positive women tried to 
be, negative thoughts and anxieties regarding metastases and death were 
evident and led some women to mentally prepare for the worst. According to 
Folkman and Moskowitz (2004) this can represent future-oriented coping which 
reflects efforts to save strength to deal with future events. 
While the Drageset et al. (2009) study conveys several findings of importance in 
the field it is limited, as are many similar studies, by the specific time span 
involved (e.g. between diagnosis and surgery). However, acceptance at 
diagnosis has been found to be a predictor of better adjustment and well-being 
during the first year following diagnosis. A quantitative study with a sample of 72 
Greek women with recently diagnosed breast cancer investigated coping efforts 
and distress the day before surgery, three days post-surgery and three months 
after surgery. The findings showed that the use of multiple coping strategies 
negatively predicted distress (i.e. less reported by women) (Roussi, Krikeli, 
Hatzidimitriou & Koutri, 2007). The study additionally reported that acceptance 
and humour were negatively related to distress at all three time points however 
denial and emotional expression were positively associated immediately post-
surgery and three months later. Further analysis revealed that women who used 
emotion-focused engagement coping (acceptance or emotional expression) at 
pre-surgery experienced less distress three months later than women who did 
not engage in emotion-focused coping. The use of a specific sample of Greek 
women with low socio-economic status and low educational levels limits the 
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generalisability of the findings. In addition, the measurement instrument used 
asked women how they coped with breast cancer in general and did not 
differentiate between different aspects of the illness. Finally, as follow-up was 
undertaken after only three months and accordingly women's experiences of 
coping in the longer term were not ascertained. 
A longer term study assessed women's coping processes and adjustment 
during the year following diagnosis in seventy women with early stage breast 
cancer (Stanton, Danoff-Burg & Huggins, 2002). Acceptance at diagnosis was 
found to predict positive adjustment over time whereas avoidance-oriented 
coping predicted greater fear of cancer recurrence. Coping through religion was 
reported as being more effective for women who were less hopeful and younger 
age predicted greater distress one year on. The use of a homogenous sample 
from the USA, the use of multiple self-report questionnaires and the design not 
allowing for causal inference to be established limits the conclusions that can be 
reached. However, Hack and Degner (2004) provided support for these findings 
recording that women who respond to a breast cancer diagnosis with passive 
acceptance and resignation were at significant risk of poor long-term 
psychological adjustment. 
Adopting a different methodology one large scale longitudinal UK research 
project examined the meaning of illness for women with breast cancer at the 
time of diagnosis and approximately twenty one months later (Luker, Beaver, 
Leinster & Owens, 1996). One hundred and five women were interviewed and 
after being shown a series of cards depicting eight different coping strategies 
were asked to choose the card that best represented their experience at that 
time. Descriptive statistics were used to ascertain the distribution of preferences 
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and qualitative analysis was undertaken on the comments women provided 
explaining their choice. Breast cancer was reported to be a challenge for the 
majority of women at both time points with comments expressing the need for 
positivity, emphasising change in their lives and giving them an appreciation of 
life and reconsideration of priorities. The authors highlight that identifying 
women's individual coping strategies may facilitate effective tailoring of 
psychosocial support for women with breast cancer. The paper does not 
present any demographic or treatment details and the descriptive nature of the 
paper restricts the conclusions that can be drawn. 
A recent review of the literature on coping with a diagnosis of breast cancer (Al-
Azri, Al-Awisi & Al-Moundhri, 2009) summarised factors that can influence 
coping strategies. Demographic characteristics, educational level, positive 
thinking and psychosocial support were identified as of importance in 
determining women's methods of coping. Educated women were better at 
engaging in positive coping strategies and women who were less educated, 
single, divorced, or widowed had a greater use of cognitive defences such as 
denial (Drageset & Lindstrom, 2005). 
3.3.2 Social support 
Reference to social support is common in the stress and coping literature and 
refers to support received (e.g. emotional, informational) or the sources of 
support (friends, family, healthcare professionals) that enhance recipients self-
esteem or provide stress related interpersonal aid (Dumont & Provost, 1999 as 
cited in Kim et al., 2010). The most influential theories regarding social support 
state that support reduces the effects of stressful events as the supportive 
actions of others facilitate coping (Thoits, 1986) or that a belief that support is 
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available if needed leads to an appraisal of events as less stressful (e.g. Lakey 
& Cohen, 2000). 
Two models dominate the literature concerning the effects of social support on 
alleviating stress, the main effects model and the stress buffering model. The 
main effects model proposes that social support is beneficial irrespective of 
stress level while the stress buffering model predicts that social support holds 
less value when stress levels are low given there is less to buffer (e.g. Cohen & 
Wills, 1985). Support has been found for both models through the adoption of 
different measures of social support. Support for the main effects model has 
been found when the number of people in a person's network is measured, 
however support for a buffering model has been established when perceived 
quality and appropriateness of support are measured. In the context of early 
stage breast cancer multi-level analysis of ninety five women's daily reports of 
emotional and physical experience and factors relating to spousal support 
elicited results in accordance with a stress buffering effect for social concerns 
(Gremore, Baucom, Porter, Kirby, Atkins & Keefe, 2011). However a reverse 
stress buffering effect was established for emotional and physical concerns 
whereby the buffering effect of spousal support was attenuated when high 
levels of breast cancer related emotional and physical concern were reached. 
Social support has been reported to not only reduce the stress of a breast 
cancer diagnosis but to also improve emotional well-being in women with breast 
cancer (e.g. Holland & Holahan, 2003). The final theme ascertained from the 
phenomenological qualitative study by Doumit and colleagues (2010), as 
discussed previously, was the impact of positive social support from family and 
work colleagues on the coping process. This was considered to help with 
95 
acceptance and gave women encouragement to cope. Holland and Holahan 
(2003) found that breast cancer patients who perceived high levels of social 
support made greater use of positive reappraisal and planned problem-solving 
as their coping strategies which led to these higher levels of emotional well-
being. More recently, Kim and colleagues (2010) found data from 231 women to 
support a mediation model of emotional well-being whereby breast cancer 
patient's perceptions of how much social support they receive from others 
influenced their choice of coping strategies and in turn their well-being. This is in 
contrast to a moderation model which proposes an interaction between social 
support and coping strategies in affecting psychological well-being. While the 
measurement instruments used had recognised reliability and validity this study 
conducted in the USA is limited given the cross-sectional research design 
thereby not providing the direction of causality. 
Nonetheless, a UK based qualitative longitudinal study also reported that close 
interpersonal relationships were core mediating factors in how individuals, 
including twelve women with breast cancer, experienced their illness 
(Illingworth, Forbat, Hubbard & Kearney, 2010). Over the course of the twelve 
month study period relationships were found to be central even prior to 
diagnosis. Interaction and debate between partners often instigated a visit to the 
GP for symptom investigation and the supportive environment created by 
partners and close family members meant any reluctance to seek help was 
overcome. Partners were additionally identified as playing a role in treatment 
decision-making with some partners assuming a dominant role. Partners' 
awareness and interpretation of the information received was particularly crucial 
in the decision-making process. Cancer was reported to impact both the person 
with the disease and their partner, which Illingworth et al. (2010) referred to as 
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"joint ownership" (p. 26) with cancer leading to the renegotiation of roles and 
tasks in the relationship and difficulties making future plans. The lack of focus 
on relationships within the context of breast cancer somewhat limits these study 
findings given previous discussions on the uniqueness of the disease. 
Moreover, women may have difficulty relating to people in their social network 
about their illness which can put strain on their relationships (Gremore et al., 
2011). Unsupportive negative behaviours are often reported by cancer patients 
including problem minimising, forced cheerfulness and insensitive comments 
(e.g. Dunkel-Schetter, 1984). Such undesired support may lead women to, for 
instance, view their partners as insensitive or patronising (Dehle, Larsen & 
Landers, 2001) and is associated with poor psychosocial adjustment to breast 
cancer (Manne, Sherman, Ross, Ostroff, Heyman & Fox, 2004). Through an 
exploration of the suffering experiences of seventeen women with breast cancer 
and their significant others a qualitative case study elicited an overall theme the 
authors termed 'a field of force' (Arman, Rehnsfeldt, Lindholm & Hamrin, 2002). 
This metaphor represented women's experience of changed lives, perspectives 
and relationships as a result of breast cancer. A sub-theme 'doubled suffering' 
referred to how women's suffering was perceived to increase when it was 
concealed or unspoken. This was found to be undertaken by women 
themselves to protect others and women were denied suffering by those around 
them including the health care system which treated their body neglecting their 
suffering. Relief from suffering came from confidantes who gave the woman 
strength and courage though women often suffered in silence. A breast cancer 
diagnosis resulted in existential questions pertaining to the meaning of life and 
the possibility of death. Through this process of inner reflection suffering was 
made more bearable and led to a transformation of the self and greater sense 
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of embodiment. Like the majority of qualitative studies exploring women's 
experiences of breast cancer Arman et al. (2002) reported a wide ranging time 
since diagnosis, from one year to just under five years and the stage of breast 
cancer differed among the sample, including some women with metastases. 
Furthermore, participants were from Sweden and Finland limiting the 
applicability to the UK given differences in the healthcare systems. 
The complexities of providing social support to a relative with breast cancer has 
been underlined by a recent cross-sectional mail survey of seventy two breast 
cancer patients and their relatives' psychosocial needs (Schmid-Buchi, Halfens, 
Dassen & van den Borne, 2011). This Swiss study reported that relatives were 
found to have higher levels of anxiety (25.0% vs. 22.2%), depression (12.5% vs. 
8.3%) and distress (40% vs. 34%) than patients. Younger age, having higher 
levels of depression and having a disease themselves were associated with 
relatives' need for help. The cross-sectional design, use of numerous self-report 
measures and low response rate limits the study findings and does not allow for 
an assessment of change over time. Furthermore, not all of the relatives 
questioned lived with the patient and the majority of patients had undergone 
breast conserving surgery with varying combinations of adjuvant therapy and 
accordingly differing treatment modalities may influence relatives' perceptions 
and experiences. 
The importance of support from healthcare professionals can additionally be 
highlighted via a study which aimed to categorise the psychosocial needs of 
women with breast cancer specifically in relation to healthcare system 
(Lilliehom, Hamberg, Kero & Salander, 2010). This Swedish study further 
sought to synthesise the identified needs in a model using grounded theory. 
98 
Seventy one women younger than 60 years who were treated with radiotherapy 
were interviewed three or four times over an 18-24 month period. The emerging 
core category was 'admission into a helping plan' comprising the overlapping 
categories of needs: 'access', 'information', 'treatment' and 'how approached'. 
The authors contextualised their findings in relation to attachment theory 
denoting that in times of stress people seek a 'safe haven' to attach to, in this 
instance, a helping plan through which breast cancer patients seek to be 
admitted into a supportive system and well thought out plan of care. The paper 
concluded that such a helping plan is created by easy access, continuously 
adapted information, continuity and competence in treatment, respect and 
commitment from healthcare professionals delivered in a positive atmosphere. 
The strengths of this research included the large sample size for a qualitative 
study and the use of repeated interviews. However while all women were being 
treated with radiotherapy they had also undergone a variety of combinations of 
treatments including mastectomy, breast conserving surgery, chemotherapy 
and endocrine therapy and therefore the specificity for an inclusion criteria of 
completing radiotherapy is puzzling particularly when findings were not 
discussed in these terms. Furthermore, undergoing different treatment 
modalities may influence women's experience of the healthcare system and the 
professionals supporting their care. 
3.4 Psychological well-being and breast cancer 
Undoubtedly, throughout their breast cancer experience women face a 
multitude of stressors, navigating the complexities of the medical environment 
while adapting to a cancer diagnosis and treatment. Women with breast cancer 
are frequently reported as suffering from decreased physical and social 
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functioning, uncertainty, and anxiety and depression, all of which may influence 
quality of life (Salonen, Kellokumpu-Lehtinen, Tarkka, Koivisto, & Kaunonen, 
2010). 
A recent review of research focusing on the impact of a breast cancer diagnosis 
advised that women were at risk of developing psychological morbidities, sexual 
and body image problems as well as an overall decrease in quality of life (Al-
Azri et al., 2009). However, only two of the forty five retrieved articles were 
conducted in the UK with the overwhelming majority of studies being located in 
the USA followed by Canada and Norway respectively. Twenty nine of the 
studies were described as quantitative including the two UK pieces of research, 
fourteen were qualitative and two were mixed methods. This highlights the 
relative paucity of qualitative research exploring aspects of breast cancer care 
in the UK. 
During the first year following diagnosis women often demonstrated 
considerable psychological distress (e.g. Glanz & Lerman, 1992) which can be 
influenced by psychological traits such as coping style, trait anxiety, emotional 
suppression and optimism (Ando et al., 2011). Furthermore, a number of factors 
have been identified to increase psychological distress including financial 
problems (Golden-Kreutz & Anderson, 2004), educational level and marital 
status (Carver et al., 2005) and personal psychiatric history and level of social 
support (Grassi, Malacarne, Maestri & Ramelli, 1997). However, many studies 
investigating the risk of psychological distress have adopted measures of the 
number of life events combining both positive and negative events. This has 
been criticised given that negatively perceived life changes have been shown to 
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influence psychological distress to a greater extent than positive life changes 
among patients with breast complaints (Ando et al., 2009). 
Fann et al. (2008) noted that many women experienced "normal distress" but 
that there is a subset of women who experienced a major depression. In their 
review of epidemiology and treatment for major depression following a breast 
cancer diagnosis they argued that there are a lack of studies on this topic with 
the few existing studies lacking replicability. They proposed that major 
depression is frequent yet unrecognised and under-treated among breast 
cancer patients which can amplify women's physical symptoms, increase 
functional impairment and hinder treatment adherence. 
One large scale survey of 2595 women living in the USA investigated predictors 
of depression (Bardwell et al., 2006). The results suggest that depressive 
symptoms are not associated with objective cancer-related factors including 
treatment type, cancer stage and time since diagnosis, but are strongly 
associated with subjective psychological variables. Stressful life events, 
ambivalence over expressing negative emotions, less optimism, poor social 
functioning and disturbed sleep were associated with greater risk for depressive 
symptoms. The paper also reported that the prevalence rates observed in the 
study sample as comparable to the general population strengthening the finding 
that depression has little to do with breast cancer itself. The study was 
described as demographically representative of women with breast cancer 
however the use of cross-sectional data means causality cannot be determined. 
Furthermore, the measure used to assess depression has been criticised for not 
discriminating individuals who meet the criteria for mood disorder. 
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Mood disturbance has been found to be the most significant predictor of cancer-
related fatigue before, during and after adjuvant therapy for breast cancer in the 
study of Von, Kang and Carpenter (2008) who analysed questionnaires and 
blood samples from 44 women in the USA. Symptoms of anxiety and 
depression following a breast cancer diagnosis have been found in numerous 
studies (e.g. Badger et al., 2004; 2007) including a five year observational 
cohort study of 222 women, aged 60 years or younger, with early breast cancer 
(Burgess et al., 2005). This UK based research found that nearly half of the 
sample had depression, anxiety or both one year after diagnosis, 25% after two, 
three or four years and 15% after five years. The authors suggested that during 
the first year following a breast cancer diagnosis the prevalence of anxiety, 
depression, or both, is around twice that of the general population. This 
suggests a need for specialised service provision addressing women's 
psychological needs during this time. Previous psychological treatment 
predicted anxiety, depression, or both, in the time around diagnosis and in the 
longer-term. Lack of an intimate confiding relationship, younger age, and 
severely stressful non-cancer life experiences were additionally associated with 
long-term anxiety and depression. 
The latter finding supports that of Tjemsland and Soreide (2001) who 
documented that a cancer diagnosis has been identified as harder to handle 
when an individual has other personal or family problems. In line with the 
aforementioned findings of Bardwell and colleagues, the Burgess study (2005) 
reported that treatment and prognostic factors including tumour size, histology 
and type of adjuvant therapy were not associated with anxiety or depression at 
any time. The exclusion criteria of women over 60 years old confines 
generalisability to the specific demographic group and it is worth emphasising 
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the caveat that studies assessing the validity of distress screening tools used 
for detecting depression have found a high rate of false positives (Mitchell, 
2007). Consequently, not all individuals who are positively diagnosed are 
depressed. 
One of the few studies utilising a different methodology to investigate 
depression, anxiety and quality of life explored the meaning of breast cancer via 
a cross-sectional survey of 1012 Canadian women (Degner, Hack, O'Neil and 
Kristjanson, 2003). The research reported that the majority of women (57.4%) 
indicated "challenge" or "value" (27.6%) as being most representative of their 
experience and that fewer women chose "enemy" (7.6%) or "irreparable loss" 
(3.9%). Subsequent follow up of 205 women three years later identified that of 
those women who had chosen "challenge" or "value" 78.9% did so again and 
women who had ascribed a negative meaning to their illness reported 
significantly higher levels of anxiety and depression and poorer quality of life 
than those women who had chosen a positive representation. However, 
measures of depression, anxiety and quality of life were not undertaken in the 
primary study which also recruited women from varying time points in the 
healthcare trajectory. The two samples also differed in terms of demographic 
characteristics and disease status which may have influenced the results 
obtained. 
While the suitability of a quantitative measurement of a personal perception is 
debated (e.g. Gill & Feinstein, 1994), quality of life measures can provide 
information about an individual's responses to illness and treatment. As in the 
aforementioned study by Burgess and colleagues younger women, chiefly those 
under 55 years, have been found to fare worse in relation to quality of life (e.g. 
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Salonen, Tarkka, Kellokumpu-Lehtinen, Astedt-Kurki, Luukkaala & Kaunonen, 
2009). They often contend with a series of different issues compared to older 
women, for example, having dependent children, concerns about premature 
menopause and fertility loss, sexuality and career concerns (e.g. Andrykowski 
et al., 2000). The term quality of life has lost some favour among some 
researchers and is now frequently termed patient reported outcomes (Garcia et 
al., 2007). These outcomes may measure parameters related to patient's health 
status and perception of treatment effects including quality of life and symptom 
severity typically based on self-report measures (Efficace, Novik, Vignetti, 
Mandelli & Cleeland, 2007). 
The negative effect of chemotherapy on quality of life has also been reported 
resulting in decreased activity and social participation, more physical symptoms 
and lower general well-being (Turgay, Khorshid & Eser, 2008). Changes in 
women's physical and psychosocial well-being as a result of the combined 
effects of surgery and oncology treatments can additionally influence women's 
quality of life beyond treatments. However, in the longer-term Engel, Kerr, 
Schlessinger-Raab, Sauer and Holzel (2004) reported improvements over four 
years in emotional and social functioning with decreases in fatigue, nausea, 
future health worries and pain and increases in global quality of life scores after 
three years. While this is an encouraging finding it equally suggests that breast 
cancer may have negative physical and psychological consequences for 
women during the first year in particular when active treatment is undertaken 
but also that the effects may extend to several years post diagnosis. 
Studies on well-being, distress and adjustment are typically limited by the 
dichotomising of scores in case-based analyses. This grouping of patients on 
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the basis of whether they score above or below a cut off on the psychological 
outcome measure can exaggerate small differences between participants and 
create variability that is not representative of the sample (Millar, Purushotham, 
McLatchie, George & Murray, 2005). Research into distress and breast cancer 
has a tendency to focus on specific meaningful illness-related phases and such 
studies do not take into account that the timing of events often differs for 
individual women depending upon the number of surgeries required and type of 
adjuvant treatment(s). The latter issues are of particular significance when 
considering longitudinal studies as investigations on course of distress are 
therefore difficult to interpret. 
These issues were considered in the design of a recent investigation into the 
patterns of change in distress among women with breast cancer (Henselmans, 
Helgeson, Seltman, de Vries, Sanderman & Ranchor, 2010). Measures were 
administered at time points linked to events rather than, for example, time since 
diagnosis. The sample of 171 women in the Netherlands, were younger than 75 
years and treated with adjuvant therapy (e.g. chemotherapy or radiotherapy). 
Four trajectories of distress were identified, firstly, a group that experienced no 
distress (36.3%), a second group showed a pattern of recovery experiencing 
distress only in the active treatment phase (33.3%), a group that experienced 
distress in the re-entry (the transition to survivorship) and survivorship phase 
(15.2%), and a group that experienced chronic distress (15.2%). Consequently, 
the majority of patients were not identified as being distressed or could be 
defined as distressed only on a temporary basis while others remained 
distressed from diagnosis to six months after treatment completion. 
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Participants experiencing no distress reported significantly fewer complaints 
resulting from adjuvant therapy. Personal characteristics unlike demographic 
and objective medical characteristics, had a significant effect on group 
membership as women with a lower sense of mastery, less optimism, and 
higher scores on neuroticism were more frequently found in the recovery and 
chronic groups compared to the no distress group. Nevertheless, the results 
must be interpreted with some caution as the study authors admit to having 
data suggesting that participants who were excluded from analysis due to a 
considerable amount of missing data may have been more distressed than the 
included participants. What is more, the sample sizes of the four groups that 
emerged from the modelling analysis were small, decreasing power and in turn 
leading the authors to report the analysis of predictive variables to be 
exploratory. Finally, the study focused only on general distress and other 
variables such as social support were not considered. 
In support of the aforementioned longitudinal study a recent literature review of 
studies relating to quality of life Knobf (2011) reported that research has shown 
that the majority of breast cancer survivors go on to demonstrate a pattern of 
recovery after treatment. Furthermore, age, information, social support, degree 
of symptom distress and unmet psychological needs were found to be key 
factors influencing quality of life outcomes. The following section considers the 
notion of control and how this may influence women's experiences of stress and 
psychological adjustment to breast cancer. 
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3.5 Control 
In general, individuals who experience loss of control over their situation tend to 
exhibit more stress related problems such as fear, depression, and somatic 
symptoms than those with a belief in their own ability to influence their situation 
(Bailey & Clark, 1989). With regards to breast cancer, Mathieson and Stam 
(1995) found that wanting control over the cancer, treatment, side effects, 
possible recurrences and a host of other personal issues and yet knowing that 
complete control was not possible caused anguish for some women. Research 
findings have additionally shown that women who believed that they could 
control whether or not it returned were better adjusted psychologically (Taylor, 
Lichtman & Wood, 1984). In the longer term Barez et al., (2009) in their 
research study with 101 women with stage I or II breast cancer found a 
consistent and direct relationship between perceived control and adaptation to 
illness over five assessment periods during one year post diagnosis, 
independent of the medical procedures received. Barez et al., (2009) reported 
that the evolution of distress could be predicted from the initial value and rate of 
change of perceived control suggesting that this could be used as an early 
predictor of adjustment to breast cancer. The participants in this Spanish study 
had a specific type of cancer and a good prognosis which may have influenced 
the study findings. Similarly, the small sample size limits the statistical 
conclusions that can be drawn. Moreover, the study authors acknowledge that 
participants were more distressed than women who chose not to take part and 
that extraneous variables associated with psychological change over time may 
have had an effect on the small changes in scores observed. 
Discussing the issue of control Moch (1995) describes how a breast cancer 
diagnosis can lead women to feel "turned over" to the medical profession and 
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no longer in control of their lives. She asserts that many women feel so 
vulnerable that they willingly or unwillingly give their bodies over to those, 
known or unknown, trusted or not trusted, whom they believe or hope will care 
for them best. Such findings may provide an explanation as to why some 
women refer treatment decision making to healthcare professionals. From a 
theoretical perspective, in times of good health, locus of control is balanced 
between internal and external forces. While internal locus of control relates to 
the capability of independent decision-making conversely external locus of 
control pertains to decisions being imposed by external factors (Shaha & Cox, 
2003). When faced with uncertainty during illness, deference to healthcare 
professionals may be undertaken reinforced by their expert status and 
assumptions that they have patients' best interests in mind (Shaha, Cox, 
Talman & Kelly, 2008). With these notions supporting an external locus of 
control, coping with cancer and the uncertainty it brings, may be made more 
bearable. 
However, Moch (1995) refers to women perceiving themselves to be "picked at" 
and "looked at" more often than they should wish, and cites how for one woman 
in her research sample, despite having confidence in the medical team her 
feeling of "losing control" persisted. In discussing his own experience of 
testicular cancer Frank (2001) describes having to submit himself to medical 
workers for whom her knew he was another category requiring tasks to be 
completed, "In treatment, I knew I would become a task that workers would 
have to address as one of a series of tasks that were part of a working day" 
(p.361). Likewise, van der Riet (1998), in her qualitative research with 18 cancer 
patients, documents how one woman spoke of her breasts as private yet when 
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she became ill with breast cancer, her breasts became the public property of 
medical discourse. 
Nonetheless, it has been suggested that the acquisition of new coping 
strategies such as information seeking in conjunction with regaining an internal 
locus of control (taking greater control over decision-making) may lead to the 
integration of cancer into everyday life (Ramfelt, Severinsson & Lutzen, 2002). 
3.6 Chapter summary 
Accordingly, a breast cancer diagnosis can elicit a variety of emotional 
responses and as such places extraordinary demands on women's coping 
abilities (e.g. Landmark, Bohler, Loberg & Wahl, 2008). Indeed, women's 
acceptance of their diagnosis, post-surgical body and altered self and whether 
they will regain an emotional balance, manage uncertainty and improve quality 
of life, depends on their stress assessment, coping mechanisms and sense of 
locus of control. 
3.7 The present study 
While the number of published longitudinal studies investigating the 
experiences of individuals with cancer has increased over the course of the last 
five years a paucity of qualitative research on breast cancer remains. However, 
as demonstrated throughout the preceding chapters women constitute the vast 
majority of breast cancer cases and the disease holds specific connotations for 
women given the cultural meanings ascribed to women's breasts. The literature 
reviewed highlights the importance of breasts to women's sense of self and 
identity and the potential physical and psychological impact of undergoing 
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breast surgery. Yet, the focus of existing qualitative studies on specific aspects 
of meaning and experience (e.g. coping strategies, relationships, the healthcare 
system) limits the extent to which the issues of importance to women at different 
time points are discovered as well as the interplay of these factors and 
associated change over time. Furthermore, the lack of UK based research, use 
of retrospective designs and the overwhelming use of participation criteria 
including only women undergoing a particular treatment regime (e.g. 
mastectomy) restricts the applicability of current findings to British women with 
breast cancer. 
As detailed previously the North East of England constitutes a unique study 
population with a high prevalence of breast cancer and projections suggesting 
an increase in cases throughout the next decade. It is a region with notable 
deprivation and which despite a general move in developed countries towards 
breast conserving surgery reports the highest rates of mastectomy without 
reconstruction in the UK. Accordingly, the current study aimed to explore 
women's lived experience of breast cancer over time using a study sample 
drawn from the North East of England. Specifically, the research sought to 
capture women's stories of living with breast cancer encompassing aspects of 
meaning within their experiences from shortly after surgery to one year post 
diagnosis. This timeframe, also adopted by McCann et al. (2010) and Tighe et 
al. (2011), recognises the re-classification of cancer from acute to chronic 
(Tritter & Calnan, 2002). Moreover, in the present study this enabled exploration 
of women's experiences throughout the healthcare trajectory as they occurred. 
Consequently, the data presented in this thesis is restricted to this time period. 
The study design is discussed further in the following chapter which reviews the 
methodology and research methods utilised. 
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CHAPTER 4: METHODOLOGY 
4.1 Introduction 
This chapter outlines the study methodology and research methods used 
throughout the research process. The novel use of hermeneutic 
phenomenology supported by illness/treatment grids to explore women's 
longitudinal experiences of breast cancer is discussed. 
4.2 Design 
Developed by Edmund Husserl as an alternative to the positivist paradigm and 
a belief that natural science provided an incomplete understanding of human 
experience the aim of transcendental phenomenology "is to describe human 
experience as it is lived" (Merleau-Ponty, as cited in Beck, 1994, p. 500). In 
introducing the study of the 'lived experience' Husserl aimed for methodological 
objectivity and being influenced by Cartesian duality believed that the mind is 
directed towards objects, a concept known as 'intentionality'. Paramount to the 
Husserlian approach is the use of phenomenological epoche, or 'bracketing' 
whereby the researcher seeks to put aside any pre-conceived ideas pertaining 
to the phenomenon under study. Husserl additionally advocated the putting 
aside of any temporal-spatial awareness such that only consciousness 
remained (Barry, 1983) and thus experiences are viewed regardless of context. 
Husserlian transcendental phenomenology is by nature descriptive and focuses 
on the structure of experience. The desire to move from such description to 
interpretation as well as conflicting views with a number of Husserlian concepts 
resulted in Martin Heidegger, a former student of Husserl, to develop 
hermeneutic phenomenology. 
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The philosophy of hermeneutic phenomenology is both descriptive and 
interpretive describing individual's accounts of their experience as well as 
interpreting the meaning they ascribe to these experiences (van Manen, 1990). 
Heidegger considered hermeneutics to be a '...way of studying all human 
activities' (Dreyfus, 1991), the basis for interpretation with the aim of allowing 
the text to speak for itself (McConnell-Henry, Chapman and Francis, 2009). The 
rejection of mind-body duality resulted in a focus on deriving 'meaning from 
being' (Mulhall, 1993, 2005) and the coining of the term Dasein, a concept that 
Heidegger argued was not static and thus cannot be objectively measured 
(Stumpf, 1994; Stumpf & Frieser, 2008). Suggesting that understanding is at the 
core of human existence the notion of bracketing was also refuted with 
Heidegger postulating that the researcher is a legitimate part of the research, 
given their Being-in-the-world of the participant. He argued that the researchers' 
prior knowledge and understanding influenced their ability to interpret the data, 
the notion of fore-structure or fore-conception (Dowling, 2004), and that no 
interpretive research can be free of the judgement or an effect of the 
researcher. Furthermore, having such prior knowledge was seen to ensure that 
the questions asked would be pertinent to the inquiry (Thompson, 1990 as cited 
in McConnell-Henry, Chapman & Francis, 2009). A process of questioning and 
re-examining the text was seen as generating a cycle of ideas regarding what it 
might mean to be, the so called hermeneutic circle. Understanding is 
accordingly achieved via interpretation and the hermeneutic circle which 
suggests that everything is interrelated and experiences can be considered as a 
whole or in parts (e.g. Heidegger, 1996). Consequently in considering parts of 
an experience (the data) as well as the whole experience (understanding of the 
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phenomenon) the circular process whereby each element gives meaning to the 
other is initiated. 
In contrast to Husserl, Heidegger emphasised the importance of context, 
believing that it influences both existence and experience as humans are at all 
times immersed in their world (Steiner, 1978). Moreover, he contended that as 
past experiences impact upon present and future to conceptualise human 
experience in an a-temporal manner, as postulated by Husserl, was not 
possible (McConnell-Henry et al., 2009). Gadamer (1960/1995) added to 
Heidegger's hermeneutic phenomenology suggesting that it is via conversation, 
through the language of an interview, that a phenomenon, something that was 
previously concealed, is revealed. In other words, through interpretation 
meanings in transcripts that participants themselves may not be able to 
articulate may be explicated. In acknowledging that meaning is unique and is 
within the particular historical and cultural contexts relevant to the individual, 
more interpretative engagement with the data is advocated, consequently going 
beyond the level of analysis associated with Husserlian transcendental 
phenomenology (Rapport, 2005). More recently Max van Manen (1990) has 
furthered the work of Heidegger expanding on the hermeneutic nature of his 
philosophy in emphasising interpretation via reflection on language. 
While phenomenologists might have similar objectives the philosophical and 
epistemological standpoints of Husserlian transcendental and Heideggerian 
hermeneutic phenomenology differ. It is proposed that the choice of 
methodology should be governed by the research question and the 
philosophical implications inherent in the question as well as the 
epistemological perspective of the researcher (Caelli, 2001). Specifically, the 
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current research was underpinned by the approach of van Manen (1990), 
though is grounded in that of Heidegger and Gadamer, in order to illuminate 
understanding of women's experiences of breast cancer throughout the 
healthcare trajectory by revealing the meanings embedded in text of the 
interview transcripts (van Manen, 1997). 
As the focus of this research was on women's experiences of breast cancer 
throughout the healthcare trajectory a longitudinal approach was taken. While 
longitudinal qualitative methods have been used extensively in sociological and 
social history research to explore life course patterns they have been slow to 
permeate breast cancer and health psychology research. As outlined in the 
previous chapters women's experiences and responses to breast cancer may 
differ given a variety of factors. Furthermore, if experiences are viewed as the 
product of time and place and accordingly multiple realities exist then 
experiences must change over time. A longitudinal qualitative approach aims to 
capture the fluidity of these experiences and provide rich information pertaining 
to such change. Accordingly, longitudinal qualitative research would seem to be 
ideally suited to exploring women's experiences of breast cancer in the year 
post diagnosis and in doing so offer information relevant to policy and practice. 
Though crucially, the present study aimed to explore women's experiences of 
breast cancer as they occurred rather than collect long-term retrospective 
accounts. Semi-structured interviews were conducted to enable a 
conversational style of interviewing necessary for hermeneutic phenomenology 
allowing meaning to emerge between the interviewer and interviewee while 
ensuring focus on the phenomenon. The use of semi-structured interviews as 
opposed to structured interviews enables participants to tell their stories and 
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respond to questions and probes without the requirement of a specific answer 
thus providing greater breadth and richness of data (Morse & Field, 1995). 
Unlike other interpretative phenomenological methods (e.g. Interpretive 
Phenomenological Analysis) hermeneutic phenomenology proposes greater 
flexibility during data collection with the goal of encouraging the production of 
meaning between interviewer and interviewee. A unique aspect of the present 
study is that this interview process was facilitated via the use of an adapted life 
grid approach in order to enhance the implicit meanings to be elicited through 
interpretation of text. The history of life grids began in health inequalities 
research with the exploration of life course information (e.g. Holland, Berney, 
Blane, & Smith, 1999) as well as in sociological research studying social 
change and economic life (e.g. Gallie; as cited in Parry, Thomson, & Foukes, 
1999). Such a method is typically used to provide a summary of major life 
events in a time line fashion. In previous research (e.g. Parry et al., 1999) the 
first column consists of dates (or years) usually followed by columns depicting, 
for instance, the categories of personal, occupational, residential, health, or 
family. The data is collected during an interview and is by nature retrospective 
as the participant is asked to provide information on past events. The approach 
has been adopted in these fields as it allows the interviewer to see with ease 
the clustering of life events and their impact on, for example, health (e.g. 
Holland et al., 1999). The predominant criticism of this approach is that of the 
accuracy of information recalled. However, in hermeneutic phenomenology a 
reflection of historical events has meaning in its own right - unravelling its 
meaning is more imperative than a correct account since it might reveal 
concealed experiences interwoven in contradictions and factual inaccuracies 
which might be crucial in understanding women's lives. Consequently, for the 
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purposes of the present research the life grid was developed not as a means to 
collect retrospective data but as a qualitative research tool to aid the interview 
process. 
Parry and colleagues (1999) found that completing the grid (while in the context 
of smoking history) was a joint endeavour which necessitated the co-operation 
of the respondent, resulting in a "productive rapport" (p.9). The authors note that 
this rapport can be vital because the quality of data in the interview transcripts is 
largely dependent upon the discussion around events entered into the grid and 
associations made between them. Such a notion would seem to complement 
that of hermeneutic phenomenology and facilitate the process of eliciting the 
landscapes of the selves. Furthermore, as the respondents used events as 
markers it was easier for the researcher to return to these in more depth in 
subsequent interviews. Parry and colleagues additionally state that the grid 
method appeared to enable respondents to draw on personally traumatic 
experiences in a way which diffused what were potentially emotionally charged 
areas. This was felt to be highly pertinent given the nature of the present study. 
Finally, grid interviewing has been found to allow respondents to take some 
control over the course of the interview and in the construction of their 
biographies (Parry et al., 1999) and can in turn increase their enjoyment in the 
interview process (Holland et al., 1999). 
In the present study illness/treatment grids were completed during the course of 
each interview by the researcher in conjunction with the participant, and 
documented in summary format the key experiences and perceptions discussed 
during the interview. The grid columns were designed to aid the documentation 
of key events in each woman's experience (e.g. treatment commencement, 
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completion) as well as decision-making processes, women's perceptions of the 
self and additional comments. An example of a completed illness/treatment grid 
can be found in Appendix 1. This depicts 'Laura's' reported experiences at each 
data collection point in the year following diagnosis, charting her diagnosis, 
course of treatment and her perspectives on the decision-making process, 
perceptions of control and impact on her sense of self and identity. The final 
column of the grid was used to note, for example, psychological responses and 
coping mechanisms. 'Laura's' grid provides a snapshot of her experiences and 
includes direct quotations from each interview that captured the researcher and 
issues that 'Laura' perceived to be of particular importance at that given time. 
This joint venture between researcher and participant was led by the woman's 
experiences, facilitating a sense of control over the interview situation. While the 
illness/treatment grids were not analysed per se, as they were utilised as a tool 
to aid the interview process, the content of the grids is inevitably reflected in the 
emergent themes. 
The study aimed to conduct three interviews including completion of the 
illness/treatment grids throughout the 12 month period following the diagnosis of 
breast cancer. This was in order to capture women's experiences from shortly 
after diagnosis to early follow-up, while minimising issues associated with 
retrospective data collection. The ongoing completion of the grids served to 
provide an aide memoire for researcher and participant with regards to the 
previous discussions and facilitated further reflection on issues highlighted 
throughout each woman's experience. Three interviews were conducted with 
sixteen of the twenty participants with the remaining four participants each 
completing two interviews. One woman had become a full-time carer for a 
terminally ill relative between interviews one and two while during this time 
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another woman lost her mother for whom she had been a carer and, given such 
circumstances, the researcher did not deem it appropriate to request an 
additional interview. One woman was non-contactable during the third phase of 
interviewing and another was experiencing ill health unrelated to breast cancer. 
Interviews lasted between 35 and 90 minutes and were conducted in 
participants' homes, at their request. In order to adhere to ethical guidelines 
participants were not seen for the first interview until after they had undergone 
surgical intervention. The time between diagnosis and surgery was typically one 
to two weeks. The range of time between diagnosis and the first interview was 
one to five months with an average of 2 months since diagnosis and one month 
post-surgery. The time elapsed between diagnosis and the second interviews 
ranged from four to ten months with a mean of 6.5 months. Third interviews 
were conducted ten to seventeen months after diagnosis, with an average of 13 
months post diagnosis. The timing of women's interviews was based upon the 
circumstances of the participant and the researcher during each period of data 
collection. 
4.3 Participants 
The sample was recruited from a symptomatic breast cancer unit in the North 
East of England. In line with hermeneutic phenomenology purposive sampling 
was undertaken such that all participants shared the experience under 
exploration, in this case women with a diagnosis of breast cancer. Women 
attending the unit between April and December in 2006 receiving this diagnosis, 
who were aged 18-75 years and were able to give informed consent, were 
approached to participate by the breast care nurses. Given the busy nature of 
the clinic, time constraints during periods of staff absence and a requirement set 
118 
by the hospital ethical approval board to implement a delay between diagnosis 
and first researcher contact in order to ensure informed consent, recruitment 
was guided by the breast care nurses. For such reasons it was not possible to 
monitor exact response rates however in order to contextualise the sample size 
of this research, the clinic where recruitment was undertaken receives over 
3000 new referrals each year, of which approximately 200 women are 
diagnosed with breast cancer annually. However, diagnoses of new cases of 
breast cancer can vary widely week to week (averaging 2-5 cases) and are 
often noted by clinic staff to occur in clusters. Indeed, during the first half of the 
recruitment period the number of women diagnosed was deemed to be lower 
than average by the breast care nurses. The quantity of data provided by the 
women recruited in these first few months as well as the recruitment difficulties 
detailed prompted the researcher to cease recruitment once twenty women 
meeting the inclusion criteria had returned a signed consent form. 
The aim of obtaining a homogeneous sample within this scope was limited by 
the diversity (detailed below) of women attending the clinic at the time of 
recruitment. However, all participants underwent surgical intervention, 
described their ethnic origin as white British and were between the ages of 41 to 
68 years (mean age of 54 years). Such characteristics are nevertheless highly 
representative of the women diagnosed with breast cancer via the clinic each 
year. For one woman this experience was of a cancer recurrence and for 
another the breast cancer diagnosis was given ten years after a high risk 
genetic assessment and bilateral prophylactic mastectomy. At the time of the 
first interview all women had undergone surgery (either lumpectomy (N=7), 
mastectomy (N=12) or removal of remaining breast tissue (N=1)) and were 
receiving additional treatment(s) such as chemotherapy, radiotherapy, 
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pharmacotherapy or combinations of these interventions. Three women initially 
underwent a lumpectomy returning for a mastectomy within a four week time 
period following histology results. One woman completed reconstructive surgery 
during the timeframe of the study (nine months post diagnosis) and an 
additional three women were in the process of pursuing this surgery at the time 
of interview three. 
Twelve participants were married at the time of the first interview with one of 
these women becoming separated from her husband by interview three. Four 
women were recently divorced with one currently having a partner and the 
remaining four women were widowed. Nineteen participants had children, of 
which eight participants had children residing with them. Fifteen women were in 
full-time employment prior to diagnosis, four women were retired and one 
described herself as a 'housewife'. A tabulated overview of participant 
characteristics can be found in Appendix 2. 
4.4 Materials 
A study information sheet (Appendix 3), consent form (Appendix 4), debrief 
sheet (Appendix 5) and a stamped addressed envelope comprised the study 
materials. A semi-structured interview schedule (Appendix 6) was also 
constructed to facilitate women to tell their stories. All initial interviews began 
with the broad lead-in question "Please can you tell me about how you came to 
be at the breast clinic?" These first interviews focused on the events that had 
taken place from identification of possible breast disease and for some women 
their history of breast disease to the point in the healthcare trajectory that had 
been reached to date. Participants were encouraged to freely describe their 
experience though discussion was supported by prompts where necessary 
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regarding the process of diagnosis and experiences around undergoing surgical 
intervention including the impact of these events on their everyday lives. All 
subsequent interviews began with a review of previous interview discussions 
which enabled the accuracy of the data and the interpretation undertaken to be 
confirmed. Interviews two and three were structured around individual 
participants' experiences over the preceding few months each beginning with 
the question "Please can you tell me about your experience of breast cancer 
since our last interview?" Again participants were encouraged to express their 
experiences without constraint with questions including "How would you 
describe yourself at this moment in time?" Questions focused on the emerging 
themes relevant to the individual. The illness/treatment grid (Appendix 1) was 
completed by the researcher during the course of each interview being led by 
participants' individual experiences and perceptions. This documentation of 
experiences was listed under the headings of events, decision-making, control, 
self and other comments. Participants were given a copy of their grid to review 
at the beginning of interviews two and three providing a visual representation of 
their reflections and their progress. This methodological tool and the related 
outcomes with regards to three case studies were presented at the European 
Health Psychology Conference in 2007 (Swainston, Campbell & van Wersch, 
2007; Appendix 7). 
4.5 Procedure 
Ethical approval was obtained from the School of Social Sciences and Law 
University of Teesside research ethics committee as well as from the University 
Hospital Research Approval Board and the Regional Committee of the National 
Research Ethics Service (see Appendix 8). An honorary contract was awarded 
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by NHS Trust for the duration of the study. Once approval had been obtained 
study information sheets and consent forms with stamped addressed envelopes 
were supplied to the symptomatic breast cancer unit. The breast care nurses 
disseminated these materials to women newly diagnosed with breast cancer 
who they felt would be able to give informed consent. Upon receipt of signed 
consent forms participants were contacted to arrange a suitable time for 
interview. Written consent was obtained prior to commencement of each 
interview. All interviews were tape-recorded and transcribed verbatim and each 
illness/treatment grid was typed up ready for the subsequent interview. 
Participants were given a debrief sheet including details of local breast cancer 
support groups and a variety of support services available to women with breast 
cancer. Each woman was assigned a pseudonym in order to protect their 
identity and maximise anonymity. Only the researcher had access to the data 
provided by participants and all information stored electronically was password 
protected and written documentation was stored securely at the University of 
Teesside. 
4.6 Data analysis 
Data were analysed in accordance with van Manen's (1990) approach utilising 
his six steps for hermeneutic phenomenological research as a framework for 
the analysis: 
1. Exploring a phenomenon of interest to us and commits us to the world 
2. Investigate experience as it is lived rather than as we conceptualise it 
3. Reflecting on the themes characterising the phenomenon 
4. Describing the phenomenon through the writing and rewriting 
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5. Maintaining a strong and oriented (psychological) relation to the 
phenomenon 
6. Balancing the research context by considering parts and whole 
This method of analysis moved away from an application of coding in order to 
elicit meaning hermeneutically (Langdridge, 2007). The aim was to engage in a 
'free act of "seeing"' (van Manen, 1990; p.79) and search for what is universal, 
the general meaning, from the particular, in relation to a specific person or 
situation. 
The data analysis process was applied to the research data as follows however 
interpretation began during the first interview and developed throughout the 
course of data collection: 
1. Analysis of all first interviews (20) 
2. Analysis of all second interviews (20) 
3. Analysis of all third interviews (16) 
4. Overall analysis of interviews (56) 
In depth reading and re-reading of each relevant transcript ensured emersion in 
the data following which data analysis began with the holistic or sententious 
approach. During this stage individual transcripts were read and sentences or 
phrases that were deemed to be representative of women's experiences of 
breast cancer as a whole were identified. This provided understanding of 
women's stories of breast cancer. Subsequently, the selective reading or 
highlighting approach involved reading the text several times and highlighting 
statement(s) or phrase(s) in order to reveal elements of these experiences. The 
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quotations that best captured women's experiences and demonstrated 
similarities and differences across individual women's experiences as well as 
across the three time points were highlighted. While a line by line analysis 
approach can also be adopted given the quantity of data generated by this 
research this was not felt to be the most appropriate method. 
The sententious and highlighting approaches were combined in order to ensure 
a balance was obtained between the whole and parts and that emergent 
themes were representative of the phenomenon. A summary was written 
containing an interconnected list of themes and sub-themes for each 
interview/participant and comparisons were made across each woman's story 
over time. Writing and re-writing was undertaken throughout the analysis 
process in order to aid the development of descriptions of participants' 
experiences. This is viewed as an essential part of phenomenological reflection 
(van Manen, 1997) and in conjunction with the completion of a research journal 
tracking the research process and the researcher's thoughts and feelings, 
added greater depth to the interpretation. 
At the core of hermeneutic phenomenology is the notion that the researcher is 
part of the research as they become 'in the world' of the participant and 
accordingly the approach recognises the ongoing influence of the researcher 
via the research practices conducted. The researcher's own history is seen as 
influential in framing understandings and interpretation is not deemed to be an 
additional procedure but rather comes from the researcher when being involved 
in the world that they are investigating. Indeed, when researching 
phenomenological approaches the acknowledgment that no interpretative 
research can be free of judgement or the effect of the researcher was a concept 
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that matched my own philosophy. Reflexivity is further addressed in the 
discussion chapter (page 345) where epistemological reflexivity, relating to the 
assumptions underlying the research and how these have shaped the research 
process, as well as personal reflexivity, relating to aspects specific to the 
researcher (Willig, 2001) are reviewed. 
Cross-checking interpretations with individual participants, with the assistance 
of the life grid to enable a review of previous interview data, ensured 
interpretations were grounded in the data. The ultimate objective was to use the 
voices of participants to illuminate data analysis such that 'evocative, true-to-
life, and meaningful portraits, stories, and landscapes of human experience' 
(Sandelowski, 1993, p.1) was revealed. Engaging in free imaginative variation 
the phenomenon (e.g. van Manen, 1990) i.e. women's experiences of breast 
cancer was imagined without each theme. If the phenomenon was deemed to 
lose its meaning, the theme was considered an essential element. For this 
study women's real names were replaced with a pseudonym for reason of 
confidentiality. 
The themes that emerged from data analysis are considered in the following 
three chapters which represent the medicalisation of breast cancer, women's 
perceptions and management of the body, and women's psychological 
responses and adjustment to breast cancer. Within each data chapter a series 
of themes are presented some of which are subdivided into several sub-
themes. Indeed, the longitudinal nature of the current study elicited a multitude 
of findings some of which emerged at one time point while others permeated 
women's experiences throughout the year post diagnosis. In accordance with 
the diverse nature of the themes identified, the research findings have been 
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compared to the extant literature in the data chapters. The discussion chapter 
subsequently considers the participants 'whole' experience of breast cancer by 
linking themes in the context of policy developments and theoretical 
perspectives. Specifically, the discussion aims to consider the participants' 
experiences of breast cancer in order to develop current theories of self, 
identity, embodiment and coping (as discussed in Chapters 2 and 3). 
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CHAPTER 5: THE MEDICALISATION OF BREAST CANCER 
5.1 Introduction 
This chapter depicts the elements of the twenty women's experiences that 
reflect the medicalisation of breast cancer. The journey through the healthcare 
trajectory is discussed from the point of symptom identification and waiting prior 
to help-seeking to the process of diagnosis and treatment decision-making. The 
way in which these women's lives become medicalised through treatment 
regimes and hospital appointments and the resulting impact on their identity and 
self is discussed. Acceptance of medical opinions and trust in healthcare 
professionals to assist in removing breast cancer from the body and participants 
lives is addressed with a focus on the consequences for treatment decision-
making. Subsequently, the influence of cancer schema are reviewed including 
participants perceptions of breast cancer and coping strategies pertaining to 
information provision and acquisition. Finally, control and responsibility are 
discussed with regards to breast health (primarily breast self-examination) 
incorporating the struggles experienced resuming responsibility for healthcare 
following hospital-based treatment completion. The timing of the emergence of 
each theme/sub-theme is considered within the context of the year post 
diagnosis. The findings detailed in this chapter that are specific to treatment 
decision-making have recently been published (Swainston, Campbell, van 
Wersch & Durning, 2012) and can be viewed in Appendix 9 though all themes 
are considered here in greater depth. The chapter commences with participants 
experiences of waiting throughout the year following diagnosis. 
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5.2 Waiting 
As noted by Mulcahy, Parry and Glover (2010) waiting is integral to the 
experience of a cancer patient "waiting for tests, waiting for lab tests, waiting for 
results, waiting for diagnosis, waiting for prognosis, waiting for remission, and 
waiting for recurrence" (p. 1062). The present study has uncovered that in the 
context of breast cancer waiting began prior to diagnosis, was central during the 
trajectory of healthcare and permeated participants' lives to early follow-up. The 
first interviews conducted shortly after surgery in which the women focused on 
describing the identification, diagnostic and treatment decision-making 
processes were particularly crucial in uncovering the elements encompassing 
this theme. The multifaceted nature of the participants experiences of waiting is 
represented through several sub-themes, the first of which, discussed below, 
considers waiting with regards to help-seeking behaviour. 
5.2.1 Waiting to seek help 
Participants were recruited from a symptomatic breast unit and accordingly 
these women were being seen routinely at clinic due to prior breast disease, 
had been referred following a routine mammogram or after presenting to the GP 
with either a lump or a change in breast tissue. While some women in this latter 
group sought GP advice immediately, numerous women waited to do so. The 
possible implications of such delays have been demonstrated via a systematic 
review of 87 studies which found that longer delays in presenting with a breast 
symptom is associated with lower survival rates from breast cancer (Richards, 
Westcombe, Love, Littlejohns & Ramirez, 1999). 
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Delays in help-seeking following self-identification of a breast symptom have 
been previously reported via a quantitative survey of one hundred Irish women 
(O'Mahony & Hegarty, 2009). The paper stated that 26 women delayed seeking 
help from a healthcare professional such as a GP of whom 14 women delayed 
from one to three months and 12 women did not seek help for over three 
months. The study additionally recorded that women who had greater anxiety 
about the breast symptom delayed less as did women who believed that early 
detection was crucial. Conversely, belief that the breast symptom was harmless 
and temporary was associated with a delay in help-seeking. Social issues 
including lack of a confidante and a complex lifestyle were also positively 
related to delay. The present study supports the latter of these findings as 
participants focused on others to the detriment of their own health. 
'I went via my GP because I found a lump in my left breast. The trouble 
was I had to delay that because my mother was ill...so it was about seven 
weeks after I found the lump that I went to clinic. I know it's stupid of me. 
I'm a trained nurse and I know it's a stupid thing to do but I just didn't have 
the opportunity' (Lily; Interview 1; Lines 5-6; 16-19). 
Torpy, Burke and Glass (2006) noted that women neglect their health needs 
focusing instead on their spouse and children yet this research has identified 
that caring for older relatives was more commonly the reason cited by women 
for the delay. The majority of women participating in the current study were 
midlife, a stage 'where a number of competing status passages are 
experienced' (p.420) including care for elderly relatives, changes in 
employment, marital status and health concerns (Ballard, Kuh & Wadsworth, 
2001). These issues commonly featured in women's lives prior to and during 
their experience of breast cancer and may be pertinent in this sub-theme. One 
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of the youngest participants reflected on how her caring responsibilities for her 
child instigated help-seeking for her own breast symptom. 
'I just found a lump. I was in the house...I must say I waited a few weeks, 
which is a bit naughty isn't it and the reason I went, funnily enough, is 
because I had to take my son to the doctors and I thought right while he's 
in, I'll ask them to look at this. I went to the doctors on.one day... and I 
was referred within a week' (Laura; Interview 1; Lines 5-9). 
The two aforementioned quotations depict that participants who did delay 
seeking medical advice assigned negative connotations to doing so by 
highlighting their awareness that delaying help-seeking could be detrimental to 
their health. Uncertainty as to the nature of the lump particularly when previous 
breast disease had been experienced was influential in this waiting process. 
'Well I'd actually had the lump for quite some time and it was only by 
chance that I mentioned it to the doctor... I mean twenty years ago I 
actually went to the General (District General Hospital) because I had a 
lump in exactly the same place.and nothing came of that, they just said 
it was a little bit of a fatty deposit. So, all those years when I checked 
myself I just thought I had lumpy boobs (Amanda; Interview 1; Lines 9-
10, 20-23). 
The misattribution of symptoms to non-cancerous conditions, including past 
chronic conditions, as well as patient monitoring of symptoms have been found 
to be associated with patient delays in seeking help in a UK based sample 
though to a lesser extent with breast cancer patients compared to other cancers 
(Molassiotis, Wilson, Brunton & Chandler, 2010). Nevertheless, the present 
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research suggests that some participants did monitor their breast symptom as a 
result of the uncertainty experienced. 
'Basically I examined myself and thought I felt something but it wasn't a 
definite. You see six years ago I had a lump in this breast but it was a 
definite. You know it was yeah, could see it, it was there, no 
problem...For a couple of weeks about a fortnight or three weeks I 
didn't.. .because one minute it seemed to be there and the next minute it 
didn't' (Maria; Interview 1; Lines 5-7, 10-12). 
These elements are present in the following extract from Jenny's initial interview 
though in addition she was the only participant to explicitly describe attempting 
breast self-examination when identifying a potential symptom. 
'It wasn't a lump, it was a firmness and I'd been watching a programme, 
This Morning, and there was a lady on there and they were showing how 
to examine yourself. I was going in the shower so thought I'm gonna 
have a go at that so I did and I could feel the firmness but I thought well I 
breastfed the kids so maybe one side has got firmer than the other. I left 
it a week and then did it again and no, it was still there so I thought I'd 
better go and see (the doctor)' (Jenny; Interview 1; Lines 9-14). 
The misattribution of breast abnormalities to breastfeeding experiences has 
been reported elsewhere (Lu, Lin & Lee, 2010) as resulting in a delay to seek 
help. In the current study pain was one of the factors cited as inducing the 
participants to overcome their uncertainty and visit their GP. 
'It was only that I'd turned over in bed and it had started to nip and I 
actually mentioned it (to the GP)' (Amanda; Interview 1; Lines 23-25). 
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As discussed further in the final theme in this chapter participants frequently 
cited a belief, otherwise termed cancer schema, that cancer was associated 
with pain. The emergence of this symptom may have led these women to re-
assess the potential severity of the change in breast tissue and instigate 
behaviour change, in this case seeking medical advice. Accordingly, the lack of 
pain often led participants to believe that they could not have breast cancer and 
this lack of symptomatology was linked to greater difficulty accepting their 
diagnosis. 
To be honest I didn't believe it when I was told because you don't feel 
any pain with it. I didn't feel it at all' (Elizabeth; Interview 1; Lines 89-90). 
The absence of physical discomfort has been identified as leading women 
including those with a visibly noticeable breast abnormality to delay seeking 
medical help (Lu et al., 2010). While this aforementioned research is limited in 
its applicability due to cultural differences which led some participants to seek 
alternative therapies prior to a medical opinion and women feared accepting 
medical treatment, all of which was not identified in the present study, delay due 
to a lack of pain is supported. 
Contrary to the findings of O'Mahony and Hegarty (2009) and Illingworth and 
colleagues (2010) having someone to talk to about their breast symptom did not 
always encourage help-seeking behaviour. The following quotation from Fiona's 
first interview suggests that this actually led to greater uncertainty and an 
extended wait to attend the GP. 
'I kept saying to him (husband) I've got lumps and he was saying it's just 
your boobs, just your boobs. I kept saying to him can you feel it and he 
kept saying no' (Fiona; Interview 1; Lines 36-38). 
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One large scale mixed methods UK based study found that men consistently 
ignored health symptoms and avoided seeking help from healthcare 
professionals (Sharpe & Arnold, 1998 as cited in Galdas, Cheater & Marshall, 
2005). Similar results have since been reported (e.g. Sanden, Larsson & 
Eriksson, 2000) via qualitative research as have men's attempts to normalise 
symptoms (Gascoigne & Whitear, 1999). These factors may have been 
influential in Fiona's husband's reaction to her symptoms. Locally advanced 
breast cancer presentation following a delay in help-seeking has been found to 
be associated with passivity, denial and fatalism in both women and their male 
partners as identified through qualitative semi-structured interviews (Mohamed, 
Williams, Tamburrino, Wryobeck & Carter, 2005). The authors report that these 
views were not endorsed on psychometric measures and that women reported 
giving socially desirable answers on these tests and consequently urged 
caution in relying on psychometric data as women's responses may be 
influenced by the same factors inhibiting their help-seeking behaviour. 
Trusting her own experiential knowledge ultimately led Fiona to acquire 
professional help. Furthermore, the following quotation from Margaret's first 
interview illustrates that, as reported elsewhere (O'Mahoney & Hegarty, 2009; 
Facione & Facione, 2006), some women consciously choose to keep their 
discovery from others until after particular events such as a holiday. 
'I found a lump in my breast. I'd had it for about six or seven weeks 
because I knew I was going on holiday and I thought I'm not gonna say 
anything until I've had my holidays and worry everybody. Anyway, we 
came back off my holidays and I went the next day and I was referred' 
(Margaret; Interview 1; Lines 5-9). 
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This indicates an element of distraction while waiting to seek help perhaps to 
manage the anxiety and fear of having found a potentially life-threatening breast 
lump. The suspicion of cancer is argued to be the moment at which an 
individual enters liminality (Little, Jordens, Paul, Montgomery & Philipson, 
1998), a term often used to describe the phase between health and illness (e.g. 
Forss, Tishelman, Widmark & Sachs, 2004). In the present study, at this stage 
of having identified an abnormality yet not receiving a diagnosis, women may 
neither be classified as healthy nor ill. 
Delays were not only the result of women themselves waiting to seek help but 
for several participants delays were experienced in being referred from the GP 
to the breast clinic. 
'I found a lump erm.round about May this year, went to my GP. The first 
time she didn't think it was anything, second time she didn't think it was 
anything but in July before I went on my holiday I just felt there was 
something not quite right so I went back. She referred me and in August 
when we came back off our holidays I went to see (the breast surgeon)' 
(Gillian; Interview 1; Lines 9-13). 
Diagnostic delays due to primary care practitioner factors were equally noted by 
Molassiotis and colleagues (2010). Accordingly, there are implications for early 
cancer detection and fast referral for diagnostic investigations advocated in the 
NHS Cancer Plan (Department of Health, 2000). Given these results it is 
perhaps not surprising that while some targets have been met (e.g. 
implementing an age extension for breast cancer screening), 'slippages' have 
occurred in meeting others (e.g. raising public awareness of the signs and 
symptoms of cancer) (Department of Health, 2006). Once help-seeking had 
been instigated and referral to the symptomatic breast unit initiated, all women 
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interviewed described being seen in accordance with the two week rule 
(discussed in Chapter 1, p.23). However, the participants' experiences of 
waiting did not cease and the following sub-theme considers the wait for a 
diagnosis of breast cancer. 
5.2.2 Waiting for diagnosis 
Similar to the findings of Mulcahy, Parry and Glover (2010) who explored 
waiting in the context of a variety of cancer patients, the waiting process for 
women in the current study receiving a breast cancer diagnosis was traumatic. 
During the first interviews all participants described the process leading up to 
diagnosis. As outlined in Chapter 1, this began with a physical examination and 
subsequently a mammogram and either fine needle aspiration or a core biopsy, 
the latter of which the relevant women described as the most physically painful 
aspect of their experience. While for the majority of participants investigations 
and diagnosis happened on the same day the notion of waiting was integrated 
within their descriptions. 
'I was there ages. I mean I thought I'd get to work but I had to have the 
night off from work. My appointment was something like ten thirty and I 
was still there at five o'clock. I waited about a bit, she checked me and 
then I seen her face fall and "right, go and have a mammogram"...So I 
had to wait around for the mammogram, goes back after the 
mammogram and "there's a shadow...I'm afraid it is, can we do a 
biopsy?"...Then I had to wait for the results' (Jenny; Interview 1; Lines 
35-39; 41-44; 52-53). 
The above quotation is one of several suggestive of the breast surgeons 
preparing women for receiving bad news, a behaviour which led to a wait for 
135 
their worst case scenario. For Susan waiting to hear the word cancer was one 
of the most difficult aspects of her experience. 
'I think waiting to hear her say the words was worse than hearing it' 
(Interview 1; Line 90). 
As illustrated below the participants who were experiencing a recurrence or who 
had a family history of breast cancer described waiting, in some cases years, to 
be given this diagnosis. 
'My daughter had breast cancer four years ago and so I've been...sort 
of...waiting because I know it's hereditary. I think I'd half been expecting 
it' (Pauline; Interview 1; Lines 7-9). 
Mental preparation has been reported elsewhere through analysis of written 
narratives of receiving a cancer diagnosis (Salander, 2002) though this was 
specific to the diagnostic phase, an element which was also present in the 
accounts of several participants. 
'Somehow, something in me just knew. I was saying yeah, it could only 
be something like that again (cysts) but we don't know but just in case it 
is we have to be prepared. I said well whatever it is I'm looking on it as if 
it is because then if it isn't great and if it is then I'm ready for it' (Maria; 
Interview 1; Lines 62-66). 
Accordingly, as illustrated above Maria, who suspected a breast cancer 
diagnosis was likely, began a process of mentally preparing herself and her 
family in order to ensure readiness for the experience ahead. The time between 
diagnosis and primary intervention constituted an additional period of waiting 
and is described in the next sub-theme. 
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5.2.3 Waiting for intervention 
Contrary to previous findings the most distressing period of waiting was found 
not to be that leading up to receiving the diagnosis of breast cancer but from the 
time of diagnosis to undergoing surgical intervention despite all participants 
undergoing surgery within one week following diagnosis. 
'If I could have gone into hospital and had my breast taken away the next 
day I would quite happily have done that' (Rose; Interview 1; Lines 112-
113). 
Joan elaborated on this element of waiting as well as highlighting the desire for 
reassurance from healthcare professionals and medical regimes. 
'I think initially its devastating news that you get then once you've had the 
bad news and had it delivered you're looking for somebody to tell you 
something positive. You're looking for that reassurance that there is 
treatment available, that you're not going to die, that you know.this is 
your plan of action and I think you just wanna get started. You don't want 
any delays, you just want it to happen yesterday' (Joan; Interview 2; 
Lines 267-273). 
Pauline further reflected on why this waiting period was so distressing: 
'It's the living with it and nobody doing anything' (Pauline; Interview 1; 
Lines 36-37). 
Waiting is theorised to be associated with a loss of control for those made to 
wait (e.g. Levine, 1987) and in relation to healthcare can elicit feelings of panic, 
anxiety, depression, and uncertainty (Bailey, Wallace & Mishel, 2007). In 
support of the findings of the present study this period, termed preliminary 
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diagnosis as the extent and aggressiveness of the tumour is unknown, has 
been found to elicit the highest levels and percentages of distress among 102 
women with breast cancer (Andreu et al., 2012). Knowing that they were 
currently living with cancerous breast tissue not only had a psychological impact 
but influenced everyday activities of daily living. 
'When I first found out what it was and I was waiting to go into hospital 
whenever I went in the shower I couldn't take my bra off. I couldn't wash 
myself, couldn't touch that area knowing that it could be killing me' 
(Jenny; Interview 1; Lines 213-216). 
Lindwall and Bergbom (2009) reported similar findings in women perceiving 
their bodies to have failed them by housing a life threatening tumour. This led to 
a loss of confidence in the body and fear of an uncertain future, again linked to 
the unpredicability of breast cancer and lack of symptoms experienced. 
'It's hard to describe because because it's been there and it seems to 
come from nowhere and you have no signs and if I hadn't prodded 
myself that day...I might have needed chemo. You just have that fear 
now all the time' (Jenny; Interview 1; Lines 190-193). 
As such, issues regarding waiting extended to receiving results from surgery 
including those pertaining to lymph node sampling. 
'Once I came round from the anaesthetic I had a strong feeling of relief 
but had the big fear of has it spread? That was a couple of weeks later 
when you find out so you're sort of in limbo for those couple of weeks 
and that is a horrendous time but you've got to try to be positive' (Jenny' 
Interview 1; Lines 146-149). 
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For participants requiring additional treatments the concept of waiting continued 
throughout their descriptions of their experience both in terms of commencing 
and completing individual interventions. 
'I went to see the oncologist about three weeks ago and he said the 
waiting list was about ten weeks, which I mean really, you want to go in 
and get it over and done with. It's like I'm hanging on and hanging on...I 
feel it's inconvenient because I'm having to wait. I really want to get back 
on with my life and I feel as though I can't do that until I've had the 
radiotherapy' (Margaret; Interview 1; Lines 100-103; 128-130). 
Similarly, for the few participants in this sample who sought reconstructive 
surgery a further phase of waiting was experienced. 
'I was quite disappointed at the time because I had to wait five months 
for my appointment with the plastic surgeon, which I thought was a long 
time really. Erm...but you know waiting lists are waiting lists aren't they' 
(Gillian; Interview 2; Lines 6-8). 
Gillian further commented: 
'I just want my life back and I will but not until I've had the reconstruction' 
(Line 47). 
Gillian's quotation reflects the ongoing desire demonstrated by all participants 
throughout this research to regain their life and to return to how things had been 
prior to receiving their diagnosis of breast cancer. This is reflected in the 
subsequent sub-theme, waiting for normality. 
5.2.4 Waiting for normality during a medicalised existence 
The notion of waiting was found to be integral to participants' discussions 
around striving to regain 'normality' while experiencing a medicalised existence. 
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The disruption to the life-world (Bury, 2001) throughout the year following 
diagnosis was perceived to hinder a return to these women's former identity and 
self. The aim to return to life and the self as it was prior to diagnosis, in other 
words a desire for a restored self (Charmaz, 1987) rather than a "new" self, was 
evident throughout the healthcare trajectory as the study participants lives 
revolved around medical regimes. 
'I think when you're going through all of this, a mastectomy in the 
December then chemotherapy January to May, radiotherapy mid June to 
July, then another mastectomy in August so I haven't been in control in 
as much as everything I've done I've had to look in my diary to see 
where else I'm supposed to be' (Susan; Interview 2; Lines 20-24). 
In line with the findings of Kelly and Field (1996), those women experiencing 
hospital-based treatment regimes found breast cancer to dominate their lives 
disrupting their participation in the world and compounding deviation from 
normality. 
'I didn't feel in control of the radiotherapy because for that whole time, for 
that whole twenty days your life's not your own, it's literally around your 
hospital appointments. You've got to plan your day, everything around 
that hospital appointment so you can never possibly have control over it' 
(Laura; Interview 3; Lines 183-186). 
As illustrated by Moch (1995) being provided with a hospital appointment in 
itself takes control away from women and as demonstrated in Laura's quotation 
acquiring a medicalised existence contributed to her sense of lost control. The 
women interviewed began to describe experiencing an existence that was 
medicalised being focused around hospital appointments and as the body 
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became subject to treatment regimes these women seemed trapped in the 
present and continued to wait for a return to their former lives and self. 
'I think once the chemotherapy's finished I'll get back to normal (Louise; 
Interview 2; Line 190). 
Accordingly, rather than accepting a degree of contingency as discussed by 
Frank (1995) such participants pursued control through a disciplined body 
(Frank, 1991) by focusing on the completion of medical regimes. While 
undergoing chemotherapy participants spoke of a contrast between undergoing 
treatment and the ability to resume a normal life at least for a few days in 
between treatments. Waiting for treatment completion and a state of normality 
were nonetheless integral to these women's narratives including that of Louise 
who, like many other participants, was counting down each treatment. 
'Well I've had three chemotherapies now, so there's three more left to go. 
The first one was alright it's just the sickness afterwards and you feel 
weak for about four days and you finally recover...and sort of...the week 
before your next chemotherapy you're fine and back to normal and then 
you have to go again. So, the whole process starts again' (Louise; 
Interview 2; Lines 5-9). 
For participants who were prescribed Tamoxifen the drug was viewed as 
extending their wait for normality by maintaining an illness identity potentially for 
five years until the end of the treatment course. 
'When I first knew I was taking Tamoxifen I was gutted.I wanted to have 
either chemo or radiotherapy so that I could do it in a bunch and get rid 
of it, be done. Five years on Tamoxifen seemed...oh...' (Ellen; Interview 
3; Lines 306-308). 
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Participants who had been employed prior to their diagnosis frequently 
associated normality with a return to work and resuming interactions with 
others. 
'I suppose...being able to go to work and...to me you lead a normal life 
when you can see people and just being able to travel in the car to see 
other places because now you're stuck in your house' (Louise; Interview 
2; Lines 197-199). 
Louise's quotation illustrates how treatment regimes can lead to an alienation 
from the outside world (Charmaz, 1983) and in turn threaten women's identity 
and sense of self. Similarities to Kleinman's (1988) study of the chronically ill 
can be drawn in terms of the impact on social occasions though in this research 
this is through both medical regimes and as is demonstrated in the following 
chapter, an impact on the body. The existing literature considering women's 
experiences of returning to work following breast cancer is limited with the few 
existing studies being dominated by quantitative retrospective designs. A recent 
literature review (Tiedtke, de Rijk, Casterle, de Christiaens, & Donceel, 2010) 
found that most women decided to return to work to regain some normality in 
their lives and while this review is limited by the synthesis of primary studies 
with differing methodological details, this notion is mirrored in Janet's comment. 
'I'm always busy, I have a job...Now, they've put me on the sick and I'm 
thinking God.I feel a bit lost without going to work. Financial, that's a big 
thing as well. So it's changed just like that.lifestyle. I like to still do as 
much as possible but to think one week I was working and was normal 
and now this has happened and its.not normal. It's not normal, even 
though you try to keep things as normal as possible' (Janet; Interview 1; 
Lines 138...141-146). 
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Financial pressures have been reported as key factors influencing women's 
decision to return to work following breast cancer in a UK population (Kennedy, 
Haslam, Munir & Price, 2007). Experiencing financial difficulties was frequently 
cited by participants of working age for whom an extensive regime of medical 
intervention was undertaken. This resulted in these women taking less time to 
recover before making attempts to regain this aspect of normality. 
'I had about ten or eleven weeks off but I have three jobs but I only got 
sick pay from one of them so it's a money thing why I've gone back, you 
know' (Jenny; Interview 2; Lines 105-106). 
Participants' desire to return to normality and their underlying focus on 
diagnostic processes and treatment regimes substantiates Frank's (1995) 
restitution narrative in relation to breast cancer. Thomas-MacLean's (2004b) 
consideration of breast cancer narratives supports its prevalence in women's 
retrospective accounts of their illness. Participants experiencing breast cancer 
for the first time consistently discussed their belief that normality would return 
once they no longer required medical intervention. That said, as previously 
proposed by Thomas-MacLean (2004b) albeit in relation to women's changed 
bodies, the discourse of several women eluded to the fact that full restitution 
(i.e. regaining the life and normality that they had previously) was not possible. 
'I've always gone to full time work and I can't even go back to the job that 
I was doing so I don't know what I'm going to do. It's driving me 
absolutely mad. I'm always so busy and I just can't do anything until I've 
finished all this treatment' (Emma; Interview 1; Lines 51 -54). 
While participants had waited throughout their experience to return to normality, 
and anticipated a return to activities of daily living and their working lives 
following treatment completion, this was often not the case. 
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'Well when I went back to work I really thought I was ready to go back to 
work. I thought I'd more or less got over everything and I was back to 
normal but when I got back to work I realised that I really wasn't ready to 
come back. I really couldn't get my head around my work, it was taking 
me three times longer to do things because things just weren't 
registering. I found I was quite weepy and erm.and I'm not really a 
weepy person. Once I'd got back to work it took me really up to the 
Christmas time to feel back to normal and that I was in control of what 
was going on whereas before I just didn't feel as if I was in control. Then 
once I started to feel like that it gradually got better and better and just 
back to normal really' (Margaret; Interview 3; Lines 9-18). 
Women have previously been reported to experience interference in the return 
to work due to the physical limitations caused by breast cancer treatment 
including arm pain, fatigue and poor concentration (Tiedtke et al., 2010). A 
realisation and in turn a sense of disappointment that returning to "normal" 
would be a gradual process requiring further waiting was inherent in Susan's 
description of this time in her journey. 
'I think why I feel frustrated now.all the way through my goal was to get 
back to work and I didn't really think beyond that. In my head I was 
gonna be completely back to normal by Christmas which realistically was 
never, ever gonna happen but because it was in my head I wasn't letting 
anything get in the way of that' (Susan; Interview 3; Lines 32-37). 
Charmaz (2002) argues that when a hospital is viewed as an alien environment, 
treatment regimes lead to a disconnection of an individual's real life and 
everyday habits, and a perception of waiting time or time lost from life may be 
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evident. This is demonstrated in the below extract as Sarah who had 
experienced breast cancer over ten years ago reflected on once again 
experiencing a year waiting for normality. 
'It's meant my life's been put on hold again for another year. I think it 
takes a year. I was diagnosed in December and I won't finish my 
treatment until the end of August so its eight months and then it'll take 
you four months to recover from it, so it's a year you're giving up again' 
(Sarah; Interview 2; Lines 104-108). 
This is suggestive of physical normality returning in the longer-term yet as 
discussed in the final theme of this chapter moving away from a medicalised 
existence raised concerns regarding resuming control and responsibility for 
breast health. 
The longitudinal approach employed in this research study has helped to reveal 
that in the context of breast cancer the concept of waiting is multifaceted and 
manifests differently over time. Periods of waiting emerged throughout the 
healthcare trajectory and waiting for normality frequently remained one year 
post diagnosis. It has been argued that waiting is often associated with the 
constraints of healthcare systems such as high workloads and understaffing, 
which may lead to more traditional doctor-patient relations with an authoritative 
doctor and passive patient (Street, 2003). This may in turn limit patient's 
opportunities to gain control over their illness and participate actively in the 
treatment decision-making process (Sharf & Vanderford, 2003). Women's 
experiences of treatment decision-making and specifically their role in this 
process are explored further in the upcoming theme. 
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5.3 Role in the treatment decision-making process 
The increasingly short timeframe between diagnosis and surgical intervention 
(in the case of the clinic from which the study participants were recruited this 
was approximately one week) has resulted in a need for rapid surgical 
treatment decision-making. Similarly, non-surgical treatment decisions are 
typically made as soon as possible after surgery. Consequently, the data 
relevant to this theme was predominantly captured during participants' initial 
interviews when diagnosis and primary treatment were at the fore of women's 
experiences. That said, the final sub-theme explores how the study participants 
maintained ownership of decisions throughout the year post diagnosis even 
when a passive approach was adopted. Throughout this theme the findings are 
considered in relation to current Government policy and the debates highlighted 
in Chapter 1 (p.36-41) commencing with women's role in surgical treatment 
decision-making. 
5.3.1 Surgical treatment decision-making 
Though limited in terms of comparison the relatively low rates of passive 
involvement in treatment decision-making reported in previous quantitative 
research from 8% (Lam et al., 2003) to 13% (Janz, Wren, Copeland, Lowery, 
Goldfarb and Wilkins, 2004) would seem to contrast the current study findings. 
For those participants experiencing breast cancer for the first time a passive 
role was typically assumed in surgical treatment decision-making. This is 
illustrated in the following comments: 
'I think it was the doctor that made the decision (to have a mastectomy) 
because when I had the biopsy I had to wait for the results to come back 
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so I think they made the decision to have that' (Elizabeth; Interview 1; 
Lines 36-38). 
'Well the doctor said it'll be a lumpectomy, it won't need to be a 
mastectomy because it's only small. They said what we do is we take the 
lump away and some of the lymph glands under your arm and they said 
you might have to come back if we find something in the lymph glands, 
come back for more treatment. I said whatever you think needs to be 
done do it' (Fiona; Interview 1; Lines 72-76). 
The speed at which diagnosis and surgical treatment were undertaken following 
referral to the symptomatic breast unit, as discussed more broadly by Charmaz 
(2002), may have influenced these women's compliance with treatment 
decisions. Furthermore, it could be argued that while already attempting to cope 
with the stress of diagnosis some participants may have opted to distance 
themselves from surgical treatment decisions as a means of positively coping 
with a situation where the possibilities for self-directed action are limited 
(Jadoulle et al., 2006). Research to date has largely neglected to consider 
women who have experienced previous breast disease (e.g. cysts), or had a 
family history of breast cancer without themselves experiencing cancer. This 
research found that these women took a more active role in making surgical 
decisions. This was the case for Jenny who opted to have a mastectomy 
following the deaths of two significant women in her life as a result of breast 
cancer. 
'The doctor said "well we'll do a lumpectomy" and it was my decision to 
say no and she (doctor) came out of theatre and said "right what are we 
doing?" and I said "take it off"' (Jenny; Interview 1; Lines 87-90). 
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Post-surgical analysis of the breast tissue confirmed that a lumpectomy would 
have been an appropriate intervention for Jenny however she commented: 
'As it turned out they reckon I could have had a lumpectomy because my 
lymph nodes were clear but I couldn't take a chance. Right up until the 
last minute I could have changed my mind but I felt I was fighting it one 
hundred percent by doing that' (Jenny; Interview 1; Lines 95-98). 
During interview one, Sarah who was experiencing a recurrence of breast 
cancer described having made the decision some years previously to have a 
bilateral mastectomy if she were to be given the diagnosis for a second time. 
'There was no sense of shock, it was almost as if I sensed that this would 
happen, looking at my family history at some stage I knew I would have a 
re-occurrence (Lines 68-70). When you've gone through a process for 
eleven years you actually see an end and the only way I can describe it 
is it's almost like running a marathon, you hand the baton over and 
somebody gives you it back and says go and run it again but not the 
same journey, we'll give you a different route. So, it's almost as if I don't 
want to do it again eleven years on (Lines 45-49). I've spent a lot of time 
reflecting on my life and what I would do so the decision was made prior 
to me going' (Sarah; Interview 1; Line 65). 
Accordingly several participants perceived an active role in surgical treatment 
decision-making yet typically described being given the confidence to do so by 
the Consultant Surgeon. Linda, for example, requested a mastectomy though 
still sought approval to ensure that she was making the right decision. 
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'Me and the doctor looked at it together and I asked him what do you 
think, do you think I'm making the right decision and he said yes, 
definitely and that really did it for me' (Interview 1; Lines 328-330). 
While Linda described herself as taking an active role in surgical decisions her 
desire for medical advice, facilitated by definition, a shared decision-making 
approach. Whether it is possible for women to take ownership of this process is 
debatable. Karnilowicz (2011) argues that ownership is delegated rather than 
negotiated with regards to treatment decision-making as ultimate control, power 
and responsibility are held by the healthcare provider. 
5.3.2 Non-surgical treatment decision-making 
Irrespective of their perceived involvement in the surgical treatment decision-
making process, all participants reported a passive role in making decisions 
regarding further treatments (e.g. chemotherapy, radiotherapy and adjuvant 
drug treatments). 
'I was told I needed the radiotherapy for follow-up and the team 
prescribed the Tamoxifen. They've prescribed and I've just accepted 
what they said. I don't ask questions, I just go along with it' (Lily; 
Interview 1; Lines 232-235). 
Greater preferences for passive involvement, up to 40% (Vogel et al., 2008), 
have been documented through quantitative research investigating unspecified 
breast cancer treatment decision-making. This suggests that the type of 
treatment decision may affect women's role in this process. However, following 
surgery women may be tired, may lack confidence or the resources to be as 
engaged as they would like (Mulcahy et al., 2010) which may contribute to the 
passivity reported in this sub-theme. 
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As discussed in Chapter 1, research focusing on non-surgical decision-making 
is sparse particularly utilising a qualitative methodology though the results of the 
present study support prior findings regarding older women's decisions 
concerning chemotherapy (Kreling et al., 2006). The women in the present 
study did not perceive a choice to participate in such decision-making and nor 
did the vast majority of women report a desire to do so. Participants cited the 
multidisciplinary team (MDT) and their Consultant as the decision-makers in the 
context of further treatments. 
'I think they have a multi-disciplinary team and I think they discussed the 
radiotherapy in the team meeting and they obviously considered that to 
be the best plan' (Susan; Interview 1; Lines 55-57). 
A recent UK based study analysed post-operative consultations in which twenty 
women who had undergone surgery for breast cancer discussed further 
treatment and subsequently interviewed both patient and practitioner regarding 
the decision-making experience (Mendick, Young, Holcombe & Salmon, 2010). 
The involvement of a multi-disciplinary team was described as providing 
reassurance that appropriate decisions were being made. Ellen also 
commented on the role of the MDT and her understanding of how decisions 
were made. 
'Apparently there it goes to a board and it's all discussed between 
everybody in this meeting. I was told that they would decide which was 
best. I was told that there were three things that could happen. I could 
have radiotherapy, I could have chemotherapy, I could be on Tamoxifen 
or I could be on a mixture of any of them. They tested everything that 
was taken away (breast tissue) and when I went back to see the breast 
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nurse she already had the prescription there waiting for me' (Ellen; 
Interview 1; Lines 80-86). 
Handing over control of treatment decisions to healthcare professionals was 
viewed in a positive manner and was rationalised in terms of the need for such 
decisions to be made quickly in order to receive timely medical intervention. 
This combined with the shock experienced at the time of diagnosis was 
perceived by many participants to limit their capacity to take a more active role. 
'I just said to her "I'll do whatever you think" because I was just that 
shocked I didn't know what to say. I just said to her "whatever you think 
is best just do because you know what you're doing"' (Emma; Interview 
1; Lines 18-20). 
Developed from the coping literature of Lazarus and Folkman (1984) the model 
of emotional trade-off difficulty (Luce, 2005) purports that treatment decision-
making, for example in relation to breast cancer, is influenced by a desire to 
cope with difficult trade-offs such as breast loss versus long-term survival. In 
choosing passivity participants avoided consideration of these trade-offs and 
the stress associated with making an autonomous decision when positive 
outcomes were not guaranteed. Furthermore, this research has highlighted that 
as in the qualitative research by Seale (2005) decisions to adopt a passive role 
in treatment decision-making were undertaken consciously, were one of choice 
and as such relinquishing control may be viewed as a positive coping strategy. 
Consequently, participants' actual level of involvement even though 
predominantly passive for both surgical and non-surgical treatment decisions 
would seem to be in accordance with their preferences. This contradicts 
research findings by, for example, Degner and colleagues (1997) who noted 
that over half of women do not attain their desired level of involvement. What is 
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more, despite adopting a passive role, participants continued to feel in control of 
the treatment decision-making experience as opposed to experiencing a loss of 
control given passivity as depicted by Halkett and colleagues (2007). Feeling 
able to ask questions and being responsible for their healthcare in terms of 
attending clinic appointments and adhering to treatment regimes were factors 
influencing this perception. 
'I could have questioned or argued but I chose not to because I felt that it 
was a decision to be made by professionals and a team of professionals, 
not just one person. Erm...but I think ultimately I decided whether to go 
through with the surgery and I decide whether to take the Tamoxifen 
each day' (Pauline; Interview 1; Lines 217-221). 
The following sub-theme focuses on the notion of maintaining control while 
enacting passive involvement in treatment decision-making. 
5.3.3 Choosing passivity while maintaining ownership 
The concept of 'conscientious autonomy' (Kukla, 2005) can be used to aid 
understanding of the decisional involvement demonstrated through this 
research. The focus on ownership of, and commitment to, decisions as opposed 
to responsibility for making a decision suggests that a patient may describe 
accepting a clinician's decision without presenting as being passively compliant. 
Though many women in the current study may not have felt involved in the 
decision-making process (for surgical and/or adjuvant treatments) their choice 
for passivity did not characterise disengagement. Participants sought ownership 
of the decisions by stating, as in Pauline's previous quotation, that they could 
refuse treatment at any point. Moreover, finding justification for the decisions 
made and treatment regime itself, as well as being committed to completing the 
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treatment course supports the notion of ownership. Indeed, throughout the year 
following diagnosis participants continued to purport that their level of 
involvement had been apt given their individual circumstances and that 
appropriate treatment decisions had been made, frequently stating that they 
would take the same course of action again. 
'If I had to do it again I would have exactly the same. I cannot fault the 
doctor at all, in fact I think he's magic and if it was to come again I would 
want to go with him' (Linda; Interview 3; Lines 107-109). 
This satisfaction could extend beyond the healthcare trajectory as Sarah's 
reflection (following a recurrence) on undergoing a lumpectomy over ten years 
ago suggests that she continued to believe the decision to have been 
appropriate. 
'Strangely enough my sister-in-law had said "I think you should have had 
a mastectomy eleven years ago" and I said "why would you say that 
because it didn't come back in the same breast?" You know, so a 
lumpectomy was right at that time and I would say to any lady now, in 
fact one of my closest friends who comes with me, her sister-in-law's just 
been diagnosed and is having a lumpectomy and I would say if you can 
have a lumpectomy just have it. You may get eleven to twelve year or 
they may be fortunate and may never have another problem so I wouldn't 
say to go for the major surgery that I've chose' (Sarah; Interview 1; Lines 
575-583). 
This was despite having consciously handed over decisional control to 
healthcare professionals at the time of her first diagnosis and more recently 
given a recurrence actively requesting a mastectomy. This is in contrast to the 
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findings of Thomas-MacLean (2004a) who reported that women continue to 
question decision-making once treatment has ended. Furthermore, as the 
present study did not identify discordance between women's desired and actual 
levels of involvement the decisional regret recorded elsewhere (e.g. Lantz et al., 
2005) was not supported. 
These findings hold clinical implications given the promotion of "shared 
decision-making" in the recent Government White Paper for Health (2010). 
Advocating "involving patients fully in their own care, with decisions made in 
partnership with clinicians, rather than by clinicians alone" (p. 13) may reflect 
observations of positive long-term health outcomes (e.g. Anderson, Bowen, 
Morea, Stein & Baker, 2009) and greater compliance with medical regimes 
(Cameron, 1996) given patient involvement in decision-making. However, the 
findings within this theme suggest that not all women with breast cancer desire 
such involvement and make a choice in the early stages of their experience to 
take a passive role. Yet, these women retained a sense of control and 
ownership of treatment decisions and displayed a resolute satisfaction with the 
decisions made throughout the healthcare trajectory and into survivorship. 
Acceptance of and trust in medical opinions was crucial in facilitating decisions 
of passivity but as discussed in the following theme led to the seemingly long-
term high satisfaction with treatment decisions. 
5.4 Acceptance of medical opinions 
Discussions pertaining to this theme initially emerged during the first interviews 
as women recounted their experiences of treatment decision-making. However, 
irrespective of the role in the treatment decision-making process, previous 
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medical history or treatment regime, participants' acceptance of medical 
opinions and trust in the expertise of healthcare professionals was unwavering 
throughout the reflections on their experience. 
In the context of healthcare, trust is known to be a multifaceted construct (Berry, 
2004) incorporating dimensions such as competence and honesty which are 
underpinned by perceptions of accuracy, knowledge and concern with welfare 
(Frewer, 2003 as cited in Berry, 2004). Participants frequently referred to the 
competence of the breast surgeons: 
'She (the breast surgeon) makes you feel.. .confidence, she makes you 
feel like she knows what she's doing.you couldn't be in much better 
hands than hers, she's one of the best in the country' (Susan; Interview 
1; Lines 209-211). 
With regards to risk messages Paling (2003) highlights the necessity for 
medical professionals to portray both competence and a caring approach in 
order to engender trust. These elements were evident in participants' 
descriptions of their experience albeit in terms of differing healthcare 
professionals. In contrast to women's focus on the surgeon's abilities and 
experience, discourse regarding the breast care nurses was centred around 
their caring nature. 
'(The breast care nurse) was lovely, she was absolutely fantastic, talked 
us through it... she was just so professional, so.put your mind at rest 
and at ease' (Laura; Interview 1; Lines 58...63-64). 
As both parties were present at the time of each woman's diagnosis (with the 
breast care nurses remaining after the surgeon had left to address any 
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additional issues) the team as a whole were trusted to manage participants 
health needs. 
'They had my best interests at heart and I had to put my trust in the team 
to do their best...I trusted them to do the best possible job they could do' 
(Gillian; Interview 1; Lines 125-128). 
Such quotations sustain Moch's (1995) argument that the vulnerability 
experienced following a breast cancer diagnosis can lead women to hand over 
control of their bodies to healthcare professionals with the underlying hope that 
they will be well cared for. Similarly, women have been reported to adopt an 
external locus of control with regards to treatment decision-making referencing 
the expertise of healthcare professionals in order to aid management of the 
uncertainty associated with receiving a breast cancer diagnosis (Shaha et al., 
2008). In support of such conclusions when asked about control over treatment 
decisions Laura commented: 
'You've got to put yourself in their hands. They are the professionals who 
know what's best for you and that's the route you've got to take' (Laura; 
Interview 1; Lines 127-129). 
This finding supports that of Temple and colleagues (2006) who identified 
doctor's advice as a key factor in women's breast cancer treatment decision-
making. What is more, the implicit sense of trust enabled the majority of women 
in the present study to choose a passive role in surgical treatment decision-
making. While Laura had initially proposed undergoing a mastectomy medical 
advice to the contrary led her to assume a passive role and accept medical 
advice. 
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'When they did the operation they found out it was only tiny. Now, 
however many months on I think that it would have been a bit drastic. 
You know they're doing what's best for you' (Laura; Interview 1; Lines 
91-94). 
Kukla (2005) argues that deferring to the expertise of healthcare professionals, 
as demonstrated in the previous quotations, is rational when an individual 
assesses practitioners to be better placed to make a medical treatment 
decision. 
The passivity seen in relation to surgical treatment decisions extended to all 
participants for non-surgical decisions. This enabled these women to avoid 
additional anxiety and handing over control was perceived by all participants as 
ensuring smooth progression throughout the post-diagnosis phase of medical 
regimes. 
'It (treatment decision-making) was taken out of my hands but because 
of that it has all really flowed, everything's gone according to plan and 
according to timescales' (Amanda; Interview 1; Lines 80-82). 
Parallel to the present study patient's trust in the surgeon's expertise has been 
found to lead to an unquestioning attitude (Mendick et al., 2010) and being 
given a treatment plan facilitated greater confidence in the surgeon's abilities. 
When initial Consultant led surgical treatment decisions were found to be 
incongruous with histology results and subsequent surgical intervention was 
required participants described feeling shocked and distressed at this 
unexpected result. Moch (1995) notes that women may give their bodies and 
decision-making power over to those who are trusted or not trusted on the basis 
of a belief in the capabilities in the medical profession. The current study has 
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found that when this premise was flawed participants continued to trust the 
healthcare professionals. For three women a lumpectomy had been undertaken 
however a mastectomy was required shortly thereafter. Rather than this 
adversely influencing the trusting relationship previously established with the 
medical team Amanda commented on the expertise of her Consultant. 
'I was devastated because I was just getting used to the smiley scar 
underneath my boob which was very, very neat and I must admit she's 
fantastic at the job she does. Just shock and disbelief but I felt lucky to 
be truthful with you. I do feel lucky because if I hadn't gone and had the 
lumpectomy and if she hadn't taken the extra bit then who knows?' 
(Interview 1; Lines 88-93). 
Similarly, Mary remarked: 
'That was a complete shock. I didn't expect that. I think if I'd have been 
told in the first place I'd have just gone with the flow so I just didn't expect 
her to tell me that but you know you either go along with what you're told 
or...well if you don't it's obvious isn't it' (Interview 1; Lines 135-139). 
Trusting healthcare professionals to maximise the chances of survival was 
frequently inferred in as participants contemplated the acceptance of medical 
opinions though rarely were issues of mortality explicitly faced in this context. 
Louise is the exception to this though the following quotation demonstrates her 
desire to accept only favourable medical opinions. 
'Well when he (Consultant Surgeon) said he would remove the lump and 
I would have twenty years to live, I thought well that's marvellous. When I 
was talking to the oncologist she said that it could come back to the 
same breast or it could come back to another part of the body, in another 
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place. It's not everyone it happens to so looking on the good side...I think 
the first version's better so I'll accept that. I'm just putting my life in their 
hands and trusting their experiences' (Interview 1; Lines 125-131). 
Women's ultimate reliance on healthcare professionals to eradicate breast 
cancer is discussed in the subsequent theme. 
5.5 Getting rid of it 
The theme 'getting rid of it' is one of the few identified in women's longitudinal 
experience of breast cancer that is specific to one time point, that from 
diagnosis to surgical intervention. Consequently, as with the previous theme 
(acceptance of medical opinions), discussions relevant to this element of 
women's experiences were central to their initial interviews. However, once 
again, as this theme was so fundamental to women's experiences it was 
frequently reflected upon and echoed in successive interviews. Unquestionably, 
removal of the diseased breast tissue was of paramount importance to all 
participants and was spoken about repeatedly during the first interview. 
'My priority was to remove the problem, the cancer' (Sarah; Interview 1; 
Line 85). 
For several women an initial reaction was to request removal of the whole 
breast as doing so was perceived to maximise chances of survival. 
'I said if you think you're gonna have to take the breast off then just do it. 
I said just get rid of it all and then I'll be alright' (Fiona; Interview 1; Lines 
78-80). 
As reported in previous research (e.g. Katz et al., 2005) participants who did 
take a more active role in surgical decision-making did so by requesting a 
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mastectomy. However, contrary to previous qualitative research (e.g. Fang, Shu 
& Fetzer, 2011) for women in the present study the meaning of the breast was 
not perceived to be a key factor in the surgical decision-making process. 
However, echoing the work of Cassell (1976) participant's lexical choices as 
illustrated throughout this theme through references to breast cancer as "it" and 
"the cancer" and to breasts as "the breast" and "them" suggests an 
objectification of the body and the disease. This additionally indicates that 
women in this study viewed breast cancer as separate to the self and in doing 
so and in perceiving the body as a physiological system (Radley, 1996) were 
able to distance themselves from breast cancer. As theorised by Maclachan 
(2004) such distancing may be a self-protective coping mechanism to minimise 
stress and anxiety but also given participant's acceptance of and trust in 
medical opinions could reflect a desire to hand over responsibility for making 
decisions that will induce significant bodily changes. The choice of passive 
involvement in treatment decisions would seem to further support this notion. 
Accordingly, while Jenny took a more active stance in vocalising her desire for a 
mastectomy due to past experiences of cancer signifying death, removing the 
breast led to a decrease in stress by eliciting a sense of action. 
'Right up until the last minute I could change my mind but I felt I was 
fighting it one hundred percent by doing that (having a mastectomy). I 
just couldn't.my sister and partner both lost their lives and I just couldn't 
take that chance' (Jenny; Interview 1; Lines 97-99). 
This corroborates the findings of studies reporting that women fear cancer more 
than breast loss (Demir et al., 2008; Fallowfield & Hall, 1991). Women's priority 
of survival in order to fulfil responsibilities such as childrearing has been noted 
elsewhere (Fang et al., 2011) though was particularly evident in the current 
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study as women described the need to 'get rid of it' (whether via mastectomy or 
lumpectomy) to 'be around' for the sake of others. 
'If they got it away then that would be alright. I've got two children and a 
loving family. I've got them to consider' (Gillian; Interview 1; Lines 94-95). 
This finding may provide some support for the 'tend' response of the "tend-and-
befriend" model (Taylor et al., 2000) (discussed in Chapter 3, p.80) as women 
engaged in such surgery in an attempt to protect their offspring and reduce 
distress. Laura, one of the youngest women in the sample, described initially 
requesting a bilateral mastectomy, her motivation being to enable her to watch 
her children grow up. Laura was however advised against this course of action 
by the Consultant Surgeon and she subsequently reflected on this decision-
making process. 
'Initially, my reaction was just to get it taken off altogether, well both 
actually and I really wanted that...I really did. I've had my kids and I'm 
living my life and I just wanted to get rid of them both. I don't think it was 
a mental thing I was going through I just thought that was the best thing 
and then it'll never come back but the Consultant said that was far too 
drastic, it wasn't to that degree. She told me for a reason that I only 
needed a lumpectomy...so you do what they say don't you, you do what 
they think is right' (Interview 1; Lines 84-89). 
This further supports the previous findings regarding acceptance of medical 
opinions and women's conscious decision to assume passive involvement. 
Avoiding the need for further surgery and interventions were also reasons cited 
for wanting a mastectomy by, for example, Linda. 
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'I've no chemotherapy, no radiotherapy, nothing because they've taken 
everything away' (Interview 1; Lines192-193). 
Such findings within this theme concur with those of Collins and colleagues 
(2009) in that undergoing a mastectomy elicited some peace of mind and was 
seen to avoid the need for additional adjuvant therapies. Consequently, 
participants hoped that a return to normality would ensue shortly thereafter. 
Completing surgical intervention was clearly viewed as a milestone in this 
process. 
'You've got something in there, in your body that could kill you, take your 
life and until you get rid of that your life's not your own, how can it be?' 
(Jenny; Interview 2; Lines 177-179). 
This remained the case even for those participants facing several months of 
treatment. 
'I feel as though that's it, it's gone now, it's a case of just getting on with 
my life, getting sorted, so I can't wait for the chemo to end and then I can 
get back to normal' (Rose; Interview 1; Lines 63-65). 
This quotation also illustrates that once participants had undergone surgical 
intervention and the diseased breast tissue had been removed they no longer 
perceived themselves as having breast cancer. This is supported by the 
following reflection from Susan. 
'I believe at this moment in time I haven't got breast cancer in me. I think 
they got all of it out with the surgery and the treatments that have 
followed are just to make sure it doesn't come back' (Interview 1; Lines 
127-129). 
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Similarly, Sarah sought ultimate predictability (Frank, 1995) following a 
recurrence by taking control of her body and breast cancer through an active 
role in surgical decision-making. 
'I can say yes I'm in control of breast cancer because I haven't got any 
breasts but you don't know what the future holds in other ways, nobody 
does. I feel that breast cancer is behind me through the decision I made 
to have the double mastectomy. Without that I would never have been 
free of it' (Sarah; Interview 1; Lines 628-632). 
Perceiving the eradication of breast cancer at the point of surgery may have 
implications for how subsequent non-surgical treatment decisions are made and 
specifically may explain the increased passivity relating to such decisions as 
discussed previously in this chapter. Women's perceptions of breast cancer 
were additionally influential in treatment decision-making and form the basis of 
the following theme. 
5.6 Cancer Schema 
Women's beliefs about breast cancer as well as information provision which 
influences understanding of the disease have been found to be influential in the 
treatment decision-making process (Halkett et al., 2005) and these aspects are 
discussed further in this theme. The participants prior knowledge and 
experiences of cancer were found to define their cancer schema (i.e. what they 
believe constitutes cancer (or not)) and these perceptions are discussed in the 
following sub-theme. 
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5.6.1 Perceptions of cancer 
Participants' cancer schemas were evident throughout the data collection period 
and were found to influence these women's experiences of receiving the 
diagnosis of breast cancer as well as their psychological response to the 
disease. For Mary, whose husband had previously been diagnosed with cancer, 
this was evident prior to receiving her diagnosis. 
'They told us to come back to the waiting room and we could see that 
she was putting three chairs out and as soon as she put the three chairs 
out I said to my husband this is not good...three chairs is bad news...I 
knew someone would be sitting with me' (Interview 1; Lines 58-60; 68). 
Cancer schemas were also found to influence the process of accepting the 
breast cancer diagnosis as illustrated below. 
'I just felt like she had the wrong notes in her hand, sometimes even now 
I still do. I still think they've got it wrong because I felt fine. I wasn't 
aching, I wasn't tired, I was still at work full-time...there was nothing, so I 
really thought she had the wrong notes in her hand' (Laura; Interview 1; 
Lines 37-40). 
Disbelief was a prevalent reaction among participants experiencing cancer for 
the first time and was typically linked to a schema attributing physical symptoms 
and a limitation on activities of daily living to having breast cancer. 
Consequently, and as previously recorded by Lindwall and Bergbom (2009), 
feeling well at the time of diagnosis was linked to difficulties accepting having 
breast cancer. 
'It's quite frightening to think that you've got something growing in your 
body and you feel fit and healthy and it's hard to get your head round the 
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fact that it could kill you. You just feel like there's nothing wrong with you, 
you don't feel any pain or anything...its very strange. It was only when I 
had the operation that I didn't feel well and that's just like the recovery 
process and I think that's why it's hard to come to terms with really, that 
you have actually got breast cancer because you don't feel it' (Gillian; 
Interview 1; Lines 362-368). 
The following quotation taken from Laura's second interview further highlights 
this issue and the perception of being well until undergoing treatment regimes. 
'I wasn't tired, I wasn't sick, I wasn't losing weight. Sometimes I still think, 
I think about that all the time, it's not that that makes you ill, it's the 
treatment for it. So you feel like they're making you ill because I wasn't ill 
before, I was absolutely fine. It's such a strange disease or illness or 
whatever you wanna call it. It's quite scary that you have no effects, 
nothing at all until you find this little tiny lump but you never think for one 
minute that it's that because you feel so alright. You feel so.normal, you 
don't feel anything' (Laura; Interview 2; Lines 170-177). 
While discussing their breast cancer diagnosis during interview one participants 
often reflected on schemas linked to aetiology and relayed a series of potential 
events leading up to their diagnosis. 
'We went to the Caribbean in 2002 and went on a cruise and it was hot, it 
were like 30 and when we came back it were like -3 in Manchester. 
From there we were both poorly until April. I had a boil on my back, never 
got shot of colds.I just wasn't well. From then onwards if I've done a job 
I've then sat down and gone ooph.as though I don't feel really 
well.and now I feel great. Last May we had a very bad accident.you 
just don't know, you wonder what starts these things don't you...I don't 
know how the hell we got out alive but there wasn't even a scratch. The 
only thing that hurt was the strap across my chest, it really, really dug in 
and I just wonder, how do these things happen?' (Linda; Interview 1; 
Lines 123-132; 137-139). 
In discussing the results of a series of focus groups Wilkinson (2000) reported 
that individual participants used multiple versions to explain the aetiology of 
their breast cancer and relay a variety of potential causes. In addition, as is 
further exhibited by Linda's above quotation Wilkinson identified one of the most 
common lay explanations as being 'secondary to trauma or surgery' including a 
'knock' to the breast. However, while Wilkinson found the most frequently 
mentioned cause of breast cancer to be reproduction/childbearing issues, 
interestingly, this rarely appeared in women's explanations of the origins of their 
breast cancer during the present research study. 
An association between breast cancer and stressful life events was discussed 
in depth by several participants who cited divorce, bereavement, financial 
difficulties and work-related stress as potential contributors. The following 
extract from Louise's first interview highlights that such a conclusion was often 
reached when other lifestyle related risk factors had been discounted. 
'My husband left me twelve years ago, suddenly out of the 
blue.because we'd just bought this house and moved in on the 
February and in the April he said he's met somebody else and said I'm 
leaving and he just went' (Lines 183-186)...'I know inside my stomach 
was churning, thinking I was going to lose the house. That really worried 
me and that's the only thing I can think of. I mean I'm tee-total apart from 
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the office party once a year so it's not alcohol problems and my weight's 
alright.it's a mystery' (Lines 199-201; Lines 204-205). 
While comparison to quantitative research is limited, Lavery and Clarke (1996) 
found that 34% of a sample of 244 women with breast cancer focused on stress 
as a perceived cause. A more recent qualitative content analysis (Arman, 
Backman, Carlsson & Hamrin, 2006) of 118 interviews with women with varying 
stages of breast cancer reported that 71% of women perceived a link between 
their breast cancer and their life lived. This encompassed aspects of stress and 
other psychosocial factors such as bereavement, mental distress, and 
psychological trauma. As data collection progressed several women continued 
to reflect on the causes of their illness though subtle changes in the context of 
these discussions were noted. For instance, rather than discussing modifiable 
risk factors such as smoking and alcohol use as was undertaken in interview 
one, in subsequent interviews women began to focus on non-modifiable risk 
factors and alternate explanations. Mary, for example, considered her own 
schemas regarding possible contributing factors and like many women made 
reference to a genetic link though one that was interlinked with fate. 
'Sometimes I think the area we live in isn't good. If you look at other parts 
of the country they're probably not as high as us. I do think my stress had 
something to do with it. I'm not saying it caused it but I think it maybe had 
a contribution because my body was vulnerable. I do think some of its 
genetic; these things are destined from birth' (Mary; Interview 3; Lines 
151-155). 
Consequently, women's sense of control over breast cancer and in turn the 
responsibility they assume for their breast health may be linked to the cancer 
schemas they hold. The research by Arman et al. (2006) described how 4% of 
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women believed heredity to be the sole genesis following a family history of 
breast cancer. However, while genetics were discussed extensively by the 
women in the current study who had experienced breast cancer within their 
families, a genetic predisposition with other contributing factors was often 
described as were current issues in genetic testing. 
'It's not conclusive but I left blood because apparently they need blood 
from somebody who's had breast cancer and if in the future they wish to 
do that test they can and of course my children have permission to use 
that if I'm not here. What I did find out, which was a contradiction from 
ten years ago, they told me it would only pass down the female side of 
the family but now they're now telling me it could pass down to my sons 
as well and down to their children so I've got two little granddaughters in 
that (moderate) risk bracket as well' (Ellen; Interview 2; Lines 159-166). 
The final theme in the study by Arman and colleagues (2006) reflects the 
rejection by some women of a link between breast cancer and one's life 
behaviours with a preference for believing in chance. This too was found by this 
research though such a conclusion was often the result of deliberation over the 
origins of cancer and women's previous cancer schemas which led to a 
distancing from such a possibility. For instance, participants who held a cancer 
schema attributing poor lifestyle with breast cancer now found this belief to be 
challenged and continued to question "why me?". 
'You've got all these people smoking, drinking, unhealthy eating and why 
have I got it?' (Janet; Interview 1; Lines 188-189). 
When such uncertainty arose, typically following a period of reflection, 
participants sought counsel from the breast care nurses which seemed to 
support the notion of chance. 
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'I spoke to the breast care nurse and she said it doesn't discriminate; 
you're just unfortunate if you get it. It's as if you've had a sprinkling of 
magic dust and if it's landed on you you've got it' (Mary; Interview 3; 
Lines 149-151). 
Consequently, while many participants made reference to the biomedical risk 
factors discussed in Chapter 1 (p.13-15), with the exception of genetics, these 
risks were often rejected as possible causes of women's breast cancer. Instead, 
these women cited the influence of psychological factors and fate as influential 
in the aetiology of the disease thereby adding further complexity to current 
understandings of risk perceptions pertaining to breast cancer. The ways in 
which participants described breast cancer further provided an insight into their 
cancer schema and the psychological impact of their illness. 
'In my mind I saw it as a spider (breast cancer) and after I was diagnosed 
I actually had lots of horrible dreams about spiders. When I closed my 
eyes it was green and had lots of tentacles...I think when you're told it's 
gone to your lymph nodes, it's like where else has it gone, it's reaching 
out' (Amanda; Interview 1; Lines 174-177...183-184). 
The use of analogies and experiencing cancer-related dreams were most 
prevalent during the primary interviews as participants were attempting to 
understand the nature of their illness. Interestingly once Amanda had completed 
treatment she reported no longer having such dreams. The influence of 
healthcare professionals was often evident in such analogies. 
'She (breast care nurse) described it like a garden...I've had a dandelion 
removed, which is the tumour, and all the seeds of the dandelion have 
spread into the breast, which are the cells, so now we need weedkiller to 
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destroy all of the bad ones. I laughed, I thought well that explains it so 
much easier' (Louise; Interview 1; Lines 76-81). 
This quotation additionally highlights that the use of this strategy by the breast 
care team to facilitate women's understanding of treatments can be successful. 
Furthermore, the use of analogies by the breast nurses would seem to contrast 
the biomedical focus of the written information packs given to all of the study 
participants at diagnosis. The following sub-theme further considers women's 
informational needs with a specific focus on the management of information as 
a coping strategy to manage the stress of experiencing breast cancer. 
5.6.2 Managing information - access and sources 
Cancer schemas were modified with the acquisition of new information and all 
participants reported receiving verbal and written information about both breast 
cancer and relevant surgical procedures from the healthcare professionals 
involved in their care at the time of diagnosis. The provision of information that 
provides clear explanation of proposed treatments including risks and 
alternatives was central to the development of the Patient's Charter 
(Department of Health, 1992) and health communication has since become part 
of medical training in the UK. In 2003 Kreps highlighted the importance of 
effective health communication by suggesting direct links to cancer risks, 
incidence, morbidity and mortality as well as quality of life. A systematic review 
reported that healthcare professionals are the most frequently cited sources of 
information by individuals with cancer and those cancer patients rely on medical 
information packs and verbal communication from doctors particularly during 
the diagnostic and treatment phases of their experience (Rutten, Arora, Bakos, 
Aziz & Rowland, 2005). However, the review was not limited to papers 
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regarding breast cancer and the majority of primary studies did not utilise a UK 
population. In a study specific to breast cancer, giving women the choice of 
surgical intervention (mastectomy or lumpectomy) was not found to prevent 
psychiatric morbidity but "consulting style, in particular offering satisfactory 
information about treatment options was crucial to long-term adjustment" 
(Fallowfield, Hall, Maguire, Baum and A'Hern, 1994; p.203). While all 
participants described receiving verbal information including about potential 
treatment regimes, at the time of diagnosis hearing the word "cancer" was 
discussed by some of these women as limiting information processing capacity. 
'I think it was watching him (husband) that made me realise what she'd 
(Consultant Surgeon) said because I heard the word and I can honestly 
say I don't think I heard another word after that' (Laura; Interview 1; Lines 
49-51). 
Attributing cancer to death was discussed as resulting in such a reaction and 
emotional state has been identified as a core issue in health communication 
(Edwards & Hugman, 1997 as cited in Berry, 2004). This may help to explain 
research findings purporting that women exhibit limited knowledge about the 
rates of recurrence and survival associated with differing surgical treatment 
options (Fagerlin, Lakhani, Lantz, Janz, Morrow, Schwartz et al., 2006). Women 
in the current study sought to minimise the extent to which such negative 
schemas prevailed in their psyche and instead focused on improving survival 
rates. 
'It's a scary word...it's like a death sentence...and really it's not any more 
is it? I think that's what needs re-educating, that it's not a death sentence 
any more. It's not like it was twenty years ago or even ten years ago. 
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People are recovering, are being cured. I just wish they'd use another 
word, it's so scary. I still can't say the word' (Laura; Interview 1; Lines 
214-218). 
The longitudinal nature of this research has enabled an insight into women's 
subsequent information decisions and highlights that many of the study 
participants used information avoidance and management as a coping strategy. 
The patient information pack providing general medical details regarding breast 
cancer and its treatment was recurrently considered to be anxiety provoking. 
This form of information designed to supplement verbal consultations is widely 
acknowledged as being beneficial in allowing patients to refer to relevant 
information away from the stressful environment of the consultation room 
(Berry, 2004). That said, information bringing negative cancer schemas to the 
fore was avoided by participants. 
'I've read through it but I don't like reading it because it just reminds you 
of what you've been through and what you've had. I think I've read 
through it once and then my son has had a look at it...I did read in there 
that you can get it in the other breast and I think that's put me off reading 
any more' (Jenny; Interview 1; Lines 329-355). 
Patient difficulties understanding medical information leaflets have been 
reported in the UK with readability and legibility being criticised (e.g. Payne, 
Large, Jarrett & Turner, 2000) yet the findings documented here suggest that it 
was not that women struggled to read and comprehend the information about 
breast cancer itself, it is that they did not want to do so. Accordingly, for 
numerous women in this sample, including Mary, the information pack received 
at the clinic at the time of diagnosis was set aside shortly after returning home. 
This supports the notion of escaping emotional triggers by avoidance of 
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information as previously reported in Lally's (2010) grounded theory study of 
women prior to first breast cancer treatment. 
'They gave me some books about breast cancer and I started to read 
them that day but then I think there's only so much you can face and so I 
put it to one side' (Mary; Interview 1; Lines 96-98). 
The cognitive-social health information-processing model (Miller, Shoda & 
Hurley, 1996) purports that individuals cognitively and emotionally process 
health information and describes a stable individual difference of monitor-
blunting coping style as motivating health behaviours. Contrary to the 
information-seeking traits of monitors, blunters do not seek detailed information 
about their illness, find a large amount of information, particularly that including 
statistics, to be stressful and have a tendency to become overwhelmed by 
threatening information (Miller, 1995). The information avoidance demonstrated 
by numerous participants may suggest that they conform to the blunter style of 
coping. This finding also echoes those of Donovan-Kicken and Caughlin (2011) 
regarding topic avoidance though in the present study this was in relation to 
written information as opposed to verbal communications. With the passage of 
time several participants did reflect on facing a dilemma as while they did not 
want to read the medical information provided they felt that they should do so 
though did describe attempts to manage the quantity and content of their 
readings. 
'Well I tried not read it at first but then as time went on I thought I'd better 
be reading some of this. I must say I only read what I wanted to read. I 
didn't go into loads of details, I mean she was on the computer and was 
asking the doctors at work and I just read what I'd more or less been 
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given from the hospital. I didn't want too much detail' (Margaret; Interview 
3; Lines 145-149). 
The information was returned to by many participants, including Janet, once 
surgery had been undertaken and decisions had been made regarding follow-
up treatments. 
'They've given me loads of information which now I'm reading because 
when they first told me I put the books away in the drawer, I didn't want 
to think about it. Now I've had the operation I'm taking all the information 
in now' (Interview 1; Lines 152-155). 
In this context reading medical information was reported as reducing anxiety. 
'Well I'm sort of a worrier so really I don't like to know things because I 
know I'll worry about it. So when I read those leaflets it helped me a lot 
because it was comforting' (Louise; Interview 2; Lines 112-114). 
It is plausible that given the aforementioned finding that removal of the tumour 
was viewed as eradicating breast cancer that the participants were more able 
post-surgery to begin accepting the implications of their diagnosis. Moreover, by 
focusing on medical facts these women may have felt more able to prepare for 
upcoming medical regimes. This information management enables women to 
achieve some sense of control over their situation and lessen anxiety (Drageset 
et al., 2009). By contrast some participants continued to actively avoid 
information regarding the treatments being experienced in order to minimise 
concerns and the chances of side-effects occurring via psychological 
processes. 
'With the radiotherapy I didn't even look to what the side effects were 
gonna be because I think your mind...I think your mind's a wonderful 
thing but I also think it can be terrible. You see I knew what the side 
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effects were gonna be for the first part of the chemotherapy and I think 
you talk yourself into them. When I was going onto the tablets I didn't 
wanna know what the side effects were gonna be and so everything that 
happened...I haven't made it happen, the same with the radiotherapy' 
(Mary; Interview 2; Lines 319-325). 
Research indicates that information regarding treatment side-effects can result 
in patients attributing symptoms being experienced to listed side-effects 
however the likelihood of such adverse effects occurring is not increased (e.g. 
Raynor, 1998 as cited in Berry, 2004). Furthermore, in relation to chemotherapy 
while patient expectations can be predictive of subjective bodily experiences 
such as nervousness and nausea, this is not the case for objective toxicity 
experiences (e.g. vomiting and constipation) (Olver, Taylor & Whitford, 2005). 
Knowing that they could contact the breast care nurses for advice and support 
provided reassurance for all women interviewed, whether they chose to do so or 
not. The following quotation from Ellen highlights this as well as the interaction 
between striving for survival, having trust in the medical team and treatment 
decision-making. 
'If it'll keep me alive I'll have anything. I honestly do have all of my faith in 
the team. I get so much information from them and they explain 
everything to me. I rang them about the pain in my arm and they 
reassured me about that. I do have faith that they know what's best and if 
they say taking Tamoxifen is the best treatment for me I would not argue 
about that' (Ellen; Interview 1; Lines 267-271). 
Several women disclosed giving the information to a family member to review 
as and when they felt it necessary, typically if they began experiencing 
treatment related side-effects. 
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'My mam has the breast pack of mine and I say to her will you have a 
look to see if there's anything in there about your mouth ulcers whereas if 
I had the book in front of me I'd be thinking well I didn't have that but I've 
got it now. If you read it you get into your head that you've got it' (Emma; 
Interview 1; Lines 261-265). 
Consequently, for some participant's medical information, and adding to their 
cancer schema, was perceived to hinder their recovery and was consciously 
avoided though the social support elicited via this strategy is noteworthy. A 
step-by-step approach to knowledge acquisition was noted to occur by 
Drageset and colleagues (2009) in relation to the pre-treatment phase. The 
present study demonstrates that this approach was undertaken in the longer-
term. The desire to remain positive may help to explain why these women 
undertook such information avoidance and rarely reviewed other treatment 
options and when doing so attached negative connotations to these treatments. 
'Some people can deal with that, having a mastectomy and having a 
false, but I couldn't have done that. You never really think about it until 
you talk about it but I think my breasts are a part of me as a woman. It's 
important to me as a person. I don't think I would feel a whole woman if I 
didn't have breasts and I still feel a little bit like because of the scars I've 
got on them but I've still got my breasts so it's the best of a bad 
thing.that's how I look at it' (Margaret; Interview 1; Lines 228-234). 
The myriad of issues regarding femininity and womanhood are discussed in the 
forthcoming chapter though negative perceptions of alternative treatments were 
additionally identified in relation to adjuvant therapies. 
'I was pleased to hear all I would need was radiotherapy and Tamoxifen. 
I was so glad I didn't need chemotherapy to tell you the truth...I didn't 
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want to lose my hair and have all the other side-effects associated with it' 
(Lily; Interview 1; Lines 127-134). 
These findings can be framed in relation to Festinger's (1957) theory of 
cognitive dissonance whereby women's management of information allowed 
them to avoid reflection on treatment decisions and in turn uncomfortable 
feelings of cognitive dissonance. Furthermore, in line with the aforementioned 
emotional trade-off model of Luce (2005) when making such difficult decisions 
the advantages of other treatment options would not be confronted in order to 
minimise potential stress. Coping through avoidance/distancing is typically 
deemed to be a negative coping strategy however it served a purpose for many 
participants and moreover the management of information access and flow 
would seem to represent a positive means of coping. 
The importance of women's satisfaction with the information they receive about 
their breast cancer diagnosis and treatment can be demonstrated through its 
significant association with quality of life and both physical and social well-being 
(Davies, Kinman, Thomas & Bailey, 2008). Although a cross-sectional study 
relying on self-report data, similar findings have been reported elsewhere in that 
unmet needs for information about a cancer diagnosis have been linked to 
negative psychological outcomes including anxiety and depression (Mesters, 
van den Borne, De Boer & Pruyn, 2001). While women in the current study 
often chose to avoid and/or manage the flow of medical information only Ellen 
expressed dissatisfaction with regards to the quantity of information though this 
was specific to Tamoxifen. While direct comparisons are limited this appears to 
contradict the quantitative study of Temple and colleagues (2006) who reported 
that only 13.6% of women perceived that they had received their preferred 
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amount of information regarding surgical treatments. Nonetheless, for Ellen, the 
lack of information pertaining to the side-effects of Tamoxifen led to a sense of 
being unprepared and that this in turn had an impact on her family. 
'I think maybe had I been given a bit more warning about the side 
effects.. .they tend to play the side effects down. You know, I was told 
you've gone through the menopause, it's highly unlikely you'll feel any 
side effects at all, you'll just be fine and that's so not true. I've never 
spoken to anybody who's been on Tamoxifen who hasn't thought it was 
horrific. I think if I'd had a bit more information I think I might have been a 
little bit more prepared and I think the rest of the family might have been 
as well' (Ellen; Interview 2; Lines 78-85). 
Higher unmet needs for health information and emotional support have been 
shown to be associated with a greater likelihood of women consulting the 
Internet during the course of their illness (Lee & Hawkins, 2010). While the 
remaining women in the sample did not indicate being dissatisfied with the 
quantity or quality of information provided by the breast unit the Internet was 
utilised by over half of the study participants for the further acquisition of 
knowledge. This was despite them reporting being advised against doing so by 
the breast care nurses. Such information seeking behaviour commenced only 
after surgical intervention and, as illustrated below facilitated a more active role 
in further treatment decisions. 
'At the minute I'm researching all about reconstruction, all the different 
types of things you can have, what they do. So when I go I'll just say I 
don't need to come back to decide because I already know' (Gillian, 
Interview 1; Lines 293-296). 
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Resisting being made to wait for information from healthcare professionals 
instead seeking answers to their own questions engendered a sense of control 
over participants' experiences, a process Sharf (2005) refers to as patient 
engagement. This corroborates the findings of Mulcahy and colleagues (2010) 
and illustrates a step away from traditional doctor-patient dynamics whereby the 
doctor acts as information keeper. This finding also suggests that some women 
do not wish to be fully dependent upon healthcare professionals and highlights 
their ability to develop coping strategies to manage the stress and uncertainty of 
having breast cancer as well as their desire for information about their bodies. 
Information seeking has previously been identified as playing a crucial role in 
women's efforts to cope with disruption to quality of life following a diagnosis of 
breast cancer (Arora, Johnson, Gustafson, McTavish, Hawkins & Pingree, 
2002). For Sarah this monitoring coping mechanism (e.g. Miller, 1995) 
appeared when experiencing a recurrence as she moved from a previous 
avoidance of information to actively seeking to update her cancer schema. 
'Looking on the Internet. Whereas before I wouldn't read articles now I'm 
much more aware of watching and looking at new drugs that have come 
out and have become interested in drugs that haven't been licensed and 
an awareness of all of that. It's almost gaining information in case I need 
it for the future' (Sarah; Interview 1; Lines 540-544). 
Participants also sought, where possible, information and support from friends 
who had experienced breast cancer, a strategy which was perceived to be 
particularly beneficial. 
'When I had a pain in the top of my arm I thought ooh I wonder what that 
is so I asked a friend who'd had a mastectomy and she said oh don't 
worry, that's normal, you know, sort of thing so it's nice to be reassured 
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by people like that who've gone through it. I also had a magazine as well 
that they send you twice a year, MONA magazine and that's marvellous. 
Its people who are in the same position as you that have wrote in asking 
questions or for advice and then you realise that you're not on your own' 
(Rose; Interview 2; Lines 265-272). 
Reacting to a stressor through affiliation with groups who may aid the reduction 
of distress echoes the befriend component of the "tend-and-befriend" model 
outlined in Chapter 3 (p. 80) (Taylor et al., 2000). A recently published 
secondary analysis of interview data obtained from eighteen women with newly 
diagnosed breast cancer prior to breast surgery (Dickerson, Alqaissi, Underhill 
& Lally, 2011) provides further support for this sub-theme. The American 
research found that women accessed information from a variety of sources, 
including books, the Internet, and others who had experienced breast cancer, 
and that this was undertaken in accordance with a woman's individual need for 
information. Dickerson and colleagues further stated that women made 
attempts to control access to information to the self and to others however 
unlike the current study the use of others to achieve this was not reported. 
Likewise, the use of avoidance of information to minimise anxiety was illustrated 
via one participant's quotation though the specific timing of data collection prior 
to surgery and the lack of longitudinal design did not facilitate insight into 
women's use and non-use of information throughout the healthcare trajectory. 
This theme has highlighted that participants held cancer schema even prior to 
diagnosis and that these schema were often factually inaccurate. Furthermore, 
while these schemas were modified throughout participants' experiences (given 
the input of healthcare professionals), many women avoided adding to their 
knowledge of the disease and relevant treatments. Irrespective of participants 
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strategies of information management women's cancer schemas influenced 
their responses to breast cancer throughout the year post diagnosis. This 
chapter has considered women's experiences of health-related decision-making 
and associated issues of control. The final theme continues this exploration 
through women's attributions of responsibility for their breast health. 
5.7 Responsibility for breast health 
Discussions pertaining to control and responsibility for breast health were 
centred on breast self-examination. A lack of breast self-examination was 
reported both prior to diagnosis as well as in the initial few months post 
diagnosis when an active avoidance of checking breast tissue was frequently 
evident. 
'I mean I know I'm a trained nurse and have always known what you 
should do to check your breasts but at times I haven't. I was actually 
washing when I found it and it was quite prominent so it must have been 
there for some time.so I'm very wary of checking the other. Nobody 
expects they will get cancer, especially being a cancer nurse you know 
that anybody can get cancer but you never think it will happen to you' 
(Lily; Interview 2; Lines 99-104). 
Unrealistic optimism (Weinstein, 1983) featured in Lily's account though the fear 
of finding another breast lump constituted the primary reason provided for not 
checking the remaining breast/breast tissue. This suggests that participants 
utilised avoidance as a means to cope with the stress elicited by a breast 
cancer diagnosis. To some extent, bodily changes experienced during 
treatment regimes were viewed by Janet as limiting her previously vigilant 
behaviour instigated by prior breast disease. 
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'I think I've always checked my breasts because for the last ten years 
I've been having mammograms because I've been having cysts so.but 
then again since this has happened I've never checked them. I think I've 
got that many chemicals in my body.I feel like my body's being 
poisoned, it's a horrible feeling and I've never checked them as such...In 
case I find another one. Now that's a funny attitude for me to have 
because I'm...I rub cream in this one for the scars but I never think I'm 
looking for lumps, I don't know why. I always used to do it regular before 
and I probably will do when it's all over and done with, the radiotherapy 
and everything and when I get back to normal' (Janet; Interview 2; Lines 
110-114; 118-122). 
Accordingly, when these women were engaged in active hospital-based 
treatment assuming control and responsibility for the monitoring of breast health 
was offset by the reassurance of ongoing follow-up appointments. In particular, 
annual mammography screening and regular follow-up hospital appointments 
were critical in providing participants with the reassurance they sought. 
'Sometimes I'm too nervous to touch it in case there's anything there. I 
don't know yet, I don't think I'll check it yet. Well I'm getting checked 
through the hospital anyway so I feel quite relieved anyway, I'm gonna 
be having mammograms before the twelve months is up for that' (Jenny; 
Interview 1; Lines 201-204). 
In line with Frank's (1995) argument that the lack of focus on patient's bodily 
awareness in favour of diagnostic images and hospital checks is another way in 
which medicine encourages dissociation of the body and self. This may help to 
explain why the reassurance gained from follow-up was found to limit the extent 
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of women's breast self-examination despite their perception that greater breast 
vigilance was needed. 
P: 'I think you have two sides. You have the side where you know you 
should be more vigilant than you ever were before but I've also got this 
other side that says I don't ever wanna check them again because I don't 
wanna know. There's my sensible side that says check them and my silly 
side that says no don't'. 
I: 'and which side wins?' 
P: 'Probably my silly side at the moment because I'm still going to the 
hospital for checks and things' (Laura; Interview 3; Lines 199-208). 
Women have been found to have high expectations from follow-up as well as 
shortcomings in knowledge about recurrence and metastases (de Bock, 
Bonnema, Zwaan, van de Velde, Kievit & Stiggelbout, 2004). This cross-
sectional survey conducted in the Netherlands identified factors including the 
prevention of breast cancer and hereditary factors and changes in the untreated 
breast as well as the long-term effects of treatment to be of central importance 
to women two to four years following breast cancer surgery. De Bock and 
colleagues reflected on the questionable effectiveness of follow-up particularly 
those including additional investigations and given improvements in adjuvant 
therapy. Yet the current research highlights that even for those women who 
were engaging in breast self-examination the ongoing trust in medical 
professionals, now to identify recurrence, was striking. 
'They checked both, even this one you know and even though I'm 
checking I'm pleased they're checking because I might miss it. A full 
examination and it makes me feel at ease because if there's anything 
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they'll pick it up, quicker than me. I can't feel anything but they might' 
(Maria; Interview 2; Lines 232-235). 
Supporting a previous UK study involving observations of breast cancer follow-
up consultations (Beaver and Luker, 2005) participants expected that a physical 
examination would confirm or deny recurrence and when disease was not 
identified (either via breast examination or mammography) they felt reassured. 
However, detection of recurrent breast cancer is more likely to be identified by 
women themselves between hospital follow-up visits (Grunfeld et al., 1996). The 
findings of Beaver and Luker additionally indicated that healthcare professionals 
created an illusion that recurrences would be detected at a hospital follow-up 
(Beaver & Luker, 2005) as healthcare professionals continued to search for 
recurrence despite not expecting to discover recurrent breast disease. It is 
argued that this is indicative of the UK healthcare system fostering a reliance on 
follow-up appointments and in relation to the line of reasoning within this 
chapter would appear to extend the medicalisation of women's lives. 
Furthermore, the assurances of healthcare professionals while well intended 
may negatively impact on women's desire to resume control and responsibility 
over their healthcare, particularly those women who exhibit a reluctance to do 
so following completion of hospital-based treatments. 
The following extract from Laura's third interview illustrates the challenge of 
regaining control over health while managing anxiety particularly once life was 
no longer focused on medical regimes. 
'Although you're thinking God I have to go to the hospital every day for 
twenty days...when it wasn't there it was the weirdest, insecure feeling 
I've ever had in my life I think. I think you've gone through these months 
184 
where your life's been surrounded by hospital and then it's a sudden stop 
and you're like God what now? I don't think I've seen anyone for about 
six weeks and it's the longest in a year that I've not been to the hospital, 
it's really strange. Part of me was glad obviously that it was all over with 
but.I think it was time to start and get back to normal when you weren't 
surrounded by the hospital and everything...try as much as you can to 
get your life back. I think it's while you're going up and down there you 
know it's going away, it's getting better, they're treating it. Obviously you 
know it's not gonna go on forever and it comes to an end.I think it's 
because it so bluntly ends. I could feel myself getting more and more 
insecure and nervous as it was coming up to the time of it finishing and I 
expected to feel really relieved that it was over and I didn't. I totally 
shocked myself thinking "why do I feel like this, why do I feel so scared?" 
Obviously it's no joy going up and down there every day but it's that 
safety net'. 
I: 'and that's been taken away...' 
P: 'Yeah, suddenly it's not there. It's like.this is me now, it's down to 
me. I remember saying before to you that you don't have any control 
over it at all because you're surrounded by hospital appointments and 
doctors and everything was going on in your head and you had no time 
and now there is time, it's down to me, it's up to me to get over it now' 
(Laura; Interview 3; Lines 11-45). 
This is further demonstrated through Joan's concern over the increasing time 
she faced between clinic appointments though she also refers to a perceived 
need to be vigilant yet keeping this under control. 
'It's a sign that you're making progress but you're unsure about being on 
your own with it but then with the increased vigilance you would hope 
that you yourself don't turn into a blithering idiot or a hypochondriac but 
at the same time are alert to finding something' (Joan; Interview 3; Lines 
195-199). 
Ellen concurred that greater time between follow-up appointments represented 
recovery but highlighted that she was now also in a psychological state of 
readiness to take control of her healthcare. 
'I don't need reassurance so much now... I was ready psychologically to 
move to six months, never mind medically. It was good to make sure 
somebody was checking me out but now I've got things into perspective, 
I'm doing everything they're telling me to do and I feel much, much better 
in myself. So I'm moving through that process and six months was lovely 
to hear' (Ellen; Interview 3; Lines 392...397-402). 
In contrast to those participants who relied on the healthcare system to maintain 
control for their breast health, hyper-vigilance was an alternate reaction 
documented during the second and third interviews with some women reporting 
checking their breast tissue on a daily basis. 
'Well I have a shower every day and I always have a little feel, always 
have a little feel' (Linda; Interview 3; Lines 239-240). 
Likewise, Mary commented: 
'I mean I know normally before I would maybe have only checked them 
once or twice a month but now it's all the time. I'm petrified even though 
there's no breast there on this side I know you can still get cancer in the 
area' (Mary; Interview 2; Lines 106-109). 
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Excessive breast self-examination, characterised as more than once per day, 
has previously been reported in a small subset (8%) of first degree relatives of 
women with newly diagnosed breast cancer (Epstein, Lin, Audrain, Stefanek, 
Rimer & Lerman, 1997). Such hyper-vigilant behaviour as opposed to 
avoidance has been found to more prevalent in at-risk women who report high 
cancer and general anxiety (Brain, Norman, Gray & Mansel, 1999). Research 
rarely considers women's experiences of breast self-examination post 
diagnosis. More commonly, the behaviours of women with a family history of the 
disease are the target for such research yet this has waned in recent years 
perhaps, as discussed in Chapter 1 (p. 21), given the controversy surrounding 
this method of screening. Using self-report questionnaires one study conducted 
in the USA has reported the breast self-examination practices of 345 breast 
cancer survivors four to eleven years post diagnosis (Trask, Pahl & Begeman, 
2008). The study suggests that survivors do practice breast self-examination 
and that over 75% of the sample had self-examined within the previous thirty 
days. However, perceived barriers to conducting BSE influenced the frequency 
of this behaviour though the study did not consider hyper-vigilance and it may 
be that this manifests during the first year and wanes from this point. In the 
current study excessive vigilance through repeated checking of the breasts was 
perceived by Gillian to be potentially counterproductive. 
'I think you do it the point where you're trying to find something that's not 
even there. I think you need to put it to the back of your mind really and 
maybes every.once a month, have a feel about and see if you can find 
anything and hopefully you don't' (Gillian; Interview 2; Lines 77-80). 
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Becoming familiar with changes in breast tissue as a result of the treatments 
received in order to maximise the effectiveness of breast self-examination was 
described by Joan during a discussion regarding her increased vigilance. 
'I mean I'm examining the other one and getting used to this because 
there's quite a lumpy bit where the radiotherapy.. .you know. I'm getting 
used to what's normal for that particularly so from that point of view I 
think I do it more often, perhaps every week.have a look' (Joan; 
Interview 3; Lines 160-164). 
Where previously some participants had been anxious regarding checking their 
breasts having completed treatment for breast cancer functioned to reduce the 
sense of the unknown. Furthermore, these women's perception of the potential 
benefits of early detection facilitated greater vigilance. 
'I was frightened of doing it before but now I just do it automatically. I 
don't know I think it's just if you find something what will happen but now 
I've gone through it, I know what happens if you find something and I 
know I can cope with it. So the sooner I can find it, the sooner I can get 
on with dealing with it' (Rose; Interview 3; Lines 169-170; 174-177). 
Rose's quotation illustrates how breast cancer via monitoring breast health 
became a routine element of her life. Her continual use of 'I' additionally 
suggests that she perceived herself as having ultimate control and responsibility 
for her health and the management of illness. In discussing a conversation with 
another cancer sufferer Louise provided further insight into the anxiety women 
experienced when self-examining yet also depicts how confidence in the 
healthcare system to successfully treat breast cancer facilitated a change in her 
behaviour towards resuming responsibility. 
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'So I said to her I know you have to check for lumps, before I got cancer 
and erm.I said I'm frightened now of checking the other one 
because.just in case it has come back in the other breast. Erm.but 
because the last few weeks because I know the radiotherapy has all 
clearing.I do now, I check my other one so I thought oh well I'm glad 
about that, that I'm not frightened of looking for any lumps now...Well I 
think because to me it was getting better the other.you know.the one 
with the lump, I think I thought if it comes back in other breast then I'm 
not gonna be rid of it, that you've still got it so when I was able to feel for 
lumps so I thought I'm glad about that. Then towards, well, the last day of 
the treatment talking to this lady I said to her that it wouldn't bother me if 
cancer did come back because I know it's treatable' (Louise; Interview 3; 
Lines 223-228; 233-238). 
Having undergone treatment for breast cancer Louise's quotation illustrates how 
the women's perception of themselves as being free of breast cancer and their 
continued trust in healthcare professionals influenced behaviour directed 
towards breast health. However, for participants who adopted a strategy of 
avoidance due to both anxiety and the reassurance of follow-up appointments it 
is plausible that conducting regular breast self-examination may have served to 
remind these women of their experience. 
5.8 Chapter summary 
This chapter has demonstrated how for the women interviewed their lives 
became medicalised from symptom identification to early follow-up. Participants' 
high level of contact with the healthcare system during the months around 
diagnosis, treatment decision-making and surgical intervention is reflected in 
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this chapter with several themes being specific to this time period. 
Nevertheless, the longitudinal approach has additionally uncovered women's 
continuing rationalisation and satisfaction regarding the decisions made, 
including when a passive role had been adopted. Furthermore, this study 
design has revealed key aspects of women's experiences such as cancer 
schema and waiting that were prominent throughout the healthcare trajectory 
and even prior to diagnosis. 
The study participants were often found to delay help-seeking behaviour for a 
breast symptom frequently citing caring responsibilities, pre-organised events 
and their cancer schema, as evidenced through a lack of symptoms, as reasons 
for this behaviour. However, the negative connotations these women assigned 
to delaying obtaining a medical opinion in conjunction with their cancer schema 
suggests that fear of mortality and cancer anxiety relating to a medicalised 
existence were influential in their wait. 
Participants' subsequent attempts to manage the stress of being diagnosed with 
breast cancer led them to draw on their cancer schemas to facilitate treatment 
decision-making. While participants with a history or family history of either prior 
breast disease or cancer perceived themselves to have had an active role in 
surgical treatment decision-making their reliance on medical opinion suggests a 
shared approach was taken. Furthermore, the majority of participants chose to 
be passive in this process and this extended to non-surgical treatment 
decisions. This passivity was underpinned by acceptance of medical opinions 
and trust in the expertise of the breast surgeons to rid them of breast cancer. 
Nevertheless these women retained ownership of decisions and were not 
disengaged from the decision-making process. It is also possible that the 
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observed differences in levels of involvement in surgical and non-surgical 
decision-making reflect the tangible nature of the differing treatments. 
All women interviewed described waiting for normality as their lives became 
medicalised revolving around hospital appointments and treatment regimes. 
This drive to return to a previous state of normality with a focus on diagnostic 
tests and medical regimes is suggestive of women adhering to Frank's (1995) 
restitution narrative type. However, while Frank states that a key component of 
this is the move from health to illness and back again even through the 
longitudinal nature of this study the return to normality was not always identified 
one year post diagnosis. Undergoing treatment for breast cancer had an effect 
on participants' activities of daily living including employment and had financial 
implications leading to several women returning to work before adequate 
recovery was attained. Moreover, such changes resulted in participants 
relinquishing identities, particularly those aligned with womanhood, and elicited 
change to their sense of self. 
While these women desired a 'restored' self, the frequently unanticipated long-
term impact of medical regimes made disengaging from a medicalised 
existence difficult even once hospital-based treatment had been completed. 
Women's long-term reliance on healthcare professionals for reassurance was 
seen across the sample yet while hyper-vigilance over breast self-examination 
was commonly observed by contrast for some participants the consequence 
was limited personal responsibility for breast health. This can once again be 
linked to the combination of fear, uncertainty and trust in medical teams and 
procedures. The strategy of avoidance may be further explained, at least in 
part, by participants' ongoing struggles to accept changes to the body and self. 
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The impact of breast cancer on women's bodies is the focus of the following 
chapter. 
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CHAPTER 6: THE BODY 
6.1 Introduction 
The ensuing chapter is separated into three parts, the first focuses on 
participants' perceptions of their body encompassing themes relating to the 
meaning of women's breasts and how this emerged during women's initial 
interviews through rationalisations of breast surgery to breast loss. Transitions 
from a healthy to an ill body are discussed in themes considering the long-term 
impact of physical limitations on participants' self and identity and the enduring 
influence of treatment side-effects on women's perceptions of their external 
appearance. The second section of this chapter considers the strategies women 
adopted to manage changes in the body from immediately post-surgery to those 
experienced as breast cancer treatment progressed and beyond to one year 
post diagnosis. The longitudinal management of changes resultant to breast 
surgery comprises themes focusing on women's experiences of using external 
breast prostheses and associated changes in dressing behaviour. Management 
of chemotherapy-induced alopecia and the use of complementary therapies to 
manage treatment-induced side-effects are also themes in this section. The 
final component and theme of this chapter explores how women's bodies and 
the long-term management of their appearance served as a permanent 
reminder of breast cancer. 
Part 1 - Body perceptions 
The themes detailed in this first part of the chapter focus on participants' 
perceptions of their body and how these perceptions changed throughout the 
year following diagnosis as a result of breast cancer treatments. To begin, the 
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meanings these women associated with their breasts are discussed and their 
perceptions of both the necessity and conversely the non-importance of their 
breasts are represented. 
6.2 Rationalising breast surgery through the meaning of the breast 
Irrespective of their role in the treatment decision-making process all women 
interviewed rationalised the need for their specific breast surgery and 
perceptions of their breasts were integrated in these accounts. Given the 
recency of treatment decision-making this was primarily a feature of the 
women's initial interviews. For participants who had undergone a mastectomy a 
medicalisation of the breast was evident, as previously documented by 
Langellier and Sullivan (1998), with these women placing an emphasis on 
breasts being an external organ that was no longer needed. 
'I lost my husband seven and a half years ago and it would have been an 
impact had he still been alive but I know this is just an organ outside the 
body. Everything else is functional and it's not gonna make a big 
difference to my life in the future. I'm not looking for another partner 
though I do have a friend who lost a breast, went on the Internet, married 
a lovely fella on it and they're very happy since (laughing) but I'm not 
really looking in that sense. I'll not get married again so it doesn't matter' 
(Lily; Interview 1; Lines 157-163). 
For several women breasts were no longer considered a necessity once child-
rearing had been completed and/or when women were either in a stable long-
term relationship or conversely did not anticipate having an intimate relationship 
in the future. Moreover, reinforcing the notion that breast loss does not limit 
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activities of daily living and rationalising in relation to survival were prominent in 
participants' discussions on this issue. 
'You look different...but I am what I am because of what goes on in my 
head. When I have a prosthesis in nobody knows any different when I'm 
out. I haven't had any problems. It's an appendage that at my age I'm not 
going to need. It's not like having stomach cancer or lung cancer where 
losing a part can impede on your life. I can get back to doing what I did 
before. Nobody will have any idea that I have lost my breasts. I think the 
days of thinking about being a page three model went a long time ago. I 
would rather lose the whole breast and get rid of the cancer. I still feel 
like a woman, it hasn't taken away my feeling of being feminine' (Susan; 
Interview 1; Lines 140-148). 
Sarah described having similar feelings though reflected that these perceptions 
and her desire to have a bilateral mastectomy had only emerged following her 
previous breast cancer diagnosis. 
'I think again it's about maturity, about recognising that yes breasts are a 
very important part of a female body but to be alive is even more 
important than having a pair of breasts. It's survival really, it's your own 
mortality that you've looked at and then it becomes more important and 
you know, the cosmetic side of life comes second' (Sarah; Interview 1; 
Lines 274-278). 
These results are supportive of previous findings indicating that survival is of 
paramount importance to women (e.g. Fang et al., 2011). However, 
paradoxically perceptions of breasts as not being a necessity may be one 
explanation as to why some women do not conduct breast self-examination or 
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do so infrequently. Nonetheless, the meaning of an individual participant's 
breasts heavily influenced her adjustment to breast loss. For Gillian needing to 
have her breast removed was particularly distressing and she struggled 
considerably post-surgery to accept this loss. 
'Someone who couldn't drag themselves out of bed on a morning I think, 
just thinking my life would be over and I couldn't face anybody. I think 
that's how I imagined myself to be before I had my operation. I couldn't 
see life beyond having a mastectomy but it's surprising how you come to 
terms with things. At the end of the day I haven't lost a leg or an arm or 
anything that would stop me from doing a lot of things. Its more...I think 
it's a vanity thing' (Gillian; Interview 1; Lines 225-231). 
Similar to findings by Fang et al. (2011) Gillian persuaded herself to accept 
mastectomy as illustrated through her rationalisations, and knowledge of post-
mastectomy alternatives were discussed as alleviating some of the negative 
impact of breast loss. The prospect of rebuilding her body through 
reconstructive surgery and avoiding delays in this procedure was of central 
importance to Gillian. 
'The majority of the time I'm pretty alright with it really, especially more so 
now as I know I don't have to have chemo or radiotherapy, which would 
have meant my reconstruction would have been a long way away. Now, 
it's only a matter of months away' (Gillian; Interview 1; Lines 186-190). 
The knowledge that reconstruction was possible also reinforced Amanda's 
rationalisation for having a mastectomy. 
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'I've felt more for how my husband's been feeling about it than myself 
because it's happened, it's like that. It wasn't pleasant when the 
bandages came off but as long as it didn't bother him then it didn't bother 
me. Like the breast care nurse said, it's something you can have re-built, 
it's not as if it's your liver or your heart, it's not a vital internal organ and I 
think she's right' (Amanda; Interview 1; Lines 294-299). 
The above quotation supports the opinions of Young (1992) by revealing the 
role of the breast care nurse in nurturing a medicalised view of breasts as being 
objects that are replaceable. Amanda's extract additionally highlights the 
importance of women's partners in promoting their psychological well-being 
through attachment validation (Bertero & Wilmoth, 2007). This aspect of self 
that emerged through a meta-synthesis refers to validation from women's 
partners that they are loved regardless of a changed body. 
Unlike the findings of Fang and colleagues (2011) this research study has found 
that such rationalising was also undertaken when lumpectomy was conducted. 
Perhaps this served as a means through which women could regain some 
control over the surgical treatment decision-making process. Importantly these 
rationalisations were made in the context of the meaning of women's breasts 
specifically their symbolic nature and links to womanhood and femininity. 
'Some people can deal with that, having a mastectomy and having a 
false breast, but I couldn't have done that. You never really think about it 
until you talk about it but I think my breasts are a part of me as a woman. 
It's important to me as a person. I don't think I would feel a whole woman 
if I didn't have breasts and I still feel a little bit like because of the scars 
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I've got on them but I've still got my breasts so it's the best of a bad 
thing.that's how I look at it' (Margaret; Interview 1; Lines 228-234). 
Similarly, Louise opened up about her fears of breast loss, a finding that was 
formerly described in the Turkish phenomenological study of Demir and 
colleagues (2008) albeit from a sample of women pre-diagnosis. 
'I think the fear of the breast not being there sort of thing.it could be 
vanity but I wasn't really looking forward to having a false breast there' 
(Louise; Interview 1; Lines 220-222). 
Louise's quotation suggests that had a mastectomy been required an 
alternative would have been sought yet that this would equally have elicited a 
negative reaction. Accordingly, in support of the writings of previous authors 
(e.g. Wilmoth et al., 2004) participants' breasts were consistently aligned with 
meaning related to femininity, womanhood, child-rearing and as part of a sexual 
relationship. This corresponds to the representation of the 'functional' and 
'gendered' notions of breasts derived by Langellier and Sullivan (1998). These 
meanings as revealed through women's rationalisations represent efforts to 
cope with whichever breast surgery had to be undertaken. As reviewed in 
Chapter 2 (p.60-65), mastectomy has been reported as resulting in an altered 
body image (e.g. Kunkel et al., 2002; Lindwall & Bergbom, 2009). The following 
theme discusses the impact of this surgical intervention as experienced by the 
women in the present study. 
6.3 Breast loss 
For those participants who did undergo mastectomy breast loss had both 
physical and psychological consequences that became apparent even before 
the women left hospital. 
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'I didn't dare look at it and erm.they came in on the Tuesday to change 
the dressing and I just looked at the ceiling, I didn't want to look but on 
the Wednesday I was talking to a nurse off the ward. I already know her 
personally and she sat with me and helped me. She took my dressing off 
and helped me come to terms with looking at it and I was shocked at 
what it looked like because I really didn't know what to expect and the 
pictures you get in a book.it doesn't really show you does it, it's a 
drawing isn't it, it's not a picture. So, I didn't really know what to expect 
and of course it was all swollen and sore and I found it quite distressing' 
(Mary; Interview 1; Lines 179-187). 
Participants continued to discuss the impact of breast loss during the second 
interviews once they had begun to reflect upon their changed bodies though 
focused more on their physical appearance as opposed to rationalising and 
accepting breast surgery. Linda was one of the few women to describe 
increasing pain and discomfort directly related to the chest. 
'I miss my bust, I'll be honest with you.you know like I get a sore.well 
it must be bone and it gets a bit sore there, I'm gonna mention it to him 
when I go next time but I think it's like when you lean on the chair and 
things and when you're in bed on a night instead of rolling onto your bust 
you roll more onto the bone' (Linda; Interview 2; Lines 66-70). 
Participants' accounts demonstrate a grief for the loss of their breast and as in 
previous research findings (e.g. Thomas-McLean, 2005) women described 
having to cope with changes to their body shape including a loss of symmetry, 
hollowness in the chest wall and scarring. 
'I always feel lop-sided' (Lily; Interview 2; Line 142). 
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'I'm actually very scooped out even where the breastbone is it's not the 
same on either side. I mean mine is really, really hollow' (Amanda; 
Interview 2; Lines 233-235). 
The impact on this participant's body image was unmistakable. 
'It looks horrible, absolutely horrible. One's missing and I feel a bit 
freakish. I suppose I'm still getting used to it' (Jenny; Interview 2; Lines 
127-128). 
Two women underwent bilateral mastectomies and while this was deemed to 
make adjusting to a changed body image easier than experiencing a loss of 
symmetry the impact on women's body shape had an ongoing psychological 
impact. 
'I think the fact that I have no breasts makes it easier than just having 
one. My body shape seems very different to what it was before and 
adjusting to that is a difficult thing' (Sarah; Interview 2; Lines 265-267). 
Susan, who underwent the second mastectomy shortly after her first interview, 
additionally discussed having a bilateral mastectomy in relation to her sense of 
femininity. 
'When I look at myself I don't really look very much like a woman. If you 
see me minus these (prostheses), if you were to see me erm.sort of 
naked from the waist up if you like I feel very much like I have lost my 
feminine identity. That isn't...it doesn't look...it's a funny thing because I 
don't get desperately upset by it because it doesn't actually look ugly, the 
scars are very neat and it looks fine. Obviously they're still quite new 
wounds so they're gonna settle down a lot and I appreciate that, I 
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just.because I haven't got breasts any more I don't look like a woman 
(Susan; Interview 2; Lines 118-125). 
Accordingly, in support of previous qualitative research breast loss and the 
associated altered bodily appearance led participants to question their 
femininity and womanhood thereby disrupting identity (McCann et al., 2010) and 
affecting their sense of self requiring them to re-define the self (Bertero & 
Wilmoth, 2007). 
The negative emotional change resultant to Jenny's changed body is 
demonstrated in the following extract from her first interview. 
P: 'I don't ever, ever expect to find another partner... 
I: because you've had a mastectomy? 
P: Yeah. How I look.well right now I don't ever want anyone to see me 
naked, ooh God no, absolutely not' (Jenny; Interview 1; Lines 232-237). 
Disturbances associated with women's sexuality are widely reported particularly 
during the first year post diagnosis (e.g. Emilee et al., 2010) though like other 
women Jenny subsequently hoped that the passage of time would aid 
adjustment to her changed body. 
'Maybe one day I will be used to it' (Jenny; Interview 2; Lines 128-129). 
In adopting a longitudinal approach further exploration of these feelings was 
possible during the subsequent interview and indeed in her final interview Jenny 
reflected on coping with her changed body. 
'I haven't felt very emotional about myself since the first interview after I 
came out of hospital and I couldn't even look at myself could I? It doesn't 
really bother me now. It feels quite funny because it's hard, on the chest 
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and it's funny to feel but it doesn't upset me as much as it used to and 
hopefully it'll just get better' (Jenny; Interview 3; Lines 218-222). 
The use of "it" to describe the absent breast was prevalent in participants' 
accounts of their experience and can be observed in many of the quotations 
used to substantiate this theme. A difficulty finding words to describe the post-
mastectomy body was previously noted by Manderson and Stirling (2007) 
though interesting the present study has found this to be prevalent throughout 
the year following diagnosis. This in itself may be an indicator that some women 
experience long-term disruption to their relationship with their body. 
To provide an alternate perspective, for several women breast surgery (partial 
breast loss and to a lesser extent mastectomy) did not induce the feeling of 
losing femininity that they had anticipated and instead they reflected on 
womanhood as being beyond the physical body. 
'I think breasts are a part of being feminine, or that's how I've always 
looked at it. As I say I've always tried to keep myself trim and looking 
okay and now I've had it done and I'm thinking well...it's not actually.I 
still feel like a woman and I still feel feminine' (Janet; Interview 1; Lines 
258-261). 
The women participating in this research study rarely spoke of cancer in relation 
to breast loss and did not discuss breast surgery including mastectomy in terms 
of representing an unhealthy body. Instead, the physical limitations that 
emerged as a result of having breast surgery and partaking in and managing 
the side-effects of subsequent prescribed treatment regimes were associated 
with gaining an illness identity. 
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6.4 Physical limitations: losing a healthy identity 
As discussed in the previous chapter in relation to a medicalised existence, 
participants craved and waited for normality. With regards to the body this 
typically began in the post-surgical recovery period when the impact on the 
body, habits and activities of daily living became so apparent that these 
women's sense of self became altered (Charmaz, 2002). 
'I don't know really it's such a shock because I've been so fit, I never 
stop. When I'm at work I come home and go to my daughters and take 
her dog out and do some painting but not now, I can't do anything' 
(Elizabeth; Interview 1; Lines 24-26). 
Elizabeth's quotation highlights how during times of illness individuals focus on 
physical activities (Leventhal, Idler & Leventhal, 1999) as bodily limitations 
distorted body-self relations. Women's way of being in the world altered with a 
loss of self-integration (Gadow, 1980) as breast cancer treatment restricted their 
world and led to a separation from their previous way of life and former identity. 
The illness and treatment side-effects such as pain and fatigue that were 
experienced from as early as the first interviews and which for many women 
persisted throughout the data collection period were perceived to constitute a 
lack of normality and suggest an alienation from the body. 
'What isn't normal is the aches and pains, the tiredness...I mean I've had 
to slow down and sometimes I have to rest and stop what I'm doing 
which is quite annoying but it's because I'm tired. It slows you down a 
little bit' (Amanda; Interview 1; Lines 248...269-271). 
Pain was a commonly reported side-effect, due to lymph node removal and 
contributed to a sense of losing a healthy identity and associated normality, 
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particularly at time one as women were recovering from the immediate effects 
of surgery. 
'I get quite a lot of pain in my arm from where they took the lymph nodes. 
I've got quite severe pain right the way down to my wrist so periodically 
that'll pull me up and when it does it jolts me back into, oh my God' 
(Ellen; Interview 1; Lines 180-183). 
Feelings of frustration as a result of physical limitations were evident in 
women's accounts of their experience particularly in the weeks following 
surgery and this focus suggests a lack of agency regarding the body. 
'A little tired and a little frustrated at the things that I can't do. My arm's 
doing really well I think but there are still things like I can't peg the 
washing out because I can't stretch without quite nasty pain' (Pauline; 
Interview 1; Lines 273-275). 
Frustration at bodily limitations remained evident during women's second 
interviews. 
'I do feel more tired. I'm a very energetic person but I find that I can't do 
as much before I'm tired and I get frustrated because I haven't got the 
strength in my arm that I had and I've found that really, really frustrating 
because I've got to pace myself' (Pauline; Interview 2; Lines 57-60). 
Several authors (e.g. Corbin & Strauss, 1988) argue that a new self-concept 
arises from accepting bodily limitations and from the new way of acting in the 
world. The women in the current study had no choice but to accept some level 
of change during the first few months post diagnosis, change which threatened 
their self and identity. 
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'That can get to you, that can get you down I will admit, not being able to 
do your everyday tasks, your housework. People say you should be glad 
of it and you are because you can't do it but at the same time, well for me 
I felt as if I was not being myself because I couldn't do it' (Maria; 
Interview 2; Lines 216-220). 
As illustrated, physical restrictions during this time led to participants being 
unable to carry out traditional gendered roles such as housework. Handing over 
control of their roles was described as distressing for these women and 
accordingly taking back relevant tasks signified some return to normality. The 
disruption of the relationship with the body leads to one of Frank's (1995) 
acknowledged problems of embodiment - lost control. Seeking normality to 
regain control over life following a diagnosis of breast cancer supports the 
review of Bertero and Wilmoth (2007). The longitudinal approach adopted in the 
present study has additionally revealed that this search for normality (in a 
physical sense) began immediately following breast surgery. It was, however, 
particularly notable during participants' second interviews as adjuvant therapies 
were undertaken. Yet, despite the fact that participants recognised their 
limitations the following quotation from Gillian portrays the hope that these 
would not be permanent. 
'I still get quite a bit of pain sort of under my arm and in my arm. They've 
told me it's just time, a time thing, it'll get better in time and just.I think 
you need to know your limitations' (Gillian; Interview 2; Lines 272-276). 
Consequently, although participants adopted a "transitional identity" of an 
individual temporarily afflicted by illness (Clarke & James, 2003) they did not, at 
least initially, contemplate long-term change. The majority of participants 
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continued to strive for physical recovery and the potential for such an 
occurrence is acknowledged in the model of Morse (1997) who views this as 
preceding acceptance of bodily limitations and an altered self. Research 
focusing on fatigue following a breast cancer diagnosis is relatively limited and 
dominated by quantitative studies of association using self-report measures. 
One of the few qualitative interview studies exploring the fatigue experiences of 
older Taiwanese women with breast cancer discussed the impact of emotions 
and treatment side-effects on fatigue (Tsai, Lin, Chao & Lin, 2010). The 
research reported women's perception that fatigue was a normal reaction to 
breast cancer given uncertainty and stress, one that they were embarrassed to 
share with others. One finding that it did not report however was the difficulties 
experienced in deciphering the origin of fatigue. Rose reflected on how she may 
have misinterpreted potential symptoms, predominantly fatigue, and felt that 
she needed to learn to listen to her body once again which suggests a loss of 
confidence in the body. 
'When I think about how I was before, I was quite tired before.I used to 
come home on an afternoon and just shut my eyes for ten or fifteen 
minutes and then I'd be fine. You put that down to age but then you 
wonder if that was one of the telltale signs, feeling a bit tired. I suppose 
that's the problem really when you get into your fifties you put a lot down 
to age and you don't know what your body's telling you really' (Rose; 
Interview 2; Lines 159-164). 
Symptoms of pain and fatigue typically prevailed throughout the data collection 
period influencing participants' physical and psychological well-being. Such 
findings for those women who had chemotherapy supports the conclusions of 
Engel and colleagues (2004) who reported long-term psychological 
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consequences given the joint effect of chemotherapy and breast surgery. 
Equally, however, participants who did not undergo chemotherapy continued to 
experience these issues. 
'I do soon get tired. When I said to the doctor she said what do you 
expect so...and that's what I don't like, the soon getting tired. I like to be 
able to get up and go' (Linda; Interview 3; Lines 156-158). 
Research suggests that women may continue to experience fatigue up to 
sixteen months after completing breast cancer treatment (Thompson, 2007) 
which may help to explain why women often considered it's presence as an 
ongoing symbol of illness. Furthermore, while participants had anticipated 
regaining physical health within the year from diagnosis as highlighted by Susan 
this was often not the case. 
'I'm not thinking of myself as a cancer patient, I'm thinking of myself as a 
woman who should be back doing what she was doing and hasn't got 
there yet' (Susan; Interview 3; Lines 75-77). 
The above quotation suggests that while Susan perceived some return to 
normality in no longer being a woman with breast cancer she demonstrates 
conflict in referring to an ongoing wait for a return to her previous healthy 
identity. This supports the notion that women hope even up to a year on from 
diagnosis that returning to their former life and self remained a possibility 
whether this was feasible or not. Integral to this longer term change was the 
impact on the body of non-surgical treatment regimes. All participants were 
prescribed at least one treatment in addition to surgical intervention and the 
majority of women interviewed underwent a combination of therapies. The 
following theme illustrates how treatment side-effects were perceived to be 
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signs of ill health and consequently led to participants primarily viewing 
themselves in terms of illness. 
6.5 Treatment side-effects as signs of illness 
For many participants, the onset of treatment-induced symptoms in conjunction 
with generalised physical limitations, as discussed in the previous theme, was 
perceived to be the point at which the body began displaying signs of illness. 
Accordingly, this point in time signified the transition from a healthy to an ill 
body, self and identity. The present theme considers women's experiences of 
treatment side-effects as signs of illness and is divided into several sub-themes 
pertaining to differing treatment(s)/side-effects. The impact of chemotherapy 
was particularly evident and resulted in women replacing the transitional illness 
identity seen post-surgery and accepting that longer-term change was 
inevitable. Given the treatment timeline participants typically raised these issues 
during the second interviews when active hospital-based treatments were 
significantly underway. 
6.5.1 Chemotherapy-induced nausea and fatigue 
The physical impact of chemotherapy is widely reported and research exploring 
psychological effects pertaining to, for example, reduced social participation and 
more generally decreased quality of life is becoming increasingly evident 
(Turgay et al., 2008). Even prior to commencing chemotherapy participants 
reflected on the potential impact of this intervention perceiving side-effects, 
specifically nausea, to have the greatest potential to challenge their abilities to 
cope with breast cancer. 
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'Really only the sickness bothers me. (The doctor) said it might only last 
two days but she said we'll find a sickness drug that helps you. I know I'll 
be lethargic, tired, that could be a side effect but I think once the 
sickness goes I can cope with the tiredness' (Louise; Interview 1; Lines 
271-274). 
The following extracts capture how once chemotherapy was underway 
participants began to detach the body from the self (e.g. Radley, 1994) as the 
body became dysfunctional and unfamiliar. In accordance with Frank's (1995) 
disciplined body the quotations suggest a dissociation with regards to 
embodiment however contrary to Frank's notion of body-relatedness these 
women exhibited a heightened awareness of, and attention to, their bodies. 
'I see what they're putting inside me and that's around your body and I've 
got to...you're weeing it out and its obviously killing your blood cells 
because your hair's falling out and I'm bloated up. I just don't feel as if 
this body's mine at the moment because I was quite fit beforehand' 
(Janet; Interview 2; Lines 145-148). 
Consequently, these women had moved from a state of perceived good health 
immediately prior to diagnosis to a position wherein, as discussed in the 
previous chapter, the body had become subject to medical regimes, 
interventions that were now resulting in an unhealthy identity. 
'When I looked in the mirror the other day I thought I look as if I have got 
cancer because my hair's gone, I've got that pasty look and the bloated 
look and I think it's the first time I've thought you look as if you've had it 
or you've got it' (Janet; Interview 2; Lines 169-172). 
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The discrepancy between undergoing treatment(s) designed to re-establish a 
healthy identity which, as discussed previously in relation to 'getting rid of it', 
participants believed had already returned (doing so following surgery) 
seemingly influenced perceptions of this aspect of women's experience. 
Nausea and fatigue were reported as key issues for all participants undergoing 
chemotherapy and were symptoms that influenced their daily lives throughout 
the treatment course. 
'Every night I keep thinking of the chemotherapy and all the injections. I 
noticed, I haven't said it to anybody because when you go to 
chemotherapy you forget about things...sleeping patterns...I seem as if 
I'm tossing and turning all night. I don't seem as if I'm getting a 
comfortable night's sleep. I mean I do because I haven't been as tired as 
the first session.. .you know, I was very tired. The last two I haven't been 
falling asleep like I was with the first one so I'm obviously getting the 
sleep but whether it's with sort of.thinking about the chemotherapy 
every night that I feel as though.I think also when you sleep on your 
side your stomach feels all uncomfortable, so it's probably that and then 
when you turn over you get the same again. Then when you sleep on 
your back it seems as though your stomach draws into you, which makes 
it not so comfortable' (Louise; Interview 2; Lines 80-92). 
Tsai and colleagues (2010) described chemotherapy associated fatigue as the 
most intense symptom prevalent in the majority of the fifteen participants as well 
as the vicious circle, as depicted in the above quotation from Susan's second 
interview, encompassing nausea, vomiting, poor sleep and lack of appetite. A 
number of factors have been identified as of importance in affecting the 
likelihood of post-chemotherapy nausea including chemotherapy regime (e.g. 
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Hesketh, 2008) and experiencing nausea during pregnancy (e.g. Grunberg, 
2004) though it should be noted that neither study was focused on women with 
breast cancer. As previously noted in this theme participants anticipated 
chemotherapy-induced nausea and positive associations between expectations 
and nausea have been reported via a meta-analysis incorporating numerous 
studies with a breast cancer population (Colagiuri & Zachariae, 2010). A 
psychological role in the physical experience of nausea was acknowledged by 
several participants however the following quotation depicts a unique aspect of 
this relationship. 
'Before the last session of intravenous chemotherapy obviously it's all 
psychological.a couple of days before I was going, I have the cold 
cap.and I found a tissue in my pocket and it's a tissue they use to put 
on your temples and when I took the cap off I must have put it in my 
pocket and when I put my jeans on this tissue was in my pocket and as 
soon as I saw it, it made me wanna be sick' (Mary; Interview 2; Lines 53-
58). 
Consequently sensory association was found to play a role in Mary's 
experience of chemotherapy though a number of physical changes to the body 
were more commonly reported. 
'There's eight days where I'm really sick and then the rest of the time just 
feeling it, tired. It changes your whole body really.it must be the 
sickness tablets, they give you steroids as well. That just changes the 
shape of your body and your tastes.I get that metal taste all the time. 
My taste in foods changed.I like salt and pepper now and anything 
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spicy and I think it's just to cut through that taste' (Janet; Interview 2; 
Lines 16-21). 
Similarly, Mary commented: 
'Other than the sickness it's just feeling very lethargic and the horrible 
feeling in your mouth that you get, you really don't fancy any food and 
even when you do have food it doesn't taste right. Well, it's more the 
feeling anyway. I just feel like my mouth is covered in wax and the more 
you brush your teeth to make it go away you make your mouth sore' 
(Mary; Interview 1; Lines 389-394). 
Unlike other side-effects these women had not anticipated gustatory changes 
however, this led several participants to begin a process of experimentation with 
foods to cope with this symptom. Experimental research has revealed that 
chemotherapy significantly decreases the olfactory and gustatory function of 
women diagnosed with breast cancer (Steinbach et al., 2009). Although found 
to be a transient effect with salty tastes being most affected and gustatory 
function significantly influenced by chemotherapeutic agent, the changes had 
an impact on women's chemotherapy associated morbidity and quality of life. 
The effects of chemotherapy are further discussed in the following sub-theme 
with consideration of relevant participants' experiences of hair loss. 
6.5.2 Chemotherapy-induced alopecia 
Developing an illness identity, one which participants associated (given their 
cancer schemas) with cancer, often stemmed from hair loss as opposed to 
having undergone breast surgery. This was evident during the first interviews as 
even prior to the commencement of chemotherapy some participants began to 
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engage active anticipatory coping strategies to minimise the potential stress of 
undergoing chemotherapy and to take control of hair loss. 
'I know it's not gonna be nice and.I'm more bothered about being sick. I 
hate being sick, I can't cope with it. I know there's gonna be a good 
chance my hair will fall out, of losing that, so I've had it chopped off quite 
a lot. I thought it's not such a drastic thing if I do it in stages. She says I 
might not and I can have a cold cap or something but we'll see. I always 
take things as they come' (Janet; Interview 1; Lines 114-119). 
This finding provides support for a UK based qualitative study that aimed to 
overcome some of the criticisms of the existing literature available on 
chemotherapy-induced alopecia. Focusing on hair loss in breast cancer patients 
Frith, Harcourt and Fussell (2007) reported interview data from nineteen women 
collected either immediately prior to or at the beginning of chemotherapy and 
again at the end of treatment. They too found that women anticipated hair loss 
but reported this to be the most feared symptom which contradicts the views of 
the women in the current research study who perceived sickness to be the 
worst possible outcome. Managing hair loss before its occurrence as depicted 
in Janet's previous quotation was also identified by Frith and colleagues which 
they noted to be acceptance of the inevitability of hair loss. However, as is to be 
shown later in this chapter women often retained hope that they would not lose 
all of their hair and took measures to minimise such loss from the first treatment 
rather than equip themselves with a range of attire to disguise chemotherapy-
induced alopecia prior to its commencement. 
Hair is historically viewed as a symbol of social, cultural, religious and political 
status and is associated with age, gender, and beauty (Hansen, 2007). The 
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importance of hair loss can be illustrated through several studies which have 
shown that the fear of hair loss can lead to a refusal to undergo chemotherapy 
(e.g. Batchelor, 2001). Previous research has shown that for some women 
coping with hair loss is more difficult than losing a breast (Freedman, 1994). 
The following quotation from Susan suggests that for her it was the combination 
of a bilateral mastectomy and hair loss that caused the greatest period of 
suffering in relation to the changed body. 
'I think if I'd had both breasts removed right at the beginning erm.in 
those days I had reasonably long hair, shoulder length hair, I think I 
would have felt that all of my feminine attributes hadn't gone because I 
still had my hair' (Susan; Interview 2; Lines 125-128). 
The findings of the present study support those documented in a literature 
review of thirty eight studies examining chemotherapy-induced alopecia 
(Lemieux, Maunsell & Provencher, 2008). Hair loss was reported to be amongst 
the most troublesome side-effects being consistently ranked in the top three by 
women with breast cancer. The review further concluded hair loss to be 
traumatising and distressing for women though highlighted the lack of studies 
considering its importance and the psychological impact for women with breast 
cancer. For women in the current research study hair loss was described as an 
outward sign of illness, a visual representation of cancer, and was associated 
with being stigmatised by others. 
'It sounds really vain and I'm not vain at all but I think when you lose your 
hair you look like you've got cancer don't you' (Laura; Interview 2; Lines 
81-82). 
Likewise Emma commented: 
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'I think the way people are they just glare and that don't they. I mean if I 
see someone with hair like this, even before this happened to me and I 
wouldn't think oh look at her she's got no hair. I would look at someone 
like this and think she's on some sort of treatment' (Emma; Interview 1; 
Lines 93-96). 
Using Goffman's notion of stigma as a conceptual analytic framework Rosman 
(2004) applied grounded theory to interviews with thirty five individuals at least 
one year post diagnosis with breast or lung cancer. She subsequently described 
how, as illustrated through Emma's quotation, hair loss can lead to a direct 
confrontation with the seriousness of breast cancer. Rosman (2004) argues that 
patients with chemotherapy-induced alopecia are discredited given when hair 
loss is not hidden, their stigma is instantly visible and as such increases an 
individual's identity as a cancer patient. Women's accounts of their hair loss 
illustrate such concerns and the potential impact on the self when the individual 
is not recognised as the same person by others. 
'I think it just attracts attention to what's happening to me. Perhaps that 
people I meet might think this is a cancer sufferer not a person' (Joan; 
Interview 1; Lines 162-163). 
Rosman (2004) additionally contends that the stigma associated with being 
labelled a cancer patient can lead to an individual being vulnerable to negative 
self identification and self definition. The following quotation from Rose 
demonstrates how women's beliefs about the perceptions of others regarding 
their hair loss can be at odds with their own feelings regarding their health. 
'The hair loss has been horrible, that's been the worst part. I've tried to 
keep my hair by wearing the cold caps but it's gone very thin. I think 
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really it's what people see isn't it. People see you without hair and they 
look.and know.I don't want people to think.I don't feel ill' (Rose; 
Interview 1; Lines 119-123). 
In support of previous research findings, several women in the sample including 
Emma explicitly linked hair loss with a loss of feminine identity and experiencing 
a life threatening illness. 
'My hairs completely fallen out and I'm devastated. I have to wear my wig 
when I go out because I don't want anyone to see me without any hair... 
you don't look like a woman do you and you look like you're dying' 
(Emma; Interview 2; Lines 10-12...16). 
In relation to breast cancer chemotherapy-induced hair loss has been found to 
denote a loss of individuality, attractiveness, and sexuality (Freedman, 1994) as 
well as a lack of vitality, strength and health (Rosman, 2004). Similarly, through 
ethnographic fieldwork comprising participant observation of women 
undertaking cancer rehabilitation courses in Denmark Hansen (2007) reported 
baldness as being associated with gender, death and a loss of womanhood, the 
latter being influenced by women's perceived loss of femininity, sexuality, self-
confidence and attractiveness. Facial hair loss further changed women's 
appearance thereby confirming their illness status. 
'I lost my eyelashes and eyebrows.that was the worst thing.your 
eyebrows define your face' (Susan; Interview 1; Lines 222-223). 
The loss of eyelashes was identified by Sarah as particularly problematic 
resulting in discomfort. 
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'I lost a lot of my eyelashes, which has caused me quite a lot of problems 
because I've had more irritation in my eyes and more erm.well 
inflammation of the eyelids I've had actually. I've had more infections 
where the drips have gone, less tolerant I think to my body' (Sarah; 
Interview 2; Lines 30-34). 
Sarah was the only woman in the sample experiencing a recurrence and the 
above quotation provides some insight into her view of her body's decreased 
ability to cope with chemotherapy for a second time and depicts her 
disembodied status. In contrast to a secondary analysis of interview data 
gathered from UK participants with chemotherapy-induced alopecia (Hilton, 
Hunt, Emslie, Salinas & Ziebland, 2008) the women in the present study spoke 
not only of hair loss above the eye line but of alopecia from wider bodily 
surfaces. 
'It's still coming out with every treatment and I've lost it from my armpits, 
legs and everywhere else you have hair' (Janet; Interview 2; Lines 62-
64). 
The study by Hilton and colleagues found such discussions to be limited to male 
cancer patients however women in the current research relished relaying events 
such as once again having to shave as for them this was another representation 
of normality. 
'A very exciting thing was when I had to shave my legs (laughing) and I 
thought what a sad person getting excited about shaving your legs but it 
is, it's a sign of normality coming back' (Susan; Interview 2; Lines 385-
387). 
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By the third interview, when chemotherapy had been completed, participants 
made efforts to discuss positive outcomes. 
'I've always had straight hair and its come back curly...I lost most of my 
hair but it's come back curly, I've always wanted curly hair and I've got it' 
(Janet; Interview 3; Lines 39-40). 
While the completion of chemotherapy and hair re-growth was perceived to be a 
sign of health returning, women subsequently attended radiotherapy which, as 
illustrated in the following sub-theme, had an unexpected impact on the body. 
6.5.3 Radiotherapy: an unanticipated impact on the body 
Contrary to previous qualitative research findings (Halkett, Kristjanson & Lobb, 
2008) the thirteen women in the present study prescribed radiotherapy did not 
report what could be considered fears about this treatment and did not actively 
seek information about radiotherapy. For the ten women who had previously 
undergone chemotherapy this intervention was perceived to be less problematic 
in terms of side-effects and displaying the signs of illness. 
'I feel a bit.I feel a bit.I think.gutted because I feel so okay and I 
think I feel really well and I'm still having to go through this but.I don't 
feel half as worked up as I did about the chemotherapy and I think it's 
because there's not as many side effects' (Laura; Interview 2; Lines 25-
28). 
As illustrated by Laura radiotherapy was perceived to extend women's wait for 
normality however while participants did not anticipate experiencing side-effects 
the majority of women interviewed did describe skin irritation. This was the case 
both for participants who did and did not undergo a course of chemotherapy. 
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'I realised I had no sensation in this area here (points to part of chest and 
lower arm) so when you can't feel anything it doesn't hurt does it. I 
started to peel in the area that had the radiotherapy, it was like having 
bad sunburn, and it itched like mad all around the edges where I did 
have sensation' (Lily; Interview 2; Lines 17-21). 
Joan additionally commented on the visible nature of this treatment effect. 
'You can probably see on my neck there because the clavicle was done. 
I keep plastering sun block on that but it's a lot better than it was. It was 
an open wound at one time' (Joan; Interview 2; Lines 59-61). 
Attending hospital each day for an allocated time period was also viewed as 
contributing to physical limitations by adding to a generalised fatigue. 
'With the radiotherapy, going down every day doesn't give you enough 
time to stand back and think. To lie on a table with your legs on this thing 
so you can't move and your head in a thing and an enormous machine 
above you, is quite intimidating. You can hear the machine warming up 
and then discharging.it felt like I was in a Sci-Fi movie...entering my 
body and burning away these cells. I don't think I ever came to terms 
with it.and I had five weeks of it.it was odd. If I had to do it again I 
don't think it would be as bad. It does make you tired, just going to 
hospital every day.finding somewhere to park.is quite strenuous' 
(Susan; Interview 1; Lines 187-196). 
Susan's quotation provides an insight into how the continuous adherence to 
medical regimes throughout the healthcare trajectory can limit women's time for 
reflection and how she viewed her body in relation to the process of 
radiotherapy. While Susan does make reference to "my body" suggesting an 
embodied perspective she subsequently comments on "these cells" 
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contradicting the notion of embodiment. Throughout this research it was not 
uncommon for women to speak of their bodies in a way that indicates the 
individual body parts and internal structures of the body were seen from a 
disembodied perspective yet the body as a whole was their property and to 
some extent under their control. Given its self-administered nature it could be 
argued that women had ultimate control over taking Tamoxifen yet as is 
considered in the forthcoming sub-theme this was also not without noticeable 
effects on the body. 
6.5.4 Tamoxifen: inducing the menopause 
For all participants with oestrogen receptor positive tumours Tamoxifen was 
prescribed for five years however side-effects were experienced almost 
immediately ranging from mild hot flushes to profuse sweating and insomnia 
with varying degrees of severity. 
'Since I've been taking it I'm not sleeping on the night, I've got like 
insomnia. It must act as a sort of diuretic because it makes you pass 
water quite frequently. I don't get the nausea and the headaches 
now.after about ten days.so that's quite a good sign. So, whether all 
the other things will.sort out after I've been taking it a while' (Gillian; 
Interview 1; Lines 114-118). 
While the longitudinal approach has uncovered that these side-effects tended to 
improve over time, several participants continued to experience issues, some of 
an externally visible nature, several months after commencing the drug 
treatment. This prolonged these women's wait for normality and limited the 
extent to which a healthy identity could be resumed. 
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'Tamoxifen is horrible. You don't get more than two hours sleep at a time 
and you wake up soaked in sweat, so you've got to change your nightie, 
sometimes change the sheets. So, I'm never sleeping more than two 
hours at a time.and then once I'm awake that's it...I guess initially when 
I was thinking well it doesn't matter if it prevents the cancer 
returning.now, now the reality of five years of this isn't very nice' (Ellen; 
Interview 2; Lines 43-46...50-52). 
There is a paucity of qualitative research exploring women's experiences of 
Tamoxifen though similar findings have been reported in a French interview 
study considering the adherence of thirty four women who had commenced 
Tamoxifen (Pellegrini et al., 2010). As in the present research study Pellegrini et 
al. described side-effects including hot flushes and night sweats which 
characterised a loss of control over the body and led to concerns regarding 
femininity and further deterioration of body image. These latter issues are 
illustrated through the following quotation from Ellen who commenced 
Tamoxifen within days of undergoing breast surgery. 
'I thought I was going to have nasty symptoms with it because the first 
week I took it I felt really sick, really awful, but they've passed. Just 
knowing that the oestrogen in my body is now blocked.I'm waiting to 
grow a beard and.(laughing) waiting for all sorts to happen, you know. 
Erm.and I think that's a really big stumbling block for me, knowing that 
outwardly I don't look like a woman should and now I'm thinking internally 
as well that's getting blocked' (Ellen; Interview 1; Lines 189-195). 
Severe side-effects have been identified as an influential factor in women's 
adherence to Tamoxifen particularly during the first year (Owusu et al., 2008). 
Moreover, in a self-report survey of side-effects and both physical and mental 
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status Tamoxifen was found to have detrimental effects on women's quality of 
life (Boehm et al., 2009). As demonstrated below, this study's participants 
accepted whatever side-effects they experienced and even when given the 
option of temporarily ceasing the treatment chose not to do so. 
'She did say she would take me off the Tamoxifen but that it would be a 
mind game for me if I did but she said it's entirely up to you but she said 
I'd only let you come off it for three months. So I thought about it and I 
thought it really isn't worth it, I'll try the glucosamine and luckily for me it 
has worked' (Amanda; Interview 3; Lines 61-65). 
Like Amanda, the other participants typically faced a multitude of treatments 
and in turn side-effects which were experienced to varying degrees. This theme 
has depicted the impact of these side-effects on women's body perceptions 
though in accordance with the previous quotation, it is noteworthy that fear of 
mortality outweighed experiences of such side-effects and led a small number 
of participants to seek out alternative therapies to cope with treatment-induced 
symptoms. This is one area explored further in the second part of this chapter. 
Part 2 - Body Management 
Strategies relating to the management of the body and external appearances to 
minimise the impact of breast cancer on participants' lives is the focus of the 
second part of this chapter. Use of external breast prostheses, reconstructive 
surgery and long-term management of appearance via clothing choices are 
examined. The methods of managing chemotherapy-induced alopecia adopted 
by women in this study are reviewed as is the use of complementary therapies 
to manage the impact of treatment-induced side-effects on the body and mind. 
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6.6 The practicalities of external breast prostheses 
There is a paucity of empirical research focusing on post mastectomy care and 
specifically the provision of breast prostheses (Gallagher, Buckmaster, 
O'Carroll, Kiernan & Geraghty, 2010). However, the majority of women who 
have undergone breast cancer surgery particularly mastectomy will require use 
of an external breast prosthesis (e.g. Scanlon, 2004). All women in the current 
study who underwent mastectomy were offered a soft breast prosthesis 
following surgery, typically prior to discharge. In line with writers such as Lorde 
(1985) it could be argued that this sanctioning of prostheses is of benefit to 
society ensuring that public optimism regarding breast cancer is not spoiled. 
Moreover, Bredin (1999) argues that this reinforces the concealing of breast 
loss and the need to maintain "normality" of the body. Nevertheless, participants 
viewed the provision of prostheses in a positive manner and it was evident that 
the impact of the changed body was felt immediately after surgery. 
'I just kept looking at it and thought well this is how it is but then when I 
was coming home and they gave me the erm.the little softie, the soft 
prosthesis, that was just.a massive change for me because I came out 
and I looked normal. That's what I didn't like and I couldn't.probably it 
was worse for me because my breasts are quite big anyway, that it was 
so flat on one side and not on the other so.you've got your dressing 
gown on and it's so obvious when you're in hospital' (Mary; Interview 1; 
Lines 191-197). 
The provision of a good-quality prosthesis and prosthesis fitting service have 
been identified as of importance for women's post-surgical recovery including 
psychosocial well-being and body image (Breast Cancer Care, 2006). 
Sensitivity and understanding have been identified as key qualities of the 
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person fitting the prosthesis with women preferring a knowledgeable fitter such 
as a breast care nurse to conduct the primary fitting (Roberts et al., 2003). 
While all women in the present study required this service preparation for the 
fitting appointment has been reported to be useful. Acquiring a prosthesis prior 
to discharge limits the extent of possible preparations and for Pauline such 
issues are reflected in her concerns as to the introduction of the prosthesis. 
'It was almost as an afterthought that I was given a prosthetic on the 
morning that I was going home and it was just the presentation of it. It 
was a huge bag with all different sizes and it was well this one looks 
about right, here you are. I can cope with that but I think a lot of people 
would have been very distressed and would have to have been taken to 
one side' (Pauline; Interview 1; Lines 238-243). 
Aspects of the prosthesis fitting environment including insufficient space and 
poor display of stock have been repeatedly criticised by women as negatively 
impacting upon the fitting experience (Breast Cancer Care, 2006; Gallagher et 
al., 2010) though while Pauline expressed concern for others none of the other 
women in the sample commented on the fitting itself. As in the focus group 
study of Irish women's accounts of external breast prostheses (Gallagher et al., 
2010) a number of practical issues pertaining to the characteristics of the 
external breast prostheses were raised as, for example, several women 
reported experiencing pain and discomfort during the post-operative period 
when wearing a bra. 
'I had an appointment at the clinic and they gave me a bra and it was 
really good, with pockets in. Now, oh get this, I've got a little old lady who 
sews me pockets into my bras, I bought her a bottle of wine, all these 
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pockets in my bras. So it's just like placing it inside and you feel so much 
better. I've got the soft one on at the minute but I've got my prosthesis as 
well, that's in my other one, my posh bra upstairs. For work I'm wearing a 
soft one at the minute because when I started wearing, when I first got 
the prosthesis and started wearing it, I was still quite tender but I put it on 
and I felt great and thought this looks great. I felt more normal than I'd 
ever felt but I didn't know you had to do it gradually so I wore it all the 
time and now I have a very slight tenderness. It doesn't even hurt to the 
touch, it's hard to describe, it's a funny sort of thing, but it's like when you 
have your socks on tight and it leaves a mark' (Jenny; Interview 1; Lines 
285-299). 
Jenny's quotation provides an opportunity to mention that once surgical wounds 
had healed sufficiently women were offered a follow-up appointment for the 
fitting of a silicone prosthesis and bra containing pockets in which either type of 
prosthesis could be inserted. The bras were well received by participants 
however the silicone prostheses were deemed to be heavy and were described 
as inducing a sticky sensation due to sweating particularly during warm 
weather. 
'I wore my prosthesis on the day I got married. All the men wore kilts and 
they were so busy seeing to him (husband) and the bloody kilt I was 
struggling with the bra. My husband fastened me the bra and erm.I 
think I wore this falsie upside down all day. I'll be honest with you I don't 
like it. I don't like it because when you've got it on you've got to sit like 
that and with it being this hot weather when you take it off you're 
sweating' (Linda; Interview 1; Lines 216-222). 
Furthermore, Linda found that achieving a symmetrical bust line with an 
external breast prosthesis was difficult and the assistance she required in doing 
so resulted in feeling self-conscious. 
'I've promised to try with my falsie a bit more. Yesterday when it was so 
hot I just have my cotton trousers and a T-shirt on, like now...I feel more 
self-conscious when I've got it in but we're putting it in now, we've had 
two attempts at putting it in and my husband's looking to see if my bust is 
level and I feel more self-conscious then' (Linda; Interview 1; Lines 279-
288). 
The issues experienced when wearing external prostheses seemed to be 
amplified for those participants who had both breasts removed though is a 
neglected element within existing research. 
'Having two prostheses is much hotter than when I just had one and the 
perspiration just pours off me. I think it's because they're plastic and are 
flat to the skin so there's no movement of air around them. They move in 
a different way to your own breasts. Breasts hang from the shoulders in a 
way but the prostheses hang in your bra and it's almost like getting used 
to foreign bodies. Putting one in I could get used to it but now I have two 
I'm always aware they're there. I know that sensation will go. Those are 
the sorts of things you don't really think about. I'm not wearing them all 
day' (Susan; Interview 2; Lines 395-402). 
Accordingly, in support of the findings of Gallagher and colleagues (2010), 
participants experienced issues associated with prosthesis weight, discomfort 
and the body shape that could be achieved with the prosthesis that had been 
supplied by the NHS. As a consequence, experimentation with different types of 
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prosthesis was common practice amongst the women interviewed. A need to be 
confident in wearing whatever prosthesis was chosen was also evident. 
'I wear quite firm ones for work but they're very hot. I've got hollowed out 
ones to exercise in and they're great, I just daren't wear them for work in 
case they collapse.I think I need to wear them around the house a bit 
more to get more confidence with them. They are much, much better 
when you're exercising because they don't pull the sweat back onto your 
skin and don't pull your scars so they're much, much nicer so I've bought 
myself a set' (Ellen; Interview 3; Lines 360-366). 
As reported elsewhere (e.g. Gallagher et al., 2010) the perceived need to find 
appropriate prostheses and clothing to suit was described as having financial 
implications. 
'I'm not a fashion victim but I do like to wear stylish things and I find it 
quite restrictive. You get away with a lot with camisoles but it's the 
underwear issue that's the problem and because I'm small chested 
anyway I get a ridge here. I've got a couple of softies now and I've 
bought an extra one and what I did was get some filling, about a 
centimetre across the top and that's helped but it's still not.with ordinary 
foam, the nature of the foam, it's so fragile, they can't cut it to a wafer 
thin edge like they can with the latex but I didn't like it at all. I even 
bought a stick on one thinking that would be better.and the prices are 
horrendous. I feel as though I've been punished almost, penalised 
because I've had breast cancer and a mastectomy so I have to pay one 
hundred pounds for a prosthetic and another sixty pounds for the 
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adhesive and they don't last very long' (Pauline; Interview 2; Lines 37-
49). 
Pauline's quotation makes reference to having small breasts though seemingly 
in contrast to the research of Fang et al. (2011) this did not minimise the impact 
of mastectomy but actually elicited issues regarding finding an appropriate 
prosthesis. Moreover, while participants had received a "pocketed" bra from the 
breast clinic any adjustments to existing or newly acquired bras were the 
responsibility of the individual woman, often incurring a financial cost. The 
subsequent theme explores the difficulties participants experienced with 
external breast prostheses and illustrates how their desire to restore their body 
to as full an extent as possible occasionally led women to consider and in some 
cases undergo breast reconstructive surgery within the year following diagnosis. 
6.7 Reconstructive surgery 
Women's consideration of reconstructive surgery was complex and by the end 
of the data collection period information seeking about this procedure did not 
necessarily extend to scheduling surgery. Susan, for example, reported severe 
soreness following a bilateral mastectomy and by her final interview was 
contemplating all options despite previously being against reconstruction. 
'Everyone knows I've been against it and I said I wasn't getting away with 
the prostheses...I know a few people who've had it and they're not 
always as successful as people like to think and so I'm debating. I doubt 
I'm properly healed inside yet either so it might just be pressing on a bit 
that's still healing for all I know but I suppose it needs looking at and 
sorting out. I just think you get all these scars all over your body and a 
false breast doesn't really look like a breast when you take your bra off 
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does it, you look like a Barbie doll' (Susan; Interview 3; Lines 113-
114...117-123). 
Interestingly, the experiences of others and specifically concerns about the 
success of the surgery in terms of altered appearance formed Susan's 
rationalisation against breast reconstruction. This may link with the study 
findings reported in Chapter 1 (p.27) noting that breast reconstruction does not 
meet all women's expectations (e.g. Crompvoets, 2006) and moreover, that 
being aware of this may influence some women's decision to decline this 
procedure. However, despite experiencing few issues with external breast 
prostheses a minority of women in the sample did not perceive adjustment to 
their changed body to be possible and actively sought a breast reconstruction 
during the year following diagnosis. At a very early point in her first interview 
Gillian made reference to how losing her breast was of greater significance than 
having cancer. This is not only in contrast to previous literature (e.g. Fallowfield 
& Hall, 1991) but to other women interviewed as part of the present study as 
detailed in the previous chapter. 
'I was absolutely devastated about the mastectomy. At that time I don't 
think breast cancer even entered my head really, it was just the fact that I 
was losing my breast and I didn't want to. It wasn't the fact that I had 
cancer, that didn't come into it at the time' (Gillian; Interview 1; Lines 40-
43). 
Medical reasons meant that immediate reconstructive surgery was not possible 
for Gillian and accordingly even at this early stage her primary focus became 
this intervention. 
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'I think I've been asking for that ever since they first told me. I think I ask 
every time I see her. She'll get sick of me but hopefully I'll then be at the 
top of the list' (Gillian; Interview 1; Lines 71 -73). 
Lorde (1985) purports that reconstruction and the use of external breast 
prostheses undermines women's attempts to reassert control over their lives. 
Yet for Gillian the process of seeking this surgery seemed to engender control 
over her future body-self. Not surprisingly, her wait for breast reconstruction 
was the first topic Gillian raised during her second interview which subsequently 
revolved around this discussion point as Gillian did not perceive being able to 
regain her former life without the surgery. 
'I just want my life back really and I will but not until I've had that. I'm 
quite a.I've got quite a good social life and I like to go on holiday and I 
just wouldn't feel comfortable. I don't know even the clothes I like.you 
cannot even wear little like vests, particularly when you're leaning 
forward.you know.it's not.I'm not comfortable. So yeah.for me.I 
just feel it's like the next step in my recovery really.for that' (Gillian; 
Interview 2; Lines 47-52). 
As described elsewhere (van Wersch, 2001) clothing was an influential factor in 
Gillian's quest for breast reconstruction as she continued to feel self-conscious. 
By the third and final interview Gillian had undergone breast reconstructive 
surgery and the following quotation illustrates the impact on her body image and 
well-being. 
'When I look in the mirror now I don't.like before I used to be upset and 
that but now.although I've got scars and everything at least you've got 
something there' (Gillian; Interview 3; Lines 27-29). 
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Higher levels of satisfaction with appearance both with and without clothing and 
greater confidence in social situations have been reported in women who have 
undergone delayed breast reconstruction compared to women with unilateral 
mastectomy (The NHS Information Centre, 2011). 
Gillian's difficulties accepting breast loss were the most prominent in the sample 
and the longitudinal qualitative approach was particularly valuable in revealing 
her experience of seeking and undergoing reconstruction. Elements of her first 
and second interviews conform to Frank's (1995) conceptualisation of a chaos 
narrative whereby the story is one of wreckage and the individual cannot 
imagine life improving. Her continual pursuit of reconstruction, however, 
indicates the presence of a restitution narrative and consequently Gillian's case 
provides an example of how women may display multiple narrative types often 
simultaneously during their experience. It additionally provides evidence that a 
minority of women may reject living with breast loss from the point of diagnosis. 
In accordance with van Wersch (2001) reinstating her outer self may have 
minimised the change required to Gillian's inner self in the long-term. 
While quantitative research has shown that women perceive one of the major 
benefits of immediate breast reconstruction to be avoiding the need for external 
prosthesis use (Contant et al., 2004) this was not described as an influential 
factor by Gillian, rather breast loss itself underpinned her drive to have 
reconstructive surgery. Her use of an external breast prosthesis was viewed as 
simply serving a temporary purpose though was not deemed as alleviating her 
suffering sufficiently to warrant long-term use. It is noteworthy that even those 
participants who emphasised survival over breast loss and did not perceive the 
changed body to impact their sense of self chose to wear an external breast 
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prosthesis when in social encounters and/or altered their dressing behaviour in 
some way. This thereby supports Crouch and McKenzie's (2000) observation 
that it is unusual for women to forego either the use of a prosthesis or breast 
reconstruction. It should not be forgotten that many participants did just this 
when in a "safe" environment such as at home with loved ones or when breast 
loss could be adequately disguised through careful consideration of clothing. 
Yet it is this daily change to these women's lives that indicates, as in the 
previous chapter, that in relation to Frank's (1995) restitution narrative that full 
restoration is not possible given the consciousness required to maintain 
"normality". 
With regard to those women who had undergone a lumpectomy the 
commentary in this theme is not intended to imply that, as empirical research 
shows, (e.g. Fobair et al., 2006; Moreira & Canavarro, 2010) participants with 
mastectomy did not experience greater altered body image than those having 
undergone breast conserving surgery. Rather the themes of this chapter 
illustrate the profound impact of breast loss however, the qualitative approach 
adopted in the present study has helped to identify that irrespective of the type 
of breast surgery women had undergone, an altered sense of body-self and 
associated social identity may be experienced. Discussion of women's 
management of their external appearance is expanded in the next theme 
wherein participants dressing behaviour is reviewed in relation to both 
mastectomy and breast-conserving surgery. 
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6.8 Re-imaging the body to manage breast surgery 
Despite the daily difficulties participants faced wearing external breast 
prostheses the positive psychosocial impact attained by restoring their body 
shape and appearing "normal" was, as found by Roberts and colleagues (2003), 
central in women's accounts of their experience following breast surgery. 
'When I have a prosthesis in nobody knows any different when I'm out. I 
haven't had any problems. I can get back to doing what I did before. 
Nobody will have any idea that I have lost my breast. I think the days of 
thinking about being a page three model went a long time ago. I would 
rather lose the whole breast and get rid of the cancer' (Susan; Interview 
1; Lines 141-147). 
The previous quotation from Susan reiterates the viewpoint of several women 
that losing a breast is a small price to pay compared to losing one's life. 
Furthermore, while the wearing of a prosthesis did not typically restrict activities 
of daily living, adjustment to breast surgery and an external prosthesis required 
participants to re-consider their dressing behaviour. 
'I phoned the breast care nurse actually because we're going out on the 
25th, which is before I get my prosthesis because I've only got the softie 
at the moment erm.and so I phoned and said could I go in earlier 
because I would like it for when we go out. She said yeah, not a problem 
but why and I said well I just have this feeling that when I go in 
everyone's gonna stop, turn around and stare at me. I know they're not 
but I have this vision in my head like everyone's gonna go quiet and look 
at me, although nobody will know apart from my close friends. Nobody 
will know but you just have this perception of people staring at you, or if 
they look at you, that's why they're looking at you.not because you look 
nice or anything like that. I think I'll probably still wear the softie one 
because it's pretty comfortable really and it doesn't weigh anything 
whereas I think the actual prostheses are quite heavy so I'll probably only 
wear that if I was going out' (Gillian; Interview 1; Lines 320-335). 
The fear of being stared at, formerly recorded by Rasmussen and colleagues 
(2010), and having others speculate about their breast surgery was a common 
reaction during the first months. Indeed, the influence of others permeated 
women's accounts of this element of their experience. As in the present study 
Thomas-MacLean (2005) reported that women attempt to restore the body and 
in doing so avoid stigmatisation from others via managing their appearance. 
The following quotation from Margaret, who underwent a lumpectomy, 
illustrates how feeling self-conscious resulted in her disguising her breast 
surgery. 
'I must say when I first went away (on holiday) I thought oh sod it if they 
don't like it they don't have to look and I did and then I thought no I can't. 
I just couldn't do it I had to put my top back on. So...I feel as though...I'm 
self-conscious and I'd think well people would be looking at you and 
thinking what's she had done...so I feel as though that part's been taken 
away from me so you do feel a little bit...unhappy' (Margaret; Interview 1; 
Lines 197-206). 
Manderson and Stirling (2007) reported that women frequently feel self-
consciousness post mastectomy yet the current research findings highlight this 
too is the case for women following breast-conserving surgery. Women's 
concealment of the body, withdrawal and changed behaviour when around 
others following breast surgery is argued to represent women's altered social 
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identity (e.g. Bredin, 1999; Spence, 2001). The extract below taken from the 
second interview with Rose exemplifies the complex interplay of factors and 
decision-making processes involved in dressing the body and the wearing of 
external breast prostheses following mastectomy. 
'I've got quite a few camisoles in various colours that I can wear 
underneath anything, anything that's slightly revealing and I find that at 
the moment I can't wear.I'm going to have to order a new 
contact.prosthesis bra. At the moment I haven't got one so when you 
bend over, if something's a bit sort of.(low cut), it's going to go over like 
that, your bra comes away, the weight of it pulls your bra away. 
Obviously that's not a very nice sight so hopefully once I get a contact 
bra I'll be able to wear something that's not as tight around my chest, so 
when I do bend over you just see my bra basically. It's amazing how 
many clothes are low necked and it doesn't matter you know, it could be 
here, but you could still see because it's deep here. It doesn't really 
bother me that much but I would hate to upset somebody else, you know, 
for what they could see, if you know what I mean. So, hopefully I'll get 
this new filler and see how that works because once you get your clothes 
on you're just like everybody else. It's the preparing in your head, what 
am I gonna put on and also with the scarves as well, what have I 
got.can I wear that top, have I got something that's gonna go with that. 
So, it's a bit more complicated to get ready and you've got to think about 
your clothes more rather than going in the wardrobe and thinking oh I'll 
put that on' (Rose; Interview 2; Lines 93-110). 
Disguising breast loss was therefore viewed as a means of protecting others 
and led to careful consideration each day as to the appropriate clothing given 
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potential social interactions. The following quotation from a highly emotional 
section of Gillian's first interview reveals the moment she began to perceive 
necessary changes in dressing her body. 
'A couple of weeks ago my daughter bought some clothes and it was the 
sort of things I would have worn before my operation so it sort of brought 
it home to me that I won't be doing that sort of thing for a while. I wouldn't 
feel comfortable wearing clothes that I wore before, not like everyday 
clothes but clothes you wear when you're going out socialising. All the 
clothes are low cut because that's the fashion and I just wouldn't feel 
comfortable any more wearing that sort of thing, not at the moment 
anyway' (Gillian; Interview 1; Lines 161-170). 
Feeling comfortable in one's clothes was identified to be of importance however 
for some participants the notion of being comfortable represented a move away 
from a former focus on their external appearance and ultimately their identity. 
'Yeah, it's my appearance and.even my clothes don't fit me now. Now 
instead of dressing to look nice, I'm dressing to feel comfortable' (Janet; 
Interview 2; Lines 201-202). 
The existing literature on the impact of breast surgery focuses on mastectomy 
noting women's dissatisfaction with their appearance without clothes (Alicikus et 
al., 2009). In a recent audit of women eighteen months post breast cancer 
diagnosis 83% reported to be satisfied with their clothed appearance following 
mastectomy while 42% were satisfied with how they looked in the mirror 
unclothed (The NHS Information Centre, 2011). Consequently, clothing would 
seem to be integral to some women's satisfaction with their appearance yet 
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such results also indicate that for many women breast loss will have a prevailing 
impact beyond the timeframe of the present study. 
Not having to change clothing options has been reported to be a perceived 
benefit of lumpectomy (van Wersch, 2001) however, the above quotation from 
Janet (and also those from other women such as Margaret), depicts how 
participants who had a lumpectomy also experienced issues with body image 
and clothing. The need to feel confident in one's dress when interacting with 
others at work is reflected in the following quotation. 
'I've got to feel confident in what I'm wearing otherwise I can't do my job. 
If I'm thinking about what I'm looking like, I'm not with the client. It's very 
important to me that I look reasonable' (Ellen; Interview 2; Lines 128-
131). 
Despite the majority of participants dressing to cover up any signs of having 
undergone breast surgery a small number of women were less concerned with 
managing their appearance. 
'It's not very often I wear it (prosthesis). If I'm honest with you.I mean it 
weighed two and a half kilograms didn't it, my bust so to be honest with 
you it's not comfy... If we go out for dinner I will put it on, if I've got a 
jumper on but if I'm like this I won't bother' (Linda; Interview 2; Lines 234-
236...237-239). 
This corroborates the findings of Roberts and colleagues (2003) who note that 
some women choose not to wear their prosthesis when alone at home. 
Nevertheless, a minority of women in the current study chose to solely use 
clothing as opposed to a combination of dress and prostheses to hide their 
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mastectomy when outside of the home. When questioned further Linda 
elaborated by stating: 
'I think I've enough confidence not to bother. Sometimes I think about it 
but as I said I usually wear a jacket so it wouldn't show. When I've 
thought about other people noticing I've always thought did I ever notice, 
I can never say that I ever noticed anyone with one breast' (Linda; 
Interview 2; Lines 265-269). 
This is an interesting observation from Linda and could be argued demonstrates 
not only women's proficiency at disguising breast loss but the overwhelming 
desire to maintain a public display of a "normal" appearance. Older age was 
often perceived to influence the views of those participants who chose not to 
alter their wardrobe. 
'I don't see any reason why I won't wear vest tops. My summer clothes 
are there and last weekend I was wearing them no problem, it didn't 
bother me but it might affect a younger person, they might be self-
conscious. I don't feel as if I'm not a complete woman or anything like 
that, not at my age' (Maria; Interview 2; Lines 153-156). 
For some participants, however, there were exceptions to not hiding breast 
surgery including sunbathing and swimming. 
'I think because it's been winter I've been wearing big baggy things 
anyway but I'll have to think more during the summer, but I'm not 
ashamed of having had a mastectomy. I just probably wouldn't put on 
any beachwear but anything else I'm sure I'll be fine' (Lily; Interview 2; 
Lines 149-153). 
While changing their "normal" attire was evident throughout many participants' 
experiences, for Ellen who some years earlier had undergone a previous 
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bilateral mastectomy following high risk genetic testing, buying new clothes and 
specifically underwear, had become a means to gain confidence, boost mood 
and promote a positive sense of self. 
'You go along with weeks and you're okay and then you catch yourself in 
the mirror when you go in the shower and you're oh I'd forgotten. Not that 
you ever forget but you catch that glimpse and you feel different and 
strange and you've got to go out and buy yourself some fancy underwear 
to make yourself feel okay again' (Ellen; Interview 1; Lines 148-152). 
However, the impact of further surgery to remove a cancerous lump had 
resulted in a dramatic change to her body image and her previous coping 
strategies were no longer adopted. 
'(I have) lumps and bumps so I can't get a prosthesis that sits on my 
chest wall. I need two different sizes because this side has a tiny 
amount, a tiny amount of shape, flat but a tiny amount of shape. This 
side actually caves in, but it caves in and has lumps at either side so the 
prosthesis won't sit against me so I don't feel really.confident in my 
clothes. So, I've had to look through my clothes and I'm in the process of 
throwing loads out and re-arranging. When I first went through the 
surgery I bought all high necks, not this surgery, ten years ago, slowly 
got a bit more confidence and lowered them and got nicer clothes, 
dressed a bit better and now I feel worse than I was then' (Ellen; 
Interview 2; Lines 104-113). 
When reflecting on these comments in her final interview Ellen acknowledged 
that: 
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'I was suddenly stripped of my protective way of dressing. I couldn't 
dress as I normally dressed, didn't want to see neighbours, didn't want to 
see anybody, couldn't bear my prosthesis on' (Ellen; Interview 3; Lines 
346-348). 
Ellen's account suggests that some women continue to experience emotional 
pain in the longer term as a direct impact of breast loss (e.g. Langellier & 
Sullivan, 1998) though the passage of time elicits new efforts to cope. For Ellen, 
seeking out specialist clothing and prostheses designed for women following 
breast surgery was undertaken by the third interview though she noted her 
fortunate financial position as enabling her to acquire tailor-made items. In 
contrast to previous discussions within this chapter concerning women's 
proficiency in disguising breast loss, chemotherapy-induced alopecia was 
perceived to be more difficult to conceal. Women's management of hair loss 
constitutes the following theme. 
6.9 Minimising the impact of hair loss 
Research has shown that unlike men women are actively encouraged by 
healthcare professionals to prevent and disguise hair loss (Hilton et al., 2008). 
Participants did indeed often attempt to minimise the likelihood of hair loss while 
undergoing chemotherapy by opting for scalp cooling otherwise known as scalp 
hypothermia. The potential benefits of using a cold cap were introduced by the 
oncology team however when this was not as successful at preserving hair as 
had been hoped women were encouraged to cease its use. 
'My hair erm.the last one.by the last one it had dropped out a lot so I 
asked the nurse if I should continue with the cold cap and she said no 
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because you wouldn't be able to tolerate it because there was so much 
dropped out. So.you know, I've got over that because it was a bit of a 
shock my hair falling out' (Louise; Interview 2; Lines 9-13). 
Trials testing scalp hypothermia versus no use of the cold cap in a breast 
cancer population have not elicited statistically significant differences in 
women's alopecia related distress (Protiere et al., 2002 as cited in Lemieux et 
al., 2008). However, for women in the present study who commenced use of the 
cold cap, subsequent hair loss seemed to elicit a greater sense of shock. Once 
hair had started to thin as in the study by Rosman (2004) not all women could 
bear the process of scalp cooling and preferred to lose their hair than continue 
with this regime. 
'I was wearing the cold caps at first, I wore them for the first three months 
and I found that it was starting to drop out and go very thin and it was just 
making me feel physically sick. It just seemed to have this smell to it, it 
hasn't but it just seemed to have this cold smell to it. So I thought well 
this is ridiculous, putting myself through something I don't have to so I 
decided not to wear the cold cap and I lost most of my hair' (Rose; 
Interview 2; Lines 10-15). 
When hair loss was becoming increasingly noticeable it was not uncommon for 
the study participants to take measures to reduce the distress this caused. 
Having hair cut short and shaving off the remainder of their hair constituted 
such coping strategies. 
'Well if I had to give any advice to anyone going through this.as soon 
as you start losing your hair have it cut off. I had quite long hair and then 
I had it bobbed. Just before I started the radiotherapy it started coming 
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out so I'd wear my hats and erm...having to change the sheets each day, 
losing hair and being self-conscious of it. It started round the edges, I 
was losing a little bit around the edges and so you couldn't really tell but 
constantly every day checking yourself for hair. So one day we took the 
shears, myself, my partner and my friend and we just did it. I thought that 
would be a big step but it wasn't, it was a relief to have it all cut off' 
(Janet; Interview 2; Lines 41-49). 
While for some of the women interviewed alopecia was viewed as an inevitable 
consequence of chemotherapy all relevant participants chose to disguise their 
hair loss to some extent through the use of hats, scarves and wigs. The choice 
of headwear was influenced by the weather, confidence in wearing the item and 
potential social interactions. This is broadly supportive of Rosman's (2004) 
sociological study which contextualises findings in relation to Goffman's notions 
of full and partial camouflage. These terms represent how individuals do not 
hide alopecia in the company of "initiates" such as close family yet disguise hair 
loss when in the presence of "non-initiates" with whom they do not wish to share 
their visible stigma. This is illustrated in the following quotation which also 
exhibits the importance these women assigned to hair loss in comparison with 
mastectomy. 
'This has now come second place (mastectomy) and my hair is my focus, 
my hair loss. Although you see you've come into my home and I don't 
even know you and I've let you see me like this and yet there's members 
of the family I won't let see me like this. I wouldn't dare answer the door 
with my hair like this but only because I knew you were coming' (Mary; 
Interview 1; Lines 248-253). 
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However, having support from family and a community which held an 
awareness of their recent diagnosis seemed to lessen the impact of hair loss 
and enabled participants to choose methods of disguising baldness on the basis 
of comfort as opposed to normalising appearance. This finding may also link to 
the befriending pattern of the "tend-and-befriend" model (Taylor et al., 2000) as 
the maintenance of social networks reduced these women's stress response. 
'I think because I've had good support from my family, my partner and 
my girls so it hasn't been as bad. We do it together and I think with living 
in a small community I think everybody knows my condition and the girls 
down at work know so when I go in with my head scarf on it's not a big 
issue. I was supplied with a wig but I hated it. It was uncomfortable' 
(Janet; Interview 2; Lines 62-68). 
Rose chose to wear head scarves citing similar reasons to Janet though 
highlighted that for some social occasions the wearing of a wig seemed 
somehow appropriate. 
'I went along there (holistic centre) and they were absolutely marvellous 
and a wonderful range of coloured scarves, one fifty each and they show 
you how to tie them. I think without them I would have been stuck 
because I got a wig and I've worn the wig twice and I'm going to a ball at 
the end of this month so I may wear it again then. I've found that most 
people I know, most people, living in a small place, they know what my 
problem is so they know I have no hair. So obviously when I put a wig on 
they'll say oh it's a wig whereas if they didn't know me they wouldn't 
know it was a wig so I haven't worn my wig much at all. The scarves 
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have been marvellous and just a little thing like that' (Rose; Interview 2; 
Lines 41-50). 
In accordance with Rosman's findings Rose's account shows her fear that the 
wearing of a wig may itself become a symbol of stigma. Rosman (2004) 
documented that while not wearing a wig can lead the individual to be 
discredited due to stigma, when wearing a wig an individual may become 
discreditable and afflicted with an invisible stigma that influences social 
communication and leads the woman to consider the disclosure of their secret. 
Wearing a wig can thereby lead the person to move from discreditable to 
discredited. Feeling self-conscious when wearing a wig was rarely reported 
though for Janet concerns relating to failing to adequately hide her hair loss led 
to her largely choosing not to do so. 
'I was invited for my Christmas meal with the girls from work so I thought 
oh well I'll put my wig on and it did look nice and if people didn't know, 
they wouldn't have known but I was so self-conscious. I always thought it 
wasn't on straight (laughing). I'm quite happy to wear my hats and my 
scarves' (Janet; Interview 2; Lines 72-76). 
Nonetheless, the wearing of wigs was commonplace as like the external breast 
prosthesis it was associated with looking normal and effectively disguising the 
signs of illness. 
'I decided not to have the cold cap. I got a wig and treated it as another 
item of clothing. When I was out in public nobody knew...but I had to 
stop wearing it in the hot weather as it makes your head sore. I did think 
they've taken my breast and now they're gonna take my hair. It came out 
very quickly but the worst stage was the in between stage when I had too 
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much hair to wear the wig but not enough.I didn't want it to be obvious 
that I was having chemotherapy. Once I got the wig I felt loads better.I 
felt I could walk out and nobody would think twice. The thing that's 
always been important to me is being able to walk out in places where 
people don't know me and for people not to give me a second look. I 
want to try to look as normal as possible.cancer doesn't give you two 
heads' (Susan; Interview 1; Lines 220-231). 
Susan's quotation demonstrates the issues associated with wearing a wig and 
the importance of normalising appearances to avoid the stigma of cancer. This 
conclusion was additionally reached by Hansen (2007) who argued that the use 
of wigs and make-up to suppress iconic cultural references to hair loss and 
attempt to regain womanhood is a means of regulating the body. Louise 
explicitly referred to the influence of managing her appearance on her sense of 
self. 
'Once I put the wig on.it seems to take a long time but it probably isn't, 
combing it and everything. It feels really at first as if you're wearing a hat 
but once you forget about that, it just feels like normal hair. When I put 
that on I feel as though I'm back to my normal self' (Louise; Interview 2; 
Lines 213-216). 
Wigs were seen to engender confidence in continuing with everyday activities 
as illustrated in the following quotations. 
'I've got a great wig and I think that's helped me such a lot. Erm.some 
of my friends have even said well I like your hair in that style and I've had 
to say to them well it's a wig you know, so I've had a lot of confidence in 
wearing the wig' (Joan; Interview 1; Lines 133-136). 
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Joan additionally provides support for the notion of disclosing information 
regarding hair loss yet this was only undertaken when women felt confident in 
wearing their wig. Moreover, Louise's forthcoming comment represents several 
women for whom location, most notably being inside the home, was the sole 
place they felt comfortable enough to minimise dressing the head. 
'The wig.. .everyone says I look better than with my own hair (laughing), I 
look younger.so I'm not frightened of going out and then when I'm in 
the house I can wear my scarf and I'm comfortable' (Louise; Interview 2; 
Lines 22-25). 
Mary, who in terms of the women interviewed for this study, reported a unique 
experience in that a negative association was made between her newly 
acquired wig and undergoing chemotherapy. 
'When I went to the wig clinic I was very anxious about going but again I 
had a lovely experience, the lady was lovely and I come out laughing and 
I felt brilliant. I came home and I put this wig on and I went to see my son 
and I had the box and I sat in his house for an hour and he didn't know I 
was wearing this wig. He said to me "is that the wig in the box?" and I 
said "no, it's on my head" and he didn't even know, so that gave me a 
real boost. It is a fantastic wig but the day I went for my first chemo and 
like I say I felt so frightened and I was feeling sick and I was anxious and 
I met a lady and her mother-in-law and they were lovely, the pair of them, 
and that lady had a very similar wig on to mine and all I can do is relate 
that wig to that day. I've never took it out the box since and I hope I never 
have to because all I can relate it to is the day that made me feel so sick' 
(Mary; Interview 1; Lines 270-282). 
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As a result of this experience Mary purchased both hats and scarves however 
she perceived wearing scarves on the head as an external indicator of illness 
which left her vulnerable to being stigmatised and labelled a cancer patient. 
'Hats, yes. I went to the erm.I've forgotten what they call it now.the 
Head Strong clinic and they showed me how to tie the scarves and I 
bought some scarves. I haven't even worn them because that makes it 
look obvious. They're still in the bag as well, next to the wig' (Mary; 
Interview 1; Lines 288-291). 
As undertaken by Hansen the experiences of women discussed in this theme 
can be applied to Foucault's (1988) technologies of the self and technologies of 
power. The former concept refers to the coping strategies adopted by individual 
women with the goal of changing or transforming herself while the associated 
term 'technologies of power' can be considered to be mechanisms and 
initiatives incorporated at organisational level with the aim of targeting 
individuals and regulating the body, such as the NHS provision of free wigs. 
While Hansen's research is specific to hair loss the themes of this chapter 
demonstrate that the process of regulating bodies is also undertaken in relation 
to breast surgery and accordingly the conceptualisation of Foucault's 
technologies of the self can be applied more broadly to women's experiences of 
the changed body. Again, as in Hansen's study women here were not found to 
be passive recipients of technologies of power, whether for breast prosthesis or 
wig provision, but rather developed a range of coping strategies for different 
aspects of bodily changes. Moreover, these women manipulated the forms of 
power designed to regulate the body to suit their personal preferences in the 
longer term. The knowledge that hair loss was a temporary issue helped the 
study participants to cope with this element of their experience. 
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'It was a bit of a shock at first but you get used to it and you know it is 
going to grow again, you know when the treatment finishes' (Louise; 
Interview 2; Lines 21-22). 
As has been demonstrated in the first part of this chapter the participants 
experienced a variety of treatment-induced side-effects from chemotherapy and 
other non-surgical interventions. The following theme reports the use of 
complementary therapies to manage the physical and emotional side-effects of 
breast cancer treatment. 
6.10 Complementary medicine and bodily symptom management 
Access to the holistic centre offering a range of therapies including 
acupuncture, Reiki, reflexology, and herbal remedies, was offered to all women 
attending the oncology unit. The oncologist recommended the centre to a small 
number of women in this sample to aid the management of treatment side-
effects. Women who did take up this option frequently did so for the remainder 
of the data collection period, beyond adjuvant treatment completion. Amanda's 
rationale for seeking holistic therapies was to avoid taking additional drug 
treatments. 
'I would prefer mind over matter than pumping a system that was already 
overloaded with drugs' (Amanda; Interview 1; Lines 344-348). 
Complementary therapies were used by these women not only for direct 
symptom management but also for psychological support following treatment 
side-effects. 
'I've been going to the holistic centre and I had Reiki and I found that was 
marvellous. I mean I wasn't sleeping very well and after the treatment I 
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had a good night's sleep and each time I was going as soon as I got 
home I felt relaxed and my sleep pattern has got back to normal. I've 
also been going for the Bach's treatment, you know, the droplets and I'm 
still going for that because that's for sort of.confidence building and 
anxiety' (Louise; Interview 3; Lines 6-12). 
A recent best evidence synthesis examining the effectiveness of biofield 
therapies including Reiki and therapeutic touch identified only eight such studies 
in relation to cancer (Jain & Mills, 2010). The authors report moderate evidence 
for positive effects on acute cancer pain and conflicting evidence for longer-term 
pain, physiological indicators of relaxation, cancer-related fatigue and quality of 
life. However, the studies were heterogeneous in terms of types of cancer, 
therapy used and outcome measures under investigation. A paucity of research 
examining the effectiveness of alternative and complementary therapies in 
supporting the physical and psychological recovery of breast cancer patients is 
strikingly evident. Nevertheless, women in the present study spoke favourably 
of engaging in complementary therapies with Ellen opting for acupuncture to aid 
relaxation. 
'I have to admit I went in probably the most sceptical of all the people 
that go there (both laughing) but it's brilliant. It hurts when they go in, I do 
find it painful when they go in and sometimes I get a sore ear for a day or 
two afterwards but the relaxation.something's working' (Ellen; Interview 
3; Lines 299-303). 
Amanda initially tried acupuncture to aid chemotherapy-induced nausea 
symptoms and the following extract highlights the perceived importance she 
placed on this therapy in helping her to cope with this aspect of her experience. 
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Given this success Amanda once again sought out acupuncture when 
experiencing vasomotor symptoms as a result of taking Tamoxifen. 
'The first one was really, really nasty because I was sickly but on the 
second one I went to see the oncologist and told her that I was really sick 
with the first one and she recommended acupuncture at the holistic 
cancer care centre. If I hadn't have had that I don't think I would have 
coped really because every Tuesday come rain or shine I went for 
acupuncture and she's (holistic therapist) been absolutely fabulous. I 
mean it worked for me. It might not work for everyone but it did for me, 
fabulous and she's now helping me with the hot flushes' (Amanda; 
Interview 1; Lines 121-128). 
A randomised trial evaluating the effect of applied relaxation and electro-
acupuncture in breast cancer treated women found both therapies to have a 
positive effect on vasomotor symptoms with significant reductions in hot flushes 
and improvements in psychological well-being (Nedstrand, Wyon, Hammar & 
Wijma, 2006). Despite having completed medical treatment regimes, these 
women's longitudinal use of complementary therapies may have served as a 
reminder of their breast cancer diagnosis. Participants experiences of the body 
acting as such as reminder is discussed in the subsequent theme. 
Part 3 - Perceptions and management 
This final part of the chapter brings together the participants' perceptions of the 
body and their strategies for managing appearances by arguing that these 
elements of women's experience constitute a permanent reminder of breast 
cancer. 
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6.11 The body as a permanent reminder 
Supporting empirical research evidence for this theme is somewhat limited 
perhaps as women's longitudinal perspectives of the impact of breast cancer 
are rarely the focus of attention. Nevertheless, the women interviewed for this 
study frequently referred to the body as a reminder of breast cancer as while 
they tried to disguise breast surgery inevitably when dressing/undressing and 
bathing the changed body became visible. 
'When I look in the mirror I.when I get up on a morning and I get 
dressed I forget about it all day.well most of the time.it's not until it 
comes to a night time when I get undressed and go in the bath or the 
shower and then it's sort of like.it's there again' (Gillian; Interview 1; 
Lines 183-186). 
Previous research has indicated that the body becomes a permanent reminder 
of the body's failings (Lindwall & Bergbom, 2009), the unpredictable nature of 
the body, fear of recurrence and death (e.g. Crouch & McKenzie, 2000). 
Women's accounts did not explicitly support these findings though conceivably 
given the cancer schemas identified (discussed in the previous chapter) and 
persistent concerns regarding recurrence (discussed in the following chapter) 
such conclusions could be drawn. However, women's explanations tended to be 
more positive highlighting how with time scars were fading which facilitated an 
increase in confidence in their body. 
'I don't feel so bad about it now.the scar is still noticeable but it is 
starting to go invisible. So probably by the time I go on my holidays next 
year I won't feel so self-conscious' (Margaret; Interview 2; Lines 167-
169). 
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Furthermore, in symbolising the completion of breast surgery scars were viewed 
as enabling a smooth transition to the next stage in the treatment plan. 
'I mean okay there will be a constant reminder there with the scar but 
everything has healed up fabulously so I could go on with the next step 
of the treatment' (Amanda; Interview 1; Lines 287-289). 
McCann and colleagues (2010) describe how physical scars meant that breast 
cancer had an ongoing effect on women's lives though the quotation below from 
Laura's second interview illustrates how for some women scars were a 
reminder of having had breast cancer. 
'I think it makes, well it makes me think that well that scar's there but the 
cancer isn't' (Laura; Interview 2; Lines 240-241). 
The following quotation from Lily does nevertheless highlight that for some 
women the changed body was anticipated to have a lasting effect on their lives 
though as reported by Roberts and colleagues (2003) integral to this was 
women's process of managing appearances particularly through the use of 
breast prostheses in the long-term. 
'Not forget it completely because I have to put this false boob in every 
morning, which is quite a job in itself (laughing). I'm sure it will just 
become a habit eventually. I am conscious that it is an ugly scar but no 
one else will be looking at it and I won't be wearing a bikini ever again 
(laughing). Nobody can see you've had anything done' (Lily; Interview 2; 
Lines 82-86). 
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The ongoing nature of medical regimes such as Tamoxifen and having to "treat" 
the body on a daily basis was a further reminder of participants' experiences so 
far. 
'Tamoxifen's nasty.so every morning I've got to get up and swallow that 
Tamoxifen and have got to look at the fact that this is what's happened' 
(Ellen; Interview 3; Lines 95-97). 
Similarly, Pauline reported: 
'Most of the time I can forget about it and it doesn't enter my head at all 
but occasionally on a morning when I'm taking my pill.it's a constant 
reminder' (Interview 3; Lines 62-64). 
The continuing side-effects of hormonal therapy were also reported by McCann 
and colleagues (2010) as making it difficult for women to see an end to their 
experience of breast cancer. As demonstrated throughout this chapter 
participants experienced a heightened awareness of their body and external 
appearance which elicited a variety of responses and coping strategies. 
6.12 Chapter summary 
In accordance with Frank's (1991) narrative type of the mirroring body this 
chapter suggests that the study participants attempted to re-create an image 
commensurate with an ideal "healthy" and "whole" body. This began at the point 
at which each individual woman perceived bodily changes to portray an 
unhealthy body and was exacerbated when adjuvant therapies were underway. 
Frank purports that with visual image being of such importance disfigurement is 
feared and predictability sought through normalising appearance. This is largely 
supported by the present research as all women engaged in problem-focused 
253 
active coping strategies (Lazarus & Folkman, 1984) to reduce the effects of 
breast surgery and adjuvant therapies throughout the study timeframe. 
However, while Frank considers the desires of this body-self to be monadic 
women in this study did not want to manage bodily appearances solely for 
themselves but for the protection of others. Moreover, the individual differences 
in women's acceptance of and responses to breast and hair loss evidenced 
throughout this chapter implies variation in the extent to which women adhere to 
Frank's notion of the mirroring body. As identified in the previous chapter the 
women interviewed typically displayed the characteristics of the disciplined 
body-self via medicalisation and pursuit of wellness through medical regimes. 
Accordingly, women may manifest differing body-self types at different stages in 
their illness or even simultaneously with variation arising given context, for 
example location (e.g. home or hospital) and social influence. 
As concluded in a prior review (Al Azri et al., 2009) issues pertaining to body 
image were present in participants' accounts of their experience and while 
chemotherapy-induced alopecia was a temporary problem these women 
continued to manage their appearance throughout the year following diagnosis 
and intended to do so indefinitely. Women's process of coping with a change to 
their sense of self as a result of altered body image (e.g. Beatty et al., 2008) 
can be considered in relation to Morse's (1997) model of the development of a 
new self-concept (described in Chapter 2, p. 50). The primary stages of the 
model propose that the acute illness phase overshadows identity change. 
Women did indeed focus discussions in their first interviews on medical aspects 
of their illness and treatment yet began to experience a changed body 
immediately post-surgery. Morse's third stage describes how individuals are 
forced to recognise physical changes and begin attempts to restore functioning. 
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Taken in a literal sense this level of the model is perhaps not apt in the case of 
breast cancer as breast (or partial) loss is immediate at surgical intervention 
and women can do little else but recognise the occurrence of hair loss. The 
implication in Morse's model is for a strive for full restoration yet in relation to 
breast loss few women interviewed for this study took up the option of breast 
reconstructive surgery. That said, the study participants did attempt to restore 
outward appearances through external breast prostheses and for some women 
on a temporary basis wigs and other headwear, though this did not necessarily 
take place at the same point at which 'recognition' occurred. 
Morse's subsequent stage termed 'striving to restore self' would seem more 
akin to participants' attempts to normalise appearances and again while grief 
and mourning for the loss of their former body was experienced this was 
demonstrated immediately post body change and throughout these women's 
experiences even when restoration was underway. Morse argues that some 
individuals will still strive for complete physical recovery and women frequently 
do so in relation to regaining normality in terms of everyday tasks (as discussed 
in the previous chapter) and the normalising of appearances though rarely seek 
more permanent solutions (breast reconstruction). The final stage of the model 
focuses on acceptance and learning to live with the altered self. Although the 
study participants did come to accept their changed body this did not mean that 
they did not continue to feel the impact of their altered appearance and bodily 
limitations due to treatment side-effects given the long-term need to manage 
appearances, even if for some women over time it becomes situation specific. 
The subsequent chapter illustrates participants' emotional journey throughout 
the year post diagnosis focusing on the psychological effects brought about by 
breast cancer and associated treatment. 
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CHAPTER 7: THE MIND 
7.1 Introduction 
Participants' reflections on their experience of breast cancer illustrated an 
emotional journey encompassing reactions to loss as has been shown in the 
previous data chapters, in relation to the body, self and control over their lives. 
While these women's experiences were unique some commonalities in their 
psychological responses to breast cancer were evident with some emerging 
themes echoing the stages of loss represented in the models of Engel (1961) 
and Kubler-Ross (1969). Engel (1961) defined grief as a characteristic response 
to loss be it the loss of a person, job, home, body part, or treasured possession. 
His early conceptualisation of grief begins with the individual entering a state of 
shock and disbelief in which denial is a feature as the individual attempts to 
protect themselves from reality. The subsequent stage is marked by developing 
awareness of the loss during which time individuals exhibit the effects of 
sadness, shame, guilt, sense of loss, sleep disturbance and changed appetite 
as well as numerous other psychological effects. The final stage in Engel's 
theory is a prolonged phase of restitution and recovery wherein while mourning 
continues the individual experiences reinvestment in new relationships as the 
trauma of loss is overcome and the individual moves towards an improved state 
of health and well-being. 
In arguably the most renowned model of the emotional processes experienced 
following diagnosis of a terminal illness Kubler-Ross (1969) identified five 
stages characteristic of grief reactions. The model proposes denial as stage one 
followed by anger and subsequently bargaining during which individuals may 
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consider strategies to bring about a longer life. Kubler-Ross argued that 
depression follows wherein an individual may for example ponder on the point 
of continuing to fight, and finally individuals develop an acceptance of their 
illness and upcoming death. However, unlike at the time of Engel's model 
conceptualisation and Kubler-Ross's (1969) publication of 'On death and dying' 
a diagnosis of breast cancer no longer automatically means death. 
This chapter discusses participants' emotional adjustments to breast cancer 
and draws comparisons, where possible, with the models of Engel and Kubler-
Ross. It begins with consideration of acute stress reactions which emerged at 
the time of diagnosis and were displayed in the immediate post-surgical period. 
Participants' search for meaning in relation to their illness is subsequently 
discussed including women's questioning of 'why me?' and facing mortality. The 
chapter continues by reviewing the mental distress these women experienced 
during the mid-point in the year following diagnosis with a focus on depression 
and disorientation and the most common strategies employed to facilitate 
coping including positive cognitive restructuring. The process of resolution 
incorporating participants' changed perspective and personal relationships are 
reported and finally the ongoing psychological impact on these women's lives is 
explored. Accordingly, this chapter commences with a theme depicting women's 
initial stress responses to receiving a diagnosis of breast cancer. 
7.2 Acute stress reactions 
Women's experience of stress was most pronounced in their initial interviews 
conducted during the acute phase of their illness. Such stress reactions to 
diagnosis have been reported by women with breast cancer and associated 
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healthcare professionals (Beatty et al., 2008). Consequently these primary 
reactions constitute the first element in depicting participants' emotional journey. 
In accordance with Frank's (1995) chaos narrative women's stories at this time 
are of "wreckage" and highlight negative psychological reactions grounded in 
the present with a lack of discussion of hope for the future. Several sub-themes 
constitute the theme of acute stress reactions beginning with shock and 
disbelief. 
7.2.1 Shock and disbelief 
Diagnosis resulted in the participants typically entering an 'alarm' stage (Selye, 
1950) and anticipating a breast cancer diagnosis did not minimise the shock 
and disbelief experienced including by those with a history of benign breast 
disease. 
'That was erm.like a punch in the face, a shock. I felt quite sickly, faintly 
and then erm...yeah it was a big shock. You think oh my God its 
happened but in the back of my mind with going back and forward with 
cysts and things you always think this time it might not be or it could 
be.so yeah a big shock' (Janet; Interview 1; Lines 19-22). 
This finding supports that of Lally (2010) who following a grounded theory study 
of 18 women in the United States reported that shock and disbelief occurred at 
diagnosis despite preparedness for this news. Experiencing a lack of symptoms 
that women associated with cancer (cancer schema) and the short timeline from 
referral to diagnosis heightened the shock encountered. 
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'It's such a shock isn't it. You feel so fit, go to the doctors one day and 
the next day they tell you you've got cancer, it's shock isn't it really more 
than anything' (Elizabeth; Interview 1; Lines 142-144). 
In terms of the common-sense model (Leventhal et al., 1980) women's 
formation of illness representations with regards to breast cancer would seem to 
be complicated by their limited somatic symptoms and in some cases history of 
breast disease as benign. Consequently, pre-existing schemas of cancer being 
associated with mortality combined with external information, specifically that 
provided by the breast care team, were of greater influence in determining the 
emotional representation of breast cancer and in turn coping efforts. While 
women were often visibly upset discussing this aspect of their experience for 
one woman humour was used to illustrate her reaction. 
'It's one of those moments where.I don't know.your eyes just, you 
know like the Walkers crisp adverts where the eyes just cry and you can't 
control yourself. It was one of those moments.disbelief (Amanda; 
Interview 1; Lines 35-37). 
Humour has been found to be negatively related to distress pre-surgery, post-
surgery and three months after surgery (Roussi et al., 2007) and was used as a 
coping strategy throughout some women's experiences though Amanda was 
one of the few to adopt this during this early phase. Her quotation also suggests 
a perception of lost emotional control upon diagnosis. 
Echoing the findings of Lally (2010) these women's initial emotions of shock 
dissipated quickly and Lally reports this to be particularly the case for older 
women (aged 78-87 years) and those who had previously experienced a life 
altering event. All of the women who participated in the present study were 
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younger than 70 years at the time of diagnosis however many recalled a history 
of stressful life events which, in addition to the limited timeframe from diagnosis 
to first treatment in this sample may account for this finding. Lally (2010) argues 
that moving on from such reactions enables women to begin to respond 
cognitively to their breast cancer diagnosis. 
Only one woman in the sample did not describe being shocked at receiving the 
diagnosis. Linking with the theme of waiting discussed in chapter 5, Sarah who 
had undergone treatment for breast cancer ten years previously, had been 
expecting to have a recurrence. 
'There was no sense of shock, that was another point, it was almost as if, 
I almost sensed that this would happen, looking at the histories and at 
some stage I knew I would have a re-occurrence' (Sarah; Interview 1; 
Lines 68-71). 
Consequently for Sarah acceptance was instantaneous and denial did not 
feature in her account of her experience. The following sub-theme considers 
participants' experiences of denial and acceptance and highlights the 
complexity and inter-relationships between these notions when applied to 
breast cancer. 
7.2.2 Denial versus acceptance 
Denial and acceptance are argued to have become a 'legitimate' marker in 
understanding responses to chronic illness (Telford, Kralik & Koch, 2006). For 
Kubler-Ross (1969) denial denoted the first stage in her grief model and like 
acceptance was viewed as a distinct stage. Engel (1961) conceptualised denial 
as being an integral component of shock and disbelief with acceptance 
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following over an extended period of time interlinked with a multitude of 
emotions. However, when analysing participants' accounts in relation to breast 
cancer denial and acceptance were found to be two extremes on the same 
continuum. 
On denial, Kubler-Ross (1969) documented: "Denial, at least partial denial, is 
used by almost all patients...and functions as a buffer after unexpected or 
shocking news, allows the patient to collect himself, and with time, mobilize 
other, less radical defences" (1969; p.52). One could argue that those women 
who delayed help-seeking after identification of a breast symptom, as identified 
in chapter 5, may have been in a state of denial. However, participants' 
depiction of monitoring their symptoms, consciously waiting to seek help and 
uncertainty as to the presence of breast cancer suggests otherwise. On the 
surface denial did nevertheless seem to be present in the accounts of a minority 
of women when reflecting on receiving their diagnosis as illustrated in the below 
extract from Laura's first interview. 
'There was a little lady in the room opposite and I just looked at her and I 
thought she's picked her notes up, they're not mine. I went to the toilets 
and I was crying in the toilet and I thought now she's gonna tell me she's 
got the wrong notes.but obviously I suppose everyone thinks that, or 
hopes that don't they' (Laura; Interview 1; Lines 40-44). 
The use of denial pre-breast cancer surgery has been suggested to be an 
effective defensive strategy aiding women's coping with the stress of requiring 
major surgery (Jelicic, Bonke & Millar, 1993). The following quotation from Mary 
is also suggestive of denial at the point of diagnosis and during the initial weeks 
post diagnosis though illustrates the conflict in women's reactions. While Mary 
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exhibited denial in being unable to accept the breast cancer diagnosis she 
simultaneously described believing healthcare professionals, which may relate 
to prior discussions regarding trust in medical opinions. 
'I think.I probably just.was in shock. You're taking it in, I believed what 
they were saying but didn't believe what they were saying. It's funny 
really I still think I view this as if I'm on the outside looking in. I still don't 
really believe this has happened to me' (Mary; Interview 1; Lines 35-38). 
Denial may be viewed as a means of emotion-focused coping (Lazarus & 
Folkman, 1984) and in accordance with the theory of Folkman and colleagues 
(1979) this form of coping "fits" with breast cancer given its uncontrollable 
nature. Moreover, denial is believed to hinder acceptance of illness 
(Pennebaker, 1997) and is associated with general distress in women with 
breast cancer (e.g. Stanton et al., 2002). Nonetheless, women in the current 
research did not exhibit denial per se beyond the acute phase of their illness as 
they acknowledged having breast cancer and requiring treatment for the 
disease. This may be explained via the diagnostic process and treatment 
planning being typically undertaken on the same day with surgical intervention 
following within a week, and thereby the timeframe for being in a state of denial 
was limited. In the case of early-stage breast cancer the findings from this study 
suggest that the positive benefits of denial in terms of a buffer effect are 
consequently short-lived. The influence of taking part in this research study on 
women's state of denial is also unknown. As noted by Pennebaker, Zech and 
Rime (2001) writing and talking about a traumatic event may oppose denial by 
encouraging emotional processing, in this case, of the trauma of breast cancer. 
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Participants frequently exhibited avoidance rather than denial citing a "knowing" 
that their breast symptom was cancerous. 
'I think you feel as if you've been hit by a train. All you want him 
(Consultant) to do is say it's not cancer but at the back of your mind you 
know it's going to be. You just want him to tell you that it isn't' (Joan; 
Interview 1; Lines 45-47). 
These women often made reference to cues to such awareness. 
'They don't ring you at home and ask you come in for nothing do they? I 
think that was a bit of a giveaway. So, although I was in shock a bit of me 
knew' (Laura; Interview 1; Lines 32-33). 
Accordingly, despite a prevailing hope that breast cancer would not be 
diagnosed an element of acceptance was common even at this early stage 
perhaps stemming from having self-identified the change in breast tissue. 
Acceptance, for Louise, was an automatic process as she did not perceive a 
choice in doing so. 
'To me cancer was just a word. I'm just accepting it. I'm not really 
worried. When you go and speak to the doctors and they're telling you 
everything.and its only when you come home and you're on your own 
you sort of think ooohhhh. I mean what can you do, you just have to 
accept it and hope that the treatment cures everything and then if it 
comes back, it comes back' (Louise; Interview 1; Lines 137-142). 
While research findings suggest that acceptance at diagnosis is negatively 
related to distress three months later (Roussi et al., 2007) and up to one year 
post diagnosis (Stanton et al., 2002) this would seem to be specific to active 
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acceptance with associated emotion-focused coping. Women who exhibit 
passive acceptance at diagnosis, as demonstrated in Louise's quotation, have 
been found to be at significant risk of poor long-term psychological adjustment 
(Hack & Degner, 2004) and Louise did subsequently develop anxiety and 
confidence issues. 
Other participants described acceptance as emerging a few weeks post 
diagnosis and seemed to indicate that this followed denial. However, as 
illustrated in the subsequent extract some women perceived acceptance to be 
signified by informing acquaintances of their diagnosis and saying "breast 
cancer" aloud even when their accounts of their experiences indicated private 
acceptance had already occurred. 
'It's taken me a long time to even admit that I've got it. One of the girls at 
school said oh how are you, are you alright and one of the other girls 
said oh have you been poorly and I said yeah I've had breast cancer. 
Then I though eehh I've said it, a couple of months down the line, and it 
was the first time I'd said it...maybe it was acceptance. It was a really big 
thing for me, it's real now, I had it' (Laura; Interview 1; Lines 345-350). 
The accounts of those women who participated in the present study suggest a 
far-reaching influence of family, friends, acquaintances, and healthcare 
professionals in shaping their experiences. The following sub-theme illustrates 
this impact of others and women's attempts to protect loved ones from the 
stress of a breast cancer diagnosis and treatment. 
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7.2.3 Protective buffering 
While participants made efforts to cope with the shock they were experiencing 
they simultaneously implemented strategies to minimise eliciting shock in those 
closest to them. Hiding concerns through protective buffering has been 
associated with female cancer patient's distress (Manne, Dougherty, Veach & 
Kless, 1999) yet as in previous research (e.g. Arman et al., 2002) was 
commonplace for women interviewed for the current study. 
'I think you're sort of brave for everybody else. I had to tell my son, I've 
only got one son and I had to tell him and of course he was devastated 
and I said look I'm gonna be fine and I put a front on. I had to go and tell 
my dad, who's getting on in his years and you don't really wanna tell your 
dad things like that and so you put a brave face on for everybody' (Mary; 
Interview 1; Lines 161-165). 
Research indicates that women may conceal feelings and emotional distress to 
avoid changes in routine patterns of life and uphold a sense of normality (Beatty 
et al., 2008). Furthermore, in line with the suggestion of Clarke and James 
(2003) participants may have perceived social pressures to be heroic and cope 
so as not to be a burden on others. This may be particularly relevant in relation 
to breast cancer given the positivity associated with survivors of the disease 
(e.g. Broom, 2001; Farrell Yelland, 2000) which may have led these women to 
make attempts to be strong and develop beyond their former self. Disguising 
one's emotions was often undertaken consciously however, Ellen reflected on 
receiving less empathy from her family following her breast cancer diagnosis 
compared to previously undergoing a bilateral mastectomy due to a high risk 
genetic predisposition. 
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'I'm very aware that my family kind of think, oh she's done this before so 
she'll be alright. So, if I am quiet or I am a bit lost in it they tend to want to 
just jolly me along. So, I've got to put on kind of a front on it as well, I've 
got to be happy' (Ellen; Interview 1; Lines 275-279). 
Women's suffering has been suggested to increase when it is concealed for 
example to protect others (Arman et al., 2002) and can lead to some women, 
such as Ellen, suffering in silence. 
'I've held an awful lot back, I've bottled an awful lot up because I haven't 
had that place to go' (Ellen; Interview 3; Lines 130-131). 
In conveying their diagnosis to others these women in turn experienced shock 
reactions directed towards themselves. 
'When I went into work and saw all my friends at work and told them that 
I was gonna go back in and they were crying and I was saying, "look, I'm 
fine, don't cry" and I ended up comforting them...and I didn't like that bit, 
I didn't like shocking people and upsetting people' (Mary; Interview 1; 
Lines 172-175). 
This was identified as being difficult and distressing which may be explained by 
the 'looking-glass self' hypotheses which denotes that we understand ourselves 
by understanding others' reactions to us (Cooley, 1902 as cited in Else-Quest et 
al., 2009). Cooley argued that the self-consciousness that results from 
continually monitoring the self from the perspective of others leads individuals to 
experience either pride or shame. Women's cancer schema as discussed 
previously may suggest that in seeing the reactions of others women are forced 
to consider their own perceptions of breast cancer relating to, for example, 
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mortality and stigma, which in turn leads to stress and anxiety. Yet, contrary to 
the monitor-blunter hypothesis as distinct personality traits (e.g. Miller, 1987), 
previously discussed in chapter 5, while participants demonstrated monitoring 
information pertaining to the reactions of, for example, close relatives and 
friends, they subsequently enacted blunted responses frequently avoiding 
informing others outside of their immediate social circle about their diagnosis. 
'I didn't tell many people I was going, because if people start with the "oh 
are you alright" and all this it upsets you' (Linda; Interview 1; Lines 84-
85). 
This finding supports those indicating that women actively avoid people who 
increase their anxiety and vulnerability via too much compassion as pity from 
others led to a feeling of being seriously ill (Drageset et al., 2009; Doumit et al., 
2010). The topic of avoidance as demonstrated in this theme has however been 
linked to higher levels of anxiety and depression and may influence women's 
coping strategies (Donovan-Kicken & Caughlin, 2011). The complex nature of 
women's relationships with others following a breast cancer diagnosis was also 
discussed by Bertero and Wilmoth (2007) in relation to attachment validation. 
They reported that women sought validation from their family and wanted to be 
truthful yet simultaneously tried to protect others. However, in doing so they 
perceived a lack of understanding from their family about their experience. 
Corroborating these findings the present study has found that protective 
buffering and topic avoidance are additionally undertaken by women's family 
and friends. 
'Well my close friend.as soon as I came out of hospital she was there 
and asking if she could do anything and she's remained constant but a 
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couple of other friends either try to wrap me up in cotton wool and won't 
let me lift anything or they just.won't talk about clothes, or anything they 
think might upset me... and I feel uncomfortable with them because of 
their reaction to me. I've said a couple of times look I'm fine, I'm still me, 
there's just a bit missing that's all but they've had great difficulty 
accepting it and my husband as well. On the up side he looks the same 
but he tends to "oh don't lift that, don't do that" and I could scream 
sometimes' (Pauline; Interview 2; Lines 85-97). 
Accordingly, the study participants perceived acceptance as not being restricted 
to themselves highlighting that those close to them seemed to struggle for a 
longer period of time to accept the changes brought about by breast cancer. 
The reactions of others elicited anger in a minority of participants who thereby 
conformed to Kubler-Ross' second stage of grief. Corresponding to Frank's 
(1991) notion of the dominating body which is defined by force sees individuals 
dissociating from their bodies but being linked to others through the 
displacement of anger against contingency, these women's target was most 
frequently loved ones. Specifically anger emerged when re-negotiating roles 
and working towards acknowledging physical limitations. In their efforts to be 
sensitive to women's needs family members and in particular spouses were 
often perceived to be a hindrance and participants found others taking on roles 
associated with their identity difficult. 
'I don't mean to be nasty but they tended to.you know what I'm trying to 
say and actually I did say I'm not an invalid please don't treat me as one, 
don't smother me, let me find my own way through it. There's times they 
would say sit down and stop doing things but that's not my way, I'm not 
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that type, I need to be doing things. Obviously I'm not going to be running 
in any Olympics I still need to try to keep a norm. I had to take it steady 
at first because of the wound and my arm but when I'm top I'm able to 
hoover and when I can do it I want to do it. That's what you've got to 
work out' (Maria; Interview 1; Lines 266-274). 
It is possible that these women's desire for normality and specifically to 
undertake tasks around the home represented efforts to engage in self-
distraction as a means to regulate distress during the acute illness/treatment 
phase. Post-surgery self-distraction has been shown to predict lower distress 
three months later (Roussi et al., 2007). However, in developing negative 
feelings towards others some women interviewed expressed feeling saddened 
as demonstrated below. 
'Just silly little things you know like.I've got a dishwasher but he'd wash 
the pots. You know I used to think oh my God why are you doing that. 
Stupid little things but it got to the point, I don't think he knows but I 
couldn't stand him round me. We've been married for forty two years, I've 
known him since I was eleven and I've never ever felt like that so.that 
was upsetting me as well you know. I still get a little bit choked up when I 
talk about it because I know I was being horrible and he was only trying 
to be so kind but I couldn't cope with it' (Margaret; Interview 2; Lines 50-
57). 
This theme has demonstrated that participants' stress reactions during the 
acute phase of their illness experience included shock and disbelief, and for 
some women avoidance and/or denial, albeit for a limited time. Individual 
differences were evident in relation to acceptance however while women 
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themselves accepted their diagnosis they often perceived those close to them 
to be experiencing difficulties in doing so. Protective buffering and topic 
avoidance were used by the study participants to shield others from their 
emotional status yet these women also experienced these forms of coping 
directed towards themselves, which occasionally resulted in reactions of anger. 
Participants' expressions of anger were often underpinned by a period of 
reflection on having breast cancer between interviews one and two in which 
women considered existential issues. It is this search for meaning that 
comprises the following theme. 
7.3 Search for meaning - existential concerns 
Experiencing existential concerns regarding the meaning of life and facing 
mortality is widely reported in the literature (e.g. Arman et al., 2002) and the 
present study supports such findings though goes beyond existing 
understanding by providing an in-depth insight into these issues and the timings 
of their emergence. Consequently this theme has been separated into two sub-
themes, facing mortality and the following sub-theme, 'why me?' 
7.3.1 Why me? 
In assessing women's efforts to make sense of or find meaning for their illness 
Kernan and Lepore (2009) surveyed seventy two women at multiple time points 
during the 18 months after breast cancer treatment. Four patterns depicting the 
search for meaning were identified comprising continuous (44%), exiguous 
(28%), delayed (15%) and resolved (13%). The results showed no significant 
concurrent or longitudinal associations between searching for meaning and 
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made meaning (i.e. finding answers), suggesting that for the majority of women 
searching for meaning was futile. However, meaning variables were assessed 
on average 11 months post diagnosis at which point women may have already 
searched for meaning. This research study was further limited by the ethnic 
homogeneity of the sample and relatively small sample size. Debating "why 
me?" and re-assessing their sense of being in relation to others suggests that 
women perceived themselves differently to before their cancer diagnosis. The 
following quotation from Laura's first interview provides qualitative support for 
women's search for meaning. However, it illustrates that this search begins in 
the acute illness phase and was expected to continue throughout Laura's life as 
'why me' was perceived to constitute an unanswerable question. 
'I don't know if everybody says this, but its why me. That's the question. I 
went out with some girls the other night and there was 15 girls and.I 
didn't actually go out, I went down to give her a card.I just sat and 
thought why me, out of everybody. Not that I would wish it on anybody, I 
don't, but just why me. I think that question will bug me forever. I'll always 
ask that and I don't know why I bother myself with the question because 
you never get an answer. It's something I'll never get an answer to. I've 
just got to get it into my head that it's just one of them things and that's it' 
(Laura; Interview 1; Lines 254-261). 
Trying to avoid considering "why me" and minimising negative emotions was 
described by Ellen as a means to protect others and was achieved through 
attempts to maintain a sense of normality. 
P: 'I think there was a chance that I could have just sunk into self-pity. I 
could have just sat down and gone why me, it's not fair, why do I have to 
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have this, I thought I'd been there. I needed to kick against that. I needed 
not to allow myself to go there because that looked really.it looked 
more scary than going back to work'. 
I: 'In what way?' 
P: 'It looked like a pit that I might fall into and not be able to get back out 
of. I'm a mother of four children, I'm the one that copes with everything. It 
wasn't for me to fall into that pit and wallow in that black mist so having to 
concentrate on something else, having to get up, having to go, having to 
keep going, putting that normality back into my life' (Ellen; Interview 2; 
Lines 254-266). 
As discussed by Lally (2010) in relation to the period between diagnosis and 
first treatment such avoidance of introspection may also serve as a self-
protecting strategy to maintain women's self-integrity though as evidenced in 
the current study is not limited to the pre-treatment phase. A prolonged period 
of reflection and debating "why me" was typically linked to participants 
contemplating the uncertainty (discussed as part of the final theme in this 
chapter) brought into their lives by breast cancer and gaining awareness of their 
mortality. 
7.3.2 Facing mortality 
Contemplating their mortality was pivotal in women's discussions of their 
emotional journey, was noted from the first interviews and continued throughout 
the reflections on their experiences. 
'I feel, I mean you go through days when you do feel really positive, you 
know I've got to get over it, I've got two kids, I've got to get over it. Then 
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you'll hear on the news that somebody's recently died of it, or whatever, 
and that really frightens you. It seems to knock you back a bit that.but 
then the breast care nurse said that for every one you hear on the telly 
that's died, there's thousands and thousands that haven't and obviously 
bad news travels better doesn't it' (Laura; Interview 1; Lines 148-154). 
Indeed, while the majority of participants reported immediate fears of death, 
aligned with their cancer schemas, they simultaneously implemented coping 
mechanisms to manage death anxiety which supported a life view with hope. 
This supports the proposition of Lazarus (1999) who argued that hope and fear 
are intertwined and future-oriented. 
Learning of the death of other individuals to breast cancer via the media 
increased participants' anxiety yet rationalising such loss by reflecting on 
improvements in treatment regimes and knowledge of other breast cancer 
survivors facilitated coping. 
'You meet people and they say 'I had it twenty five years ago' and you 
know things have improved massively in that time and things are getting 
better and better. This woman I know who's had it twenty-five years, she 
goes swimming with the kids, and she wasn't given radiotherapy and 
chemotherapy then because it wasn't given as a matter of course and 
she's fine, so I should be fine' (Laura; Interview 1; Lines 162-167). 
A frequent reaction by women in the current study supports a strategy of 
avoidance, also noted by Drageset and colleagues (2009), with women making 
concerted attempts to avoid thinking about mortality and the possibility of not 
being cancer free. Cognitive avoidance coping style prospectively predicts 
emotional distress (e.g. Stanton & Snider, 1993) though rather than being a 
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negative coping strategy such avoidance seemed to enable these women to 
minimise distress and facilitated positivity and cognitive restructuring. 
'I think the experience of the cancer itself is frightening because you 
don't know whether it's gone and they can't give you a test to say it's 
gone to anywhere else. So, that's frightening, has it gone somewhere, 
am I gonna be here tomorrow, that has crossed my mind and then I've 
wiped it out because I don't want to think that way. The experience of all 
the treatment I actually can't fault any department at all, wonderful, the 
staff have been so supportive, fabulous. It is scary to think that there's 
something there. Hopefully they've got it all. I try not to think what if. I've 
got too much to do, too much to do, too much to see. I like hoovering 
(laughing).actually it's the only thing that's made me feel better, getting 
the hoover out' (Amanda; Interview 1; Lines 256-265). 
The above quotation further illustrates how the study participants emphasised 
the expertise and support provided by the healthcare professionals involved in 
their care and how women resorted to the everyday activities undertaken prior 
to diagnosis in order to elicit coping with the difficulties of their experience. It is 
also plausible that to some degree these women's avoidance may be influenced 
by the lack of symptoms experienced prior to diagnosis. 
'I think when I look back now.at the time I couldn't see that but now I 
can see that if I hadn't had it done (breast surgery) I might not have been 
here in five years time. It's quite frightening to think that you've got 
something growing in your body and you feel fit and healthy and it's hard 
to get your head round the fact that it could kill you' (Gillian; Interview 1; 
Lines 360-364). 
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As a consequence of feeling healthy many participants struggled to face 
mortality issues. 
'I don't dwell on.well I try not to dwell on.like if you die, I try not think 
about that. At the moment I think I feel well, I haven't got it so just get on 
with life. I mean I've said this all along, you can't change it. It's happened 
and you can't change it so you've just got to move along with it' (Mary; 
Interview 2; Lines 150-154). 
In addition to women's desire to be happy a belief in fate or a higher power was 
among the multiple strategies participants utilised to manage death anxiety. 
'Maybe I could've died with it and who's to say it's not gonna come back 
but it doesn't do well to dwell on that because the days I do dwell on it, 
I'm very, very miserable and I don't want to be miserable. I don't want to 
be unhappy so I just try to take things as they come and I believe that 
what will be will be and I think well there must have been somebody up 
there looking after me to send me for that mammogram' (Margaret; 
Interview 1; Lines 152-157). 
While coping through religion is one of the most prevalent strategies reported by 
cancer patients (e.g. Zwingmann et al., 2008) in the sample recruited for the 
present study few women made reference to such coping. Though not explicitly 
stating that 'God' was perceived to be in control of illness and its outcome as 
has been reported elsewhere (e.g. Doumit et al., 2010; Shaw et al., 2007) the 
implication of using prayer to facilitate recovery is suggestive of a role for 'God' 
in explaining breast cancer. Above all the participants faith engendered hope 
which is viewed by some researchers as a coping strategy in itself (e.g. Stanton 
et al., 2002). 
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'I'm on the sick list at church so I've got everybody praying for it' 
(Amanda; Interview 1; Lines 243-244). 
However, such quotations illustrate a sense of having little or no control over 
breast cancer and death and many women interviewed held a fatalistic 
perspective, one that can be likened to an external locus of control. 
'Because of the experiences I've been through before, because I'm a 
fighter, I don't give in. Yes I know it kills people but so does crossing the 
road. I try not to worry about things that I can't totally control and it's 
something that you can't totally control' (Pauline; Interview 1; Lines 320-
323). 
Unrealistic optimism (Weinstein, 1983) was additionally described by several 
participants though the complexity of this strategy is illustrated below. 
'It is a bit frightening because you never think it's gonna happen to you, 
it's always the person next door and not yourself. I still think now well, I'm 
not gonna die with it, I'm sure I'm not going to die with it, it's going to be 
the person next door who does. It will never be me.so I try to think like 
sensibly and try not to worry about it' (Margaret; Interview 1; Lines 161-
165). 
Accordingly, while many participants attempted to distance themselves from 
breast cancer they did not necessarily deny having the disease. 
Research has shown that no matter how positive women try to be, negative 
thoughts often remain and the frightening prospect of metastases and death 
leads some women to mentally prepare for the worst (Drageset et al., 2009). 
According to Folkman and Moskowitz (2004) this can represent future-oriented 
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coping reflecting efforts to save strength to deal with events that will occur with 
certainty. Louise was one of the few women to accept her mortality and 
diagnosis relatively early in her journey. 
'I'm not sort of frightened.it's an awful thing to say but everyone has to 
die at some time and I feel fortunate to have lived this long. I think it's just 
so awful if a young person gets it because they've got all.all their lives 
to think about it coming back but at my age.you've sort of lived your life' 
(Louise; Interview 2; Lines 287-291). 
In doing so some participants such as Rose were able to reflect on their life and 
make changes for the future. 
'It does make you look at life differently and think you're not here forever 
and you've got to make the most of the time you have and enjoy life and 
you also look at death and think yeah I could cope with that. You know 
really, it's an awful thing to say, but you think well I've had a good life and 
I've done this and done that. I mean it would be awful to die now, nobody 
likes the thought of dying but you convince yourself that if that happens it 
won't be such a bad thing really. It's strange really, I suppose you think 
more about the people who are left behind because it's them who have 
to continue on. It certainly makes you look at life' (Rose; Interview 3; 
Lines 55-63). 
In support of a qualitative review (Bertero & Wilmoth, 2007) as participants 
sought meaning in their illness experience an awareness of mortality and fear of 
death often led these women to review their life and re-order life priorities. In 
reflecting on their lives and the ongoing impact of breast cancer beyond the 
acute phase women frequently entered a state of psychological vulnerability 
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and disorientation which was particularly pronounced during interview two and 
which constitutes the next theme in this chapter. 
7.4 Psychosocial distress and coping mechanisms 
The term 'psychosocial distress' was conceived to reflect a broad set of 
concerns and refers to a continuum of responses ranging from feelings of 
sadness and vulnerability to disabling problems such as depression and anxiety 
(National Comprehensive Cancer Network, 2008). As highlighted in chapter 3 
breast cancer can result in a complex array of physical and psychological 
effects including anxiety, depression and decreased functioning which 
negatively impact on women's quality of life (e.g. Al-Azri et al., 2009; Glanz & 
Lerman, 1992; Salonen et al., 2010). Similarly, Chen and Chang (2012) 
reported negative feelings and emotions related to mental distress in a sample 
of Chinese cancer patients from diagnosis to treatment completion. In support 
of these findings and in accordance with Engel's second stage of grief the study 
participants frequently discussed experiencing a range of psychological 
consequences. These included depression, disorientation, and changes to their 
personality, as well as coping through positivity. These reactions, which form 
the sub-themes of this theme of psychological distress and coping mechanisms, 
were predominantly recorded during the second interviews when adjuvant 
treatments were underway. Higher levels of distress have been found in 
patients undergoing a longer course of treatment for breast cancer compared to 
those women who are treated with surgery alone (Tuinman, Gazendam-
Donofrio & Hoekstra-Weebers, 2008). Experiencing difficulties in coping were 
regularly reported though some participants highlighted that for them this did not 
constitute depression. 
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'I had a real period of.not depression but I couldn't cope. I just felt like I 
couldn't cope with anything. If I got the slightest little thing that was a little 
bit of bad news or.sort of oh anything.I just couldn't, I was in floods of 
tears and I just couldn't cope with anything' (Gillian; Interview 2; Lines 
130-134). 
All women exhibited distress post diagnosis though in support of prior research 
findings a subset of women described experiencing depression (Fann et al., 
2008) and this is discussed in the following sub-theme. 
7.4.1 Depression 
Some participants perceived they would experience depression following 
diagnosis, often on the basis of the reactions of others, and made efforts to 
engage anticipatory coping strategies at a very early stage. Linda, for example, 
believed that remaining active and having the support of her husband would be 
protective of her psychological well-being. 
'People kept saying to me you'll be depressed but I haven't really been 
depressed because he (husband) like fetches me out of it. That's not to 
say there aren't little times.with the death of my other husband, which 
was the July and I really felt it then I could have been.but I made myself 
active' (Linda; Interview 1; Lines 204-208). 
However, as formerly identified via numerous studies depression was one 
psychological issue reported by the women interviewed for the present study 
(e.g. Badger et al., 2007; Burgess et al., 2005). The consequences of 
depression post breast cancer diagnosis may extend to mortality as a large 
population based study reported an increased risk of death by five years in 
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women scoring high on depression following diagnosis though this conclusion 
requires caution given small participant numbers (Watson, Haviland, Greer, 
Davidson & Bliss, 1999). Kubler-Ross (1969) proposed depression to be a 
discrete level of her grief model though differentiated between reactive and 
preparatory depression. In the present study reactive depression transpired with 
women's realisation that they had been diagnosed with a serious illness and 
following episodes of change such as breast or hair loss as feelings of 
hopelessness and helplessness emerged with a sense of lost control. Having 
experienced breast cancer previously Sarah had an awareness of the emotional 
reactions to be expected at various points in the healthcare trajectory. 
'Vulnerable. Actually quite fragile psychologically...and physically. I think 
they're both at about the same level out of ten with one being the lowest 
level of fragile I think I'm about a four psychologically and physically 
whereas normally I think I'm up to about a seven or eight. I feel fragile 
and almost aware of the impact on me in terms of erm.reactive 
depression has come on at times but I've been aware of that, just 
reacting to the situation that I'm in. It passes quite quickly, it doesn't stay 
with me' (Sarah; Interview 2; Lines 112-118). 
While for Sarah episodes of depression remained reactionary for several other 
women preparatory depression (Kubler-Ross, 1969) was evident. This 
prolonged period of depression occurred as participants gained a realisation 
that breast cancer and its physical and psychological impact would have a 
prevailing effect on their lives and influence their future through fear and 
uncertainty. A vast body of research (e.g. Badger et al., 2007; Fann et al., 2008) 
has investigated depression following a breast cancer diagnosis though this is 
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dominated by quantitative studies which fail to capture the complexity of this 
emotional response. 
As demonstrated previously Linda actively tried to minimise the likelihood of 
depression shortly after diagnosis and did not perceive herself to be 
experiencing depression at that time. Anxiety and depression scores obtained 
at diagnosis have been found to correlate with such scores 6 months later (e.g. 
Jadoulle et al., 2006) though like other women interviewed for the present study 
Linda was subsequently treated for depression by her GP. 
'Just of late I've been a bit depressed but to be honest I never cried 
even after the operation, never cried because my husband kept me 
going. Then I did a very, very silly thing which I won't do again.I read 
that interview with Darren Clarke, that golfer whose wife died of breast 
cancer. He put in it, it was only a DCIS.well that's what mine was and 
you think uh oh but I went back to the doctors and they put me on, it's 
only 10 milligram of an antidepressant. So I'm feeling better, I'm sure I 
am but I did feel a bit depressed. I just think I'm that kind of 
person.whenever there's trouble I can deal with it but then when it all 
goes quiet, you know.' (Linda; Interview 2; Lines 15-26). 
The use of a longitudinal approach enabled one of the most striking cases 
encompassing depression to be revealed. Emma who above all others can be 
most likened to Frank's (1995) chaos narrative exhibited distress throughout the 
data collection period as living through breast cancer dominated her life. Her 
expectation that symptoms of low mood would decrease upon breast cancer 
treatment completion was unfounded and she experienced great difficulty 
engaging positive coping strategies. 
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'I thought I'd be better when the treatment had finished but I still have a 
lot of bad days' (Emma; Interview 2; Lines 32-33). 
When immobilised by depression images of activity and fitness may become 
guilty reminders of what the person is not accomplishing (Charmaz, 2006) and 
this can be applied to Emma. 
'I used to go (swimming) four times a week and I think that used to keep 
me sorted with me weight and me tummy and everything and so that's all 
to pot. Our mam bought me a bather to go with to wear my false boob 
but I hate it. I'm always worried in case it falls out so I'd rather not go' 
(Emma; Interview 3; Lines 82-86). 
Ironically while she felt able to discuss breast cancer with the researcher she 
ceased counselling finding talking about her experience exacerbated her 
symptoms. Depression remained an issue one year on from diagnosis by which 
point Emma had begun a course of antidepressants perceiving this strategy as 
being under her control. 
'I have been to see a counsellor but I found I want to just put it to the 
back of my head and the counsellor wanted to go over and over it and I 
couldn't handle that, I don't need that so I stopped going. I thought I don't 
need to hear this and so I stopped going. I'd rather deal with this myself. I 
am on antidepressants now' (Emma; Interview 3; Lines 62-66). 
However when questioned about the effectiveness of antidepressants Emma 
commented: 
'I don't think anything helps does it' (Emma; Interview 3; Line 70). 
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In line with the existing literature Emma portrayed several risk factors that are 
believed to account for prolonged depression including younger age (Salonen et 
al., 2009), lack of an intimate confiding relationship, and stressful non-cancer 
life experiences (Burgess et al., 2005). The present study provides qualitative 
support for results indicating that depression may not be associated with 
cancer-related factors (e.g. Bardwell et al., 2006) given the variability in 
diagnosis and treatment regimes of those women affected by depression. 
Moreover, the influence of subjective psychological variables is corroborated as 
evidenced by the extensive stressful life events in the lives of those women 
experiencing depression. It is possible that the period of reflection elicited by 
breast cancer triggered these women to contemplate their lives including 
divorce, bereavement, financial pressures and issues with children. The 
subsequent sub-theme illustrates the disorientation experienced by participants 
including issues of anxiety, nervousness and loss of confidence. 
7.4.2 Disorientation 
Women in the present study considered numerous psychological changes to be 
influential in how they viewed themselves throughout the year following 
diagnosis. Nervousness, loss of confidence and an altered personality featured 
in women's accounts though in accordance with Frank's (1995) chaos narrative 
discussion of these elements lacked structure. Several participants described 
becoming nervous and anxious in social situations which was unlike their 
demeanour prior to breast cancer. 
'I feel like I'm really, really nervous in situations, I'm really.I feel 
uncomfortable in situations, I don't like to be in big crowds, anywhere 
unfamiliar and that's not like me at all. So, yeah it probably has changed 
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me more than I think really. Maybe's it could be the hair thing, I've got no 
eyelashes and things like that, I can't wear any make-up or anything' 
(Laura; Interview 1; Lines 277-281). 
High levels of anxiety following a breast cancer diagnosis are widely reported in 
the literature (e.g. Schnur, Montgomery, Hallquist, Goldfarb, Silverstein & Weltz, 
2008) particularly in those women undergoing chemotherapy (e.g. Browall et al., 
2006). In support of such findings this change was noted most frequently in 
women having chemotherapy though by their final interviews women had 
sought strategies to facilitate coping with the psychological as well as the 
physical aspects of their experience. Louise, for example utilised alternative 
therapies to enhance her confidence, decrease anxiety and improve her low 
mood. 
'Well because of these anxiety problems I'm going to continue with these 
droplets because when I was taking them on a regular basis I definitely 
found it was a help and I found when I was taking it on a regular basis I 
found I was more of a happier person. When I was going into shops I 
was able to look at people whereas before I found it a problem. So 
hopefully if I keep taking these droplets the anxiety attacks will fade and 
eventually I won't need the droplets and I'll be able to control things 
myself. I'm wanting to go back to work erm.to me there's the social 
side, seeing people on a day-to-day basis.having a job to focus on. At 
the moment I feel as if want to rest. I don't feel 100% back to normal but 
day-by-day, week-by-week I think I'll feel happier in myself' (Louise; 
Interview 3; Lines 335-345). 
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Like many other women interviewed Louise's goal was to restore her former self 
and regaining confidence in undertaking everyday activities was seen to be 
pivotal in this process. 
'I did lose a lot of confidence, I was just saying this to a friend the other 
day. When I first came out of hospital after about six weeks I got back 
into the car and it's amazing how you lose your confidence but obviously 
that's all come back now' (Rose; Interview 2; Lines 174-177). 
This is further reflected in the following quotation from Susan who aligned her 
loss of confidence with hair loss. She did nevertheless feel that this would 
resolve once she returned to work, and a greater sense of normality. 
'I've lost a little bit of confidence in doing everyday things and I don't 
know whether that's what makes me think I want my hair to get back to a 
woman's hair style and I want to keep the prostheses in and look like a 
woman or whether its I'm getting used to these things that I've lost a bit 
of confidence, I don't know which way round it is. I can't sort that out in 
my head but I think that once I get back to work I won't have time to even 
think about these issues and things will just get going again basically so I 
think work will prove to be quite therapeutic' (Susan; Interview 2; Lines 
93-100). 
However, Susan acknowledged that returning to work would provide a 
distraction and would limit the time she had to reflect on her experience. 
Avoidance was a common strategy used particularly by participants who were 
employed though they did not seem to denote a lack of acceptance but a desire 
to portray a different, healthy identity. 
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'I put it into little pockets so that's the appointment and I've got to deal 
with that and then that's locked away and I put it away and I don't deal 
with that.compartmentalise.its come now.so it all goes away and I 
kind of leave it. I don't think it's particularly healthy.and I'm working too 
hard.I go to work, this is a theme that's gone on for over a year.I go to 
work and become the professional me that doesn't have cancer and 
doesn't have to think about it. Then I go home.you know I've got a 
much smaller time to deal with it, think about it or work with it' (Ellen; 
Interview 3; Lines 36-43). 
Ellen's quotation supports a previous qualitative exploration (Jensen, Back-
Pettersson and Segeston, 2000) in illustrating not only avoidance but a sense of 
striving to go on living and working on the healing process albeit in manageable 
stages. This Swedish study lacks methodological detail and retrospective data 
collection (up to seventeen years post diagnosis) limit the study findings though 
related findings can be seen throughout this chapter. Links between the notion 
of self and personality (e.g. Snyder, 1974) were particularly striking when 
participants contemplated loss and this is discussed further in the following sub-
theme. 
7.4.3 Personality 
Perceiving the loss of an element of their personality was described by 
numerous participants. 
'I feel like I've lost my zap a bit. I'm a happy go lucky type of person, I'm 
pretty laid back about things but I feel like I've lost a bit of zap, a bit of 
personality. I feel.nervous' (Laura; Interview 1; Lines 271-273). 
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During interview two Laura described perceiving a loss of self, which contrary to 
her previous belief had not returned automatically following completion of 
treatment regimes, though she was more hopeful that she would regain her 
sense of self in the near future. 
'I definitely don't think I have got my zap back but I'm more hopeful than I 
was last time I spoke to you' (Laura; Interview 2; Lines 64-65). 
Having discussed this perceived loss in the second interview Laura had 
subsequently reported her feelings to her friends. 
'I've mentioned it to my friends and they say we don't know what you're 
talking about because you've never changed so although I feel like 
nobody's ever really noticed. I've kept it well hidden' (Laura; Interview 3; 
Lines 133-136). 
Conversely, the change to participants' personalities was frequently noted by 
family members as illustrated in the following quotation. 
'I mean my mum and dad say I've changed and my husband says I've 
changed but I don't think I see it myself. It does harden you to other 
things, sort of toughens you up really' (Gillian; Interview 2; Lines 222-
224). 
Changes to these women's personalities continued throughout the year 
following diagnosis. 
'Well I think I have changed in my personality. I am a lot more quiet.no I 
wouldn't say quiet because I've never been quiet.I don't argue as much 
whereas before I would argue my case but now I think I can't be 
bothered' (Margaret; Interview 3; Lines 43-46). 
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Consequently breast cancer can be considered an ontological threat taking 
away these women's former attributes. However, in doing so many participants 
developed new aspects of their personality and in feeling like a different person 
conform to the notion of a radicalised self (Clarke and James, 2003). 
'I think I'm one of these people that likes to please everybody and keep 
everything just so, so and now I think I'll speak my mind a bit more. I'll 
still go with the flow but I think I'll be a bit more assertive and I'll do more 
what I want to do rather than what people expect me to do' (Rose; 
Interview 3; Lines 202-205). 
Furthermore, a year on from their breast cancer diagnosis the majority of 
participants were feeling more optimistic and began acknowledging the positive 
elements of their personalities. 
'Now...on the up. Happy in myself now I've got through it, quite pleased 
with myself how I've got through it. It's surprising what you can cope with. 
I think you just appreciate the little things that you took for granted. I think 
I'm a stronger person. I always have been strong but I know it I think 
now' (Janet; Interview 3; Lines 178-181). 
Janet's quotation echoes Frank's (1993) self-change narrative of the 
rediscovery of the self who has always been. Participants' use of positivity and 




A positive psychology of cancer challenges the focus on trauma, distress and 
negative psychological consequences instead arguing that most individuals find 
benefits, positive meaning and psychological growth resultant to a cancer 
diagnosis (Aspinwall & MacNamara, 2005). Throughout the year post diagnosis 
the study participants were found to engage in positively reconstructing their 
experience aiming to view events in a positive light and gain perspective on 
their situation. 
'The brain plays very stupid tricks on you at this time.a lot of this is a 
mind game, it's like getting across a mine field doing all of this and 
its.it's your sensible head fighting with your emotional head all of the 
time. You just have to sit down sometimes and say don't be such an idiot' 
(Susan; Interview 2; Lines 135-138). 
Positive self-talk was one element in women's use of this active coping strategy 
that has been found to be effective in managing uncertainty and fears about the 
future following breast cancer (Manuel et al., 2007). As discussed in chapter 5 
survival was of paramount importance for all participants and when discussing 
their experience women frequently described a process akin to positive self-talk 
in convincing themselves that they would be one of the increasing number of 
survivors. 
'I think it's a really, really dark patch in your life, it's a really scary patch in 
your life. It's a crazy experience that you could never explain to anyone, 
you could never explain that feeling, that fright but as time goes on I think 
like.you know people do get better from it and that's what you've got to 
get into your head' (Laura; Interview 3; Lines 281-285). 
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In maintaining a positive attitude the women interviewed sought to identify 
benefits arising from their experience. Theory derived from positive psychology 
denotes the possibility that benefit finding may be a personality characteristic 
given the positive aspects or outcomes consistently seen in some individual's 
narratives of misfortune or tragedy (Tennen & Affleck, 2002). Alternatively 
Tennen and Affleck considered the possibility that benefit finding is a 
representation of an individual's characteristic hedonic level. While some 
women in the present study demonstrated greater benefit finding than others 
this often seemed to be a conscious effort rather than a personal trait. 
Furthermore, as illustrated in the following quotation maintaining a positive 
stance was often perceived to be a necessity for the sake of others and 
accordingly may be another form of protective buffering. 
'I can't alter the diagnosis but I can have a positive outlook because we 
know we're going to have to go through a prolonged period of treatment. 
I think that helped me to be positive about the treatment, there was no 
point in worrying about something I couldn't change. For my family as 
well, I've got two sons at home still. I think I thought right, whatever 
treatment we need, we've got to have it, whatever the side effects are 
we'll put up with them. Just be grateful that the treatment's on your 
doorstep, you don't have to raise funds for it like some people do, let's 
just get on with it.and I still feel like that now. I mean today I think how 
awful I feel but at least I'm getting the treatment. Some people wouldn't 
even have that offered' (Joan; Interview 1; Lines 83-93). 
Benefit finding was frequently related to feeling fortunate to be offered 
appropriate intervention at a local level as well as the speed within which a 
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diagnosis was received and treatment commenced. The following extract 
reveals the reassurance Maria experienced as a result of timely diagnosis and 
treatment and how in turn this engendered a sense of being lucky. 
P: 'I think the first thing is when you're diagnosed is you want it out of 
there. It may not be the same for everyone but for me the way it was 
done, the diagnosis was quick, the surgery was quick and you knew what 
treatment you were having'. 
I: 'and do you think that helped, having everything move so fast?' 
P: 'Oh yes. For me that worked. I think it gave me the satisfaction of 
knowing that someone was there on my case straight away. If they'd 
waited I'd have been.it's still there and they're not bothered. No, for me 
it worked. They were there on the ball straight away. It is quick and you 
have to catch your breath but that's for a second. I feel really lucky' 
(Maria; Interview 1; Lines 361-374). 
Benefit finding often manifested differently throughout the healthcare trajectory 
and at the second interview time point this emerged in relation to perceiving 
hope for the future given the benefit of early identification of breast cancer. 
'I think I've been very lucky, I've been given a second chance to just 
enjoy our lives' (Gillian; Interview 2; Lines 308-309). 
'To me it means that I'm very lucky that it's been detected because 
there's lots and lots of women out there who are walking around with a 
death sentence and they don't know they have it' (Amanda; Interview 2; 
Lines 342-344). 
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These findings typically emerged following greater reflection and attempts to 
manage mortality issues. However, for Ellen who had lived without breasts for 
over a decade following a bilateral mastectomy for high risk genetic screening 
positively restructuring her experience began during the first interview with 
reference to the ease of detection of the breast lump. 
'Initially I felt like I'd been kicked in the guts. I did all that, I've lived like 
this for 15 years and it's still here, how cruel is that. It can't be that cruel 
but having spoken to the Consultant she's said it's actually saved my life 
because we would never had seen it through breast tissue, the lump was 
tiny. So, I suppose it's kind of saved my life. I still haven't got my head 
around it all' (Ellen; Interview 1; Lines 115-119). 
Feeling lucky that the cancerous tumour was encapsulated and that 
chemotherapy was not necessary were further elements in participants' 
accounts at this stage. 
'I think with everything happening so quickly you don't have time to really 
think about it and I think the type of cancer I had and I was very, very 
lucky because it hadn't spread anywhere. I just think in one way I've 
been lucky to have had the type I've had rather than you know.have to 
have chemotherapy and everything else.you know losing your hair' 
(Margaret; Interview 2; Lines 181-185). 
In the phase of early illness patients may try to make comparisons to frame their 
experience (Charmaz, 2002) and comparison to others who are perceived to be 
in a worse situation may help to enhance women's self-esteem. For Amanda 
comparison was particularly pertinent: 
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'A friend of mine actually died from an after effect from the chemo, from 
an infection so I do consider myself very, very lucky' (Amanda; Interview 
3; Lines 168-169). 
Furthermore, the participants compared breast cancer to other former or 
ongoing ailments or illnesses. However unlike in the study of Doumit and 
colleagues (2010) in which cultural factors played a substantial role in these 
comparisons women in the present study emphasised the negative impacts of 
their long-term conditions and in turn the relatively short-term effects of breast 
cancer. 
'As far as work goes it's the shoulder rather than the breast cancer that's 
keeping me away. I've had surgery and there's nothing more they can do 
and I've had such disturbed nights because I just can't get comfortable in 
bed. The pain is terrible so because of that the future is uncertain but the 
way my husband is I'll probably be glad to be at home. It's a funny way of 
looking at things but maybe this is a roundabout reason why it's 
happened' (Joan; Interview 1; Lines 349-355). 
In support of Leventhal's Common-Sense Model (Leventhal et al., 1980) Fiona 
reviewed her somatic state associated with breast cancer and compared this 
and associated representations of breast cancer with her previous diagnosis of 
multiple sclerosis. As such she coped by approaching experiencing breast 
cancer in a positive way and described benefits that she perceived as being a 
direct result of taking Tamoxifen. 
'I'm more concerned with what I've got, with the MS. This is more my 
concern because I know for a fact there's no cure for MS. Even the 
breast cancer nurse said you're taking everything too good, when she 
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came to see me in hospital and I said well I know you can get rid of this 
but you can't get rid of this (MS). So, really the breast cancer, yeah I was 
frightened but I thought it's not that bad and when they said I've got the 
all clear I thought what was I worried about. My attitude is be positive, 
always think positive and the only thing I can say about breast cancer is 
that they've put me on Tamoxifen for five years and I feel great on it. To 
me, it's helped my MS. I was walking on two sticks, now I'm down to one 
stick' (Fiona; Interview 1; Lines 105-115). 
Women with a diagnosis of multiple sclerosis who are being treated with 
immunosuppressive treatments have been found to have an increased risk of 
breast cancer (Lebrun et al., 2008). However, possible improvements in MS 
symptoms as a result of Tamoxifen are yet to be studied. Fiona represents the 
epitome of positivity and for her breast cancer did not constitute a major life 
event given her beliefs and other illness experiences. 
Meta-analyses have linked positive affect/optimism, well-being and health (e.g. 
Rasmussen, Scheier & Greenhouse, 2009) however methodological issues 
often limit the conclusions that can be drawn. Similarly, research investigating 
the outcomes of benefit finding are inconclusive as while it has been linked to 
better psychological adjustment including lower levels of distress other studies 
report no association and even negative relationships to adjustment (Coyne & 
Tennen, 2010). It is believed that this contradictory evidence base may be 
explained by the non-linear relationship between benefit finding and adjustment 
to breast cancer (Lechner, Carver, Antoni, Weaver & Phillips, 2006). 
Nonetheless, cultural beliefs and media portrayals of cancer support the notion 
of a positive attitude and character strength, often termed "fighting spirit", as 
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beneficial in coping with the disease (e.g. Farrell Yelland, 2000). However, this 
may have negative consequences (e.g. Broom, 2001) particularly for those 
women who struggle to maintain this strategy (Lorde, 1985). 
Having a "fighting spirit" has not been found to be influential to overall length of 
survival following a breast cancer diagnosis (Watson et al., 1999). 
Controversially, the authors concluded that women could be "relieved of the 
burden of guilt that occurs when they find it difficult to maintain a fighting spirit" 
(Watson et al., 1999; p.1335). This notion was later refuted by Greer (2000), 
one of the co-authors of the original paper, who argued for the importance of 
encouraging cancer patients to maintain this positive outlook. A systematic 
review has since found little evidence of the influence of psychological factors 
and coping styles on cancer progression and survival (Petticrew, Bell & Hunter, 
2002). These results are consistent with a study specific to women with early-
stage breast cancer reporting that fighting spirit conferred no survival advantage 
(Phillips et al., 2008). While none of the women interviewed for the current 
research expressed beliefs linking positivity and survival the findings suggest 
that even in the most difficult of circumstances women perceive it necessary to 
portray a fighting spirit of optimism and determination to survive, albeit for the 
benefit of others. Moreover, as breast cancer disrupted these women's lives 
and led to life-long change to the self, maintaining positivity became an evolving 
process as they adapted to emerging issues throughout the year following 
diagnosis. 
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7.5 Incorporating change following disruption to the life trajectory 
In accordance with Engel's final stage of the grief process this study has found 
that one year post diagnosis women had begun a process of resolution and 
began to reframe their lives and make changes for the future. Supporting the 
writings of Bury (1982) and Frank (1997) breast cancer was found to constitute 
a biographical disruption as participants' stories of their past, present, and 
future were altered by their experiences. Stacy (1988) noted that illness 
narratives contain a before and after quality with an idealised past that is 
unproblematic and taken-for-granted. Participants' strive for normality would 
seem to corroborate this latter point and in line with Charmaz's (2002) viewpoint 
looking to the past may be undertaken as a frame of reference as because of 
uncertainty women felt unable to look to the future. The dichotomy of life as two 
parts is particularly evident in the following quotation from Laura's final interview 
wherein she uses breast cancer as a point of reference in her life. 
'I think it's like...like say if there was a bridge and I feel as if part of my 
life is going to be on that side of the bridge and part of it is going to be on 
this side of the bridge. Even if someone says something now I think was 
that before I was bad or after?' (Laura; Interview 3; Lines 344-347). 
Accordingly, these women accepted such disruption to their life trajectory 
(Strauss & Corbin, 1989) acknowledging that their lives would be forever 
changed. 
'It's been an emotional rollercoaster and I do get weepy about things 
sometimes. It is a life changing experience and you have to go on don't 
you and do the best you can in your own little way' (Jenny; Interview 3; 
Lines 181-184). 
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In the context of cancer survivors Drew (2003) described this as "biographical 
revisioning" (p.181), a process which becomes necessary given threats to self-
development imposed by the limitations of illness and/or treatment. As has been 
shown in the preceding data chapters the study participants made changes to 
their lives in terms of, for example, body management yet their accounts also 
sustain the notion of post-traumatic growth embraced by positive psychology 
(Coyne & Tennen, 2010). Specifically, the present research supports Frank's 
(1991) proposition that illness provides an opportunity to change behaviour, re-
assess priorities and reform relationships. The former of these is depicted in the 
first sub-theme of this overarching theme of incorporating change though 
focuses on health-related behaviour change. 
7.5.1 Health-related behaviour change 
As discussed previously breast cancer elicited behaviour change towards the 
monitoring of breast health for some participants though was not the sole 
alteration to behaviour stemming from the re-assessment of priorities. In 
support of the aforementioned study of Jensen and colleagues (2000) one year 
on from diagnosis participants were engaging in natural coping strategies to 
promote a healthy life. 
'I'm my priority now, my health is my first priority. I'm doing the Race for 
Life in June with my sister' (Jenny; Interview 3; Lines 44-45). 
Several women including Jenny reported their health to have become a priority 
and consequently began undertaking health protective behaviours such as 
increased physical activity. A recent meta-analysis reported statistically 
significant and moderate effects of exercise interventions on depression, 
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fatigue, body image and health-related quality of life (Duijts, Faber, Oldenburg, 
van Beurden & Aaronson, 2011). In the current study engaging in exercise was 
deemed to reduce the potential for recurrence and as such may relate to 
Kubler-Ross's (1969) stage of bargaining wherein individuals engage strategies 
to bring about a longer life. Such behaviours were also used as a coping 
strategy to manage treatment side-effects which may explain the observations 
of the aforementioned meta-analysis. 
'I got a lot of joint pain so I went on the Tamoxifen website and it said 
that exercise was good so I've joined a gym and that has made a 
massive difference. It's given me energy and made me feel fantastic. 
When I was reading up about breast cancer it said the chance of it re-
occurring was less if you're active so I think going to the gym can't do 
any harm' (Mary; Interview 3; Lines 12-16). 
Equally, focusing on physical activities such as exercise are commonly reported 
coping strategies for taking the mind off life-threatening emotions (e.g. Giske & 
Artinian, 2008; Manuel et al., 2007) which may have been elicited by fears of 
recurrence. Furthermore, fitness activities may constitute a means of preserving 
life by regaining health, can promote independence, and may become a 
preserving self or allow for the development of an improved self (Charmaz, 
1987). 
Similarly, alterations to diet were put in place to improve general health and 
minimise Tamoxifen-induced side-effects. 
'Then with the Tamoxifen tablets it does tell you that you could gain 
weight so I'm gonna be careful and try to eat salads and things. 
Erm.but I haven't gone back to sort of eating biscuits through the day 
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as I used to and cakes. I used to eat a lot of those sorts of food so I'm 
glad about that so if I can stay off those I might keep my weight down 
because erm...when I was having the chemotherapy, obviously with 
having blood tests they must have found out that my cholesterol level 
had gone higher' (Louise; Interview 3; Lines 88-95). 
Even those participants who had previously been conscious of their eating 
habits made concerted efforts to increase their fruit and vegetable intake to 
benefit themselves and their families. 
'I had a good diet before, was always fit and active. I mean I do try even 
more now, I eat things like blueberries by the handful, broccoli with 
nearly every meal. Even my youngest son, I read the Lance Armstrong 
book so he read it was well and peas and carrots are normally his limit 
but I always put broccoli on his plate and he'll always eat it' (Rose; 
Interview 3; Lines 141-145). 
Positive self-reinterpretation via adjusting lifestyle including diet and work 
schedules have been reported as effective strategies for coping with cancer 
(Chen & Chang, 2012). The present study has found that such findings extend 
to breast cancer, typically emerge following hospital-based treatment and are 
implemented by women for the remainder of the year post diagnosis and 
potentially beyond this point. Shilling (1993) purports that seeking mastery of 
the body, for example via improving diet, increasing physical activity or electing 
to undergo reconstructive surgery, may offer certainty in an uncertain world. By 
taking control of the body, such body projects enable an individual to present an 
attractive physical image of themselves and accordingly present an attractive 
self with new activities becoming a marker of the new self (Charmaz, 2006). 
299 
Finding something important to live for, gaining insights about life and 
introducing radical change in life have been previously recorded as elements 
within women's experiences of breast cancer (Jensen et al., 2000) and are 
considered further in the following sub-theme. 
7.5.2 Re-defining life priorities and goals 
Women have been found to pay greater attention to life priorities in the time 
immediately following a breast cancer diagnosis up until breast surgery 
(Drageset et al., 2010). This research has found that this continues throughout 
the year post diagnosis. Such strategies are said to be productive in coping with 
stressful events (Folkman & Moskowitz, 2004). Deciding to move home was 
one way in which two participants quite literally re-drew their "destination map" 
(Frank, 1995; p.89). 
'It has been big life changing in one way and another. Well it's made me 
want to go to a smaller property for a start, made me think there's more 
to life than cleaning up all the time. I used to do the windows every week 
and now I can't remember the last time I did them whereas when the 
children were little it used to be washing on a Monday, ironing on a 
Tuesday and there is more to life' (Linda; Interview 3; Lines 177-182). 
Similarly, by interview three Margaret and her husband had made the decision 
to move home in order to facilitate achieving life-long goals. 
'I just think I've got a different outlook on life. I mean we're selling the 
house at the moment, well we've got it up for sale, which I might have 
never done before... hopefully we'll do a bit of travelling and.where 
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beforehand we might not have thought of doing that' (Margaret; Interview 
3; Lines 48-49...53-55). 
This suggests that rather than plans being postponed or cancelled as 
suggested by Frank (1997) once treatment was completed these women often 
instigated new plans. Margaret's quotation also resonates with Frank's (1995) 
quest narrative sub-type automythology where fate or destiny is revealed 
through illness as had she not experienced breast cancer Margaret would not 
have implemented life changes. 
As early as interview one, the participants reported having a different outlook on 
life which translated into altered priorities most commonly pertaining to work 
both inside and outside of the home. 
'It's changed my opinion about work because I've worked for thirty odd 
years and had no time off, apart from holidays of course. When you're 
self-employed you work all hours and you come home, and it's a family 
business, so you come home and you're talking work. I've really enjoyed 
the time off, so I won't be going back to working the hours I was working 
before' (Rose; Interview 1; Lines 183-188). 
Reducing working hours and having less concern about household chores were 
the most frequent alterations to these women's lives one year on from their 
diagnosis. Similarly, previous studies have reported reductions in working hours 
and voluntary ceasing of employment by women with breast cancer as well as a 
reduction in the importance of work and ascribing a more balanced approach to 
life (e.g. Maunsell, Drolet, Brisson, Brisson, Masse & Deschenes, 2004). 
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'It puts everything into perspective now, I have a different outlook on life, 
you think.it's just like.I said the other day, we've just booked a holiday, 
just for a week and I was thinking I need this doing and that doing but no, 
no we'll just go for a week's holiday. It'll all be there when I come back, 
just a different outlook. I don't think you take life for granted' (Janet; 
Interview 3; Lines 45-50). 
Appreciating life and time with others with less focus on their roles within the 
home were also noted by Margaret. 
'I don't worry about things as much, I'm more calm. Where I would be 
I've got to do this today, I must do this today.I'm not like that any more. 
If somebody comes and I haven't washed the floor, it doesn't make any 
difference, where before I would be oh someone's coming, I've got to 
wash the floor. I'm not like that now and I think I appreciate my life more. 
I appreciate my husband more, the grandchildren more and my family' 
(Margaret; Interview 1; Lines 183-189). 
Coping through a re-definition of personal values has been proposed to enable 
the maintenance of a positive self-concept and psychological integrity (Roy & 
Andrews, 1999 as cited in Drageset et al., 2010). While this seems to be 
applicable to this study the extracts presented in this theme suggest that breast 
cancer went further and challenged the participant's notions of the self which as 
noted by Goud (1995) leads to new insight. Whereas losing their identity within 
the home and handing over control of traditionally feminine roles, due to the 
physical impact of treatment, was initially distressing women's re-ordering of 
life's priorities as illustrated by Margaret indicates that women perceived a new 
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improved self or supranormal self (Charmaz, 1987) to have emerged from 
reflection on their experience. 
Indeed, Frank (1995) purports that suffering lessens when a person can redraw 
their life trajectories and visualise a future. These stories of breast cancer 
providing impetus for change can be likened to Frank's (1995) quest narrative 
and specifically the sub-type known as 'manifesto' through which illness is a 
motivator for action. On such self-development of the qualities acquired or 
realised during illness Frank (1995) writes "what we hear is not people rising 
above their suffering, but rising in their suffering" (p.66). 
In contrast other participants continued to seek normality and did not intend to 
revise their map for the future. These women may be regarded as rejecting a 
survivor identity (Kaiser, 2008). 
'I'm not one of these women who says now that I've had cancer and I'm 
through all of this I want to do all sorts of things like climb Everest or go 
down the Amazon or tour the world, I just want to get back to normality 
and pick up with my life where I left off' (Susan; Interview 2; Lines 168-
172). 
Kaiser's (2008) qualitative study encompassing thirty nine interviews with 
American women who completed treatment for breast cancer three to eighteen 
months previously described how 51% of women perceived themselves as 
survivors while 49% rejected the survivor identity. Women in this latter group did 
not want to be part of a social identity defined by illness whereas women 
embracing the notion of survivor felt empowered by the strength they had found 
to get through breast cancer diagnosis and treatment. As discussed in the 
previous data chapters a restitution narrative dominated participants' accounts 
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of their experiences of breast cancer though as suggested previously women in 
the present study demonstrated elements of different narrative types throughout 
their experience often simultaneously. While as illustrated throughout this theme 
these women may have re-defined their life priorities and goals during the acute 
phase of their illness, major life changes were not initiated until almost a year 
had passed since diagnosis. This may be explained by participants' initial focus 
on treatments and subsequently recovering from medical procedures and 
regimes. Having time for reflection may be of importance here as until these 
women had time away from a medicalised routine they could consider little else. 
Nonetheless, in re-drawing their life trajectories to take illness into account the 
women in the current study constructed a more flexible self which can be 
aligned with the postmodern notion of self as changeable rather than static 
(Frie, 2011). In addition to changing behaviour and redefining priorities, women 
spoke of incorporating change through reforming relationships and this 
constitutes the successive sub-theme. 
7.5.3 Reforming relationships 
Breast cancer is known to be viewed by some women as an opportunity for 
personal growth. In a study of 101 breast cancer survivors post treatment 83% 
identified at least one benefit such as personal growth, greater appreciation of 
life and/or relationships with others (Sears, Stanton & Danoff-Burg, 2003). 
Appreciating others particularly family members was evident early in 
participants' experiences and they frequently reflected on how the experiences 
had brought their family closer together and had strengthened the bonds 
between them. 
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'The outlook on things, you know, the thing you take for granted, you 
think let's make the most of this nice day. Actually you find out, I have 
lots of good friends but I didn't realise how good my daughters were until 
this year, not just with this but with everything. I've got a real good 
partner and I couldn't have done without him. It's brought the family 
closer' (Janet; Interview 1; Lines 229-233). 
Likewise, Mary commented: 
'Well, we were close anyway but we seem to be a lot closer and we do 
things more as a family. We've had more parties this year than we've 
ever had (laughing) and we're in touch more. We were in touch quite a 
lot before but I just think more so now and it's brought us all together' 
(Mary; Interview 3; Lines 170-173). 
These findings are supportive of a positive impact of social support on the 
coping process (e.g. Doumit et al., 2010; Holland & Holahan, 2003). 
Specifically, the support received from the participants' partners was perceived 
to be invaluable throughout their journey. 
'We've cried, we've laughed, we've shouted.. .but we've done it together. 
We've talked, we've talked it over and of course we told our son 
everything right the way along the line as well. So, it's been a process 
we've gone through together' (Amanda; Interview 1; Lines 387-390). 
Amanda later reflected: 
'At first you're very, very sad, a big sadness comes over you and then 
you learn to deal with it and as long as your family's taken into that big 
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loop right at the beginning then they can deal with it with you' (Amanda; 
Interview 3; Lines 179-181). 
Consequently, for those women who had a supportive partner breast cancer 
became jointly owned (Illingworth et al, 2010) and experienced throughout the 
year following diagnosis. Linda described how her husband was able to identify 
when she was feeling low and would use humour to lighten the mood. 
'When I came home there were some blue tits in that box and Brian says 
aren't we lucky, he says, we lose one tit and we get another four 
(laughing). He helps me snap out of it' (Linda; Interview 1; Lines 208-
210). 
Expressing their appreciation for the support they had received was also noted 
to be a component of this theme during the final interviews. 
'I think you're more able to express things that matter to you more and 
not just to your family but to your friends. You tend to value them and let 
them know what they mean to you. I think by doing things for your friends 
they know what they mean to you I don't think you ever really vocalise 
that and I don't know how many times I've now said to my friends "I don't 
know what I would have done without you"' (Joan; Interview 3; Lines 127-
132). 
To provide some contrast relationship breakdown occurred for one participant 
by interview three which she perceived to be a direct result of the strain that 
experiencing breast cancer had upon her marriage. Specifically, a discrepancy 
between their responses to breast cancer was influential as while Ellen looked 
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to incorporate breast cancer into their life story her husband did not deem this to 
be necessary preferring a strategy of avoidance. 
'I think there's just been so much stress and so much pressure and he 
hasn't been there, he couldn't pick any of it...and in fact he held me 
back...he wouldn't let me look at it' (Ellen; Interview 3; Lines 88-90). 
Patient's experiences have been identified to seem more negative if partners 
are withdrawn (Pistrang & Barker, 1995) and in line with previous research Ellen 
reported her husband engaging in problem minimising and insensitive 
comments (e.g. Dunkel-Schetter, 1984; Dehle, Larsen & Landers, 2001). 
'He once told me.we were talking about how it had been and what it 
had been like and the first surgery I had and he told me that we were 
very lucky because God had given him the ability to still love me.and 
that you know.sometimes it would have been nice to have a woman 
that had breasts.but God had given him this ability to love me still' 
(Ellen; Interview 3; Lines 476-481). 
Partners difficulties understanding women's feelings can exacerbate negative 
emotional changes (Fobair et al., 2006). It has been argued that these problems 
are more prevalent in women with pre-existing anxiety, depression or sexual 
dysfunction, which may be applicable in Ellen's case given her decade of 
managing breast loss, however these are issues for a large proportion of 
women with breast cancer (e.g. Fobair et al., 2006). Moreover, Ellen's 
perceived need to stay engaged with breast cancer yet being hindered in doing 
so by her husband may have limited her opportunities for emotional expression 
and in turn positive cognitive restructuring. The emotional responses of others 
living in the patient's environment have been suggested to decline three months 
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after surgery which may also be related to the distress seen in some women 
(Stanton et al., 2000). There was a profound change in Ellen by the third 
interview which she admitted had been highlighted by several friends and 
colleagues. When asked about this altered self Ellen commented: 
'I guess I'm coming to the point where I've got it a lot more into 
perspective, I've got my future, I'm looking forward to my future. I can 
kind of notch it up as another experience...There's not one part of me 
that will say I don't love this guy because I do...I love him dearly but I've 
suddenly become strong enough to say that's not enough, I need more 
than that' (Ellen; Interview 3; Lines 451-453...490-493). 
Recognising her own needs and looking to her future were central in Ellen 
gaining psychological strength from her experience. This theme has shown that 
the women interviewed perceived breast cancer to have disrupted their lives 
and changed their sense of self through altering their perspective on life, health-
related behaviour and appreciation of relationships. However, although 
participants emphasised the positive nature of such change, the final theme 
outlines the enduring psychological impact of breast cancer. 
7.6 Untidy ends 
Although the latter theme shows how women were able to re-draw their life 
trajectories and re-develop the self at varying points following diagnosis Frank 
(1995) recognises that "tidy ends might not always be possible" (p.183). This is 
reflected in the first of two sub-themes outlining participants' ongoing 
uncertainties about the future. 
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7.6.1 Ongoing uncertainty & the omnipresence of cancer 
Patients who have been diagnosed with cancer typically experience uncertainty 
as a reaction to their disease situation (Penrod, 2002). Conceptually, 
uncertainty can be described as the omnipresence of cancer (Shaha & Cox, 
2003), a reaction to the life-threatening aspect of a cancer diagnosis. 
Participants' reflections on issues of mortality during the initial months following 
diagnosis led to an awareness of the insecure nature of the body and self. 
Mishel's theory of uncertainty in illness operationalises uncertainty as "existing 
in illness situations that are ambiguous, complex, unpredictable and when 
information is unavailable or inconsistent" (Mishel, 1988; In Smith & Liehr, 2003, 
p. 25). It is seen as a result of stressors that affect the person concerned 
directly. An individual's appraisal of these stressors will lead to either a positive 
(opportunity) or negative (danger) identification resulting in coping strategies 
which lead to an adaptation to uncertainty (Smith & Liehr, 2003). Evidence 
suggests that uncertainty is linked with lower quality of life in women with breast 
cancer (Gaudine, Sturge-Jacobs & Kennedy, 2003). 
Moreover, a literature review exploring aspects of uncertainty experienced by 
cancer patients suggests that three themes depict this concept (Shaha et al., 
2008). Uncertainty due to limited or a lack of information, uncertainty regarding 
treatment choices, and uncertainty pertaining to everyday life and coping with 
the illness were identified, though the search identified only eight articles 
published between 1994 and 2007 in relation to breast cancer. The authors 
concluded that this area of research remains limited and lacking in-depth 
longitudinal qualitative exploration considering how and why uncertainty 
changes over time. In support of previous research this study has found that 
feelings of uncertainty constituted a prevailing experience in breast cancer 
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(Shaha et al., 2008). Uncertainty about treatment effects was common early in 
women's experiences as illustrated by Susan. 
'It is quite scary because you know you're going forth on all these 
treatments and it seems like it will be a very long haul and at times it 
seems like you will never get to the other end. Physically, it hasn't been 
anything like I expected but mentally it's a minefield. You can't even gear 
yourself up for it.you might be told to wait. Just because you got side 
effects with the last treatment doesn't mean you will with the next. You 
never know what side effects you will have' (Susan; Interview 1; Lines 
161-167). 
However, by far the most common focus of participants' reflections on 
uncertainty was, linking with existential concerns particularly regarding mortality, 
was the possibility of having a recurrence. The cognitive avoidance coping 
demonstrated by numerous women in this study has been found to predict fear 
of cancer recurrence one year after a breast cancer diagnosis (Stanton et al., 
2002). While recurrence is not a certainty it was not knowing that influenced 
these women's lives throughout the year following diagnosis. 
'I don't think I really thought about. I mean initially you think oh I'm gonna 
die and then you think no I'm not I'm having treatment and now I'm at the 
stage when I'm thinking what if it comes back' (Mary; Interview 3; Lines 
54-56). 
Corroborating previous research findings (e.g. Bottorf et al., 2007; Browall et al., 
2006) the uncertain prospects of cancer spread and recurrence influenced the 
participants' lives and their ability to cope, specifically impacting on their 
310 
capacity to put breast cancer behind them. For Joan uncertainty about spread 
as a result of positive lymph node identification permeated her daily life. 
'I've always got it at the back of my mind, these glands that were affected 
under my arm' (Joan; Interview 2; Lines 73-74). 
The possible recurrence of breast cancer has been reported to be the single 
largest concern, out of a possible twenty eight including body image, pain and 
rejection, among 223 women with early stage disease within the year post 
treatment (Spencer et al., 1999). Similarly, all women in the present study 
contemplated the possibility of recurrence though additionally aligned this with 
fear and anticipated it to be a lifelong concern. 
'It's certainly frightening.and I think for the rest of my life I'll think about 
it. I will be feeling for lumps here and lumps there.and probably if I get a 
pain somewhere and I can't put my finger on what it is it'll always be in 
the back of my mind that I've had cancer and it could return, where 
before I never thought about it at all' (Margaret; Interview 2; Lines 173-
177). 
Margaret's quotation further supports the notion that common health problems 
may be perceived as sinister risks that reinforce the omnipresent nature of 
cancer (Shaha & Cox, 2003). Increased body awareness and in turn seeking 
medical attention for ailments where previously a greater period of waiting 
would have ensued was often described. However, achieving a balance 
between concerns about recurrence and living one's life was also discussed by 
Maria as being necessary. 
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'I do the checks and if I find anything I'll be straight there no matter what. 
I think I might be say.if I suddenly started getting a lot of back 
pain.see I was the type of person it would just be a pulled muscle but 
now I think it'll be wait a few days and then go to the doctors whereas 
before oh it'll work out itself, wear it off, but because I won't be seeing 
anyone to say yes you're fine, I would go more. I'd be more aware and 
not leave things, I will get checked just in case. That will always be 
there. just in case. I'll go and get checked. just in case. I won't let it rule 
my life. I won't go through the rest of my life thinking the least pain, is it 
that come back but if I'm ill and it's not sorted I'll go to the doctors instead 
of leaving things' (Maria; Interview 2; Lines 297-306). 
These findings can be likened to the conceptualisation of abstract and concrete 
level representations (Benyamini et al., 2009). At an abstract level cancer 
worries led to a coping strategy of greater attention to bodily changes while at a 
concrete level identification of a specific symptom (e.g. breast lump), would now 
lead women to seek immediate medical care. However, obtaining a balance 
between attending to the body and moving on with life was described as being 
difficult for many participants particularly while undergoing active treatment. 
'Part of me really doesn't think that I have it any more but obviously there 
must still be something there but.I don't know. I think just to get that 
scan over and to say everything's gone, there's nothing there. I think at 
this stage and people I've spoken to say the same, everything you get 
you think it's that. Every single ailment you get.if you've got a 
headache, it's a brain tumour. Everything you get you put it down to that 
but then part of you thinks you haven't got it. Part of you thinks you have, 
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everywhere and part of you thinks you haven't. It's still all very muddled I 
think, really muddled at this point, not quite sure what you think or 
believe' (Laura; Interview 2; Lines 134-143). 
Around one in five women have been found to have strong worries about their 
future health at six and twelve weeks post breast cancer surgery (Wade, Nehmy 
& Koczwara, 2005). The study of Wade and colleagues found denial coping 
immediately after breast surgery was predictive of future health fears and that 
this relationship grew stronger over time. A low response rate and relatively 
short-term follow-up limit the conclusions that can be drawn as does the single-
item measure utilised. The current research findings demonstrates the nature of 
these health worries, that they remain interlinked with the potential for spread 
and breast cancer recurrence and that these worries remain twelve months on 
from diagnosis. 
It has been reported that uncertainty may appear differently at varying stages of 
a cancer experience from a weighing up of benefits and side-effects during 
treatment to a future with hope yet few guarantees following treatment 
completion (Shaha, Cox, Hall, Porrett & Brown, 2006). This latter component 
would seem to be supported by the present study as while women expressed 
concerns about spread and recurrence they did so in the context of living 
thereby suggesting a prevailing hope for the future. Furthermore, the passage 
of time was perceived to bring about greater reassurance and in the longer-term 
regaining confidence in the body. 
'Every single twinge I get in my body I think is it that, is it related? I mean 
I have spoken to people and they say it will pass, I will get to trust my 
body again but at the minute I don't' (Mary; Interview 3; Lines 100-102). 
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Accordingly, as reported by Bertero and Wilmoth (2007) participants' attempts 
to resume normality were influenced by their uncertainty about their future life 
which in turn affected their sense of self. Following the application of Frank's 
narrative types to breast cancer Thomas-McLean (2004b) argued that although 
many women strive for full restitution, as has also been demonstrated in the two 
preceding chapters, this may not be possible given fears of recurrence. Yet, she 
adds that some women may not want to return to their former self and the 
increased psychological strength and positive life changing decisions portrayed 
in this chapter corroborates this notion. 
Moreover, the accounts of women in the present study, as demonstrated in the 
previous quotation from Mary, suggest hope for the future, a strategy that can 
help individuals to manage the uncertainty of cancer (Giske & Gjengedal, 2007). 
Women's will to live and desire for normality while making the future meaningful 
and managing issues of uncertainty and mortality was shown through a 
grounded theory study with ten Norwegian women with newly diagnosed breast 
cancer (Landmark, Strandmark & Wahl, 2001). The authors concluded that the 
will to live encompasses women's ability to cope with existential issues. Data 
collection took place between four and nineteen months post diagnosis and all 
participants had undergone mastectomy. Importantly, the current research has 
found that concerns of uncertainty are equally prevalent in women who have 
undergone breast conserving surgery. In addition, though hope and fighting 
spirit to cope with the stress of their experience are evident, issues of 
uncertainty remained in the participants' minds from diagnosis to early follow-
up. 
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7.6.2 Back of my mind 
Despite acceptance the participants frequently experienced difficulties re-
adjusting their mindset to move breast cancer to the back of their minds. 
'My brain is, I know I've had to try and keep my brain functioning properly 
to sort all of this out and to actually physically get through it all and so 
now it is sort of to an extent running in that way, it hasn't, it is starting to 
come down but it hasn't properly come down so if anything 
happens...that is not what I'm expecting...that normally would be 
perhaps a disappointment or an irritation or gosh I've got to sort this out 
sort of thing, at the moment it is still a major problem because my brain is 
still running at this high level. Hopefully that will start to come down as 
well once I get back to work and I've got my job to concentrate on and 
the people around me as opposed to being here by myself' (Susan; 
Interview 2; Lines 306-315). 
All participants were forced to acknowledge that their experience would remain 
part of their future identity despite ongoing efforts to put it to the "back of their 
mind". 
'I think it'll always be in my head, I do. It's like a scar for life isn't it, you 
can't stop your head thinking. Obviously it's got to get easier but I don't 
think I'll ever forget it because things will set it off' (Emma; Interview 1; 
Lines 328-330). 
By the second interviews the women acknowledged that breast cancer was 
never far from their thoughts and had a psychological impact on their daily lives. 
'I think what's not normal is it's never ever more than two seconds out of 
mind, ever. Whatever I do, that's there...it's never...every...I don't know, 
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like the kids birthdays, it was hers in August and it was like please let me 
be here for the next one. Everything is darkened a bit, everything has 
that underlying something that.and that's what I hope will fade away in 
the years to come' (Laura; Interview 2; Lines 185-189). 
McCann and colleagues (2010) noted that women experienced difficulty 
managing ongoing treatment side-effects and moving on from breast cancer 
and found it difficult to see an end to their experience. The present study 
provides support for this finding but in addition has uncovered that women 
perceive others reactions to their diagnosis to be influential in their ability to 
move on from breast cancer and to regain a normal life. 
'This is going to sound awful again because I shouldn't think these things 
really, but at the moment people are still coming in and saying "how are 
you, how are you getting on?" I want life to be, people to say hi, how are 
you but not referring to cancer and cancer treatments, it just being what 
we say to one another. So not only I suppose have I put it behind me but 
the people around me have all put it behind them as well and we're all 
back to moaning about the trivial things in life that we moan about every 
day and catch up with the gossip and all that sort of thing' (Susan; 
Interview 2; Lines 372-379). 
For some participants keeping their experience at the back of the mind ensured 
mental preparation for a future in which breast cancer may once again present 
itself. 
'There's a part of me that cannot stop and put it to rest. I've got to 
stay.it's not that I've got to stay vigilant to watch for it, it's that I've got to 
be prepared that I might need further treatment or it might return or I 
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might need more surgery. If I've said that's that, it's finished and it re-
occurred it would be harder to look at it again' (Ellen; Interview 2; Lines 
203-207). 
By interview three women's reflections in relation to this theme showed 
progression. 
'It's always still at the very back of your mind and I think it always will be 
but I think it's further back in my mind than it was last time you were here 
and I'm sure next month it'll be further back still' (Margaret; Interview 3; 
Lines 221-224). 
Similarly Maria commented: 
'At first it was the getting it off, getting it out, getting it over with. As time's 
gone on it's a case of its over with now get on with it. It will obviously be 
there the back of my head and now and again it comes back, to the 
forefront. Now all the treatments over with its more at the back of my 
mind and things are back to normal but while you're having the 
treatments its all still at the forefront. Now and again it springs to mind if 
you see something on the television, or in magazines or someone brings 
it up you know but other than that most of the time it's at the back of my 
head' (Maria; Interview 3; Lines 64-71). 
At this point in their journey the participants reported less focus on experiencing 
breast cancer and being able to put their illness further to the back of their 
minds with the passage of time. 
'It's certainly not as at the forefront of my mind as it was the last time I 
saw you and it certainly isn't to that degree but it is still very much there. 
317 
I'd be a liar if I said it wasn't. It's still.I would never say there's a full day 
goes by when I don't think about it at some point, well more than one 
point, at a few points in the day. I remember going through a thing where 
I just couldn't focus or think or anything about anything, it was the only 
thing I could, that was on my mind every minute of the day. I'd try to 
distract myself by doing other things but it was just there all the time.but 
that bits gone' (Laura; Interview 3; Lines 73-81). 
Yet even at this final stage in the year post diagnosis many participants 
continued to wait for an end to their breast cancer experience and anticipated 
doing so until all treatments had been completed and/or they had reached the 
five year marker. 
'Hopefully I'm not always going to think is it going to come back. I think 
when I've got over this 5 years because they say 5 years don't they.and 
then I'll have finished with the Tamoxifen, then it'll be over with and I 
think I'll feel a lot calmer in myself. I think I'll feel more like it's come to a 
close, I can put a lid on it' (Jenny; Interview 3; Lines 117-121). 
A year on from their diagnosis a future with living at its core was envisaged by 
all participants to a greater extent than at any other point in the healthcare 
trajectory. However, this future would continue to incorporate breast cancer at 
the very least in the back of these women's minds compromising their sense of 
re-entering the world of the healthy and as such an altered and evolving self. 
Accordingly, this finding supports the conceptualisation of liminality as being 
enduring and experienced into survivorship. 
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7.7 Chapter summary 
This chapter has shown that upon receiving a diagnosis of breast cancer the 
majority of participants entered a state of shock and disbelief, the sole 
exception being a woman who was experiencing a recurrence. While at this 
time some participants appeared to engage in denial this is short-lived and 
immediate passive acceptance was not uncommon which may have provided 
an additional explanation for the role these women assumed in treatment 
decision-making and their acceptance of medical opinions. Throughout the 
acute phase participants made conscious efforts to protect the psychological 
well-being of others. However, particularly for those women undergoing 
additional hospital-based treatments this was typically reversed with family 
members trying to minimise the physical strain on women yet this often elicited 
anger and frustration as changes to women's identity occurred. Within the 
weeks post diagnosis all participants engaged in reflection regarding existential 
concerns contemplating 'why me?' and mortality issues. For a subset of women 
interviewed this subsequently resulted in mental distress including anxiety and 
depression though general changes to women's personality were frequently 
reported. Antidepressants and alternative therapies were used to manage 
symptoms during this time and the majority of the study participants engaged in 
cognitive reframing to maintain a positive demeanour. A year on from their 
diagnosis these women had altered their behaviour and outlook on life, had re-
ordered their priorities, re-formed relationships and made life changing 
decisions. However, the ongoing uncertainty brought about by breast cancer 
and specifically fears of recurrence led them to acknowledge the prevailing 
impact of breast cancer on their lives as it remained at the back of their mind 
into survivorship. 
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Accordingly, in relation to the grief model of Kubler-Ross (1969) the emotional 
reactions of women with breast cancer may correspond to the stages of denial, 
bargaining, depression and acceptance. Nevertheless, this cannot be applied to 
all women as some of the participants in the present study experienced only 
one stage and those who do go through multiple stages do not always do so in 
a linear fashion and can experience these simultaneously. The notion of stages 
fails to account for the complexity within women's responses to breast cancer 
as although some women seemed to engage in denial they spoke and behaved 
in ways to suggest the opposite. Furthermore, the process of acceptance was 
individual and encompassed differing elements given these women's belief 
system and social support. Examination of these stages has led to an 
established consensus that not all patients go through all stages and those who 
do may move forwards and backwards through the stages and while an 
individual might move through one stage within a few days they may linger in 
others for months (Lyckholm, 2004). Engel's (1961) theory would seem to 
provide a more effective framework in which women's emotional journey can be 
integrated. However the findings of the present study suggest that once again 
there are exceptions to the proposed stages most notably shock and disbelief 
which may not be relevant to women experiencing recurrence and denial may 
not be a feature of this stage for all women. 
The themes presented throughout this chapter are not intended to be 
characterised as a stage model per se as while they can be helpful in 
understanding processes of loss they miss the uniqueness of women's stories. 
Participants' responses to breast cancer were individual and variation in these 
women's experiences of the processes categorised as themes as well as the 
specific timing of reactions was evident perhaps given the multiplicity of 
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treatment regimes. Consequently, the Shifting Perspectives Model of Chronic 
Illness (Paterson, 2001) may be applicable. Rather than using terms such as 
denial, a label which it is argued may be internalised by patients damaging the 
sense of self and limiting identity re-formation (Telford et al., 2006) it instead 
recognises individuality in experiences of chronic illness. The model 
emphasises fluctuations in attention to symptoms over time and considers 
statements of optimism and pessimism to be indicators of the person's 
perspective rather than a failing to understand the reality of the disease. 
A summary of the findings presented in the data chapters can be found in 
Appendix 10. The following discussion chapter briefly summarises the key 
research findings illustrating the inter-relationships between themes and 
highlights those findings that further our understanding of women's longitudinal 
experiences of breast cancer. The discussion subsequently considers these 
findings in the context of current policy regarding breast cancer care as well as 
theories of self, embodiment, stress and coping. 
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CHAPTER 8: DISCUSSION 
8.1 Introduction 
This chapter considers the central themes discussed throughout the data 
chapters and draws conclusions as to participants' experiences of breast cancer 
from a longitudinal perspective. Since commencing this research an increasing 
number of studies have adopted a longitudinal design including qualitative 
approaches with data collection throughout the year following a cancer 
diagnosis. While a small number of women with breast cancer are frequently 
included in the study sample the research focus on broader issues of cancer 
survivorship (e.g. McCann et al., 2010) or relationships (Illingworth et al., 2010) 
has limited exploration of women's experiences throughout the healthcare 
trajectory. Those studies that are specific to breast cancer consider the 
symptom experience (Tighe et al., 2011) or collect data retrospectively (e.g. 
Thomas-MacLean, 2004a). The use of hermeneutic phenomenology and 
illness/treatment grids to support the interview process are unique to the 
present study and explorations of women's experiences of breast cancer from 
post diagnosis to early follow-up. Accordingly, the current research has 
uncovered numerous themes that constitute the elements of the study 
participants' experiences of breast cancer and which represent issues 
pertaining to the medicalisation of breast cancer, the body, and the mind. 
In adopting a longitudinal approach this study adds to existing understandings 
of the illness experience and specifically breast cancer by revealing the 
emergence and development of the themes identified throughout the year 
following diagnosis. While some themes (and particularly sub-themes) were 
distinct to one period of time (e.g. role in the treatment decision-making process 
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and getting rid of it were relevant in the two to three weeks following diagnosis) 
other themes emerged post primary treatment (surgery) and extended 
throughout the healthcare trajectory (e.g. dressing the body to accommodate 
breast surgery and untidy ends). Furthermore, several themes (e.g. waiting, 
cancer schema and responsibility for breast health) manifested throughout the 
data collection period and were influential in shaping women's experiences of 
breast cancer prior to diagnosis and potentially beyond early follow-up. 
Nonetheless, the present study has additionally uncovered variation in the ways 
in which the participants' experienced breast cancer over time in the context of 
the emergent themes. Women's biography, medical history and current 
diagnosis, prescribed treatment regime, financial circumstances, perceptions of 
cancer and social support influenced their responses to the multifaceted 
experience of being diagnosed with, and treated for, breast cancer. 
Consequently, participants' experiences of breast cancer can be viewed as 
evolving and as eliciting concerted efforts to cope with changes to women's 
perceptions of their body, self, identity and sense of embodiment. In what 
follows the inter-relationships between themes are considered in order to reveal 
the 'whole' experience in the context of relevant self, embodiment and coping 
theory and current healthcare policy. Specifically, on the basis of the research 
findings, policy developments and theoretical perspectives are evaluated in 
terms of their applicability to the breast cancer illness experience. The 
methodological approach including the use of hermeneutic phenomenology and 
illness/treatment grids is assessed as are the limitations of the study. Finally, 
directions for future research are suggested and the implications of the study 
results for the care of women with breast cancer are considered. 
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8.2 Implications for breast self-examination 
Given the nature of the sample, the participants described their experience of 
breast cancer as beginning prior to diagnosis with the detection of a breast 
symptom, most commonly a self-identified abnormality. Those women who had 
begun to experience pain in the breast, had undergone treatment for prior 
breast disease and/or conducted regular breast self-examination (these were 
often related concepts) typically consulted their GP immediately. However, 
other participants reported waiting, often for several weeks, before seeking 
medical advice. 
A survey, co-funded by Cancer Research UK and the National Cancer Action 
Team, has recently been announced with the aim of investigating the nature 
and duration of symptoms experienced prior to diagnosis in approximately 2500 
people covering 22 types of cancer (Department of Health, 2011). While this 
may help to establish at what point and with what symptoms individuals seek 
help it is unlikely to uncover the reasons for delay. The present research has 
found that disease specific factors influence women's help-seeking following 
detection of a breast symptom and these aspects may be key to successfully 
promoting behaviour change. It emerged that some participants were aware of 
the benefits of early diagnosis yet consciously chose to wait due to other 
responsibilities and commitments, the misattribution of breast abnormalities and 
their breast cancer schema, specifically, a lack of symptoms that they 
associated with breast cancer. Crucially, this research has additionally 
uncovered that these women rarely examined their breasts due to unrealistic 
optimism and perhaps given the prevalent view of breasts as an external organ 
that was no longer required following child-rearing. Moreover, these women 
engaged in a long-term process of self-monitoring prior to help-seeking. 
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Accordingly, although the benefits of breast self-examination are debated (see 
Chapter 1, p. 21) many of the women in the present study were successful in 
identifying a malignant breast abnormality. Nevertheless, they frequently lacked 
confidence in their judgment due to their limited knowledge of symptoms 
particularly those beyond a painful breast lump. This finding can be linked to 
reports indicating that Government targets to improve awareness of cancer 
symptoms have yet to be realised (Department of Health, 2006) which may in 
turn impact on Government objectives for early detection of cancer such as 
those documented in the NHS Cancer Plan (Department of Health, 2000). 
Furthermore, some of the women interviewed exhibited avoidance as while they 
cited a 'knowing' they used distraction as an interim strategy until they could 
cope with receiving a diagnosis of breast cancer. Participants' illness 
representations, as illustrated through their cancer schema, most notably those 
related to morbidity and mortality were central to this behaviour suggesting that 
increasing public awareness of symptoms may not in itself be sufficient to 
encourage all women to seek medical advice. Rather, changing perceptions of 
breast cancer and its treatment should be incorporated into health promotion 
campaigns. However, this is unlikely to be straightforward as women in the 
present study were frequently found to avoid medical information that elicited 
anxiety. This may extend to the detection of symptoms via breast self-
examination and represents an area requiring further exploration. What is more, 
the reluctance of some women to have responsibility for their breast health as 
demonstrated throughout this research may influence self-examination 
behaviour in a non-clinical population especially those women who are eligible 
for mammography screening. The following section focuses on policy 
developments with regards to information provision and contemplates the 
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effectiveness of new initiatives in light of the study findings concerning 
information management. 
8.3 Information provision and management 
Diagnosis elicited acute stress reactions, including denial, shock, and disbelief. 
Participants' psychological state combined with the limited timeframe for 
contemplation was found to influence acceptance of medical opinions and in 
turn their role in the surgical treatment decision-making process. It is worth re-
emphasising that although some women spoke of an active role in surgical 
decision-making, by definition this was more akin to a shared process and the 
majority of participants reported passive involvement. Furthermore, while all 
women interviewed reported a passive role in subsequent treatment decisions 
this was rarely contested and consciously handing over control to healthcare 
professionals represented a positive coping strategy. Similarly, during this 
process and throughout treatment, particularly hospital-based interventions, 
women managed their access to information and frequently engaged in 
avoidance, to facilitate coping. This has implications for policy advocating 
informed and shared decision-making (Department of Health, 2010) as well as 
for recent initiatives focused around information provision (Department of 
Health, 2011). 
The National Cancer Survivorship Initiative (Department of Health, 2011) is 
currently testing giving patients a care plan at the end of their primary treatment 
which includes symptoms of possible recurrence, lifestyle improvements, work 
and financial concerns and signposting to support groups. The aim is to 
promote ownership and support survivorship after treatment yet, as illustrated in 
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this study, the timing of this intervention (after surgery) may prove counter-
productive with the stress elicited leading some women to manage this 
information through avoidance. 
Similarly, Fast Access to Cancer Treatment Support (FACTS; Department of 
Health 2011) is another such programme that has developed across Lancashire 
and South Cumbria with the aim of raising awareness of patients about 
oncology emergency. The objective is to enable individuals undergoing 
chemotherapy to spot the signs and symptoms of life-threatening side-effects 
through the dissemination of information folders, a FAST alert card and a pre-
chemotherapy DVD. The findings of the present study, however, suggest that 
some women with breast cancer will choose not to view this information given 
its anxiety provoking properties. 
8.4 An altered self 
In line with Goud's (1995) writings, the disruption elicited by a breast cancer 
diagnosis and treatment regimes challenged participants' notions of the self. 
Corresponding somewhat to Morse's (1997) model of self development the 
acute phase of participants' experience rendered little discourse pertaining to 
self change as these women attempted to cope with the stress elicited by the 
shock of diagnosis. However, the distress that constituted this period of waiting 
(until surgery) and behaving differently towards the body suggests a change in 
women's self-concept, though one which may not be easily articulated. Unlike in 
many other chronic illnesses, women in the present study reported a lack of 
symptoms that impacted on everyday life during this time, which may 
additionally help to explain this finding. Furthermore, the timeframe from 
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diagnosis to surgery was rarely more than one week leaving little time for 
acknowledgement of self and identity change. Accordingly, it is proposed that 
although disruption is at the core of this stage of women's experience that 
change to the inner self began to emerge with the realisation that they were 
moving from a state of health to illness. 
Full adoption of a transitional identity occurred (Clarke and James, 2003) as 
participants began to experience the effects brought about by primary treatment 
with post-operative recovery and frequent engagement in the healthcare system 
altering these women's previously healthy identity. Women's accounts 
subsequently reflected the notion of a medicalised self (Tishelman & Sachs, 
1998) with their thought processes dominated by medical issues and treatment 
regimes. During this time these women sought normality and restitution (Frank, 
1995), focusing on regaining the self that existed prior to breast cancer in both a 
physical and psychological sense. 
However, in striving for a restored self (Charmaz, 1987) the participants 
acknowledged that change had occurred though they made attempts to restrict 
the extent of the altered self. In exploring this issue, the current research has 
provided support for the distinction between an inner and outer self (e.g. van 
Wersch, 2001). This is demonstrated through the lack of concordance between 
women's private feelings and sensations and the outer self enacted through 
social interaction, habits and women's thought processes regarding the social 
world. As an example, women's sensed feelings of distress altered their inner 
self. Yet, they simultaneously engaged in the protective buffering of others by 
concealing their inner emotions and by behaving as 'normally' as physically 
possible thereby projecting an unchanged outer self. 
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Moreover, the role of the body in forming identities and representing the self 
(Shilling, 1993; Woodward, 2002) adds greater complexity to the application of 
self theory to breast cancer as the physical impact of breast surgery and 
adjuvant therapies prevented the participants from re-establishing a healthy 
identity. Consequently, although these women tried to maintain a predominantly 
unchanged self, at least in terms of the perceptions of others, the ongoing 
impact on activities of daily living as a result of breast cancer treatment meant 
women could do little else but accept an altered self (Charmaz, 2002). 
Nonetheless, many of the women who participated in the current study hoped 
that this change would be temporary. 
Throughout the year post diagnosis participants' view of the 'self' was often 
based on interactions and relationships with others (e.g. Charmaz, 1983) which 
was particularly evident at the mid-way point given the multitude of changes to 
the body. Importantly, this was rarely linked to actual encounters but rather was 
the product of women's perceptions of how others would react to their changed 
body, in terms of breast (including partial loss) and hair loss. This can be linked 
to Harre's (1998) theory of senses of self, and specifically to the self we are 
perceived to be by others and which is based on our public expression of self 
though as noted earlier is complicated by the self we want to project. All 
participants managed the body, to some degree, through a variety of measures 
including the use of prostheses, reconstructive surgery, wigs, and clothing. In 
doing so women hoped to avoid responses that would reinforce their illness 
identity and the loss of a social feminine identity which would in turn elicit 
anxiety. Women's confidence during hospital-based treatments was often low 
and this in itself had a negative impact on interactions with many of the study 
participants avoiding social encounters with those outside of the immediate 
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family. While this improved over time women's ongoing management of the 
body to early follow-up (and potentially beyond) suggests a long-term impact on 
the outer self. In addition, although identities associated with the former self 
were often re-established (e.g. employment, housework) and the aim for a fully 
restored self remained at the heart of the accounts of some women, inner self 
change was strikingly evident. 
These women often rejected a survivor identity (Kaiser, 2008), which can be 
construed as a social identity via membership in this social category (Gergen, 
1991), as they were determined that breast cancer would not alter their way of 
life despite adjustment to their life perspective. In contrast, twelve months post 
diagnosis some women had willingly taken on the identity of a breast cancer 
survivor viewing breast cancer as a platform for action and often planned to 
undertake activities associated with cancer charities such as the Race for Life. 
In accordance with Frank's (1991) notion of illness as a vehicle for self -
transformation (as described in Chapter 2, p.50) breast cancer frequently led to 
a supranormal self (Charmaz, 1987), one that is perceived to be better than that 
prior to illness. This was illustrated through participants descriptions of an 
altered personality, which is argued to be integral to the self (Tesser, 2002) and 
which in the present study was linked to a rediscovered self, that has always 
been but had gone unrecognised for many years. Similarly, altered priorities 
and goals, changed behaviours and reformed relationships were integral to 
these women's new self, though they did not always perceive such change as 
being linked to the self. Echoing Frank's (1993) concept of an evolving self, one 
year on from diagnosis women continued to instigate behavioural and life 
changes, all of which influenced their sense of self and identity. 
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In summary, the findings from the present study reflect a postmodern view of 
the self, one that is multifaceted and changes with differing circumstances. 
However, the research additionally indicates that existing self theory and stage 
models of the development of a new self (e.g. Morse, 1997) are limited in their 
applicability to breast cancer. A complex interplay between personal and social 
identity and the influence of the body in representing the self, which is typically 
underestimated in theory, have been illustrated throughout this study. 
Accordingly, participants' use of the body to project an identity or self that was 
aligned with normality and that they themselves desired yet simultaneously 
acknowledging change, whether perceived to be temporary due to 
medicalisation or longitudinal given an altered perspective, constitute unique 
insights. 
8.5 Perspectives on embodiment 
Undoubtedly breast cancer brought about a focus of attention on the body and 
the physical limitations and appearance changes that resulted from treatment 
regimes (e.g. Leder, 1990; Kelly & Field, 1996). However, contrary to the work 
of Williams and Bendelow (1998) many participants, particularly those who had 
undergone a lumpectomy, did not speak of a fragmentation between the body 
and the self and continued to refer to "my breasts". Conversely, when 
discussing breast loss women who had undergone mastectomy referred to their 
breasts as "them" and "the breast" suggesting a disembodied perspective. 
These women perceived their breasts as external organs that by middle age 
were no longer functional which is indicative of the notion of the body as a 
physiological system (Radley, 1996). On the other hand, it could be argued that 
these perceptions of breasts constituted a separation of breasts from the body 
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rather than the self. Accordingly, women's sense of embodiment may vary given 
the meaning ascribed to breasts, the recommended surgical treatment and 
women's age in relation to childbearing years. The present study has found that 
the view of breasts as an appendage to a woman's body was reinforced by 
healthcare professionals particularly through the emphasis on the use of 
prostheses which Young (1992) argues leads to a view of breasts as 
replaceable. Women undergoing chemotherapy often displayed signs of 
disembodiment though this was short-lived, resolving following this treatment. 
Nonetheless, as suggested by Maclachan (2004) disembodiment may help 
women to cope with decision-making to change bodily appearance and viewing 
breasts as outside of the self served as a means of coping and as a self-
protection strategy. 
Irrespective of the breast surgery conducted all participants considered breast 
cancer to be separate from the self being something that was alien, had 
invaded the body and as reported by Lindwall and Bergbom (2009) was 
threatening to their existence. Moreover, women's desire to "get rid of it" 
suggests a distancing of breast cancer from the self and echoes the writings of 
Cassell (1976) who argued that it is disease itself that is objectified. While this 
has not been found for all illnesses the findings of the current research suggest 
that this is pertinent to breast cancer though embodiment issues were also 
evident for some women undergoing particular treatment modalities (e.g. 
chemotherapy). 
The multifaceted nature of the experiences of this study's participants is 
reflected through application of Franks (1995) four problems of embodiment 
(Chapter 2, p.55) to breast cancer. On the continuum marked by control at one 
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extreme and contingency at the other, each end of the spectrum was 
demonstrated. Women perceived a loss of control over the body throughout the 
year post diagnosis particularly in relation to having developed breast cancer 
and the potential for metastases and/or a recurrence as well as physical 
limitations resultant to treatment. However, they simultaneously spoke of having 
ultimate control over the body through the power to refuse treatment and via 
their ongoing management of the body including the impact of treatment side-
effects. Similarly, regarding body-relatedness participants were not dissociated 
from their body in the manner in which Frank suggests as they attended to 
treatment side-effects and managed bodily appearances. Yet at times, such as 
that between diagnosis and surgery and immediately post-surgery, women 
avoided the body, choosing not to look at or touch the body and many 
participants demonstrated a lack of breast self-examination throughout the year 
following diagnosis. 
Application of the study data to other-relatedness additionally indicates that 
women may adhere to both extremes of Frank's continuum. Although all 
participants acknowledged the influence of others (e.g. breast surgeon, partner, 
and children) in shaping their views of the body and its management (for the 
sake of others), the body was frequently monadic and separated from loved 
ones. This was evident when these women looked at, and dressed, the 
changed body as they typically did so alone. Moreover, while residing in 
hospital following surgery and for those women undergoing hospital-based 
chemotherapy, comfort was often found in the knowledge that they were not 
alone and several women formed supportive friendships from others in the 
same situation. Accordingly, this is supportive of the "tend-and-befriend" model 
of stress responses (Taylor et al., 2000) and is in contrast to Frank's suggestion 
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that the medical system reinforces a separation from other patients. Finally, with 
regards to the embodiment problem of desire all participants expressed desire 
through the body as illustrated via their desire for normality in bodily 
appearance. However, for some women this was situation specific and while at 
home they chose not to wear an external prosthesis or alter their dress. 
Consequently, women may concurrently demonstrate behaviour at each 
extreme of Frank's continuum of the four body problems throughout the year 
post diagnosis. Furthermore, the extent to which these embodiment issues 
emerged varied by situation and time within the illness experience, women's 
breast cancer schema, perceptions of the body, and social interactions and 
relationships. 
As reviewed in chapter two Frank (1991) relates the problems of embodiment to 
what he terms ideal body types. The disciplined body-self is theorised to 
attempt to reassert control through self-regimentation and consequently is 
marked by dissociation from the monadic body which becomes an "it" to be 
treated and exhibits a lack of desire. In line with this body-self a focus on and 
compliance with diagnostic and treatment regimes was noted for all participants 
and was particularly evident in accounts of the early phase of breast cancer 
including pre-surgery experiences. Yet, as discussed previously not all 
participants dissociated from the body or other individuals and the pursuit of 
medical regimes was perceived to take away women's control over their lives 
and stimulated a desire for normality. Furthermore, women's experiences of 
dissociation, control and desire varied according to the prescribed treatment 
regime which for some women facilitated social interaction. Consequently, while 
women may conform to some aspects of Frank's description of the disciplined 
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body women rarely demonstrated all aspects of this body-self. Undergoing a 
mastectomy and chemotherapy seemed to be most associated with this body 
type perhaps given the need to cope with breast loss and prolonged hospital-
based treatment regimes. 
What is more, the participants attempts to reassert normality in their lives 
included regaining control of the body through managing their appearance with 
the aim of re-creating a healthy body suggesting that these women additionally 
concurred to Frank's mirroring body. However, although all participants' 
accounts reflected this body-self they did so to varying extents with some 
women seeking reconstructive surgery but others conducting relatively little 
management of the body and in some situations this group of women chose not 
to disguise the changed body. It was also apparent that while visual image was 
central to these women's experiences, survival was ultimately paramount in all 
cases, influencing acceptance of medical opinions and role in the treatment 
decision-making process above body image. Contrary to Frank's notions 
regarding this body type the women who participated in the present study were 
found to not solely want for themselves but normalised their appearance for the 
sake of others. 
The dyadic dominating body was illustrated through women's anger towards 
others yet Frank's belief that this occurs due to a loss of desire was not 
demonstrated rather at its source was the re-negotiation of roles and associated 
loss of identity within the home (which women desired to return). The issue of 
dissociation from the body is additionally relevant to this body-self which was 
not evident for all participants though when present was demonstrated 
simultaneously with the disciplined and mirroring body-selves. Likewise, the 
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communicating body-self characterised by accepting a loss of control and the 
fragile nature of the body was evident in women's accounts particularly one 
year post diagnosis when they had contemplated existential questions. 
Women's awareness of the body as a communicating tool and their consequent 
body management has been previously highlighted though Frank argues is at 
the core of this body-self. Moreover, Frank states that individuals categorised as 
a communicative body-self want to relieve the suffering of others and it could be 
argued that as all women participated in the present research with the aim of 
helping others that they conform to this body type. 
Accordingly, with regards to Shilling's (1993) criticism that it is unclear how 
Frank's different body types are influenced and chosen the current research 
findings indicate that when applied to breast cancer, women's sense of self 
including social aspects of the self are influential. Moreover, these body types 
do not seem to be chosen as such but emerge as a result of differing changes 
to the body and consequently the extent to which these body-selves are 
enacted varies by individual. They may be embodied at different intervals in 
women's experiences while other body types occur simultaneously both in the 
short and long-term. 
Such criticism can be extended to Frank's (1995) narrative types, which have a 
basis in self and body theory, as individual women frequently demonstrated 
narratives of restitution, chaos and quest within their accounts of experiencing 
breast cancer. Women's wait for normality corresponds to the restitution 
narrative yet the distress reported during the acute and mid phases often 
reflected a chaos narrative. Quest narratives were particularly evident during 
women's final interviews as they contemplated long-term changes to their life 
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and self as a direct result of breast cancer. Thomas-MacLean (2004b) reported 
contradictions in women's restitution narrative pertaining to women's 
acknowledgment of body change but not self change. This was infrequent in the 
present research and issues regarding the recognition of self change were 
identified (see chapter 7). Consequently, this research argues that these 
women did not conform to one narrative type throughout the year following 
diagnosis but most commonly displayed elements of each, sometimes within 
the same interview, though to differing extents and for varying lengths of time. 
The present study findings also provide some support for the notion of liminality 
as a link between illness and embodiment, as conceptualised by Little et al. 
(1998) though concludes that further exploration of this concept is needed. The 
women interviewed were found to move from a state of perceived health to one 
of illness which in turn, albeit to differing extents, disrupted women's lives and 
the relationship between body and self throughout the year following diagnosis. 
The first stage of the process, acute liminality, began to emerge as women 
suspected they had breast cancer (as discussed in chapter 5) and receiving the 
diagnosis subsequently evoked reflection on existential issues and entering into 
a psychological state marked by stress reactions, disorientation and uncertainty. 
Participants' cancer schema associating the disease with mortality led to the 
body becoming a threat to these women's existence and the experience of 
bodily limitations resultant to treatment regimes further led to an alienation of 
the self from the body. In accordance with the theory of Little et al. (1998) a full 
transition back to health and a sense of embodiment did not occur during the 
data collection period with women remaining between health and illness. 
Liminality became sustained due to ongoing reminders of breast cancer via the 
body (e.g. scars, treatment side-effects), managing appearances (e.g. use of 
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external breast prostheses), ongoing treatment (e.g. Tamoxifen), medical 
regimes (e.g. hospital-based follow-up) and breast surveillance (whether by 
women themselves or healthcare professionals). What is more, the loss of 
normality, ongoing uncertainty and strive to keep breast cancer at the back of 
the mind further suggests that in the context of breast cancer liminality is 
experienced in the long-term and potentially throughout survivorship. 
As suggested by Little et al. (1998) considerable variation exists in the length of 
time of the acute liminal phase as while the completion of hospital-based 
treatments would seem to correspond to the beginning of convalescence and as 
such sustained liminality, this timing depended on the prescribed treatment 
regime. Women's financial circumstances additionally influenced their time for 
reflection and return to normality and as discussed in the previous chapter 
some women attempted to avoid contemplating existential issues. Furthermore, 
the finding that women perceived themselves to no longer have breast cancer 
following surgery, particularly mastectomy, perhaps limits the extent of liminality 
experienced by some women. The complexity of issues of control identified 
through the present study, and discussed in relation to Frank's (1995) problems 
of embodiment, also indicates that sustained liminality should not be defined by 
acts of control. It is equally noteworthy that the woman experiencing a breast 
cancer recurrence expected the diagnosis and did not experience the same 
responses, including those of uncertainty, as other participants. Accordingly it 
could be questioned whether she had re-entered a state of liminality, or whether 
she had never ceased to experience liminality. This study has demonstrated 
that women's evolving experiences of liminality and changed sense of body, 
embodiment and self required the adoption of multiple coping strategies that 
were modified throughout the healthcare trajectory. 
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8.6 Coping with breast cancer 
Breast cancer constituted a stressful experience for the women involved in the 
present study yet in contrast to the premise of Canon's "fight or flight" model 
(1932 as cited in Ogden, 2007) at the point of diagnosis these women perceived 
their only option to be fight. As such they engaged in primary treatment with the 
aim of 'getting rid of it' to ensure the survival of the self and the well-being of 
loved ones. Furthermore, the participants were found to respond to a multitude 
of stressors, an evolving process which began even prior to diagnosis with the 
identification of a breast abnormality. Consequently, the study findings provide 
some support for the "tend-and-befriend" model (Taylor et al., 2000) as women 
exhibited a tending response as well as befriending behaviour, drawing on 
social networks to aid decision-making, manage anxiety and provide support 
throughout their experience. However, individual circumstances influenced the 
extent to which the women interviewed displayed both components of the model 
and these women varied in the drivers underpinning their stress responses. 
The multifaceted nature of the experiences of the women in the study sample 
has additionally been illustrated through their use of multiple coping strategies 
to manage differing aspects of their experience. In support of prior research 
participants were found to use avoidance in relation to communication 
(Donovan-Kicken & Caughlin, 2011) and emotional suppression (Drageset et 
al., 2009) though this mechanism was a positive strategy used to manage 
anxiety. This was also evident when these women reflected on existential 
concerns and faced ongoing uncertainty about their future as they put the 
negative aspects of breast cancer to the back of their minds in order to facilitate 
a positive outlook characterised by benefit finding and having hope for the 
future. 
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That said, it was not uncommon for participants to experience psychosocial 
distress including episodes of depression particularly at the mid-point in the 
year post diagnosis. These women were typically prescribed antidepressants by 
their GP to manage this aspect of their experience. However, interestingly 
Emma, whose narrative displayed the most chaos (Frank, 1995), and for whom 
depression was a prevailing feature did not perceive this drug treatment to be 
effective. Similarly, Emma found counselling to be traumatic and consequently 
alternate means of managing this phase of women's experience should be 
investigated. Numerous women in the present study described considerable 
physical and psychological benefits from the use of complementary therapies 
and this may provide one avenue for exploration. 
Psychosocial interventions designed to decrease distress and depression in 
breast cancer patients typically incorporate psychological and pharmacological 
therapies and report some success (e.g. Akechi et al., 2007) though this 
combination may warrant revisiting. Investigating reductions in these issues 
using a longitudinal intervention raises the criticism that as seen in the present 
study women's emotional reactions to their disease varies naturally over time. 
Additionally, the passage of time can bring about treatment completion and/or 
reduction in treatment side-effects and in turn a move towards normality which 
may in itself reduce women's psychosocial distress. Moreover, the findings from 
the current study have implications for existing research predicting 
psychological distress and mood disorders via screening immediately post 
diagnosis (e.g. Ando et al., 2011) as depression typically became apparent 
several months following diagnosis subsequent to a period of reflection. This 
also raises the question of whether women were simply reacting to a stressor, a 
proposition that was supported by Sarah's account of experiencing a 
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recurrence, in which she discussed having greater awareness of reactive 
depression. Accordingly, if managed effectively episodes of reactive depression 
may not have become a prolonged state and may have decreased the 
medicalisation of breast cancer. 
Women's desire to be positive and find meaning and benefits in their 
experience has previously been noted in the preceding and current chapters 
though as reported by McCann and colleagues (2010) the challenges of body 
and self persisted throughout the year following a breast cancer diagnosis. One 
year on breast cancer continued to have a presence in women's lives (McCann 
et al., 2010) through women's body as a permanent reminder and mind via 
untidy ends including ongoing uncertainty supporting Kaiser's (2008) call for a 
model of life after breast cancer. However, while some women were found to 
struggle to regain normality in the longer-term as a result of continuing hospital 
appointments these follow-up appointments were equally considered to be 
reassuring. Routine appointments were welcomed by women particularly those 
who preferred responsibility for their breast health to remain with healthcare 
professionals and the medical system. 
As was advocated in 2002 (Bryan, Holmes, Postlethwaite & Carty, 2002) the 
breast unit from which participants in the current study were recruited held cost-
effective follow-up clinics staffed by specialist breast care nurses. When 
considering the limitations of such follow-up in relation to detecting recurrence 
and metastases and the continual high rates of breast cancer diagnoses in the 
UK, means of easing clinic pressures have been proposed. Routine hospital 
follow-up being replaced by remote monitoring for patients who are willing to 
adopt this approach is currently being trialled (Department of Health, 2011). 
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However, whether this will address women's psychological need for 
reassurance and support is debatable in light of these study findings. 
Above all this research has uncovered that the women who participated in this 
study experienced breast cancer in different ways depending upon, for 
example, their medical history, cancer schema, perceptions of the body, social 
support, and coping strategies. Consequently, not only do models of care need 
to address women's changing needs throughout the year following diagnosis, 
and potentially beyond, but psychosocial interventions need to be based in 
women's experiences. 
8.7 Reflection on methodology 
The hermeneutic phenomenological approach enabled exploration of women's 
lived experience of breast cancer throughout the year following diagnosis. The 
methodology elicited description of women's accounts of their experience as 
well as interpretation of the meaning women ascribed to these experiences. The 
longitudinal approach complemented the notion of the hermeneutic circle as the 
process of questioning and re-examining the text and accordingly the cycle of 
ideas generated could be explored further during the subsequent interviews. 
The longitudinal nature of the research proved immensely valuable in revealing 
changes in women's experiences over time. This approach uncovered 
transitions such as those from health to illness and women's ongoing wait for 
normality as well as changes in the self and crucially did so as such transitions 
occurred. Indeed, the timing of women's interviews often happened during 
periods of waiting (e.g. prior to or between chemotherapy treatments) and 
women's accounts suggest that these episodes induced the greatest reflection 
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on the impact of breast cancer on women's self, identity and emotional well-
being. 
The longitudinal approach has provided some insight into the timing of issues 
for individual women throughout the healthcare trajectory highlighting their 
hopes, fears and coping strategies from diagnosis to early follow-up. The 
findings obtained provide support for Heidegger's notion that past experiences 
impact upon the present and future. This was particularly evident in relation to 
those women who had experienced prior breast disease and/or for whom 
cancer had featured in their lives previously, influencing responses to diagnosis 
and surgical treatment decision-making. Reflection on the language recorded in 
the interview transcripts, as proposed by van Manen (1990) also enabled 
interpretation of women's sense of embodiment and the meaning of breasts. 
In an attempt to encourage production of meaning within the interaction of the 
interview illness/treatment grids were used. These were completed by the 
researcher during the interview on the basis of the ongoing discussion with the 
individual woman. Viewing completion of the grid and being in control of its 
content helped to alter the dynamic of the interview facilitating researcher-
participant interaction through a conversational style of interview. Women were 
provided with a copy of their grid to review immediately prior to commencing 
their second and third (where applicable) interviews which assisted the swift 
development of a rapport. As depicted in the illness/treatment grid of 'Laura' 
located in Appendix 1, the grids served as a visual reminder of individual 
women's experience to date and accordingly helped the researcher to ensure 
coverage of issues that had emerged previously. Moreover, women were able 
to review and reflect on the present status of these issues and their anticipation 
of relevant future change. Consequently the grids were a successful 
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accompaniment to the longitudinal approach and by the final interview allowed 
women to see a visual representation of their journey. This often led to women 
commenting on their progression and reflecting on their emotional state and 
coping at differing time points. The illness/treatments grids were accordingly a 
valuable tool when conducting multiple interviews over time. 
8.8 Reflexivity 
As a methodological approach, hermeneutic phenomenology acknowledges 
that the researcher's knowledge and experiences influence the research 
process including data collection and analysis. With this in mind, this reflection 
considers personal and epistemological reflexivity (Willig, 2001) beginning with 
the position of the researcher and the potential influence on the research 
process. When embarking upon this research study I was working in both 
academia teaching psychology and evidence-based practice as well as in the 
National Health Service in the hospital from which the study sample was drawn 
leading an evaluation of nursing and surgical roles in cardiothoracic care. I had 
experience of researching chronic illness and illness management in the context 
of back pain and in doing so had developed an interest in exploring illness 
experiences, seeing the value of gaining the perspectives of those who would 
be affected by policy decisions. I had a broad knowledge of biology and 
psychology and a working knowledge of the NHS and breast cancer, all of 
which provided me with the necessary background knowledge and research 
experience to undertake the study. I had no personal experience with breast 
cancer. 
Discussions with the breast care team led to a realisation that breast cancer 
was now recognised to be a chronic illness but that few research studies 
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explored women's experiences over time. Several areas were reflected upon 
during the early stages of the research study including would participants speak 
openly to a researcher who had no personal experience of breast cancer, was 
associated with the site of their healthcare and would women be willing and 
able to participate in a longitudinal study? 
The first interview conducted alleviated any such concerns as 'Linda' displayed 
an openness and desire to tell her story. This may in part be the result of 
women reporting viewing the role of researcher as being independent of the 
Breast Care Unit and their healthcare. This was emphasised by the researcher 
and may have been further facilitated by participants choosing the location of 
their interviews. All twenty participants requested being interviewed away from 
the hospital, preferably in their own homes. As the research progressed 
possible explanations for this decision emerged including that women had their 
own pre-conceptions about breast cancer and its treatment and did not wish to 
add to the deviation from normality elicited by medical regimes and hospital 
visits. For similar reasons several women stated that they did not want to attend 
breast cancer support groups and did not wish to speak to other women who 
had experienced breast cancer, at least while they were undergoing active 
treatment. Accordingly, in relation to these women, being a researcher with no 
personal experience of breast cancer was beneficial. It should equally be noted 
that some women sought support from friends and family who had experienced 
breast cancer though they too made a conscious decision to not attend a 
hospital based support group. Maintaining distance from the hospital 
environment and to an extent breast cancer was evidently important to many of 
the women interviewed. 
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Having a working knowledge of cancer and specifically the language of cancer 
did, however, ensure that when participants used breast cancer terminology as 
they became immersed in the medical world there was no need to disrupt the 
flow of their story to ask for clarification of terms. Having no personal 
experience of breast cancer additionally enabled me to remain open to 
questions that emerged from studying the phenomenon and allowing text to 
speak rather than constructing meaning on the basis of personal experience. 
Nevertheless, it must be acknowledged that much was learned from the first 
interviews and the process of conducting a large number of interviews enabled 
the development of lines of questioning as well as my interviewing skills. The 
longitudinal approach further enabled reflection on emerging interpretations with 
participants in subsequent interviews and facilitated the development of a 
trusting relationship. It is this relationship that I believe minimised attrition even 
when numerous women became unwell due to treatment effects, and enabled 
me to make informed decisions about returning for subsequent interviews. 
My relationship with participants grew over time and while these women shared 
their highly emotional experiences at time one reliving diagnosis and surgical 
intervention, the second interviews were frequently the most emotional. At this 
time point, women reflected on their experiences and mortality and shared 
thoughts and feelings that they had not previously divulged even to their closest 
friends and family. This was a humbling experience yet one that brought a 
sense of responsibility to ensure that these women's stories were accurately 
represented. The process of engaging with hermeneutic phenomenological 
research is argued to change the participant and the researcher and this 
became increasingly evident as the research progressed. Several women 
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acknowledged the change they experienced as a direct result of the research 
process: 
'I remember after the second one feeling so much better. I felt like I'd talked 
about it more than I'd talked about it for ages and I remember thinking that, 
feeling like I'd had this weight lifted, thinking God I feel loads better for that. I 
think you try not to tell people who are that close to you how you feel and 
probably when you sit with your friends they never ask you things like this so 
they never bring it out' (Laura; Interview 3; Lines 362-367). 
For one participant (Emma) however, the research uncovered the extent of the 
difficulties being experienced coping with the diagnosis and treatment of breast 
cancer. During interview two it became apparent that Emma was experiencing 
significant distress yet was reluctant to seek help from the Breast Care Nurses 
due to concern that she would be impinging on the time of a busy team. In 
consultation with Emma I contacted one of the Breast Care Nurses during the 
interview and facilitated an opportunity for her to acquire additional support. 
While the outcome was positive for Emma such highly emotional interviews 
rendered maintenance of hermeneutic alertness (van Manen, 1997) difficult 
during the interview. Consequently, such stepping back and reflecting on 
meanings of situations was undertaken following these interviews including 
during transcription, subsequent interviews (where possible), and data analysis. 
One of the most unexpected outcomes of this research was the individual 
variation in the personal and medical circumstances of the study participants. 
Several women recruited to the study had experienced prior breast disease, 
one participant had previously undergone a bilateral mastectomy due to genetic 
testing while another was experiencing a recurrence. Moreover, three women 
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initially underwent a lumpectomy yet were later recalled for mastectomy 
surgery. Such diversity may reflect current trends in the presentation of breast 
cancer such as the increasing numbers of women presenting with a breast 
cancer recurrence and the move towards breast-conserving surgery as the 
primary recommended treatment. Accordingly, while the lack of homogeneity of 
the sample could be criticised, such variation resulted in the capturing of these 
emerging experiences. 
Reflection is integral to the processes of hermeneutic phenomenology with 
themes being identified through reflection on what is critical to the experience 
as well as through the reading of other texts and writing up the study findings. 
These acts led to greater researcher insight though the huge quantity of data 
obtained had been unexpected. As such the data often felt overwhelming and 
transforming it into a readable story that reflected women's longitudinal 
experiences while managing the diversity of the sample was challenging. Yet, 
the longitudinal approach and rapport built with the women interviewed enabled 
the clarity of interpretation to be checked with participants. Similarly, attempts 
were made to test the intelligibility and meaningfulness of the study findings via 
presentations to the breast care team and fellow academics. 
Finally, returning to the impact of the hermeneutic phenomenological approach 
on the researcher, this research posed not only an academic challenge but has 
led to reflection on my own feelings about my body, health and self. At times, 
particularly during data collection, I found myself becoming increasingly vigilant 
of conducting screening and healthcare practices. Without doubt this research 
has had a lasting impact on my life and I am indebted to those women who 
participated. 
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8.9 Limitations of the study 
The qualitative nature of this study has enabled insight into women's 
experiences of breast cancer. However, the study is limited to a small sample of 
participants from one geographical area of the UK and accordingly the research 
findings lack generalisability reflecting the individual experiences of these 
women. As a result, this study cannot indicate the prevalence of issues raised 
such as those pertaining to treatment side-effects. In contrast to relevant 
existing longitudinal studies the present research focused on breast cancer 
thereby eliminating limitations associated with amalgamating the experiences of 
individuals with differing cancer diagnoses. Nevertheless, although none of the 
women recruited were found to have metastases during the data collection 
period women varied in their diagnoses with regards to type and stage of breast 
cancer with some women being found to have lymph node spread. These 
factors influenced the recommended treatment pathway and in turn women's 
experiences. That said, the characteristics of the sample were representative of 
the caseload seen by the symptomatic breast unit. All participants described 
their ethnic origin as White British though the inclusion of participants from other 
ethnic backgrounds may have elicited different experiences and alternate 
meaning ascribed to the issues raised in this study. Likewise, the majority of 
women who participated in this study reported experiencing stressful life events, 
including bereavement, divorce, issues with children, and financial difficulties, 
both in the months prior to diagnosis and throughout the lifespan. 
Consequently, historical factors are likely to have influenced women's 
experiences of breast cancer. However, research on stress-tumour pathways 
indicating that stress may influence tumour growth and the course of disease 
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(e.g. Antoni et al., 2006) may provide a partial explanation as to the prevalence 
of such issues in the study sample. 
The self-selecting nature of the sample constitutes an additional limitation as 
recruitment largely relied on the altruism of individual women in terms of 
returning the required materials to the researcher. The dissemination of 
recruitment materials by the breast care nurses was deemed to be the least 
intrusive and ethically appropriate method given the anxiety-provoking nature of 
attending a symptomatic breast clinic yet the busy nature of the unit meant that 
accurate response rates could not be established. Accordingly, it is possible 
that women who did not participate may have reported different experiences. 
This study addresses the paucity of longitudinal research exploring women's 
experiences of breast cancer and allowed transitions, such as from health to 
illness and women's strive for a return to their former self, to be uncovered. The 
specific coverage of the year following diagnosis leads to a focus on the acute 
healthcare trajectory and early follow-up time period. Accordingly, this study 
cannot provide description or interpretation of women's experiences beyond this 
point. The recruitment of one woman who was experiencing a recurrence after 
ten years and another who was diagnosed with breast cancer after having 
undergone a bilateral prophylactic mastectomy for risk management fifteen 
years previously enabled some inclusion of aspects relevant to long-term 
coping as well as reflection on past events though the current diagnosis 
dominated discussions. The collection of retrospective data is a widespread 
limitation within breast cancer research and a factor that this study has 
overcome by conducting a series of interviews during women's active treatment 
and early follow-up experiences. 
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Finally, a problem inherent in all qualitative research that of researcher 
interpretation of data was addressed through member checking at the end of 
each stage of analysis, facilitated by the multiple interviews conducted with 
each participant. The ongoing completion of illness/treatment grids further 
ensured the accurate representation of women's experiences and the issues of 
relevance to them. 
8.10 Directions for future research 
This research has contributed to the gap in the literature by focusing on 
women's experiences of breast cancer from a longitudinal perspective 
uncovering issues of relevance to women throughout the healthcare trajectory 
to early follow-up. This has raised several areas requiring further exploration 
including those surrounding women's responses to information and explanation. 
Women's management and often avoidance of information immediately post 
diagnosis and during the treatment course provokes questions particularly 
regarding informed shared decision-making and the influence of cognitive 
dissonance on this process. Furthermore, in light of policy on treatment 
decision-making and the present study findings regarding preferences for 
passive involvement, interactions during consultation are an additional area 
worthy of investigation. 
Having previous non-malignant breast disease and/or a family history of breast 
cancer was noted as influencing treatment decision-making and diagnostic 
acceptance yet this remains an area lacking exploration. What is more 'Sarah' 
who was experiencing a recurrence and 'Ellen' who had previously undergone a 
bilateral mastectomy following genetic screening each provided data that can 
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be considered a negative case analysis albeit in differing ways. Their 
experiences suggest that women in such circumstances may have needs that 
vary from women experiencing breast surgery for the first time. These women 
exhibited differing insight and expectations, informational needs, preferences for 
involvement in the treatment decision-making process and an impact on the 
already changed body and self which requires further examination. 
Similarly, few studies have considered the waiting experiences specifically of 
women with breast cancer and while this research has uncovered this issue 
during the year following diagnosis, for many women this wait continued at their 
third and final interview. Consequently, subsequent research could extend data 
collection beyond this point to explore the full extent of women's wait for 
normality. This is particularly vital given estimations that approximately 550,000 
people are alive in the UK following a breast cancer diagnosis (Maddams et al., 
2009). 
This research study has demonstrated that women's responses to breast 
cancer are not dissimilar across differing surgical treatments yet mastectomy 
dominates the existing literature despite increasing use of breast-conserving 
surgery. While mastectomy elicited specific themes pertaining to breast loss 
and the use of external prostheses women who underwent lumpectomy also 
experienced altered body perceptions and managed the body to disguise breast 
surgery. Moreover, lumpectomy typically brings the need for multiple non-
surgical treatments and with it a different assault on the body. Further 
exploration of women's experiences in this neglected area utilising a larger 
sample is required. Only two women in the current study underwent Herceptin 
treatment, one of whom was a private patient, and this constitutes one area 
lacking exploration. Likewise, as it is now common practice to prescribe 
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adjuvant endocrine therapies for five years to reduce the risk of recurrence 
(Harmer, 2007) women's long-term experiences of Tamoxifen warrant further 
investigation. The present research identified that many women continued to 
report side-effects and bodily changes as a direct result of the drug treatment at 
early follow-up and accordingly longer-term exploration of women's experiences 
is needed. 
8.11 Conclusion 
Through a longitudinal exploration adopting a hermeneutic phenomenological 
approach this research study has revealed the multifaceted experiences of 
breast cancer of twenty women diagnosed and treated in the North East of 
England. These women were found to experience breast cancer as a 
medicalised chronic illness resulting in issues of embodiment and liminality as 
women made a transition from a healthy identity to a life encompassed by 
hospital appointments and treatment regimes. Changes to the body disrupted 
the body-self relationship and while participants typically attempted to restore 
the inner self, there was often acknowledgment that this was not possible given 
the multitude of permanent reminders of having been diagnosed with breast 
cancer. Yet, simultaneously all participants, albeit to differing extents, managed 
external bodily appearances to maintain the outer self and disguise the signs of 
illness. Accordingly, the study participants were found to adopt a multitude of 
coping strategies to manage the body and also the stress, and often elements 
of grief, elicited by their evolving experience. However, individual variation in 
women's adaptation to their illness was evident throughout the healthcare 
trajectory. One year on from diagnosis participants had regained some 
normality yet acknowledged that they were forever changed by their experience 
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to date, and an ongoing struggle with uncertainty and treatment side-effects. 
Finally, this thesis has highlighted that while similarities have been uncovered 
there is uniqueness in the way in which each woman experiences breast 
cancer. Consequently, an individual approach to the long-term care of women 
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Participant 07 'Laura' 
Interview Events Decision-making Control Self Comments 
1 Found a lump and Consultant decided Everything was discussed but Don't feel ill due to Shock 
went to the GP a lumpectomy was "you've got to put yourself in breast cancer but the 
few weeks later necessary their hands" treatment makes you "I heard the word and I 
feel ill don't think I heard anything 
Mammogram and "It was all very quick, it "These are the professionals else after that" 
biopsy confirmed doesn't give you time who know what's best for you "Why me?" 
breast cancer to take things in" and that's the route you've got to Felt like they had made a 
diagnosis take" "I've lost my zap, a bit of mistake, were looking at the 
Initial reaction was to personality... I wrong notes 
have both breasts It is your choice but they know feel...nervous" 
Lumpectomy removed my initial what's best for you "I still think they've got it 
(20mm) thing was just to get rid Loss of hair means can wrong because I felt fine" 
of them both" though Loss of control over life while no longer wear make-up 
Lymph node the Consultant thought having treatment - "My whole life Too much information to 
sampling 3/11 this was too drastic is surrounded by it and I can't Still feel like woman due take in 
positive think of anything of else...you to husband and not 
"You do what they say, count down to the next requiring mastectomy Frightened of leaving 
Started you do what they think appointment" children (death) 
chemotherapy is right" If younger may have felt 
In control of breast cancer as no different Side effects from 
Consultant decided longer have breast cancer the chemotherapy - sickness, 
upon the treatment is "making sure I don't taste in mouth 
1 
chemotherapy and the 
Tamoxifen 
get it again" 
"The word cancer makes it 
real for me" 
"Aiming for the light" 
2 Chemotherapy No treatment decisions Difficult to feel in control as Still hasn't got "zap" Final chemotherapy was 
ended - these are made for backwards and forwards to the back and feels as if has better 
you e.g. about when hospital. "The chemotherapy lost some confidence. 
Met with the radiotherapy starts was more in control of me" However, am more Feels "gutted" about 
radiologist, hopeful now that it will starting the radiotherapy as 
planned sessions, Not making me "A year out of your life that you return as no side effects feels so well and yet still 
ready to start reassess my life have no control over, no say in" predicted with the having "to go through this" 
radiotherapy this radiotherapy. 
week Put yourself in the hands of It doesn't just happen to 
doctors and nurses Wanting to look normal other people 
Various for the sake of the 
appointments in In control of what telling the children. Still asking "why me" 
between to get children and in keeping things 
scar checked "normal" for the kids When you lose your hair Next anxious time will be 
you "look like you've got having a mammogram to 
"It makes you realise that cancer" see whether it has all 
anything's possible and worked 
nobody's immune to anything" Feeling better in self 
though is difficult as is At the moment cancer is 
the treatment that never far from your mind 
makes you ill not the 
cancer Reassurance at having a 
2 
After everything you go 
through the scar is the 
least of your worries 
Looking at the scar is 
comforting - a sign that 
cancer is no longer there 
Looking forward to going 
back to work and being 
"normal self" again 
number to ring to speak to a 
breast nurse 











Tamoxifen were made 
by the Consultant and 
her team 
Decision to return to 
work - felt ready 
Before no control but now "it's 
up to me to get over it" 
Been in control over "who knows 
and what information I've given 
to people...I've kept it all well 
hidden" 
Didn't feel in control of 
radiotherapy as "you're life's not 
your own, it's literally around 
hospital appointments" 
Control over cancer - pleased 
taking Tamoxifen as it is 
Feeling more like 
"normal self" with return 
to work, back into a 
"normal routine" 
Previously hiding self 
from others now "I'm not 
bothered talking about it 
and I'm not hiding away" 
Hair loss has had the 
biggest impact on self 
and has been the 
primary reason for the 
loss of confidence and 
Skin sore due to 
radiotherapy 
Loss of reassurance once 
radiotherapy had finished "I 
thought I'd be so relieved to 
get it over and I 
wasn't...that feeling of being 
on my own" 
"While you're going up and 
down there you know it's 
going away, it's getting 
better, they're treating it...it 
so bluntly ends...it's a 
3 
"keeping it at bay" and feeling in 
control of taking the Tamoxifen 
Control via vigilance over B S E -
"you have this side where you 
know you should be more 
vigilant but I've got this other 
side that says I don't ever 
wanna check them again 
because I don't wanna 
know...that silly side wins at the 
moment because I'm still for 
check-up's at hospital" 
"hiding away" 
Appreciating things 
more but "don't think it's 
changed me" though 
"can't imagine ever 
thinking it's over" 
Physical appearance 
altered - "they're 
definitely odd to what 
they were" 
Need for positive 
thought 
safety net" 
"It's time to forget about it 
and put it behind me" 
Breast cancer means "a 
year out of your life that's 
quite horrible but there's a 
light at the end of it" 
Life before and after breast 
cancer - "If there was a 
bridge I feel as if part of my 
life is going to be on that 
side of the bridge and part 
of it is going to be on this 
side of the bridge...it's like 





Pseudonym Age Marital status Employment 
status 







1 Linda 66 Married 
Previously 
widowed 
Retired 2 DCIS's identified; Mastectomy; 
Axillary sampling - node 
negative 
3 
2 Margaret 61 Married Full-time Lumpectomy; Axillary sampling 
of 9 nodes - node negative; 
Radiotherapy 
Previous lump in 
breast in 2005 -




3 Ellen 55 Married 
Separated by 
interview 3 
Full-time Removal of all remaining breast 







participant as high 
risk 
3 
4 Rose 51 Married Full-time 
Own business 
Mastectomy; Axillary sampling -
node positive; Chemotherapy; 
Herceptin 
8 years ago cyst in 
right breast 
3 
5 Louise 57 Divorced Full-time G3 ductal cancer; Lumpectomy; 




6 Fiona 68 Married Retired Lumpectomy; Axillary sampling -






7 Laura 41 Married Full-time Lumpectomy; Axillary sampling -




8 Susan 58 Widow Full-time Mastectomy; Axillary sampling -
2/6 node positive; 
Chemotherapy; Radiotherapy; 
Tamoxifen 
2003 blocked milk 
ducts 
2005 infections in 
breast 
3 
9 Amanda 46 Married Full-time Lumpectomy followed by 
mastectomy; Axillary sampling -
node positive; Chemotherapy; 
Radiotherapy; Tamoxifen; 
Ovaries ablated 
Previous lump in 
breast 20 years ago 
- identified as fatty 
deposit 
3 
10 Janet 49 Long-term partner 
Previous divorce 
Full-time Lumpectomy; Axillary sampling -
node negative; Chemotherapy; 
Radiotherapy 




11 Elizabeth 57 Divorced Full-time G2 lobular cancer; Lumpectomy; 
Axillary sampling of 4 nodes -
node negative; Radiotherapy; 
Tamoxifen 
2 
12 Gillian 43 Married Full-time Lumpectomy followed by 
mastectomy; Axillary sampling of 
9 nodes - node negative; 
Tamoxifen 
3 
13 Pauline 67 Married Retired G2 - lobular and ductal cancer; 
Mastectomy; Axillary sampling of 
5 nodes - node negative; 
Tamoxifen 
3 
14 Lily 67 Widow Retired G1 cancer; Mastectomy; Axillary 2 
sampling - 3/8 node positive; 
Tamoxifen 
15 Maria 58 Married Housewife Mastectomy; Axillary sampling -
5/12 node positive; 
Chemotherapy; Radiotherapy; 
Herceptin 
Removal of cysts in 
breast tissue 6 
years prior to breast 
cancer diagnosis 
3 
16 Joan 48 Married Full-time Ductal cancer; Lumpectomy; 
Axillary sampling - 20/26 node 
positive; Axillary clearance; 
Chemotherapy; Radiotherapy 
3 
17 Sarah 49 Widow Full-time Two G2 tumours; Bilateral 
mastectomy; Axillary sampling -
4/11 node positive; 
Chemotherapy; Radiotherapy 
Diagnosis of breast 
cancer 11 years 







18 Emma 49 Divorced Full-time Mastectomy; Axillary sampling -




19 Jenny 54 Widowed 
Previous divorce 
Full-time Mastectomy; Axillary sampling -
node negative; Tamoxifen 
3 
20 Mary 45 Married Full-time Lumpectomy followed by 
mastectomy; Axillary sampling -





8th July 2005 
PATIENT INFORMATION SHEET 
Study Title 
An exploration of women's experiences of breast cancer throughout the 
healthcare trajectory. 
You are being invited to take part in a research project. Here is some 
information to help you decide whether or not to take part. Please take time to 
read the following information carefully and discuss it with friends, relatives and 
your GP if you wish. Please ask the researcher (Katherine Swainston) if there 
is anything you do not understand or if you would like more information. Take 
time to decide whether or not you wish to take part. Thank you for reading this. 
Background 
Identity and a sense of embodiment become significant when at a time of illness 
the body becomes the focus of attention. So far no research has asked women 
with breast cancer to discuss their experiences of identity and embodiment 
issues throughout the health care period. These issues may influence a 
woman's perception of control over her illness and her treatment and in turn 
impact upon decision-making and treatment preferences. 
What is the purpose of the study? 
This study wants to find out about the experiences of identity and embodiment 
issues from the perspective of women with breast cancer. In particular the 
research aims to look at the implications of this for perceived control and 
decision-making. 
Why have I been chosen? 
You have been chosen because you have breast cancer. Twenty women 
attending this clinic will be asked to be part of the study. 
Do I have to take part? 
It is up to you to decide whether to take part or not. If you do decide to take part 
you will be given this information sheet to keep and be asked to sign a consent 
form. Even if you do decide to take part, you are free to withdraw at any time 
and without giving a reason. This will not affect the standard of care you will 
receive. Your doctor will not be upset if you decide not to take part. 
What will happen to me if I take part? 
I would like to interview you to discuss your experience of having breast cancer 
approximately every six weeks for up to 12 months. As part of the interview I 
would like you to help me to complete an illness/treatment grid to chart these 
experiences including the decisions that you come to about your treatment. 
Each interview will be audio tape-recorded and will take from 30 minutes up to 
one hour, though can finish whenever you wish. 
I would also like you to write down your experiences in between each interview 
in a diary provided by the researcher. This will be as and when you want and 
some months you may not want to write anything. This research does not 
require you to restrict what you eat or do. 
What are the possible disadvantages and risks of taking part? 
There are no disadvantages in taking part and there are no risks involved. 
What are the possible benefits of taking part? 
It is hoped that the study will help health care professionals gain a better 
understanding of identity and breast cancer and the implications of these for 
perceived control and decision-making. This may help improve communications 
with women with breast cancer and could be used to improve patient 
information leaflets. 
What if new information becomes available? 
You will be told if important new information about this study becomes available 
which might affect your willingness to continue taking part. If at any time the 
researcher considers it in your best interest they will withdraw you from the 
study. They will explain the reasons and arrange for your care to continue. 
What happens when the research study stops? 
You will continue just the same as you did before and during the study. 
What if something goes wrong? 
It is very unlikely that you will be harmed by taking part in this study. 
Thinking about your breast cancer may cause you to become upset. The 
researcher Katherine Swainston is aware that this may be difficult for you and 
you can stop at any time if you do not want to continue. A counsellor is available 
if you do become upset and want to talk to someone about this. 
You also need to know that there are no special compensation arrangements. 
If you are harmed due to someone's negligence, then you may have grounds 
for a legal action. Regardless of this, if you have any cause to complain about 
any aspect of the way you have been approached or treated during the course 
of this study, the normal National Health Service complaints mechanisms are 
available to you. 
Will my taking part in this study be kept confidential? 
All information collected about you during the course of the research will be kept 
strictly confidential. Any information about you which leaves the hospital will 
have your name and address removed so that you cannot be recognised from 
it. Any published report of the research will not identify you. Your GP will 
normally be informed that you are taking part. If this is a problem for you, you 
should discuss it with the study researcher Katherine Swainston. 
What will happen to the results of the study? 
I hope to share the results of this study with other doctors and health care 
professionals by presenting the findings at meetings and by publishing research 
papers that describe the study and what I found. I will also provide you with a 
summary of the results. 
Who is organising and funding the research? 
The research is being conducted by Katherine Swainston, a researcher at the 
University of Teesside. Your doctor will not be paid for including you in this 
study. 
Who has approved the study? 
The University of Teesside ethics committee, the Research Approval Board at 
the NHS Trust and the Local Research Ethics Committee have approved this 
study. 
Contact for Further Information 
Katherine Swainston 01642 738013 
07774091950 
Thank you for reading this information sheet. You can let me know that you are 
willing to take part in the study by signing the consent form that is attached and 
returning it to the researcher in the envelope provided. If you do decide to take 





Title: An exploration of women's experiences of breast cancer throughout the 
healthcare trajectory. 
Researcher: Katherine Swainston 
Please initial box 
1. I confirm that I have read and understood the information 
sheet dated 8th July 2005 (version 2) for the above study and 
have had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason, without my 
medical care or legal right being affected. 
3. I understand that sections of any of my medical notes may be 
looked at by responsible individuals from the hospital and The 
University of Teesside or from regulatory authorities where it is 
relevant to my taking part in research. I give permission for these 
individuals to have access to my records. 
4. I give permission for the researcher to audio tape-record all 
interviews that I give. 
5. I agree to take part in the above study. 
Name of Participant Date Signature 
Participant contact details 
Researcher Date Signature 





Title: An exploration of women's experiences of breast cancer throughout the 
healthcare trajectory. 
Researcher: Katherine Swainston 
The research in which you have participated aimed to explore experiences of 
breast cancer, embodiment and identity in relation to women's perceptions of 
control and decision-making throughout their treatment course. 
I would like to emphasise that all information provided by yourself will be treated 
with strict confidentiality and under no circumstances will your name or any 
identifying characteristics be included in any subsequent reports or publications. 
If you have any further questions about this study I would be more than happy 
to assist and can be contacted via e-mail on K.Swainston@tees.ac.uk or by 
telephone on 01642 738013 (University) or 07774091950 (mobile). 
The organisations listed below offer a confidential service and provide advice 
and support for women with breast cancer. 
• The Breast Cancer Support Group (Middlesbrough) can be contacted on 
01642 285418/ 01642 535935. This group meets regularly at the James 
Cook University Hospital, Middlesbrough. 
• The Breast Cancer Care Helpline is available Monday - Friday 9am-5pm 
and Saturday 9am-2pm: 0808 800 6000 
• Cancer BACUP: Freephone 0808 800 1234 
Thank you for your participation 
APPENDIX 10 
SEMI-STRUCTURED INTERVIEW SCHEDULE 
Initial Interview 
The initial interview will revolve around questions such as those detailed 
below. 
• What has been explained to you about your breast cancer? 
• How did you feel about being diagnosed? 
• What impact did this have on you? 
• What impact did this have on your family and friends? 
• What do you expect to happen now? 
Subsequent Interviews 
To be guided by individual women's experiences and issues that emerge 
throughout the data collection process. 
• What has been your experience of having breast cancer over the last six 
months? 
• What does it mean to you at this moment in time to be a woman with 
breast cancer? 
• How would you describe yourself as a person at this moment in time? 
• What decisions have been made within the last six months? 
• How did you come to that decision? 
• How would you describe the treatment decision-making process? 
• How do you think this experience will affect you over the next six 
months/the rest of your life? 
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Life charts mapping disease and treatment trajectory of breast cancer 
K. Swainston, C. Campbell, A. van Wersch; University of Teesside, Middlesbrough, 
United Kingdom 
Disease and treatment trajectory tend to differ between patients. Is this because people 
vary in their biopsychosocial responses to a condition? Or are different treatment 
decisions made on the basis of certain unknown factors? This study aims to examine 
this process of variation in more detail with respect to breast cancer. Kane (1983) 
recommended the use of longitudinal studies in order to understand how social 
circumstances and health care interventions could effect psychological outcome 
variables over time. Previous longitudinal studies in breast cancer have mainly studied 
distress (Manne et al., 2005; Wade et al., 2005) or quality of life (e.g. Hurria et al., 
2006; Segrin, 2005). This research will unravel the individual process of control and 
decision making in the trajectory of health care in relation to patients' perceptions of 
their illness, their embodiment and their identity. Twenty patients from a breast clinic of 
a hospital in the North East of England were interviewed at a regular three-months 
interval during the course of one year. In collaboration with the patients, 
illness/treatment grids were completed, which resulted in the charting of the treatment 
and decision-making processes. Three case studies will be presented, discussing and 
visually representing (via adapted life charts) the experiences of patients and 
highlighting the issues which have emerged during data analysis. 
Keywords: Breast cancer, life charts, trajectory 
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w w w . w i l e y o n l i n e l i b r a r y . c o m 
Treatment decision making in breast cancer: A 
longitudinal exploration of women's experiences 
1* 2 1 
Katherine Swainston , Carol Campbell , Anna van Wersch 
3 
and Patricia Durning 
1 
School of Social Sciences & Law, University of Teesside, Middlesbrough, UK 
College of Arts & Sciences, Zayed University, Abu Dhabi, United Arab 
Emirates The James Cook University Hospital, Middlesbrough, UK 
Objectives. To explore the lived experience of breast cancer in 
relation to the treatment decision-making process over time. 
Design. Adopting a hermeneutic phenomenological approach, 
semi-structured inter-views were undertaken at three points in time 
during the year following diagnosis. 
Methods. After ethical approval had been obtained, 20 women 
who were recently diagnosed with breast cancer were recruited 
from a Symptomatic Breast Cancer Unit in the North East of 
England. 
Results. Four themes emerged: role in the treatment decision-
making process; acceptance of medical opinions; getting rid of it; 
and cancer schemas. The majority of women reported a passive 
role in the surgical treatment decision-making process and all 
women did so in relation to subsequent treatment decisions. 
However, women adopted this role consciously and consequently 
were not disengaged from the process but maintained a sense of 
ownership and control over their health. The women did not 
describe experiencing decisional regret at any point in the year 
following diagnosis and rarely revisited the decisions made, only 
doing so in a positive manner. Trust in the abilities and experience 
of healthcare professionals and maximizing chances of survival 
were cited as reasons for not having had greater involvement. 
Despite being given information about treatment options, many 
women made the decision not to attend to this information 
perceiving this to be anxiety provoking. 
Conclusions. The findings from this study suggest a need for 
eliciting more specific psycho-social interactions in the treatment 
decision-making process in order to identify ways in which women 
can be supported throughout their experience. 
* Correspondence should be addressed to Katherine Swainston, School of Social Sciences & 




156 Katherine Swainston et al. 
Research concerning the involvement of women with breast cancer in 
treatment decisions gained popularity in the 1980s. The high proportion of 
mastectomies being undertaken led to concerns about surgical over-treatment 
and a lack of patient involvement in treatment decisions. Randomized 
controlled trials conducted at the time indicated that less invasive treatment 
options such as lumpectomy with radiotherapy yielded comparable outcomes 
to radical mastectomy (e.g., Fisher et al., 2002). Consequently, full disclosure of 
surgical treatment options for breast cancer became widely advocated. 
However, such clinical and public health policies were developed despite a lack 
of rigorous empirical data about the decision-making process (Katz & Hawley, 
2007). 
Recent research suggests that the treatment decision-making process is 
complex and one which many women with breast cancer find difficult (e.g., 
Polacek, Ramos, & Ferrer, 2007). Decisions are typically made in a short period 
of time, often during the first meeting with the general surgeon, in order that 
surgical treatment can be undertaken as soon as possible. Other treatment 
decisions, for example, regarding chemotherapy, radiotherapy, and adjuvant 
drug treatments are also made within the first few weeks after diagnosis. 
There is currently a substantial body of quantitative research on breast 
cancer treatment decision making. This encompasses genetic testing (e.g., 
Jacobsen, Valdimars-dottier, Brown, & Offit, 1997) and breast cancer screening 
(e.g., Rakowski et al., 1992), the influence of the surgeon's characteristics in the 
decision-making process (e.g., Hawley et al., 2007) and the development and 
evaluation of decisional aids in facilitating this process (e.g., Hack et al., 2003; 
Whelan et al., 2004). Patient involvement in breast cancer treatment decision 
making, particularly regarding surgical treatments options, also dominates this 
field. One study by Vogel, Helmes, and Hasenburg (2008) reported that 40% of 
patients preferred to delegate treatment decision making to the clinician, while 
29% wanted collaboration. Surprisingly, only 31% wanted to select their own 
treatment. Such results suggest that while some patients prefer a dominant role 
in surgical treatment decision making, others may prefer the surgeon to be 
more active in this process. However, having autonomy within the context of a 
traditionally authoritarian model of healthcare may be difficult for women who 
are not accustomed or prepared for this process (Thomas-MacLean, 2004). 
One prospective cohort study (Temple et al., 2006) aimed to describe the 
proportion of women anticipating having breast-conserving surgery (BCS) 
versus modified radical mastectomy (MRM). Furthermore, this research aimed 
to explore factors involved in making these treatment decisions and the degree 
of control felt in relation to treatment decisions. Of 157 participants, 28.7% 
anticipated having (MRM) compared to 71.3% who anticipated having BCS. 
Women cited doctors' advice and possibility of complete cure as the 
predominant factors in aiding the decision-making process with the majority of 
women (60%) reporting that they had participated in treatment decisions to the 
extent they desired. Multiple regression analysis found that the type of planned 
surgery was predicted by surgeon, concerns about cancer recurrence, 
contribution of the doctor, self-efficacy, and the importance of breasts to 
sexuality. However, only 13.6% of women in this study felt that they had 
received their preferred amount of information with which to make these 
treatment decisions. Similarly, a large-scale study of women diagnosed with 
breast cancer also found that the majority of women surveyed had little 
knowledge about the recurrence and survival associated with the different 
surgical options available to them (Fagerlin et al., 2006). 
Reaching informed decisions about breast cancer surgical treatments can be 
difficult for many women though Fallowfield, Hall, Maguire, Baum, and 
A'Hern (1994) found no evidence that giving women the choice of mastectomy 
or lumpectomy in itself prevented psychiatric morbidity. However, 'consulting 
style, in particular offering satisfactory information about treatment options 
was crucial to long-term adjustment' (p. 203). Likewise, an association between 
satisfaction in surgical choice and achieving the preferred amount of 
involvement in the decision-making process irrespective of treatment received 
suggests that the decision-making process may be as important as the decisions 
themselves (Sabo, St-Jaques, & Rayson, 2007). Research findings further 
indicated that women actively involved in surgical treatment decision-making 
report significantly higher quality of life than women who indicated passive 
involvement and that as women progressed along their breast cancer trajectory 
they tended towards a stronger preference for active and collaborative 
involvement in their medical care (Hack, Degner, Watson, & Sinha, 2006). 
Such quantitative research provides a valuable insight into the level of 
women's involvement in treatment decision making and to an extent the 
factors influencing these decisions. However, an in-depth understanding of 
women's experiences of the decision-making process is essential in order to 
improve the support provided by healthcare professionals afforded to women 
who receive a diagnosis of breast cancer. To date, few studies have addressed 
women's experiences of breast cancer decision making from a qualitative 
perspective and those that have done so highlight the need for extensive 
further research. One such study (Halkett, Arbon, Scutter, & Borg, 2007) 
reported that women described being required to make many decisions 
following diagnosis each of which elicited an emotional challenge and that 
women felt a need to prepare for the decisions to be made. Furthermore, the 
authors stated that women may feel a loss of control over their situation and 
may struggle to regain that sense of control. Participants in the Halkett study 
reflected on the importance of family and friends in the decision-making 
experience, and often felt that treatment decisions should be shared with 
others. Furthermore, there was a feeling that the decisions, once made, had an 
ongoing effect on their lives. 
Similarly, in the qualitative exploration by Thomas-MacLean (2004) several 
women described experiencing difficulties when making choices about surgery 
and adjuvant treatments. The study further reported that these decisions were 
questioned long after all treatments had been completed. Seale (2005) who 
performed a quantitative and qualitative comparative content analysis of 
portrayals of treatment decision making on the most popular UK breast cancer 
website identified several accounts describing handing over decision-making 
control willingly. The difficulty and stress experienced in the decision-making 
process and consideration of family obligations were also identified via data 
analysis. 
The paucity of research exploring women's experiences of breast cancer 
decision making, and particularly those treatment decisions that extend beyond 
initial surgery is to be addressed by this paper. The study objective was 
therefore to explore the lived experience of breast cancer in relation to the 




A qualitative hermeneutic phenomenological approach utilizing semi-structured 
inter-views was employed in order to elicit meaning of the lived experience of 
breast cancer and thus enable exploration of issues around treatment decision 
making. Phenomenology's 'goal is to describe human experience as it is lived' 
(Merleau-Ponty, in Beck, 1994, p. 500) and thus provides a theoretical 
orientation through which an increased understanding of the meaning of breast 
cancer can be attained. Specifically, hermeneutic phenomenology is viewed as 
both descriptive and interpretive describing individuals' accounts of their lived 
experience as well as interpreting the meaning that individuals attribute to these 
experiences (van Manen, 1990). Based on the metaphor of the hermeneutic 
circle (Heidegger, 1996), this approach suggests that experiences can be 
considered as a whole and in parts, and that everything is interrelated. 
Sixteen participants were interviewed three times in the 12 months 
subsequent to their breast cancer diagnosis and a further four women were 
interviewed twice within a 7-month time period. Data saturation occurred 
during interview 2 for three of these women and one participant was non-
contactable by the time of the third interview. 
Initial interviews were conducted within 1—5 months following diagnosis 
with the mean time between diagnosis and interview 1 being 2 months (an 
average of 1 month post operative). The range time between diagnosis and 
interview 2 was 4—10 months with a mean time since diagnosis of 6.5 months. 
Interview 3 was undertaken within 10—17 months with an average of 13 
months elapsing since the point of diagnosis. The spacing of individual 
women's interviews was dependent upon the availability of both participants 
and the interviewer. Interviews lasted between 35 and 90 min and were 
conducted in participants' homes by the first author. 
Participants 
Recruitment took place at a symptomatic breast cancer unit in the North East 
of England. All women attending the unit between April and December in 
2006 who were diagnosed with breast cancer, were aged 18—75 years and were 
able to give informed consent were approached by the breast care nurses to 
participate where possible. 
Twenty women who met the inclusion criteria and were willing to 
participate returned a signed consent form including their contact details to the 
first researcher within the recruitment timeframe. Given the busy nature of the 
clinic, it was not possible for the breast care nurses to monitor exact response 
rates. However, the clinic receives over 3,000 new referrals each year, of which 
approximately 200 women are diagnosed with breast cancer. The number of 
women diagnosed is highly variable week to week typically ranging from 2—5 
women per week. During the first half of the recruitment phase of this study, 
the average number of women being diagnosed was noted as being fewer than 
average. Recruitment was also postponed whenever staffing levels in breast 
clinic were low since no time was available for the breast care nurses to assist 
with the project. Of those women who did agree to participate in this research, 
one woman was experiencing a cancer recurrence and for another the breast 
cancer diagnosis was given 10 years after a high-risk genetic assessment and 
bilateral prophylactic mastectomy. At the time of the first interview, all women 
had undergone surgery (either lumpectomy [N = 7], mastectomy [N = 12] or 
removal of remaining breast tissue [N = 1]) and were receiving additional 
treatment(s) such as chemotherapy, radiotherapy, pharmacotherapy, or 
combinations of these treatments. Two women initially underwent a 
lumpectomy and returned shortly thereafter for a mastectomy. No women in 
this sample underwent immediate breast reconstruction. During the study, 
timeframe-one women completed breast reconstructive surgery (9 months post 
diagnosis) and a further three women described themselves as actively pursuing 
this course of action during the third interview. 
The age range was from 41 to 67 years of age (mean age of 54 years). 
Thirteen participants were married at the time of the first interview, four 
women were recently divorced, and three were widowed. Nineteen participants 
had children of which eight participants had children living with them at home. 
Fifteen participants were working full-time at the time of diagnosis, a further 
four participants were retired and one participant described herself as a 
housewife. 
Materials 
The study materials comprised a study information sheet, a consent form, a 
debrief sheet, and a stamped addressed envelope. A semi-structured interview 
schedule and an illness/treatment grid were also constructed. Initial interviews 
began by asking women 'Can you describe how you came to be at the breast 
clinic?' Women were prompted to report their stories of breast cancer from the 
point of identification to the present day including any previous history of 
breast disease. Subsequent questions focused around participants' experiences 
and perceptions of diagnosis and treatment decision making and the impact of 
these processes on their lives. Interviews 2 and 3 began with a review of the 
previous interview discussions, enabling the first researcher to check the 
accuracy of the data and thus confirm the emergence of themes. Participants 
were asked to express their experience of breast cancer over the previous few 
months and were asked questions such as 'How would you describe yourself at 
this moment in time?' Questions focused around the emerging themes for each 
individual and in particular issues relating to decision making and perceived 
control with the use of questions including 'How would you describe the 
control you feel in relation to breast cancer'. During the course of each 
interview, an illness/treatment grid was completed by the researcher in 
conjunction with the participant summarizing the key experiences and 
perceptions revealed. Additional key issues were entered into the grid at the 
time of transcription under the headings: events, decision making, control, self, 
and comments. Participants were given a copy of their grid to review at the 
start of each interview and this was used as an aide memoire by both parties 
throughout the interview. This served to engender a sense of control by 
participants over the interview process and provided a visual representation of 
women's progress throughout the healthcare trajectory. 
Procedure 
Following University research ethics approval, local hospital research approval 
as well as approval from the local branch of the National Research Ethics 
Service, the first researcher supplied study information sheets and consent 
forms with stamped addressed envelopes to the symptomatic breast cancer 
unit. Upon receipt of signed consent forms, the first researcher contacted 
participants to arrange a suitable time for interview. Written consent was 
obtained prior to commencement of each interview, all of which were 
conducted in participants' homes at their request. All interviews were tape 
recorded and transcribed verbatim. Participants were given a debrief sheet 
including details of local breast cancer support groups and a variety of support 
services available. 
Data analysis 
Data were analysed in accordance with van Manen's (1990) approach to 
analysis in order to identify the meaning of women's lived experiences of 
treatment decision making following a diagnosis of breast cancer. Engaging in a 
'free act of seeing', the method aims not to apply coding as in other methods of 
qualitative data analysis but to elicit meaning hermeneutically (Langdridge, 
2007). Obtaining a balance between the whole, the general meaning, and the 
parts, what is specific to the individual began with the sententious approach. 
This involved reading and re-reading individual transcripts and identifying 
sentences or phrases that were deemed to be representative of the experience 
as a whole. The highlighting approach subsequently identified emerging themes 
and helped to foster an understanding of a number of elements of the 
phenomenon. This process was applied to the data in four stages: analysis of all 
first interviews (N = 20); analysis of all second interviews (N = 20); analysis of 
all third interviews (N = 16); and finally an overall analysis of the interviews (N 
= 56). Each woman was assigned a pseudonym. 
Findings 
Four themes emerged from the data: role in the treatment decision-making 
process; acceptance of medical opinions; 'Getting rid of it'; and cancer 
schemas. Each theme was found to be interrelated with the other themes and 
represented women's longitudinal experiences of the treatment decision-
making process. 
Theme 1: Role in the treatment decision-making process 
When asked to reflect upon the treatment decision-making process, during the 
first interview, women who had a history of previous breast disease and/or, 
like Jenny, a family history of breast cancer, considered themselves to have had 
an active role in surgical decision making. 
'The doctor said "well we'll do a lumpectomy" and it was my decision to 
say no and she (doctor) came out of theatre and said "right what are we 
doing?" and I said "take it of f" (Jenny). 
Sarah, who was experiencing a recurrence, described having made the decision 
to have a mastectomy prior to being given the diagnosis for the second time. 
'There was no sense of shock, it was almost as if I sensed that this would 
happen, looking at my family history at some stage I knew I would have a 
re-occurrence. When you've gone through a process for eleven years you 
actually see an end and the only way I can describe it is it's almost like 
running a marathon, you hand the baton over and somebody gives you it 
back and says go and run it again but not the same journey, we'll give you 
a different route. So, it's almost as if I don't want to do it again eleven 
years on. I've spent a lot of time reflecting on my life and what I would do 
so the decision was made prior to me going'. 
Furthermore, for Sarah perceiving an active role engendered a sense of control 
over her experience. 
'Being in control, driving decisions has made it a lot easier for me this 
time around'. 
The remaining participants in the sample revealed having had a passive role in 
surgical treatment decision making. During the first interview Elizabeth 
recalled: 
'I think it was the doctor that made the decision (to have a mastectomy) 
because when I had the biopsy I had to wait for the results to come back 
so I think they made the decision to have that'. 
Similarly, Fiona commented: 
'Well the doctor said it'll be a lumpectomy, it won't need to be a 
mastectomy because it's only small. They said what we do is we take the 
lump away and some of the lymph glands under your arm and they said 
you might have to come back if we find something in the lymph glands, 
come back for more treatment. I said whatever you think needs to be done 
do it' (Fiona). 
None of the 20 women interviewed reported an active role in decision making 
with regards to other treatments (chemotherapy, radiotherapy, and adjuvant 
drug treatments). Participants often cited the multidisciplinary team as making 
all non-surgical treatment decisions. This is illustrated in the following two 
comments: 
'I think they have a multi-disciplinary team and I think they discussed the 
radiotherapy in the team meeting and they obviously considered that to be 
the best plan' (Susan). 
'The breast nurse told me the results and told me what the team had 
suggested and because it hadn't spread they said I didn't need chemo' 
(Janet). 
Having a passive role in the treatment decision-making process was described 
by women as a positive aspect of their experience. The shock of diagnosis and 
the need to make decisions quickly in order to receive timely treatment were 
cited by women as reasons for not engaging further. 
'I just said to her "I'll do whatever you think" because I was just that 
shocked I didn't know what to say. I just said to her "whatever you think 
is best just do because you know what you're doing"' (Emma). 
The level of involvement in the surgical treatment decision-making process 
therefore differed among participants given their medical history. Nevertheless, 
decisions regarding additional treatments were led by the various medical 
professionals involved in women's care. Taking a passive role in this capacity 
was accepted willingly and was not automatically perceived by women to be 
associated with a loss of control. Feeling able to ask questions and being 
ultimately responsible for acting upon the decisions made (e.g., attending 
appointments and adhering to treatment regimes) fostered a feeling of having 
ownership over the treatment decision-making process. 
'I did feel that if I wanted to question or argue I could have. I chose not 
to because I felt that decisions were made by a team of professionals, not 
just one person . . . but it was my decision to go through with the surgery 
and I decide whether to take the Tamoxifen each day' (Pauline). 
Positivity regarding treatment decision making was maintained throughout the 
year following diagnosis with women continuing to state that all treatment 
decisions, including surgical decisions, had been appropriate. During interview 
3, 1 year following diagnosis, Linda commented: 
'If I had to do it again I would have done exactly the same. I cannot fault 
the doctor at all, in fact I think he's magic and if it was to come again I 
would want to go with him'. 
Many women were so comfortable with the choices made that they did not feel 
the need to revisit the decision-making process during subsequent interviews. 
Women continued to rationalize their role in the treatment decision-making 
process and the choices made in relation to their acceptance of and trust in 
medical opinions. 
Theme 2: Acceptance of medical opinions 
Regardless of the role in treatment decision making or previous medical history 
accep-tance of and trust in medical opinions was unwavering for all participants 
throughout the healthcare trajectory. This is reflected in the following 
quotation: 
'They had my best interests at heart and I had to put my trust in the team 
to do their best, I trusted them to do the best possible job they could do' 
(Gillian). 
Likewise, in interview 1 Laura commented: 
'You've got to put yourself in their hands. They are the professionals who 
know what's best for you and that's the route you've got to take'. 
This trust in the abilities of the breast care team was described by women as 
enabling them to take a passive role in treatment decision making and avoid 
additional anxiety. Furthermore, women perceived the active role of the 
medical team as facilitating a smooth progression through the initial post-
diagnosis period. 
'It (treatment decision-making) was taken out of my hands but because of 
that it has all really flowed, everything's gone according to plan and 
according to timescales' (Amanda). 
For two participants initial medical opinions that a lumpectomy would be 
sufficient were revised following surgery and thus a mastectomy was 
subsequently required. However, rather than losing trust and confidence in the 
medical team, Amanda refers to the expertise of her surgeon. 
'I was devastated because I was just getting used to the smiley scar 
underneath my boob which was very, very neat and I must admit she's 
fantastic at the job she does. Just shock and disbelief but I felt lucky to be 
truthful with you. I do feel lucky because if I hadn't gone and had the 
lumpectomy and if she hadn't taken the extra bit then who knows'? 
Trust in the knowledge, expertise, and abilities of medical staff was reflected 
upon by all women in this study throughout the year following diagnosis. Once 
treatment had been completed, this took on the role of acceptance of opinions 
relating to wellness and trust that the breast care nurses would identify a 
recurrence. 
'They checked both, even this one you know and even though I'm 
checking I'm pleased they're checking because I might miss it. A full 
examination and it makes me feel at ease because if there's anything they'll 
pick it up, quicker than me. I can't feel anything but they might' (Kath). 
Theme 3. ' Getting rid of it 
During the first interviews, women spoke at length about the treatment 
decision-making process and in subsequent interviews reflected on the 
decisions they both did and did not make. Having the diseased tissue removed 
was, however, described by all participants as their main concern. 
'My priority was to remove the problem, the cancer' (Sarah). 
For several participants, their initial reaction to the diagnosis involved a desire 
to have the cancerous breast removed. The underlying reason for this was a 
belief that a mastectomy would increase their chances of survival. This is 
encapsulated by the following quotation: 
'I said if you think you're gonna have to take the breast off then just do it. 
I said just get rid of it all and then I'll be alright' (Fiona). 
For one participant, this strive for survival was grounded in past experiences of 
cancer resulting in death. 
'All I've known is people dying from cancer and so I said take it off, as it 
turns out they said I could have had a lumpectomy but I couldn't take the 
chance' (Jenny). 
Removing the breast was also seen as a means of returning to 'normality' 
quicker as some women associated a lumpectomy with requiring further 
treatments such as chemotherapy. 
'I've no chemotherapy, no radiotherapy, nothing because they've taken 
everything away' (Linda). 
One participant described her initial reaction as wanting both breasts to be 
removed though had been advised against this by the Consultant. While her 
primary motive was also one of survival, she was one of the youngest women 
in this sample and her prime motivation was to see her children grow up. 
Subsequently, when reflecting on the treatment decision-making process the 
participant acknowledged that a mastectomy would have been a drastic move. 
'Initially, my reaction was just to get it taken off altogether, well both 
actually and I really wanted that . . . I really did. I've had my kids and I'm 
living my life and I just wanted to get rid of them both. I don't think it 
was a mental thing I was going through I just thought that was the best 
thing and then it'll never come back but the Consultant said that was far 
too drastic, it wasn't to that degree. She told me for a reason that I only 
needed a lumpectomy 
. . . so you do what they say don't you, you do what they think is right' 
(Laura). 
Acceptance of and trust in medical opinions was therefore crucial in 
influencing the final surgical decision made. Deciding to take a passive role was 
however done so consciously and stemmed from the desire to have assurance 
that cancer has been eradicated and normality could return. Despite facing 
months of treatment, Rose also perceived 'getting rid of it' as facilitating this 
return to normal. 
'I feel as though that's it, it's gone now, it's a case of just getting on with 
my life, getting sorted, so I can't wait for the chemo to end and then I can 
get back to normal'. 
Once surgical intervention had been undertaken and the problem had been 
'removed' women reported no longer having breast cancer. 
'I believe at this moment in time I haven't got breast cancer in me. I think 
they got all of it out with the surgery and the treatments that have 
followed are just to make sure it doesn't come back' (Susan). 
This suggests that once women no longer believed they had cancer deciding on 
subsequent treatments was not perceived in the same way as for surgical 
decision making. This is perhaps reflected in the greater passivity adopted 
following surgery. Women's beliefs about cancer and the impact of these on 
treatment decision making are discussed further in the following theme. 
Theme 4: Cancer schema 
All women were found to hold a set of beliefs about what constitutes having 
breast cancer (or not), in other words, their cancer schema. Such schemas were 
modified throughout women's experiences of treatment decision making with 
the acquisition of new knowledge. All participants described being given 
information about breast cancer and treatment options at the time of diagnosis. 
In particular, they described receiving in-depth explanations by the medical 
team about surgical options as well as receiving an information pack, which 
they could take home. However, women's ability to process this information 
and to utilize this as part of the treatment decision-making process was found 
to be limited by their cancer schemas. 
'I think it was watching him that made me realise what she'd said because 
I heard the word and I can honestly say I don't think I heard another 
word after that' (Laura). 
Many women associated cancer with death and as a result found the 
information provided anxiety provoking. 
'They gave me some books about breast cancer and I started to read them 
that day but then I think there's only so much you can face and so I put it 
to one side' (Mary). 
Similarly, Jenny commented: 
'I've read through it but I don't like reading it because it just reminds you 
of what you've been through and what you've had. I think I've read 
through it once and then my son has had a look at it . . . I did read in there 
that you can get it in the other breast and I think that's put me off reading 
any more'. 
Setting aside the written information received was common among this sample 
particularly until after surgical intervention had been completed and all 
treatment decisions had been made. Several women reported giving their 
information pack to a relative to be reviewed if a specific question arose, 
typically regarding treatment side effects. 
'My mam has the breast pack of mine and I say to her will you have a look 
to see if there's anything in there about your mouth ulcers whereas if I had 
the book in front of me I'd be thinking well I didn't have that but I've got 
it now. If you read it you get into your head that you've got it' (Emma). 
Television programmes and books depicting others' experiences of cancer were 
also actively avoided by many participants during the first few months post 
diagnosis and for some this avoidance persisted throughout the data-collection 
period. That said, once the treatment decision-making process had been 
completed over half of the participants in this sample made the conscious 
decision to seek information using the Internet. This was particularly evident 
for women undergoing a long period of treatment as well as for women 
deciding whether to proceed with reconstructive surgery. 
'I'm terrible, I need to know down to every little thing. At the minute I'm 
researching all about reconstruction, all the different types of things you 
can have, what they do. So when I go I'll just say I don't need to come 
back to decide because I already know' (Gillian). 
Such information seeking facilitated women, like Gillian, to gain control over 
their experience and take an active role in further treatment decisions. 
Discussion 
The findings from these four themes illustrate the similarities and diversity 
among women's experiences of breast cancer treatment decision making. 
The first key finding to be considered is that many of the participants 
preferred to adopt a passive role in surgical treatment decision making. While 
given the qualitative nature of the present study comparisons to quantitative 
research is limited, this finding does contrast that of previous research that 
reports that only 8% (Lam, Fielding, Chan, Chow, and Ho, 2003) and 13% 
(Janz et al., 2004) of women with newly diagnosed breast cancer prefer this level 
of involvement. Other studies (e.g., Degner et al., 1997; Vogel et al., 2008) have 
reported higher rates of passivity (34% and 40%, respectively) in the treatment 
decision-making process though these were not specific to surgical decisions. 
Cultural differences and differing healthcare systems as well as variation in 
study samples and methods utilized could account for such conflicting results. 
Importantly, this study has found that women's actual level of involvement, 
including those adopting a passive role, in surgical treatment decisions was in 
accordance with their individual preferences. This finding is in contrast to 
previous research suggesting that over half of women with breast cancer do not 
achieve their desired level of involvement in surgical decision making (Degner 
et al., 1997). Breast cancer patients who feel a lack of concordance between 
desired and actual levels of involvement are more likely to report decisional 
regret (Lantz et al., 2005). Thus, it is perhaps not surprising that women in this 
study did not describe experiencing this at any point in the year following 
diagnosis. Moreover, women rarely made reference to other treatment options 
throughout the data-collection period and when doing so only commented on 
the negatives of alternative surgical options. This process can be explained 
through Festinger's (1957) Theory of Cognitive-Dissonance since either 
dissonance was not experienced over time because the women were satisfied 
with the treatment option all along, or women avoided reflecting more in depth 
on the treatment decision in order to avoid the uncomfortable feeling of 
dissonance. Their lack of interest in reading the information provided and any 
other breast cancer related texts as revealed by the women at all stages of the 
longitudinal enquiry; seems to support the latter explanation of remaining 
positive in order to avoid cognitive dissonance. 
Furthermore, the accounts provided by women throughout this research 
suggest that decision-making role can vary between surgical and non-surgical 
treatment decisions. Specifically, none of the women interviewed described any 
involvement in selecting additional treatments (e.g., chemotherapy, 
radiotherapy, or drug therapies) citing the multidisciplinary team as the 
'decision-makers'. Women accepted these decisions, often due to experiencing 
shock at the diagnosis they had been given and as a result felt unable to make 
life-altering decisions. The model of emotional trade-off difficulty in decision 
making (Luce, 2005) provides some insight into such findings. Based on coping 
literature, specifically that of Lazarus and Folkman (1984), the model suggests 
that women may be influenced by their need to cope with the difficult trade-
off s (e.g., long-term survival vs. breast loss) that characterize treatment 
decision making for breast cancer. In an attempt to minimize the emotional 
impact, a desire to avoid considering such trade-off's irrespective of the 
information available, may be generated. As such having autonomy over 
decisions, particularly when positive outcomes cannot be guaranteed, may 
increase patient stress and as a result handing over control to medical 
professionals may be a positive coping strategy. Moreover, in making 
problematic trade-off's implicit, the decision maker does not directly confront 
the advantages of other options further minimizing potential stress. 
For many women participation in non-surgical decisions was not deemed to 
be an option. This finding supports those by Kreling, Figueiredo, Sheppard, 
and Mandelblatt (2006) who in a qualitative study exploring factors associated 
with chemotherapy use in older women with breast cancer found that the 
majority of women did not feel that they had a choice though that many 
preferred this style of decision making. The visible impact of surgical 
intervention on a woman's body may be one potential explanation for women 
reporting differing levels of surgical and non-surgical decision making. The 
strong desire by women in this study to 'get rid of it' via surgery may indicate 
that non-surgical interventions are viewed as less tangible, that is, their effects 
on the body and on breast cancer are less evident. 
This study has further found that women adopting a passive role (in either 
surgical and/or non-surgical decisions) were not disengaged from the decision-
making process and as previously identified by Seale (2005), this role was 
chosen consciously. However, unlike previous qualitative research (e.g., Halkett 
et al., 2007) the present study further suggests that such passivity was deemed to 
be a positive aspect of women's experience and that control was not perceived 
to be lost but rather that ownership of decisions was maintained throughout 
the process. It must not be forgotten that several women in this research did 
perceive themselves to have had an active or collaborative surgical decision-
making role. That said, these women did report discussing treatment decisions 
with their Consultant and thus a model of shared decision making (e.g., 
Charles, Gafni, and Whelan, 1999) is more applicable. Nevertheless, all women 
were subsequently passive in relation to additional treatment decisions and were 
satisfied with this course of action. 
However, the recently published Government White Paper for Health 
(Department of Health, 2010) has the principle of 'shared decision-making' at 
its core. It advocates 'involving patients fully in their own care, with decisions 
made in partnership with clinicians, rather than by clinicians alone' (p. 13). 
While research indicates that patient involvement in decision making may result 
in better long-term health outcomes (e.g., Anderson, Bowen, Morea, Stein, & 
Baker, 2009) and increased compliance with medical regimes (e.g., Cameron, 
1996) some breast cancer patients do not desire this level of involvement and 
those doing so may engender specific characteristics, for example, a family 
history or a recurrence. 
An acceptance of and trust in the medical professionals involved in their 
care was the underlying reason for women in this sample not having greater 
decisional involvement. Throughout the data-collection period, women 
continually made reference to the confidence they had in the abilities and 
experience of the surgeon, breast care nurses, and all other team members. 
Similar findings have been reported recently by Mendick, Young, Holcombe, 
and Salmon (2010) who observed consultations and explored the perspectives 
of women with breast cancer and their doctors on treatment decisions. The 
study reported that while surgeons made the majority of decisions, women did 
not feel the need to question this given their trust in the surgeon's expertise. 
Such findings complement those of previous quantitative investigations (e.g., 
Temple et al., 2006), which have found that factors such as doctor's advice and 
hopes of being cured were fundamental in the treatment decision-making 
process. 
The strive to be cancer free was another key finding of the present study and 
was one which influenced women's decision making. A small number of 
participants requested a mastectomy due to either recurrence of their own 
tumour or through previous family experiences. Underlying these decisions was 
a need to increase their chances of survival. This was particularly important for 
younger participants who had school-aged children. 
For some women, a mastectomy was viewed as a means to eradicate breast 
cancer and as a result returning to 'normality' quicker. From a longitudinal 
perspective, this study has found that from the completion of surgery women 
state that they no longer have breast cancer. This belief indirectly influenced 
additional treatment decision making as well as the management of breast 
cancer information. 
While not measured during this study, it is noteworthy that many women's 
knowledge of the benefits and disadvantages of different surgical and other 
treatment options was found to be limited. However, the research reported 
here does identify reasons for this, one being that women's existing cancer 
schemas limited the amount of information processing that was possible at the 
time of diagnosis. Secondly, for some women reading the materials provided by 
the breast unit proved to be too anxiety provoking and active avoidance of 
cancer related information was common, particularly during the early stages of 
their experience. Managing information to avoid becoming overwhelmed and 
information increasing fears were reported in a recent study by Lally (2009). It 
is also plausible that as women trusted the healthcare professionals involved in 
their care so implicitly that it was not deemed to be necessary to engage in 
further information- and explanation-seeking behaviour, particularly given the 
anxiety that occurred as a result. 
The longitudinal nature of this research has enabled in-depth exploration of 
issues relevant to women's experiences of breast cancer throughout the year 
following diagnosis. 
Limitations 
The nature of conducting qualitative research means that this work reflects the 
experiences of the individuals in the sample recruited for this study. In addition, 
qualitative data analysis requires interpretation on the part of the researcher 
though member checking was undertaken with all participants after each 
interview was analysed in order to ensure the accuracy of the findings. 
Twenty women participated in this longitudinal qualitative study, which has 
facilitated the collection of in-depth information about the meaning of 
women's experiences of treatment decision making. However, the size of this 
sample and the difficulty obtaining an accurate response rate limits the extent to 
which the results can be generalized. 
The self-selecting nature of the sample also needs to be addressed. 
Attending a symptomatic breast care unit with a suspicious breast lump is in 
itself a highly stressful and anxiety-provoking experience for any woman. To 
have attempted to recruit participants at this distressing time would have been 
unethical and an intrusion into the lives of these women. The method of 
recruitment used was deemed to be the least intrusive and depended (to a 
certain extent) on the altruism of each participant to respond to the research 
materials provided and agree to participate in the study. As such, the decision-
making experiences of other women (who did not participate) may have been 
missed, as given ethical constraints, it was not possible to collect data on those 
women who did not choose to participate. 
Future directions 
Despite the extensive body of literature about breast cancer and decision 
making, there remains many areas requiring further exploration in order to 
build upon our understandings of women's experiences of treatment decision 
making in breast cancer. The current study also suggests that research 
investigating women's responses to information and explanation particularly 
during the immediate post-diagnosis phase is essential if we are to further 
understand women's experiences of breast cancer. 
The present study also identified that a history of non-malignant breast 
disease and the loss of loved ones to cancer were influential in surgical 
treatment decision making. However, such factors have been largely neglected 
in the literature. Similarly, women's experiences of decision making for non-
surgical interventions, in particular radiotherapy, Herceptin and Tamoxifen, 
require further exploration. Finally, in-depth analysis of how women's 
experiences of treatment decision making is reflected in the avoidance of 
cognitive dissonance and how this influences coping with their illness and 
impact upon future decision making would be beneficial in order to better care 
for women given a diagnosis of breast cancer. 
Case study: Laura 
Laura identified a lump in her breast while at home however decided to wait 
several weeks before seeking medical attention via her GP. On attending the 
breast clinic, a mammogram and biopsy were performed and Laura returned to 
the clinic the following week to receive the diagnosis of breast cancer. Her 
immediate response of disbelief turned to shock upon seeing her husband's 
reaction to the news. The lack of symptoms experienced that Laura perceived 
to be associated with breast cancer as well as having a cancer schema linked to 
mortality were described as underpinning these emotional states. After initially 
requesting a bilateral mastectomy in order to maximize her chances of survival, 
for the sake of her young children, Laura decided to follow the advice of the 
medical professionals involved in her care. As such Laura underwent a 
lumpectomy followed by chemotherapy and radiotherapy and was prescribed 
Tamoxifen for 5 years. When asked about the treatment decisions made Laura 
repeatedly discussed having trust and confidence in the knowledge and 
experience of the medical staff. She stated that although decisions were made 
by the medical team and that consequently she was not in control of the 
treatments offered to her, handing over control was performed consciously and 
willingly. Furthermore, upon reflection Laura commented that her initial 
reaction regarding surgical intervention was 'too drastic' and felt that the 
emotions being experienced at the time of diagnosis contributed to this 
response. While Laura did refer to the medical information booklets provided 
at the time of diagnosis, this was typically only looked at when searching for a 
treatment side effect. Being able to contact the breast care nurses by telephone 
for advice at any time was viewed by Laura as more reassuring than any written 
information, whether medical or otherwise, available to her. 
Conclusions 
Through a longitudinal qualitative exploration, this study has found that while 
many women adopt a passive role in treatment decision making doing so was 
viewed as a positive aspect of their experience. Furthermore, women felt in 
control of the decision-making process and did not report experiencing 
decisional regret at any point throughout the year following diagnosis. 
Women's implicit trust in the healthcare professionals and an overwhelming 
desire to 'get rid' of breast cancer also influenced decision making. However, 
avoidance of medical information was common and women continued to 
manage information-seeking post diagnosis. Further psycho-social exploration 
of interactions during consultation is needed to identify how to support women 
throughout this process and beyond. 
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APPENDIX 10 
Summary of findings 
Waiting was found to be a central aspect of the experiences of those women 
interviewed for this study, which has illustrated the prevailing nature of waiting 
in the context of breast cancer from help-seeking to the diagnostic process and 
treatment commencement. Novel findings were reported in relation to treatment 
decision-making, particularly regarding non-surgical interventions, an area 
lacking qualitative exploration in the UK. The passivity reported, including via 
deferring to the expertise of the multi-disciplinary team, was not found to denote 
a loss of control but accepting medical opinions was perceived to be a means of 
maximising the chances of survival through 'getting rid of it'. Having ultimate 
control over whether to undergo treatment further enabled participants to 
maintain ownership of the decisions made. In addition, women rationalised 
surgical decisions through contemplating the meaning, and often the lack of 
importance, of their breasts, a finding which is again unique to this research. 
The shock elicited by the diagnosis of breast cancer was perceived to hinder 
some women's involvement in treatment decision-making yet by choosing 
passivity they avoided additional anxiety. Medical information was also 
perceived to be anxiety-provoking and revealing women's long-term information 
management (e.g. through avoidance) adds to the existing literature in this field. 
While denial featured in a minority of women's accounts this was short-lived and 
women typically accepted their diagnosis and prescribed treatment regime and 
began to engage coping strategies to manage ongoing treatment and the 
physical and psychological impact of their experience. Immediately post-
surgery, and regardless of the type of surgery conducted, women began to 
experience a negative impact on their body image, one which extended 
throughout the study timeframe. Breast loss did, nevertheless, elicit specific 
issues regarding body shape and symmetry as well as grief for the missing 
breast(s). External breast prostheses, delayed reconstruction, and careful 
clothing selections were strategies used to normalise appearances for the 
protection of the self and others. 
The women interviewed reported experiencing a wait for normality which for 
many women was described throughout the data collection period though was 
particularly evident during hospital-based treatments as women waited for a 
return to a life without treatment regimes, physical limitations and psychological 
disorientation. The physical limitations stemming from surgery and adjuvant 
treatments resulted in women experiencing a loss of a healthy and feminine 
identity as their roles within the home were undertaken by loved ones causing 
conflict and upset. Treatment side-effects were further perceived to denote 
signs of illness with chemotherapy associated alopecia being perceived to be 
the most indicative of being treated for cancer leading participants to disguise 
hair loss to avoid perceived stigma. This research contributes to current 
knowledge of women's longitudinal experiences of treatment side-effects 
including the under-researched areas of radiotherapy and Tamoxifen as well as 
women's perceptions of utilising alternative therapies to manage side-effects 
and improve psychological well-being. 
The present study addresses the paucity of longitudinal qualitative research 
exploring women's psychological responses to breast cancer over time. 
Diagnosis led to reflection on existential concerns with women contemplating 
mortality and 'why me?' which often preceded an episode of psychosocial 
distress including reactive depression and disorientation. This study has 
uncovered that for women undergoing additional adjuvant therapies this 
coincided with the aforementioned issues pertaining to illness identity and (for 
all women) coping with bodily changes. Nonetheless, despite the disruption to 
women's lives they adopted positive cognitive restructuring and benefit finding 
to cope throughout their experience which resulted in participants re-defining 
their priorities and reforming their relationships with others. Women 
demonstrated variability in taking responsibility for their breast health though did 
initiate more general health related behaviour change through adaptations to 
diet and physical activity. However, breast cancer remained at the back of 
women's minds with an ongoing uncertainty about their future permeating their 
thoughts, reinforced by changes to the body and ongoing treatment regimes 
(e.g. Tamoxifen). 
